Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution
3004789	fp-transf	g/l (g/l)	51587	139873	0.03%
3004789	fs-transf	g/l (g/l)	14052	27905	0.00%
3004789	fp-transf	— (—)	9439	13677	100.00%	Distribution not available
3004789	fp-transf	g/l_______ (g/l)	2068	5120	0.00%
3004789	fp-transferriini	g/l_______ (g/l)	1924	3120	0.00%
3004789	fs-transf	— (—)	543	812	100.00%	Distribution not available
3004789	-transf	— (—)	303	321	100.00%	Distribution not available
3004789	transferriini	g/l (g/l)	165	212	0.00%
3004789	fs-transferriini	g/l (g/l)	128	166	0.00%
3004789	fp-transferriini	g/l (g/l)	126	145	0.00%
3004789	-transf	g/l (g/l)	84	143	0.00%
3004789	fp-trans	g/l (g/l)	46	56	0.00%
3004789	-transferriini	g/l (g/l)	34	36	0.00%
3004789	fp-transf	G/L (g/l)	28	40	0.00%
3004789	transferriini(4567fp-transf)	g/l (g/l)	26	35	0.00%
3004789	transferriini(fp-transf)	g/l (g/l)	21	25	0.00%
3004789	fp-transferriini	— (—)	10	10	100.00%	Distribution not available
3004789	fs-transferriini	— (—)	8	8	100.00%	Distribution not available

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Follow-up examination after treatment for conditions other than malignant neoplasms

5154

19611

1.92

323.31

2.7

2.2

2.35

2.34

g/l

1.15

4833

17836

COPD (mode)

3966

16623

2.13

323.31

3.1

2.3

2.26

2.32

g/l

6.11

3655

15173

Vocal cord dysfunction

1476

4510

3.32

323.01

2.7

1.8

2.36

2.35

g/l

0.46

1347

4173

Rheumatoid arthritis

4131

20080

2.07

321.57

2.6

2.4

2.26

2.33

g/l

13.64

3855

18456

Alcoholic liver disease

1613

6288

3.48

320.02

2.7

2.8

2.09

2.27

g/l

17.90

1482

5852

Symptoms and signs concerning food and fluid intake

1642

6372

3.28

317.40

3.0

2.4

2.26

2.35

g/l

7.88

1512

5843

Chronic lower respiratory diseases

14516

55026

1.47

316.33

2.7

2.6

2.38

2.35

g/l

11.10

13501

50759

Explicit bacterial Sepsis

1677

6643

3.27

315.42

4.5

2.2

2.18

2.31

g/l

17.83

1586

6078

Other dorsopathies, not elsewhere classified

12035

43484

1.53

314.75

2.6

2.37

2.34

g/l

5.18

11180

40106

Other diseases of blood and blood-forming organs

1237

4265

4.31

314.53

3.0

2.7

2.41

2.30

g/l

9.45

1164

3941

Bacterial intestinal infections, IBD co-morbidities

2749

13501

2.49

313.99

4.4

2.5

2.18

2.30

g/l

21.91

2583

12412

Selective serotonin reuptake inhibitors

11851

42777

1.53

312.84

2.5

2.7

2.38

2.32

g/l

18.77

10776

39899

Retention of urine

4812

22611

1.97

311.70

3.0

2.6

2.18

2.26

g/l

21.10

4415

20811

Streptococcal septicaemia, including avohilmo

1497

5669

3.55

311.43

4.5

2.3

2.15

2.31

g/l

20.49

1417

5196

Other Crohn's disease

1128

3635

4.31

310.95

3.3

2.5

2.41

2.38

g/l

0.87

1085

3384

Disorders of the thyroid gland

11612

52730

1.53

310.61

2.8

2.5

2.38

2.34

g/l

10.87

10643

48774

Cystitis

10356

42069

1.57

309.51

2.8

2.5

2.34

2.36

g/l

2.72

9560

38781

Statin medication

7420

26332

1.71

309.32

3.3

2.1

2.37

g/l

0.02

6898

24355

UC patients in KELA-register ( KELA 208 prior to 1994, or ICD K51)

2430

11359

2.57

309.04

2.8

2.6

2.42

2.36

g/l

6.77

2318

10581

Nerve, nerve root and plexus disorders

13062

56020

1.49

308.04

2.9

2.5

2.36

2.33

g/l

6.85

12076

51712

Other CVD (FINNGEN)

1968

3533

5.93

307.65

3.7

1.7

2.19

2.31

g/l

11.19

1808

3176

Other arthritis (FG)

4142

21614

2.22

307.65

3.1

2.5

2.28

2.35

g/l

12.03

3886

19938

Sleep disorders (combined)

13929

48969

1.60

307.65

2.7

2.6

2.39

2.32

g/l

34.08

12801

45320

Asthma-related infections

8089

47549

1.85

307.65

2.9

2.6

2.38

2.34

g/l

8.15

7552

43780

General symptoms and signs

15257

38691

2.23

307.65

3.0

2.3

2.32

2.39

g/l

39.64

14241

35569

Hypothyroidism and >3 levothyroxin purchases

2971

3845

5.05

307.65

2.7

1.6

2.45

2.52

g/l

6.36

2719

3571

Genitourinary diseases

6449

18407

1.91

307.65

3.5

1.8

2.29

2.41

g/l

47.62

6039

16996

Explicit bacterial Sepsis, including avohilmo

1728

6791

3.31

307.65

4.5

2.2

2.17

2.32

g/l

19.74

1635

6209

Other septicaemia

7226

27004

3.32

307.65

4.9

2.3

2.13

2.33

g/l

138.09

6792

24633

Other gastritis (incl. Duodenitis)

3238

15613

2.51

307.65

3.6

2.5

2.34

2.28

g/l

6.69

3038

14402

Myocardial infarction

6819

24248

2.31

307.65

3.7

2.3

2.25

2.27

g/l

1.21

6396

22115

Condition for Implicit Sepsis (Organ dysfunction codes)

13799

44881

2.52

307.65

3.7

2.2

2.24

2.39

g/l

146.26

12916

41196

Bacterial Sepsis

9417

30093

3.44

307.65

4.4

2.2

2.15

2.33

g/l

150.66

8873

27491

Continuous positive airway pressure

2626

6550

4.17

307.65

3.7

2.1

2.34

2.28

g/l

5.54

2416

6043

Type 1 diabetes, wide definition

2893

13125

2.60

307.65

5.5

2.3

2.12

2.34

g/l

82.19

2698

12138

Liquid cancers, including Hilmo

5895

22857

2.85

307.65

2.9

2.7

2.22

2.32

g/l

30.56

5623

20844

Hyperlipidaemia, other/unspecified

5575

25812

2.29

307.65

3.7

2.3

2.28

2.29

g/l

0.49

5193

23542

Type 2 diabetes, wide definition

12400

36424

2.55

307.65

3.6

2.3

2.37

2.29

g/l

38.77

11570

33491

Certain infectious and parasitic diseases

12673

36151

1.93

307.65

3.2

2.1

2.31

2.41

g/l

72.75

11846

33127

Ulcerative colitis, NAS

2014

8513

2.96

307.65

3.1

2.6

2.39

2.35

g/l

2.66

1933

7910

Colorectal cancer, including Hilmo

4322

18209

2.78

307.65

2.4

2.7

2.39

2.29

g/l

21.09

4135

16558

Malignant neoplasm

10388

38095

1.74

307.65

2.6

2.30

2.38

g/l

28.06

9785

35041

Kidney transplant status

1710

2748

28.38

307.65

12.8

2.2

1.96

2.35

g/l

169.07

1701

2568

Gastrointestinal diseases

7036

16958

2.29

307.65

2.8

1.9

2.39

2.38

g/l

0.41

6551

15479

Diabetes, insulin treatment (Kela reimbursement)

14114

48302

1.95

307.65

3.4

2.4

2.39

2.32

g/l

28.10

13065

44626

Other systemic involvement of connective tissue (FG)

3588

17403

2.39

307.65

2.7

2.4

2.31

2.35

g/l

4.03

3338

15906

Ulcerative colitis

3474

16408

2.54

307.65

2.9

2.6

2.40

2.35

g/l

6.19

3322

15209

Anaemia in chronic diseases classified elsewhere

704

1263

18.45

307.65

12.1

2.3

1.94

2.27

g/l

47.56

692

1173

Cirrhosis, broad definition used in the article https://doi.org/10.1101/594523

2875

10017

4.32

307.65

3.3

2.8

2.22

2.28

g/l

4.23

2695

9316

Erysipelas

8454

36433

2.35

307.65

3.6

2.2

2.24

2.35

g/l

59.99

7890

33362

Benign neoplasm: Colon

7943

42624

2.03

307.65

3.3

2.6

2.35

2.28

g/l

20.71

7441

39170

Benign neoplasm of colon, rectum, anus and anal canal

9431

44975

2.05

307.65

3.3

2.6

2.35

2.29

g/l

20.09

8835

41304

Anaemias

6467

3717

19.95

307.65

4.2

1.6

2.43

2.52

g/l

14.63

6194

3453

Intestinal stricture

4434

24442

2.13

307.65

3.2

2.6

2.29

g/l

0.04

4160

22491

Mood disorders

12904

54921

1.62

307.65

2.7

2.6

2.40

2.35

g/l

19.53

11760

50949

Constipation

12285

51440

1.79

307.65

2.8

2.6

2.31

2.34

g/l

6.02

11220

47655

Type 2 diabetes

14196

43140

2.17

307.65

3.2

2.3

2.41

2.32

g/l

51.19

13188

39724

Ischemic heart diseases

11716

35799

2.25

307.65

3.5

2.3

2.35

2.33

g/l

4.12

11037

32854

Sleep apnoea, including avohilmo

12634

50894

1.63

307.65

2.8

2.6

2.41

2.32

g/l

62.33

11574

47261

Septicaemia

8064

29294

3.29

307.65

4.7

2.3

2.14

2.34

g/l

152.08

7575

26756

Dyspnoea

14179

53299

2.23

307.65

3.1

2.5

2.34

g/l

0.30

13162

49156

Cerebrovascular diseases (FINNGEN)

3754

9698

3.17

307.65

3.6

1.7

2.31

2.40

g/l

14.61

3551

8883

Depression medications

3123

4024

4.44

307.65

2.4

1.6

2.46

2.52

g/l

6.04

2881

3742

Other bacterial intestinal infections

2764

12999

2.62

307.65

4.4

2.4

2.18

2.31

g/l

23.38

2602

11922

Other functional intestinal disorders

6451

31300

2.14

307.65

3.0

2.4

2.31

2.32

g/l

0.53

5956

28747

Solid cancers, including Hilmo

10000

38202

1.65

307.65

2.6

2.31

2.38

g/l

22.44

9417

35136

Hypo-osmolality and hyponatraemia

2987

11799

3.30

307.65

3.3

2.3

2.22

2.30

g/l

10.29

2748

10720

Disorders of lipoprotein metabolism and other lipidaemias

11716

37672

2.16

307.65

3.3

2.3

2.31

2.34

g/l

5.18

10996

34540

Other retinal disorders

8602

41695

1.74

307.65

3.9

2.5

2.22

2.31

g/l

41.82

7853

38382

Heart failure,strict

11323

23794

4.90

307.65

4.0

1.9

2.28

2.30

g/l

3.90

10723

21571

Mood disorders, excluding more controls

11952

44253

1.73

307.65

2.7

2.6

2.39

2.35

g/l

13.31

10892

41183

Spondylopathies

9877

38122

1.66

307.65

2.7

2.6

2.34

2.31

g/l

4.08

9114

35150

Obesity

9025

46106

2.11

307.65

3.1

2.5

2.47

2.36

g/l

68.72

8382

42727

Disorders of iron metabolism

520

764

30.77

307.65

8.1

2.3

2.16

2.35

g/l

11.71

500

714

Presence of cardiac and vascular implants and grafts

7653

24812

2.87

307.65

3.5

2.3

2.31

2.26

g/l

8.93

7195

22821

Non-rheumatic valve diseases

7503

21164

3.15

307.65

3.6

2.2

2.31

g/l

0.31

7062

19313

14133

49872

1.54

307.65

3.0

2.4

2.34

g/l

0.09

13046

45939

Disorders of mineral metabolism

1695

4941

5.34

307.65

5.9

2.4

2.17

2.32

g/l

22.66

1607

4552

Other septicaemia, including avohilmo

7369

27481

3.31

307.65

4.9

2.3

2.13

2.33

g/l

140.15

6928

25076

Persons encountering health services for other counselling and medical advice, not elsewhere classified

15769

47923

1.95

307.65

3.2

2.4

2.34

g/l

0.53

14879

44058

Persons encountering health services in other circumstances, wide

16244

48211

1.93

307.65

3.1

2.4

2.33

2.34

g/l

1.62

15197

44281

Bacterial pneumonia, not elsewhere classified

5178

26091

1.97

307.65

3.5

2.4

2.22

2.33

g/l

36.74

4928

23900

Obesity due to excess calories

6892

35012

2.30

307.65

3.2

2.5

2.48

2.36

g/l

52.66

6387

32496

Disorders of gallbladder, biliary tract and pancreas

13246

52405

1.73

307.65

3.0

2.5

2.34

2.33

g/l

0.25

12320

48314

Explicit Sepsis, including avohilmo

8494

31158

3.20

307.65

4.6

2.2

2.15

2.34

g/l

147.46

7974

28477

ILD medications

17562

47121

2.31

307.65

3.4

2.2

2.31

2.38

g/l

38.36

16494

43216

Other diseases of urinary system

12587

46554

1.64

307.65

2.9

2.5

2.31

2.36

g/l

16.13

11606

43028

Persons encountering health services in other circumstances

5507

29334

2.11

307.65

2.9

2.3

2.37

2.36

g/l

0.57

4983

27022

Diabetes mellitus

14729

44881

2.15

307.65

3.3

2.3

2.40

2.33

g/l

31.66

13691

41362

Examination and observation for other reasons

8890

22484

2.60

307.65

3.2

2.2

2.34

2.33

g/l

1.51

8434

20521

Preparatory care for dialysis

1461

2586

36.25

307.65

14.7

2.5

1.90

2.28

g/l

157.69

1455

2408

Glomerular disorders in diseases classified elsewhere

2914

7573

7.62

307.65

9.9

2.3

1.98

2.30

g/l

200.20

2836

6976

Other disorders of skin and subcutaneous tissue

10269

52060

1.87

307.65

3.7

2.4

2.26

2.34

g/l

37.38

9537

47951

Heart failure, not strict

15417

32667

4.45

307.65

4.5

1.9

2.25

2.35

g/l

66.87

14637

29807

Obesity, other/unspecified

4674

23368

2.34

307.65

2.9

2.5

2.49

2.37

g/l

39.20

4374

21692

Viral Sepsis

3849

14638

3.53

307.65

4.9

2.2

2.19

2.33

g/l

41.46

3627

13360

Metabolic disorders

14688

42665

2.41

307.65

3.5

2.3

2.30

2.36

g/l

30.33

13782

39185

Implicit viral Sepsis, including avohilmo

5389

22318

3.10

307.65

4.4

2.2

2.22

2.34

g/l

45.39

5074

20393

Caries of dentine

3858

14113

3.40

307.65

5.8

2.4

2.21

2.32

g/l

27.16

3679

13147

Hypothyroidism, strict autoimmune

9053

36774

1.76

307.65

2.7

2.3

2.39

2.35

g/l

5.97

8226

33779

Asthma, hospital admissions 3, pneumonia

5242

29434

2.05

307.65

3.2

2.6

2.31

2.29

g/l

1.04

4926

26996

Any event in cancer register

10785

42016

1.61

307.65

2.6

2.31

2.38

g/l

29.35

10132

38700

Care involving use of rehabilitation procedures

8711

42447

2.09

307.65

3.3

2.0

2.34

2.38

g/l

8.89

8227

38860

Anxiety disorders

10824

49598

1.61

307.65

2.7

2.6

2.42

2.37

g/l

19.62

9964

45991

Osteoporosis

3822

18889

2.21

307.65

3.2

2.5

2.26

2.32

g/l

7.01

3501

17253

Biguanides

12492

47178

1.75

307.65

2.7

2.5

2.45

2.30

g/l

127.04

11495

43571

Excluding asthma or asthma-COPD overlap

9375

28304

1.80

307.65

2.9

2.2

2.34

2.39

g/l

13.05

8731

26036

Insulin medication

9636

38148

2.50

307.65

4.2

2.4

2.27

2.29

g/l

4.22

8980

35177

Other diseases of intestine

2419

10179

3.02

307.65

3.6

2.5

2.32

2.28

g/l

3.02

2281

9402

Asthma (diagnoses ohter than nonallergic)

11253

60256

1.64

307.65

2.7

2.6

2.40

2.34

g/l

19.90

10516

55527

Intestinal infectious diseases

13022

59345

1.80

307.65

3.6

2.4

2.30

2.36

g/l

30.06

12124

54701

Malignant neoplasm, including Hilmo

10659

38643

1.75

307.65

2.6

2.31

2.38

g/l

26.77

10060

35548

Insulin, fast-acting

5627

26751

2.56

307.65

4.9

2.5

2.21

2.33

g/l

43.58

5246

24695

Dental caries

4348

15804

3.32

307.65

5.7

2.4

2.21

2.33

g/l

30.72

4148

14721

Other special examinations and investigations of persons without complaint or reported diagnosis

8035

22735

1.96

307.65

3.0

2.2

2.35

2.33

g/l

3.80

7494

20726

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

14712

48228

2.21

307.65

4.0

2.2

2.31

2.37

g/l

31.15

13725

44551

Colorectal adenocarcinoma

3162

14369

2.72

307.65

2.3

2.7

2.40

2.27

g/l

27.43

3030

13075

GI-bleeding

5464

25762

2.65

307.65

3.8

2.6

2.30

2.26

g/l

4.31

5104

23633

Colorectal cancer

3780

16756

2.69

307.65

2.4

2.7

2.40

2.28

g/l

25.32

3621

15237

Malignant neoplasm of colon, including Hilmo

3137

13041

3.14

307.65

2.4

2.7

2.41

2.28

g/l

26.63

3020

11851

Asthma

9843

28063

2.00

307.65

2.6

2.2

2.41

2.39

g/l

2.58

9189

25812

Diseases of the digestive system

7675

37071

2.51

307.65

3.6

2.5

2.32

2.30

g/l

2.27

7160

34083

Adjustment and management of implanted device

3526

12824

3.91

307.65

3.7

2.1

2.28

2.27

g/l

0.59

3313

11632

Other medical care

7896

30866

2.61

307.65

2.8

2.1

2.16

2.34

g/l

120.40

7462

28069

Peripheral artery disease

6595

28381

2.17

307.65

4.6

2.4

2.18

2.26

g/l

24.40

6190

25916

Extracorporeal dialysis

1941

3649

22.50

307.65

16.5

2.4

1.84

2.29

g/l

255.11

1927

3401

Persons encountering health services for examination and investigation

7451

22735

1.77

307.65

2.8

2.2

2.34

2.33

g/l

1.58

6950

20726

Colon adenocarcinoma

2070

8336

3.33

307.65

2.4

2.7

2.44

2.28

g/l

27.73

2000

7565

Anxiety disorders, excluding more controls

10101

40645

1.73

307.65

2.7

2.6

2.42

2.36

g/l

16.70

9302

37859

Autoimmune diseases related-to ILD

12444

57843

2.04

307.65

2.9

2.5

2.35

g/l

0.09

11677

53265

Valvular operations

2227

7964

3.68

307.65

3.3

2.3

2.34

2.25

g/l

10.28

2108

7244

Factors influencing health status and contact with health services

3220

7321

2.42

307.65

2.8

1.7

2.29

2.35

g/l

8.05

3010

6657

Malignant neoplasm of digestive organs, including Hilmo

6934

23503

2.66

307.65

2.4

2.7

2.35

2.31

g/l

5.97

6622

21453

Crohn disease

2068

7730

3.51

307.65

3.2

2.6

2.42

2.36

g/l

4.61

1982

7179

Asthma (only as main-diagnosis)

8957

28063

1.97

307.65

2.7

2.2

2.41

2.39

g/l

2.69

8352

25812

Complications of medical and surgical care

10803

55132

2.01

307.65

3.5

2.5

2.31

2.34

g/l

6.17

10070

50807

Pneumonia, organism unspecified

13817

49170

2.22

307.65

3.6

2.3

2.25

2.39

g/l

128.50

12917

45279

Asthma, hospital admission 2, infections

8089

47549

1.85

307.65

2.9

2.6

2.38

2.34

g/l

8.15

7552

43780

Asthma, excluding more controls

9362

24223

2.21

307.65

2.6

2.1

2.42

2.40

g/l

1.74

8739

22217

Gastro-oesophageal reflux disease

9181

45411

1.91

307.65

2.9

2.5

2.39

2.32

g/l

21.50

8438

41974

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

5142

13748

2.68

307.65

3.2

1.7

2.35

2.43

g/l

18.76

4821

12622

First line medication for Crohn's disease

17175

45040

2.37

307.65

3.3

2.3

2.31

2.38

g/l

39.96

16164

41218

Symptoms and signs involving the digestive system and abdomen

12676

39993

1.72

307.65

2.9

2.4

2.33

2.34

g/l

1.23

11762

36881

Benign neoplasms

11798

44116

1.55

307.65

2.9

2.5

2.36

2.34

g/l

2.99

10992

40688

Respiratory diseases principally affecting the interstitium, IBD co-morbidites

1552

2946

4.71

307.65

3.1

1.9

2.26

2.28

g/l

0.68

1448

2731

ILD medications: prednisolone, methylprednisolone, prednisone

17072

46610

2.36

307.65

3.5

2.2

2.31

2.37

g/l

39.44

16008

42756

ILD differential diagnosis

9308

28301

1.79

307.65

2.9

2.2

2.34

2.39

g/l

12.70

8669

26036

Persons encountering health services for specific procedures and health care

16899

48221

2.40

307.65

3.9

2.0

2.27

2.40

g/l

134.48

15956

44162

Autoimmune diseases excluding thyroid diseases, strict definition

15183

42596

2.20

307.65

3.3

2.3

2.30

2.36

g/l

28.31

14302

39240

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

8654

49500

1.95

307.65

3.6

2.5

2.31

2.33

g/l

3.45

8059

45572

Pain in joint

7480

26018

1.95

307.65

2.7

2.4

2.39

2.34

g/l

11.30

6935

23968

Abnormal findings on examination of blood, without diagnosis

7561

34927

2.37

307.65

3.0

2.7

2.28

2.29

g/l

0.43

7156

32137

Ischaemic heart disease, wide definition

10296

35837

2.01

307.65

3.5

2.4

2.33

2.31

g/l

1.94

9632

32947

Calcific aortic valvular stenosis, including rheumatic fever

4842

23889

2.41

307.65

3.6

2.6

2.25

2.23

g/l

1.99

4552

21750

Care involving dialysis

2763

4425

28.78

307.65

14.9

2.1

1.88

2.32

g/l

307.65

2745

4083

Operations 2 for CAVS

4831

23828

2.42

307.65

3.6

2.6

2.26

2.23

g/l

2.02

4541

21693

Heart failure and antihypertensive medication

5573

6675

8.70

307.65

4.5

1.7

2.30

g/l

0.12

5347

6127

Any reimbursement code in KELA

6912

13786

2.82

307.65

2.9

1.6

2.41

2.46

g/l

8.91

6495

12570

Nephropathy related operations

3678

7747

13.55

307.65

12.7

2.1

1.93

2.31

g/l

307.65

3629

7171

Implicit bacterial Sepsis

8426

27569

3.54

307.65

4.5

2.2

2.14

2.32

g/l

132.35

7941

25144

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

9285

48940

1.86

307.65

3.0

2.6

2.29

2.32

g/l

4.27

8657

45018

Inflammatory bowel disease treatment related agents

17656

50395

2.23

307.65

3.0

2.5

2.33

2.36

g/l

8.75

16564

46295

Exposure to unspecified factor

13071

59874

1.60

307.65

3.0

2.5

2.32

2.36

g/l

10.79

11967

55451

Hypertensive heart and/or renal disease

4352

11708

3.49

307.65

4.8

1.9

2.21

2.25

g/l

5.02

4067

10590

Neurotic, stress-related and somatoform disorders

10720

49130

1.62

307.65

2.7

2.6

2.42

2.37

g/l

20.00

9869

45568

Diseases of arteries, arterioles and capillaries

10173

40279

2.17

307.65

4.3

2.4

2.23

2.31

g/l

33.97

9542

36927

Depression or dysthymia

8304

27223

1.83

307.65

2.7

2.37

2.32

g/l

10.15

7557

25499

Antihypertensive medication - note that there are other indications

7089

17108

2.41

307.65

3.3

1.7

2.42

2.45

g/l

4.46

6634

15764

Calcific aortic valvular stenosis, diagnosis (helper)

4831

23828

2.42

307.65

3.6

2.6

2.26

2.23

g/l

2.02

4541

21693

Inflammatory bowel disease

4702

21979

2.58

307.65

2.9

2.6

2.41

2.35

g/l

9.62

4489

20394

Certain infectious and parasitic diseases, including avohilmo

8688

25571

1.85

307.65

2.9

2.1

2.31

2.41

g/l

40.30

8101

23380

Systemic connective tissue disorders

4966

27041

2.15

307.65

3.1

2.5

2.27

2.34

g/l

13.67

4650

24812

IBD patients in KELA-register

3480

14654

2.95

307.65

2.9

2.6

2.43

2.37

g/l

8.87

3337

13633

Other specific joint derangements/joint disorders

8927

35036

1.72

307.65

2.7

2.4

2.39

2.38

g/l

1.99

8292

32374

Other heart diseases, wide

13255

37871

2.44

307.65

3.4

2.2

2.35

2.40

g/l

16.73

12492

34855

Solid cancers

9658

37433

1.63

307.65

2.6

2.30

2.37

g/l

25.47

9077

34413

Iron deficiency anaemia secondary to blood loss (chronic)

3359

10727

4.75

307.65

4.5

2.4

2.39

2.26

g/l

26.08

3124

9809

Iron deficiency anaemia

11573

31843

6.00

307.65

3.7

2.4

2.46

2.29

g/l

147.99

10869

29140

Asthma (only as main-diagnosis), excluding more controls

8597

24223

2.18

307.65

2.7

2.1

2.42

2.40

g/l

1.54

8019

22217

Other and unspecified anaemias

11675

30590

6.18

307.65

3.9

2.3

2.25

2.29

g/l

12.39

11043

27849

Hypertensive Heart Disease

3641

11098

3.09

307.65

4.0

2.0

2.25

g/l

0.01

3381

10031

Presence of other functional implants

7839

31604

1.90

307.65

3.2

2.3

2.26

2.30

g/l

6.91

6990

29097

Neoplasms

8642

27768

1.76

307.65

2.8

2.4

2.37

2.41

g/l

6.57

8111

25517

Bleeding

12478

47171

2.14

307.65

3.7

2.4

2.29

2.33

g/l

9.53

11599

43473

Insulin, combination of fast acting with intermediate-acting or long-acting

9647

45490

2.27

307.65

4.2

2.4

2.27

2.31

g/l

11.58

8989

41887

Osteopathies and chondropathies

7941

41619

1.99

307.65

3.5

2.5

2.28

2.35

g/l

20.89

7368

38350

Fever of other and unknown origin

9852

34115

3.08

307.65

3.7

2.3

2.24

2.38

g/l

101.43

9291

31327

All-cause Heart Failure

12047

29713

3.99

307.65

3.9

2.4

2.28

2.27

g/l

0.24

11403

27041

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

14752

52525

2.13

307.65

3.5

2.3

2.26

2.39

g/l

130.54

13820

48417

Malignant neoplasm of colon

2566

10673

3.16

307.65

2.4

2.7

2.42

2.28

g/l

27.64

2474

9708

Liquid cancers

4912

19985

2.97

307.65

2.9

2.7

2.22

2.31

g/l

20.64

4686

18220

Nonalcoholic fatty liver disease

2034

6002

5.35

307.65

2.5

2.6

2.52

2.34

g/l

35.04

1908

5595

Cardiovascular diseases

7251

16677

2.59

307.65

3.3

1.7

2.41

2.49

g/l

22.20

6842

15302

Implicit Sepsis, including avohilmo

13844

44717

2.66

307.65

3.8

2.2

2.23

2.38

g/l

145.41

12943

41041

Malignant neoplasm of digestive organs

6121

22316

2.55

307.65

2.4

2.7

2.35

2.30

g/l

7.81

5843

20352

Cardiovascular diseases (excluding rheumatic etc)

7987

19343

2.68

307.65

3.5

1.8

2.39

2.48

g/l

27.89

7557

17762

Asthma-related pneumonia or sepsis

5242

29434

2.05

307.65

3.2

2.6

2.31

2.29

g/l

1.04

4926

26996

ILD medications: azathioprine

2583

8149

4.36

307.65

4.8

2.2

2.31

2.38

g/l

6.71

2505

7523

Infections, IBD-co-morbidities

2657

4422

5.54

307.65

5.1

1.9

2.20

2.34

g/l

22.99

2538

4102

Fall on same level

14177

51090

1.59

307.65

2.9

2.5

2.32

2.38

g/l

25.98

13078

47395

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

7939

47619

1.88

307.65

3.6

2.5

2.32

2.33

g/l

0.91

7389

43869

Medical observation and evaluation for suspected diseases and conditions

8792

22727

2.22

307.65

3.0

2.2

2.34

2.33

g/l

1.19

8193

20719

Symptoms and signs involving the urinary system

10372

47983

1.81

307.65

3.2

2.5

2.27

2.34

g/l

25.78

9515

44325

Pain (limb, back, neck, head abdominally)

8631

27123

1.72

307.65

2.8

2.4

2.33

g/l

0.35

8017

24932

Implicit Sepsis

13304

42572

2.83

307.65

3.9

2.2

2.22

2.37

g/l

143.48

12455

39072

Hypertensive diseases (excluding secondary)

6936

14868

3.19

307.65

4.1

1.7

2.37

2.44

g/l

16.77

6595

13665

Gout, strict definition

3350

13953

3.35

307.65

5.0

2.6

2.19

2.24

g/l

6.96

3166

12852

ILD medications: immunosuppressive drugs

11385

41883

3.07

307.65

4.2

2.2

2.27

2.38

g/l

86.26

10861

38538

Provisional assignment of new diseases of uncertain etiology

8451

42981

2.31

307.65

3.6

2.5

2.27

2.35

g/l

30.11

7938

39562

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

23565

44831

5.10

307.65

3.6

2.1

2.34

2.35

g/l

4.26

22256

40949

Recurrent or chronic depression

4790

17318

2.14

307.65

2.4

2.7

2.46

2.38

g/l

17.10

4362

16308

Emergency coronary revascularization (for ACS)

12750

38855

2.31

307.65

3.5

2.4

2.34

2.31

g/l

8.89

12002

35584

Sleep apnoea

12194

49862

1.69

307.65

2.8

2.6

2.41

2.32

g/l

56.32

11200

46295

Diseases of oesophagus, stomach and duodenum

15870

50517

2.11

307.65

3.1

2.4

2.37

2.34

g/l

9.38

14722

46657

Bacterial infection, other or unspecified

10374

34468

3.32

307.65

4.2

2.3

2.13

2.35

g/l

253.98

9779

31498

Codes for special purposes

8464

43015

2.31

307.65

3.6

2.5

2.27

2.35

g/l

29.72

7951

39593

Transplanted organ and tissue status

2713

5229

12.47

307.65

9.9

2.3

2.06

2.35

g/l

124.69

2674

4871

Cardiodefibrillation

4984

28837

2.03

307.65

3.2

2.7

2.35

2.25

g/l

32.65

4648

26521

Depression

12046

52410

1.67

307.65

2.7

2.6

2.41

2.36

g/l

19.28

10978

48690

Opioids

13148

36909

2.04

307.65

2.9

2.3

2.34

2.37

g/l

7.52

12215

34018

Hypothyroidism, levothyroxine purchases

2971

3845

5.05

307.65

2.7

1.6

2.45

2.52

g/l

6.36

2719

3571

5764

33887

1.88

307.65

2.9

2.6

2.42

2.36

g/l

12.11

5361

31281

Autoimmune diseases excluding thyroid diseases

15719

43921

2.21

307.65

3.3

2.3

2.30

2.36

g/l

27.39

14808

40476

Implicit bacterial Sepsis, including avohilmo

9168

29359

3.48

307.65

4.4

2.2

2.15

2.32

g/l

128.68

8643

26799

Neurological diseases, wide definition

3214

6759

2.64

307.65

2.7

1.9

2.43

g/l

0.12

2997

6283

COPD/asthma related infections

12738

40093

1.73

307.65

3.0

2.3

2.32

2.38

g/l

28.09

11825

36893

Calcific aortic valvular stenosis

4836

23860

2.41

307.65

3.6

2.6

2.25

2.23

g/l

1.95

4545

21723

Disorders of thyroid, IBD co-morbidities

2192

5248

3.32

307.65

2.8

1.8

2.39

g/l

0.04

2025

4873

Malignant neoplasm, wide definition

10636

38778

1.74

307.65

2.6

2.31

2.38

g/l

26.03

10039

35677

Type 2 diabetes, strict (exclude DM1)

13189

42062

2.05

307.65

2.8

2.3

2.45

2.32

g/l

107.69

12238

38731

Autoimmune diseases

15706

44141

2.02

307.65

3.1

2.3

2.32

2.36

g/l

10.68

14621

40678

Influenza and pneumonia

15440

51489

2.10

307.65

3.5

2.3

2.27

2.40

g/l

115.80

14469

47419

Type 2 diabetes, definitions combined, including avohilmo

12973

41702

2.01

307.65

2.8

2.3

2.45

2.32

g/l

109.34

12037

38423

Malignant neoplasm

10398

38022

1.75

307.65

2.6

2.30

2.38

g/l

27.70

9796

34975

Other and unspecified iron deficiency

9683

24931

7.08

307.65

3.7

2.4

2.49

2.29

g/l

156.03

9115

22830

Asthma (mode)

9582

28301

1.96

307.65

2.6

2.2

2.41

2.39

g/l

2.56

8948

26036

Major coronary heart disease event excluding revascularizations

8193

29060

2.14

307.65

3.5

2.4

2.28

g/l

0.15

7672

26513

Other diseases of blood and blood-forming organs, wide

3547

15672

2.91

307.65

3.2

2.6

2.28

2.32

g/l

4.85

3355

14468

Coagulation defects, purpura and other haemorrhagic conditions

2931

13784

2.63

307.65

3.7

2.6

2.27

2.33

g/l

7.69

2789

12737

Cirrhosis of liver, NAS

1308

3449

7.91

307.65

3.7

2.8

2.30

2.28

g/l

0.41

1245

3204

Colectomy operation

2996

12163

3.41

307.65

2.9

2.7

2.42

2.27

g/l

35.80

2882

11180

Type 1 diabetes, wide definition, subgroup 1

2839

12141

2.81

307.65

5.5

2.3

2.11

2.34

g/l

87.99

2645

11257

Intracranial trauma

6928

27381

1.86

307.65

2.7

2.4

2.35

2.37

g/l

1.11

6356

25519

Diabetic nephropathy, excluding more controls

2976

10258

3.48

307.65

8.4

2.4

2.04

2.42

g/l

253.08

2880

9415

Other diseases of intestines

14852

45728

2.02

307.65

3.0

2.4

2.37

2.36

g/l

2.35

13809

42180

Gout, unspecified

3650

15880

3.10

307.65

4.8

2.6

2.19

2.25

g/l

9.35

3441

14617

Disorders of lens

8315

31516

1.81

307.65

3.8

2.4

2.25

2.33

g/l

33.18

7718

29279

Implicit viral Sepsis

3847

14623

3.54

307.65

4.9

2.2

2.19

2.33

g/l

41.36

3625

13345

Disorders of choroid and retina

10380

48279

1.64

307.65

3.7

2.5

2.24

2.33

g/l

45.55

9506

44569

Pneumonias (Asthma/COPD co-morbidities)

15035

52196

2.15

307.65

3.5

2.3

2.26

2.40

g/l

135.43

14091

48081

Asthma, unspecified (mode), excluding more controls

7304

23172

2.61

307.65

2.8

2.1

2.39

g/l

0.46

6807

21246

Diabetic maculopathy, excluding more controls

1620

6200

3.37

307.65

6.5

2.3

2.09

2.27

g/l

32.44

1502

5704

COPD differential diagnosis

9313

28312

1.79

307.65

2.9

2.2

2.34

2.39

g/l

12.77

8673

26046

13297

40093

2.22

307.65

3.5

2.3

2.27

2.38

g/l

87.80

12446

36893

Other bacterial diseases

16235

47601

2.74

307.65

3.9

2.2

2.20

2.39

g/l

264.21

15262

43717

Cardiomyopathies, Primary/intrinsic

2513

6523

6.15

307.65

3.8

2.3

2.32

2.27

g/l

5.37

2413

5968

Complications of surgical and medical care, not elsewhere classified

14886

55378

2.04

307.65

3.5

2.4

2.31

2.35

g/l

14.28

13877

51017

COPD/asthma/ILD related infections

12738

40093

1.73

307.65

3.0

2.3

2.32

2.38

g/l

28.09

11825

36893

Intestinal infectious diseases, including avohilmo, including avohilmo

15207

55052

1.67

307.65

3.2

2.4

2.31

2.35

g/l

13.69

14133

50747

Nutritional anaemias

12787

36545

5.29

307.65

3.6

2.4

2.44

2.28

g/l

133.82

12006

33432

Explicit Sepsis

8324

30650

3.20

307.65

4.7

2.2

2.15

2.34

g/l

143.86

7813

28008

Senile cataract

7536

28583

1.77

307.65

3.6

2.4

2.25

2.32

g/l

20.75

6967

26521

Condition for Implicit Sepsis (Organ dysfunction codes), including avohilmo

14150

45283

2.47

307.65

3.6

2.2

2.26

2.40

g/l

136.63

13267

41592

Conduction disorders

4631

14976

3.07

307.65

3.2

2.2

2.29

g/l

0.39

4303

13595

Infections of the skin and subcutaneous tissue

7627

46188

1.80

307.65

3.7

2.5

2.29

2.36

g/l

19.70

7148

42755

Diarrhoea and gastroenteritis of presumed infectious origin, including avohilmo

13038

55642

1.62

307.65

3.3

2.4

2.33

2.36

g/l

6.05

12140

51306

Hard cardiovascular diseases

11542

35393

2.21

307.65

3.5

2.3

2.34

g/l

0.32

10904

32529

Cardiac arrhythmias

7923

21738

2.69

307.65

3.1

2.0

2.38

2.39

g/l

0.69

7460

20041

Other antidepressants

13721

42608

1.81

307.65

2.5

2.7

2.36

2.32

g/l

12.00

12492

39737

Other heart diseases

7096

14981

3.75

307.65

3.7

1.7

2.35

2.45

g/l

30.99

6755

13792

Calcific aortic valvular stenosis, operated

4836

23860

2.41

307.65

3.6

2.6

2.25

2.23

g/l

1.95

4545

21723

Cardiomyopathy

3454

9832

5.24

307.65

3.7

2.2

2.31

2.27

g/l

4.04

3301

8977

Soft tissue disorders

12324

43211

1.56

307.65

2.8

2.5

2.35

g/l

0.53

11405

39869

Bacterial infection, other or unspecified, including avohilmo

11156

36413

3.24

307.65

4.1

2.2

2.14

2.36

g/l

269.73

10517

33307

Dilated cardiomyopathy

2312

8026

4.51

307.65

3.8

2.8

2.32

2.25

g/l

9.27

2220

7433

Complications of procedures, not elsewhere classified

11741

53855

1.99

307.65

3.4

2.4

2.32

2.35

g/l

4.84

10973

49615

Injuries to the head

13788

57738

1.51

307.65

2.7

2.6

2.33

2.36

g/l

6.55

12643

53460

Atrial fibrillation and flutter

4471

8605

4.15

307.65

3.5

1.7

2.34

2.38

g/l

3.31

4243

7868

Diarrhoea and gastroenteritis of presumed infectious origin

9824

51408

1.91

307.65

3.7

2.4

2.30

2.36

g/l

21.39

9167

47403

Erysipelas, including avohilmo

10971

40776

2.31

307.65

3.4

2.2

2.26

2.37

g/l

72.26

10252

37380

Episodal and paroxysmal disorders

13442

45972

1.59

307.65

2.7

2.5

2.39

2.33

g/l

24.52

12389

42498

Percutaneous Coronary Intervention

11714

34652

2.42

307.65

3.5

2.3

2.35

2.32

g/l

6.83

11047

31788

Major coronary heart disease event

12046

37309

2.23

307.65

3.5

2.4

2.35

2.32

g/l

5.81

11341

34203

Other cataract

5757

24700

1.96

307.65

3.8

2.4

2.23

2.31

g/l

21.74

5319

22875

Other diseases of liver

3479

11877

4.20

307.65

2.8

2.6

2.43

2.33

g/l

16.42

3243

11018

Renal tubulo-interstitial diseases

16916

47872

3.32

307.65

4.8

1.9

2.18

2.41

g/l

307.65

15989

43796

Heart failure and bmi 25plus

6753

15736

4.06

307.65

3.9

2.4

2.30

2.31

g/l

0.94

6351

14236

Atrial fibrillation and flutter with reimbursement

3862

6670

4.67

307.65

3.1

1.7

2.36

2.35

g/l

0.63

3643

6074

Atherosclerosis, excluding cerebral and coronary sclerosis

6134

26766

2.12

307.65

4.5

2.4

2.18

2.26

g/l

19.59

5753

24409

Bacterial pneumoniae

5461

27474

1.97

307.65

3.5

2.4

2.22

2.34

g/l

40.41

5187

25189

Diseases of arteries, arterioles and capillaries (FINNGEN)

3828

6856

5.04

307.65

4.8

1.7

2.24

2.36

g/l

24.65

3627

6248

Disorders resulting from impaired renal tubular function

1107

2094

20.07

307.65

13.8

2.6

1.97

2.30

g/l

78.74

1095

1950

Cardiomyopathy (excluding other)

2556

6828

5.88

307.65

3.8

2.3

2.32

2.27

g/l

5.44

2452

6250

Asthma-related pneumonia

5236

29372

2.05

307.65

3.2

2.6

2.31

2.29

g/l

1.00

4920

26937

Asthma, unspecified (mode)

7586

26910

2.33

307.65

2.8

2.2

2.38

g/l

0.08

7069

24744

Angina pectoris

7317

26739

2.07

307.65

3.2

2.3

2.34

2.28

g/l

16.75

6839

24393

Gout

5149

17651

3.31

307.65

4.7

2.5

2.19

2.25

g/l

13.30

4863

16180

Obesity related asthma

4721

25671

2.13

307.65

2.9

2.6

2.46

2.33

g/l

45.53

4409

23760

L04AX Other immunosuppressants

8110

43144

2.19

307.65

3.1

2.6

2.31

2.36

g/l

12.31

7677

39888

Other specified/unspecified arthritis

3670

18687

2.29

307.65

3.1

2.5

2.29

2.34

g/l

7.44

3436

17251

Other bacterial intestinal infections, including avohilmo

3391

17154

2.35

307.65

4.0

2.4

2.22

2.33

g/l

21.33

3186

15763

Abnormalities of breathing

13112

37361

2.29

307.65

3.0

2.4

2.38

2.36

g/l

2.83

12167

34464

Unspecified kidney failure

2492

6758

6.52

307.65

6.5

1.9

2.06

2.28

g/l

69.14

2385

6108

Hernia of abdominal wall, postoperative

2859

9177

3.93

307.65

3.8

1.9

2.33

2.34

g/l

0.41

2650

8365

Diseases of the skin and subcutaneous tissue

12146

40301

1.62

307.65

3.0

2.3

2.32

2.36

g/l

14.41

11241

37127

Second line medication for Crohn's disease

8538

44241

2.26

307.65

3.0

2.6

2.32

2.37

g/l

11.19

8093

40887

Renal failure

12630

30986

5.84

307.65

6.2

1.9

2.09

2.32

g/l

307.65

12122

28115

General examination and investigation of persons without complaint and reported diagnosis

7773

22677

1.95

307.65

3.1

2.2

2.38

2.33

g/l

10.37

7245

20682

Hypertensive diseases

10424

28502

2.35

307.65

3.8

1.9

2.34

2.37

g/l

5.86

9846

26189

All chronic kidney diseases

13017

31646

4.86

307.65

6.0

1.8

2.12

2.37

g/l

307.65

12455

28813

Coronary revascularization (ANGIO or CABG)

11622

34670

2.39

307.65

3.5

2.3

2.35

2.32

g/l

7.54

10969

31804

Malaise and fatigue

9603

29365

3.24

307.65

3.1

2.3

2.24

2.36

g/l

68.62

8876

26886

Oral corticosteroids

16338

49408

2.23

307.65

2.9

2.5

2.33

2.35

g/l

7.16

15257

45390

Pain in limb

11904

42253

2.02

307.65

3.1

2.5

2.34

2.35

g/l

2.10

11028

39014

Codeine

12626

36493

2.09

307.65

2.8

2.3

2.36

2.37

g/l

0.61

11684

33645

Gout, FINNGEN

5149

22941

2.89

307.65

4.7

2.5

2.19

2.25

g/l

15.57

4863

21007

Azathioprine

2583

8446

4.19

307.65

4.8

2.5

2.31

2.36

g/l

3.72

2505

7813

Parasetamol

9001

23697

2.11

307.65

2.8

2.3

2.35

2.36

g/l

0.74

8373

21981

Tramadol

12087

34052

2.48

307.65

3.2

2.4

2.33

2.36

g/l

4.36

11226

31392

Other disorders of urethra and urinary system

9474

40294

1.81

307.65

3.1

2.5

2.29

2.36

g/l

19.22

8774

37098

Used for control exclusion in common control thyroid runs

14570

40835

2.00

307.65

3.1

2.3

2.33

2.36

g/l

5.67

13581

37591

Psychiatric diseases

11585

39678

1.56

307.65

2.7

2.6

2.34

g/l

0.15

10651

36974

AV-block

2924

9354

3.41

307.65

3.4

2.2

2.27

2.24

g/l

1.74

2731

8426

Peripheral arterial reconstruction

2724

13218

2.63

307.65

4.8

2.6

2.16

2.23

g/l

9.56

2564

12100

Cardiomyopathy, other and unspecified

1425

3896

5.58

307.65

3.8

2.3

2.29

g/l

0.11

1359

3564

Chronic gastritis

3897

19856

2.35

307.65

3.0

2.5

2.33

2.26

g/l

10.78

3581

18224

Other soft tissue disorders, not elsewhere classified

13228

42916

1.96

307.65

2.9

2.5

2.35

g/l

0.27

12260

39613

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

11988

52239

1.56

307.65

3.0

2.5

2.31

2.34

g/l

6.34

11085

48292

All influenza

3596

18316

2.30

307.65

4.0

2.4

2.29

2.35

g/l

8.15

3357

16829

Heart failure, strict

12326

30136

4.04

307.65

3.9

2.4

2.28

2.27

g/l

0.27

11668

27439

Secondary hypertension

1842

2956

11.01

307.65

9.9

1.7

2.05

2.34

g/l

80.70

1792

2679

Hypertension, essential

10329

27749

2.41

307.65

3.5

1.9

2.35

2.37

g/l

2.95

9752

25482

Hypothyroidism (congenital or acquired)

3016

3860

5.11

307.65

2.8

1.6

2.45

2.52

g/l

7.24

2759

3585

Myocardial infarction, without ST-elevation

6018

30491

2.10

307.65

3.7

2.6

2.22

2.25

g/l

5.49

5624

27899

Insulin, intermediate and long-acting

8824

42548

2.41

307.65

4.2

2.4

2.27

2.31

g/l

8.54

8222

39227

Oesophageal varices

897

2444

6.87

307.65

3.7

2.6

2.27

2.28

g/l

0.21

841

2276

Covid-19 confirmed case

6582

30026

2.78

307.65

3.9

2.5

2.22

2.31

g/l

35.94

6163

27566

Pacemaker

6501

28028

2.79

307.65

3.4

2.6

2.30

2.24

g/l

16.45

6092

25602

Venous thromboembolism

7221

43547

1.79

307.65

3.2

2.6

2.26

2.31

g/l

7.76

6733

39982

Insulin, fast-acting or short human

5642

28063

2.42

307.65

4.9

2.5

2.21

2.33

g/l

44.49

5260

25902

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

13297

40093

2.22

307.65

3.5

2.3

2.27

2.38

g/l

87.80

12446

36893

Pulmonary heart disease, diseases of pulmonary circulation

4493

25352

2.07

307.65

3.2

2.6

2.28

2.29

g/l

0.54

4229

23248

Personality disorders, excluding more controls

2990

14395

2.36

307.65

2.5

2.47

2.42

g/l

5.41

2677

13531

Any mental disorder

13406

45278

1.59

307.65

2.7

2.6

2.34

g/l

0.02

12296

42115

STROKE

6672

23625

2.14

307.65

3.3

2.1

2.31

2.34

g/l

4.07

6235

21636

Unspecified haematuria

5788

28018

1.91

307.65

3.6

2.6

2.23

2.28

g/l

9.33

5382

25842

Type 2 diabetes, definitions combined

13135

41791

2.06

307.65

2.8

2.3

2.45

2.32

g/l

107.12

12189

38475

Other anxiety disorders

5544

27695

1.87

307.65

2.5

2.45

2.41

g/l

5.84

5099

25811

Other bacterial diseases, including avohilmo

16450

48024

2.52

307.65

3.7

2.2

2.23

2.41

g/l

222.47

15481

44113

All anxiety disorders

7415

35447

1.77

307.65

2.5

2.45

2.39

g/l

12.74

6811

33017

Syncope and collapse

6302

26879

2.24

307.65

3.0

2.3

2.28

2.35

g/l

17.85

5790

24582

Mood [affective] disorders

12882

54877

1.63

307.65

2.7

2.6

2.40

2.35

g/l

19.93

11739

50908

Noninfective enteritis and colitis

7037

35112

2.37

307.65

3.1

2.6

2.37

2.35

g/l

1.64

6652

32429

Type 1 diabetes

3410

15256

2.65

307.65

5.6

2.3

2.12

2.33

g/l

80.22

3183

14108

Low back pain

10085

42619

1.75

307.65

2.7

2.6

2.38

2.34

g/l

7.23

9348

39322

Acute renal failure

5176

15484

5.44

307.65

5.4

1.9

2.07

2.31

g/l

134.30

4971

14051

Paroxysmal tachycardia

2924

8384

3.48

307.65

3.3

1.7

2.35

2.40

g/l

4.64

2747

7639

Dialysis, with operation codes

3882

7414

15.05

307.65

12.4

1.9

1.93

2.34

g/l

307.65

3834

6808

Coronary atherosclerosis

8874

29020

2.24

307.65

3.6

2.3

2.31

2.29

g/l

2.68

8311

26527

Other pulmonary diagnosis

9383

28304

1.80

307.65

2.9

2.2

2.34

2.39

g/l

13.25

8735

26036

Aplastic and other anaemias

12522

32330

6.03

307.65

4.2

2.3

2.24

2.30

g/l

22.46

11857

29443

Hypertension

10404

28480

2.34

307.65

3.8

1.9

2.34

2.37

g/l

5.78

9826

26167

Diabetes medication

14305

48859

1.90

307.65

3.2

2.3

2.40

2.33

g/l

33.82

13236

45125

Nonischemic cardiomyopathy

1958

5853

5.16

307.65

3.4

2.5

2.35

2.26

g/l

9.54

1873

5369

Other disorders of kidney and ureter

2298

9009

3.58

307.65

8.9

2.5

2.11

2.29

g/l

48.17

2213

8327

Hypertensive Renal Disease

823

1881

7.75

307.65

9.3

1.9

2.02

2.22

g/l

22.87

793

1688

Dipeptidyl peptidase 4 (DPP-4) inhibitors

8801

33969

2.47

307.65

3.5

2.5

2.35

2.25

g/l

44.38

8152

31275

Bronchitis

13787

57268

1.55

307.65

3.1

2.5

2.35

g/l

0.08

12732

52837

Lower back pain or/and sciatica

13380

58483

1.52

307.65

2.7

2.6

2.37

2.34

g/l

8.41

12426

53946

Glomerulonephritis

1706

6129

3.98

307.65

8.5

2.6

2.07

2.31

g/l

63.62

1671

5677

Diabetes, varying definitions

14652

44889

2.14

307.65

3.3

2.3

2.40

2.33

g/l

32.42

13619

41372

Disorders of other endocrine glands

6086

33441

2.05

307.65

4.7

2.4

2.33

2.37

g/l

4.77

5638

30854

Glomerular diseases

4015

12263

5.39

307.65

9.2

2.3

2.02

2.32

g/l

224.52

3909

11319

Dialysis

1228

1960

24.53

307.65

15.3

1.9

1.90

2.35

g/l

153.68

1223

1830

Glucagon-like peptide-1 (GLP-1) analogues

3850

20736

2.13

307.65

3.1

2.6

2.52

2.30

g/l

105.71

3570

19339

Pain in throat and chest

11474

36675

2.07

307.65

2.8

2.4

2.36

2.35

g/l

0.91

10608

33837

Chronic kidney disease

9293

22818

7.62

307.65

7.5

1.9

2.07

2.30

g/l

297.70

8964

20644

Other nutritional deficiencies

10170

47267

2.30

307.65

3.1

2.5

2.46

2.35

g/l

66.75

9478

43768

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

3942

8402

2.59

307.65

2.7

1.9

2.36

2.44

g/l

11.70

3668

7744

Non-invasive ventilation

3494

9312

3.95

307.65

3.1

2.0

2.40

2.34

g/l

8.60

3372

8634

Fibrosis and cirrhosis of liver

1774

4897

6.75

307.65

3.5

2.7

2.33

2.29

g/l

1.32

1686

4539

Gastric ulcer

2695

12542

2.66

307.65

3.5

2.5

2.32

2.24

g/l

8.24

2495

11513

Mucosal proctocolitis

1887

7524

3.18

307.65

2.8

2.6

2.40

2.35

g/l

3.03

1812

7014

Headache

8180

35754

1.95

307.65

2.6

2.2

2.43

2.40

g/l

2.92

7600

32893

Polyarthropathies

10791

32728

2.50

307.65

3.6

2.4

2.25

2.35

g/l

50.60

10123

30194

Other anaemias

11745

30777

6.14

307.65

3.9

2.3

2.25

2.29

g/l

12.78

11109

28023

Hernia

11443

52051

1.57

307.65

3.0

2.5

2.35

2.34

g/l

0.60

10617

48031

Other diseases of pleura

6206

33134

1.85

307.65

3.5

2.6

2.20

2.27

g/l

19.75

5740

30450

Finngen Rheumatological endpoints

12321

42718

1.79

307.65

2.9

2.4

2.34

2.37

g/l

7.29

11477

39422

Gastroduodenal ulcer

3834

19376

2.35

307.65

3.6

2.5

2.30

2.23

g/l

8.55

3553

17768

Symptoms and signs involving the circulatory and respiratory systems

12870

37412

1.89

307.65

2.9

2.4

2.38

2.36

g/l

2.90

11973

34510

Dorsalgia

12156

43414

1.59

307.65

2.6

2.37

2.34

g/l

5.48

11309

40043

Other (not insulin) diabetes medications

12991

46108

1.82

307.65

2.8

2.3

2.45

2.32

g/l

98.28

11981

42557

Inflammatory bowel disease, strict (require KELA)

3480

15004

2.87

307.65

2.9

2.6

2.43

2.37

g/l

9.30

3337

13960

Substance abuse, excluding more controls

6794

34865

1.78

307.65

2.7

2.30

2.33

g/l

2.02

6197

32554

Paralytic ileus and intestinal obstruction

3696

18361

2.38

307.65

3.2

2.4

2.28

2.27

g/l

0.38

3453

16847

Haemorrhage from respiratory passages

5306

22119

2.53

307.65

3.5

2.4

2.32

2.28

g/l

4.87

4931

20237

Heart failure and coronary heart disease

9027

21804

4.22

307.65

4.1

2.4

2.29

2.24

g/l

10.40

8578

19782

Hypothyroidism, drug reimbursement

1553

2409

5.31

307.65

3.0

1.6

2.43

2.48

g/l

2.73

1442

2227

Symptoms and signs involving cognition, perception, emotional state and behaviour

12602

54734

1.68

307.65

2.7

2.6

2.33

2.35

g/l

3.73

11607

50640

Diseases of liver

6900

25286

3.82

307.65

2.9

2.6

2.35

2.32

g/l

2.99

6447

23383

Pain, not elsewhere classified

3897

18180

2.51

307.65

3.0

2.3

2.35

2.39

g/l

2.99

3648

16715

Abnormalities of heart beat

4855

24571

2.19

307.65

2.8

2.3

2.37

2.33

g/l

6.15

4487

22563

Endocrine, nutritional and metabolic diseases

10407

23842

2.48

307.65

3.0

1.9

2.39

2.36

g/l

2.54

9692

21961

Volume depletion

1629

6022

3.62

307.65

4.0

2.4

2.16

2.27

g/l

9.37

1491

5485

Valvular heart disease excluding rheumatic fever

7562

21297

3.16

307.65

3.6

2.2

2.31

2.32

g/l

0.39

7118

19437

Ascites

1393

4591

4.49

307.65

3.9

2.5

2.07

2.29

g/l

24.92

1329

4237

Diaphragmatic hernia

5113

28284

2.12

307.65

3.1

2.5

2.38

2.30

g/l

17.35

4759

25987

Non-ischemic cardiomyopathy

5903

16431

3.95

307.65

3.4

2.3

2.28

2.26

g/l

1.88

5565

14908

Other noninfective gastroenteritis and colitis

3459

17528

2.33

307.65

3.3

2.6

2.31

2.34

g/l

2.71

3244

16153

Hypokalaemia

1910

7544

3.28

307.65

3.3

2.3

2.22

2.32

g/l

8.49

1780

6888

Anxiety (asthma-related co-morbidities)

7274

32588

1.86

307.65

2.5

2.45

2.40

g/l

10.26

6685

30484

Reimbursement for rheumatic diseases

7445

44699

1.85

307.65

2.7

2.6

2.30

2.36

g/l

12.43

6984

41171

Hyperkalaemia

1285

3511

6.19

307.65

6.7

2.4

2.12

2.25

g/l

12.07

1230

3222

Nausea and vomiting

4403

18906

2.78

307.65

3.9

2.4

2.28

2.34

g/l

9.18

4085

17342

Abdominal and pelvic pain

12310

39991

1.67

307.65

2.9

2.4

2.35

2.34

g/l

0.83

11399

36879

Other diseases of the digestive system

5490

25728

2.68

307.65

3.8

2.6

2.30

2.27

g/l

4.27

5127

23607

Any gastric operation

10809

22601

2.73

307.65

3.0

1.9

2.36

2.42

g/l

18.99

10070

20641

Gout, idiopatic and unspecified

4413

19947

2.93

307.65

4.7

2.6

2.19

2.25

g/l

9.21

4162

18339

Vascular disorders of the intestines

1270

4251

4.36

307.65

4.8

2.5

2.35

2.23

g/l

10.08

1202

3887

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

13205

42022

2.11

307.65

3.4

2.3

2.39

2.32

g/l

31.42

12223

38736

5-aminosalicylic acid

3074

12768

2.94

307.65

2.8

2.5

2.42

2.36

g/l

6.36

2925

11797

Other diseases of anus and rectum

4186

22104

2.18

307.65

3.2

2.4

2.35

2.29

g/l

9.85

3852

20277

Diverticular disease of intestine

10112

34272

2.09

307.65

3.1

2.4

2.32

2.30

g/l

3.99

9377

31532

GASTRO-related operations

10809

22601

2.73

307.65

3.0

1.9

2.36

2.42

g/l

18.99

10070

20641

Dizziness and giddiness

9556

49212

1.64

307.65

2.7

2.6

2.33

2.34

g/l

0.24

8806

45457

Neurological diseases

9868

32629

1.62

307.65

2.7

2.5

2.38

2.35

g/l

5.20

9133

30331

L04AD Calcineurin inhibitors

2845

6257

9.94

307.65

9.2

2.4

2.09

2.37

g/l

128.99

2801

5843

Benzodiazepine use

12829

58741

1.59

307.65

2.6

2.37

2.34

g/l

6.71

11615

54484

All pneumoniae

15081

52301

2.14

307.65

3.5

2.3

2.26

2.39

g/l

130.70

14133

48182

Ulcer of lower limb, not elsewhere classified

2888

10673

3.99

307.65

5.5

2.5

2.10

2.28

g/l

50.15

2729

9790

Pure hypercholesterolaemia

10525

35891

2.12

307.65

3.1

2.3

2.31

2.33

g/l

4.87

9877

32895

Use of hypnotics and sedatives

13307

51885

1.58

307.65

2.8

2.6

2.34

g/l

0.12

12232

48077

Oxycodone

6815

24225

3.02

307.65

3.1

2.4

2.20

2.30

g/l

33.99

6343

22257

Iron deficiency

814

1538

11.11

307.65

3.5

2.3

2.54

2.45

g/l

4.26

772

1412

Other disorders of fluid, electrolyte and acid-base balance

5924

21297

3.50

307.65

4.0

2.3

2.20

2.30

g/l

31.25

5515

19409

Concussion

5942

27086

1.85

307.65

2.5

2.4

2.37

2.36

g/l

0.48

5427

25248

Obesity and other hyperalimentation

9060

46266

2.11

307.65

3.1

2.5

2.47

2.36

g/l

68.87

8413

42875

Oedema, not elsewhere classified

5224

22174

2.82

307.65

3.5

2.3

2.28

2.35

g/l

15.24

4863

20284

Codeine or tramadol medication

15355

50966

1.80

307.65

2.8

2.5

2.36

2.34

g/l

4.16

14184

47060

Diabetic nephropathy

2999

14598

2.86

307.65

8.4

2.6

2.04

2.36

g/l

202.62

2902

13438

L04AA Selective immunosuppressants

4345

14699

4.28

307.65

6.6

2.4

2.18

2.37

g/l

98.44

4207

13638

Myocardial infarction, strict

6169

23041

2.20

307.65

3.6

2.3

2.25

2.26

g/l

0.51

5788

21009

All kidney diseases

17441

48882

2.92

307.65

4.5

1.8

2.21

2.42

g/l

307.65

16444

44788

Acute tubulo-interstitial nephritis

9486

39901

2.35

307.65

3.6

1.9

2.21

2.39

g/l

161.73

8813

36368

Other arrhythmias

8237

31943

2.17

307.65

2.8

2.2

2.36

2.37

g/l

1.04

7672

29329

Sodium-glucose co-transporter 2 (SGLT2) inhibitors

3850

20736

2.13

307.65

3.1

2.6

2.52

2.30

g/l

105.71

3570

19339

Budesonide

2357

8443

3.68

307.65

2.9

2.5

2.40

2.35

g/l

3.22

2252

7786

Ulcerative colitis (strict definition, require KELA, min 2 HDR)

2232

10106

2.69

307.52

2.8

2.6

2.42

2.36

g/l

5.88

2135

9424

Unstable angina pectoris

4642

20980

1.98

306.47

3.2

2.4

2.29

2.24

g/l

7.94

4328

19030

Other CVD

3124

16284

2.34

306.09

3.4

2.6

2.18

2.26

g/l

11.13

2851

14886

Ulcerative colitis (strict definition, require KELA)

2281

10444

2.64

305.52

2.8

2.6

2.42

2.36

g/l

6.17

2181

9739

Amputation

1710

7036

3.28

305.40

6.6

2.5

2.03

2.24

g/l

44.51

1618

6465

Certain disorders involving the immune mechanism

2600

12656

2.50

302.19

4.8

2.6

2.27

2.33

g/l

8.42

2484

11745

Primary_lymphoid and hematopoietic malignant neoplasms

3424

18440

2.22

301.35

3.0

2.7

2.17

2.29

g/l

29.25

3269

16933

Other reaction to severe stress, and adjustment disorders

4245

23960

1.97

300.56

3.1

2.5

2.42

2.41

g/l

0.93

3914

22325

Cholelithiasis, broad definition with cholecystitis

10687

49415

1.55

300.54

2.9

2.5

2.36

2.33

g/l

5.64

9867

45495

Crohn's disease of small intestine

1128

3724

4.20

299.43

3.3

2.5

2.45

2.37

g/l

5.57

1089

3463

DVT of lower extremities and pulmonary embolism

5579

34237

1.83

298.88

3.0

2.6

2.27

2.29

g/l

3.20

5205

31444

Streptococcal septicaemia

1450

5527

3.51

297.66

4.6

2.3

2.16

2.31

g/l

18.98

1372

5069

Biological medication for rheuma

2337

10907

2.56

296.50

2.6

2.40

g/l

0.08

2240

10169

1885

8008

2.84

296.43

3.7

2.2

2.32

2.40

g/l

6.29

1775

7379

Falls/tendency to fall

12492

44238

1.50

296.19

2.8

2.5

2.33

2.38

g/l

15.25

11550

41078

Other or unspecified ileus, impaction or obstruction

2597

12664

2.44

296.07

3.2

2.4

2.27

2.26

g/l

0.32

2430

11628

Nonorganic sleeping disorders, excluding more controls

2560

12309

2.40

294.63

2.6

2.5

2.42

2.39

g/l

1.65

2389

11526

Hypotension

2779

14127

2.44

294.16

3.4

2.6

2.17

2.25

g/l

11.83

2531

12892

Cough

4908

27097

1.87

292.90

3.0

2.4

2.36

2.33

g/l

2.54

4541

24948

Alcohol use disorder, Swedish definition

6727

39237

1.71

292.81

2.7

2.26

2.31

g/l

10.02

6158

36453

Hypothyroidism, other/unspecified

10797

49609

1.53

292.48

2.7

2.5

2.39

2.34

g/l

13.77

9853

45879

Colon adenocarcinoma, helper endpoint

2070

9495

2.85

290.53

2.4

2.7

2.44

2.24

g/l

39.55

2000

8704

Myeloproliferative diseases

1409

5448

3.68

289.92

3.0

2.6

2.40

2.28

g/l

12.15

1346

5017

Hypothyreosis and Thyroxine purchase for inclusion criteria

11164

51734

1.51

282.82

2.7

2.5

2.39

2.34

g/l

13.66

10188

47859

Enterocolitis due to Clostridium difficile

1733

7411

3.05

281.65

5.2

2.5

2.10

2.28

g/l

31.20

1638

6797

Bacterial pneumonia (organism specified)

5849

33299

1.77

280.90

3.5

2.6

2.21

2.30

g/l

24.47

5546

30476

Other acute lower respiratory infections

6825

42308

1.68

280.26

3.4

2.5

2.33

g/l

0.14

6338

38982

Peripheral artery operations in Hilmo

1969

8890

2.79

279.32

6.0

2.4

2.08

2.24

g/l

32.22

1858

8131

Coronary artery bypass grafting

3389

13515

2.17

278.80

3.5

2.4

2.26

2.20

g/l

7.48

3176

12231

Myeloproliferative diseases (CML excluded)

1297

4913

3.82

278.71

2.9

2.6

2.41

2.28

g/l

14.24

1235

4514

Cerebrovascular diseases

9108

43383

1.58

278.02

3.3

2.6

2.26

2.31

g/l

12.10

8446

39962

7334

42144

1.65

276.90

2.7

2.27

2.32

g/l

10.39

6703

39156

Implicit fungal Sepsis, including avohilmo

1196

4303

3.87

276.41

4.3

2.2

2.23

2.33

g/l

7.58

1114

3949

7028

41148

1.66

276.33

2.8

2.7

2.26

2.32

g/l

11.05

6421

38235

Cystic kidney disease

680

1756

7.24

276.20

10.3

2.6

2.04

2.32

g/l

39.27

668

1649

Abnormal findings on diagnostic imaging of lung

6301

38501

1.73

275.87

3.1

2.6

2.26

2.29

g/l

3.01

5875

35377

Pulmonary embolism

3985

22994

2.00

275.11

3.0

2.6

2.26

2.29

g/l

2.52

3737

21100

Cholelithiasis

10184

48758

1.53

273.02

2.8

2.5

2.37

2.33

g/l

8.24

9389

44871

Any death

7909

37221

1.64

273.00

3.3

2.6

2.10

2.35

g/l

211.40

7417

34288

Pulmonary heart disease

3985

23106

1.99

270.58

3.0

2.6

2.26

2.29

g/l

2.72

3737

21215

Other systemic involvement of connective tissue

3658

20689

2.04

269.59

2.7

2.5

2.31

2.34

g/l

2.53

3404

18983

Amiodarone users

1619

6957

3.19

267.54

3.8

2.8

2.33

2.25

g/l

7.04

1550

6443

Chronic apical periodontitis

13325

54734

1.45

265.65

2.9

2.5

2.35

g/l

0.31

12247

50645

Cystic kidney disease, including avohilmo

700

1907

6.44

262.16

10.1

2.6

2.04

2.32

g/l

39.58

688

1783

Elevated erythrocyte sedimentation rate and abnormality of plasma viscosity

1313

5136

3.54

261.58

3.6

2.6

2.17

2.27

g/l

8.07

1222

4698

Other disorders involving the immune mechanism, not elsewhere classified

647

1664

6.93

261.46

8.9

2.7

2.06

2.33

g/l

32.34

627

1548

Purpura and other haemorrhagic conditions

1977

9197

2.69

261.06

3.6

2.6

2.24

2.32

g/l

7.01

1883

8508

Other and unspecified disorders involving the immune mechanism, not elsewhere classified

619

1556

7.31

258.88

9.1

2.8

2.05

2.33

g/l

32.93

599

1447

Nephrotic syndrome

639

1654

7.01

257.22

10.9

2.4

2.00

2.33

g/l

39.83

630

1536

Polycystic kidney disease

584

1429

8.30

257.21

10.6

2.6

2.00

2.34

g/l

50.09

574

1341

Other external causes of accidental injury

9291

31956

1.55

256.44

2.7

2.5

2.33

2.38

g/l

12.71

8572

29728

Asthma, including avohilmo

14086

57574

1.42

256.19

2.6

2.40

2.34

g/l

30.94

13091

53106

Spinal stenosis

6379

30575

1.69

255.49

2.7

2.6

2.32

2.28

g/l

8.10

5861

28111

Viral pneumonia

1834

8307

2.70

253.42

4.1

2.4

2.24

2.34

g/l

11.94

1732

7626

Diseases of the respiratory system

7250

23736

1.64

252.80

2.8

2.2

2.35

2.38

g/l

4.84

6737

21801

Dermatitis

7703

51439

1.59

252.54

3.2

2.5

2.33

2.35

g/l

1.47

7158

47499

Chronic pancreatitis

1787

8103

2.78

251.34

3.5

2.7

2.22

2.29

g/l

4.37

1706

7513

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

2134

9971

2.48

250.20

5.7

2.6

2.30

2.37

g/l

8.45

2047

9294

Polyneuropathies and other disorders of the peripheral nervous system

3019

16572

2.16

250.12

4.1

2.7

2.21

2.28

g/l

7.80

2818

15287

Irritable bowel syndrome

3263

18064

2.03

249.34

2.4

2.3

2.43

2.37

g/l

7.74

3014

16667

Dermatitis and eczema

13370

58691

1.43

248.90

3.0

2.5

2.35

g/l

0.29

12390

54173

Crohn disease (strict definition, require KELA, min 2 HDR)

991

3384

3.99

247.78

3.0

2.5

2.44

2.39

g/l

2.06

961

3149

Acute bronchitis

5229

32387

1.75

247.55

3.4

2.5

2.34

2.32

g/l

1.09

4836

29793

Monoclonal gammopathy of undetermined significance (MGUS), including Hilmo

885

2902

4.74

247.23

4.3

2.6

2.17

2.27

g/l

5.82

849

2646

Crohn disease (strict definition, require KELA)

999

3430

3.96

247.21

3.0

2.5

2.44

2.39

g/l

2.05

969

3192

Noninfectious colitis NAS

1912

8916

2.61

246.87

3.4

2.5

2.31

2.34

g/l

1.30

1817

8233

Arthropathies

10179

36205

1.50

246.01

2.8

2.4

2.36

2.37

g/l

1.07

9453

33410

Crohn's disease NAS

1006

3483

3.93

245.65

3.5

2.5

2.40

2.36

g/l

1.02

961

3243

Laparoscopic right hemicolectomy

1051

3860

4.26

245.65

2.4

2.7

2.52

2.26

g/l

37.38

1018

3555

Cutaneous abscess, furuncle and carbuncle

3283

18378

2.03

245.61

4.0

2.5

2.28

2.36

g/l

11.64

3079

17057

Endocarditis

640

1670

5.91

245.26

5.1

2.2

2.14

2.26

g/l

5.06

618

1524

Sulfasalazine

3361

18894

2.00

245.02

2.5

2.4

2.29

2.35

g/l

8.47

3135

17399

Sequelae of external causes of morbidity and mortality

3416

19524

2.02

243.59

3.6

2.6

2.27

2.32

g/l

4.49

3203

17985

Viral hepatitis, IBD co-morbidity

677

1764

4.75

243.28

2.7

1.8

2.41

2.40

g/l

0.14

625

1633

Restless leg syndrome

2032

9814

2.55

243.18

2.5

2.6

2.42

2.33

g/l

10.01

1847

9073

Diseases of the musculoskeletal system and connective tissue

5919

18609

1.70

242.88

2.7

2.3

2.36

2.39

g/l

2.64

5512

17156

Crohn's disease patients in KELA-register (KELA code 209, or 208 with ICD K50)

1039

3681

3.78

242.54

3.0

2.5

2.44

2.39

g/l

2.34

1007

3425

Vitamin B12 deficiency anaemia

1513

6474

2.95

241.11

3.1

2.4

2.33

2.24

g/l

7.69

1419

5901

Tumor necrosis factor alpha inhibitors

2020

9656

2.47

240.51

2.5

2.6

2.41

2.40

g/l

0.15

1935

9003

Disorders of parathyroid gland

2798

14956

2.18

239.90

6.7

2.3

2.22

2.32

g/l

17.07

2592

13670

Other and unspecified polyneuropathies, also in other diseases

2681

14386

2.24

239.52

4.2

2.7

2.21

2.27

g/l

7.13

2499

13277

Acute upper respiratory infections of multiple and unspecified sites

9086

46639

1.52

239.20

3.1

2.5

2.37

2.36

g/l

2.50

8402

43120

Cardiac arrest

854

2193

4.11

238.85

4.1

1.7

2.24

2.28

g/l

1.41

806

1975

IgA nephropathy (IgA glomerulonephritis)

524

1243

8.45

238.72

10.0

2.6

2.03

2.31

g/l

30.79

508

1161

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly, including avohilmo

2232

10823

2.37

237.67

5.6

2.6

2.30

2.37

g/l

8.11

2135

10079

Other and unspecified dermatitis

6429

42947

1.63

236.34

3.2

2.5

2.33

2.35

g/l

1.69

5980

39668

Accidents

9168

31956

1.52

235.94

2.7

2.5

2.33

2.38

g/l

11.84

8467

29728

Secondary malignant neoplasm of other and unspecified sites, including Hilmo

3088

16741

2.07

234.88

2.2

2.7

2.16

2.29

g/l

25.81

2940

15307

Convulsions, not elsewhere classified

2686

14013

2.12

234.27

3.0

2.3

2.28

2.38

g/l

13.14

2465

12917

Secondary malignant neoplasm of respiratory and digestive organs, including Hilmo

2463

12869

2.27

234.19

2.2

2.7

2.27

2.30

g/l

1.71

2360

11747

Mental and behavioural disorders due to psychoactive substance use

7030

43694

1.59

234.19

2.7

2.30

2.33

g/l

2.16

6407

40613

Chronic nephritic syndrome

713

2115

5.44

233.22

9.9

2.4

2.02

2.31

g/l

46.18

701

1962

Congenital malformations of the urinary system

945

3287

4.07

232.75

9.0

2.6

2.12

2.35

g/l

34.81

922

3043

Dorsopathies

11804

43642

1.44

232.32

2.6

2.37

2.34

g/l

5.33

10952

40261

Sub-endpoint used in defining T1D endpoints

3593

20595

1.92

232.03

5.5

2.5

2.13

2.34

g/l

95.03

3358

18999

Chronic hepatitis, not elsewhere classified

642

1776

5.89

231.44

2.8

2.5

2.43

2.35

g/l

2.58

607

1652

Spondylosis

6557

34250

1.63

231.25

2.6

2.36

2.30

g/l

11.37

6020

31579

Other joint disorders

9787

36123

1.49

230.90

2.6

2.4

2.38

2.37

g/l

0.64

9036

33332

Asthma, hospital admissions , main diagnosis only

9658

60445

1.48

230.81

2.7

2.6

2.41

2.35

g/l

21.22

8999

55775

Amputation of toe

1204

4824

3.50

230.74

6.8

2.6

2.02

2.24

g/l

35.13

1146

4444

L01XX Other antineoplastic agents

1020

3789

4.03

230.04

2.8

2.7

2.33

2.26

g/l

3.49

984

3494

Urinary track infection

6429

21006

1.65

227.41

2.8

2.1

2.40

2.47

g/l

15.89

5939

19289

Disorders of calcium metabolism

1009

3668

3.72

226.63

5.1

2.4

2.16

2.32

g/l

14.31

950

3389

Injuries to the abdomen, lower back, lumbar spine and pelvis

5161

32740

1.71

226.52

2.9

2.6

2.26

2.33

g/l

12.52

4714

30165

Idiopathic gout

1467

6474

3.00

225.31

4.7

2.6

2.17

2.25

g/l

5.17

1385

5979

Congenital malformations of the urinary system, including avohilmo

979

3530

3.84

225.14

8.8

2.5

2.12

2.36

g/l

36.61

955

3268

6-mercaptopurine

598

1564

5.54

224.69

2.6

2.5

2.44

2.42

g/l

0.38

582

1441

Substance abuse

6794

42926

1.59

224.34

2.7

2.30

2.32

g/l

1.78

6197

39898

Primary Sclerosing Cholangitis, IBD and UDCA required

462

1022

8.33

224.24

3.7

2.5

2.42

2.37

g/l

0.84

445

950

Hypothyroidism, strict autoimmune, 3 medication purchases required

9885

47930

1.48

224.17

2.7

2.5

2.39

2.35

g/l

9.71

8961

44321

Seropositive rheumatoid arthritis

2999

16704

2.03

223.49

2.6

2.4

2.25

2.34

g/l

15.51

2810

15277

Other/unspecified dorsalgia

4534

27954

1.76

223.32

2.7

2.5

2.38

2.33

g/l

5.84

4181

25724

Sequelae with surgical and medical care as external cause

2746

15136

2.14

223.29

3.7

2.6

2.25

2.31

g/l

4.66

2572

13949

Polyarthrosis

2618

12646

2.15

221.75

2.6

2.5

2.35

2.32

g/l

1.31

2380

11573

Cellulitis

2850

15852

2.07

219.92

4.1

2.6

2.25

2.33

g/l

11.48

2678

14692

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperum or nerve system disorders, excluding more controls

2941

16080

1.99

219.74

2.5

2.46

2.41

g/l

3.38

2656

15099

Other diseases of pericardium

719

2182

4.67

218.78

4.7

2.1

2.19

2.30

g/l

5.12

682

1998

Missing teeth due to accident, extraction or parodontitis

7549

47162

1.55

218.64

3.0

2.6

2.34

2.31

g/l

3.05

6855

43606

Essential (haemorrhagic) thrombocythaemia

683

2051

5.27

218.44

2.9

2.6

2.33

2.31

g/l

0.53

652

1882

Dysphagia

3201

18481

1.96

216.51

2.8

2.5

2.30

g/l

0.06

2956

16990

External causes of morbidity and mortality

7270

24639

1.57

215.04

2.7

2.3

2.34

2.38

g/l

9.75

6756

22887

Injuries to the hip and thigh

6182

37435

1.62

213.90

2.9

2.6

2.23

2.31

g/l

21.78

5663

34459

Undetermined asthma, excluding more controls

1562

6996

2.60

213.87

2.6

2.1

2.39

2.37

g/l

0.44

1457

6390

Open wound of head

6660

42835

1.58

213.49

2.9

2.7

2.28

2.32

g/l

4.55

6088

39659

Intracranial injury

7072

45620

1.55

213.02

2.7

2.6

2.34

2.33

g/l

0.12

6442

42184

Coxarthrosis [arthrosis of hip](FG)

6366

29449

1.61

212.03

2.7

2.5

2.30

2.31

g/l

0.97

5866

27081

Gonarthrosis [arthrosis of knee](FG)

8389

33991

1.51

210.67

2.5

2.34

2.33

g/l

1.34

7701

31335

Diseases of the eye and adnexa

8505

29817

1.51

210.61

3.0

2.3

2.35

2.40

g/l

12.47

7938

27737

Acute peritonitis

1028

3958

3.58

210.49

9.7

2.6

2.01

2.28

g/l

39.99

995

3664

Cholangitis (primary sclerosing, PSC)

1014

3867

3.57

210.04

3.2

2.6

2.32

2.29

g/l

1.08

957

3565

Status post-ami

3199

13978

1.98

209.76

3.6

2.3

2.27

2.21

g/l

7.37

2982

12656

Persons encountering health services for specific procedures, not carried out

1180

4762

3.07

209.44

3.4

2.0

2.28

2.39

g/l

7.25

1081

4363

Left bundle-branch block

1032

3915

3.36

209.21

2.7

2.2

2.29

2.28

g/l

0.25

960

3556

Abnormal serum enzyme levels

3939

23551

1.84

208.72

2.7

2.8

2.30

2.25

g/l

6.44

3765

21721

Ulcerative colitis (strict definition, all Crohn cases excluded)

1804

8734

2.44

208.62

2.6

2.42

2.35

g/l

6.29

1725

8127

Other neurological diseases

8700

48542

1.49

208.19

2.9

2.6

2.30

2.31

g/l

1.37

8061

44668

Haemolytic anaemias

657

1995

5.33

208.19

5.0

2.6

2.20

2.31

g/l

5.47

623

1854

Other abnormal findings of blood chemistry

812

2775

4.24

207.70

3.0

2.6

2.35

2.31

g/l

1.05

783

2560

Other intervertebral disc disorders

9446

40657

1.47

207.14

2.5

2.6

2.38

2.33

g/l

14.68

8752

37510

Arthrosis

7958

30427

1.52

207.08

2.6

2.4

2.34

2.33

g/l

1.20

7337

28061

Personality disorders

2990

17053

1.95

206.50

2.5

2.47

2.41

g/l

6.39

2677

15923

Hydronephrosis

1521

6935

2.66

206.47

4.1

1.9

2.12

2.34

g/l

36.51

1442

6317

Rheumatoid arthritis, including avohilmo

4559

29207

1.73

206.36

2.6

2.27

2.34

g/l

12.12

4251

26830

Enlarged lymph nodes

1897

9360

2.34

205.02

2.8

2.4

2.30

2.37

g/l

5.80

1810

8618

Functional dyspepsia

3188

18639

1.92

204.14

2.8

2.4

2.39

2.33

g/l

7.87

2949

17199

Use of pramipexole

2840

16272

2.03

202.52

3.3

2.6

2.37

2.30

g/l

7.21

2574

14992

Other arthrosis

6026

27076

1.61

201.74

2.7

2.5

2.35

2.32

g/l

4.34

5582

24978

Hyperparathyroidism

2432

13155

2.15

201.39

7.2

2.3

2.20

2.31

g/l

18.56

2255

12012

Benign neoplasm of other and ill-defined parts of digestive system

2363

12853

2.18

201.33

3.5

2.6

2.39

2.30

g/l

9.51

2216

11863

Non-selective monoamine reuptake inhibitors

4277

25908

1.74

200.90

2.5

2.6

2.40

2.31

g/l

17.17

3889

24087

Other symptoms and signs involving cognitive functions and awareness

5857

35168

1.61

199.80

2.6

2.27

2.29

g/l

2.95

5378

32374

Caries of dentine, including avohilmo

9236

34010

1.47

199.77

2.7

2.5

2.31

2.32

g/l

0.70

8443

31510

Thrombocytopenia, unspecified

1120

4612

3.25

199.20

3.4

2.7

2.20

2.29

g/l

5.33

1064

4264

Combinations of oral blood glucose lowering drugs

3369

20243

1.88

199.06

2.7

2.6

2.47

2.24

g/l

92.52

3142

18767

Other extrapyramidal and movement disorders in other diseases

3185

18905

1.93

198.92

2.5

2.6

2.38

2.31

g/l

9.52

2882

17448

Benign neoplasm: Colon, unspecified

3296

19809

1.92

198.64

3.6

2.6

2.32

2.27

g/l

5.29

3058

18245

Migraine

5388

27609

1.63

198.03

2.4

2.47

2.40

g/l

14.39

4977

25643

Viral infections characterized by skin and mucous membrane lesions, including avohilmo

10552

61301

1.42

197.44

3.0

2.6

2.34

2.36

g/l

1.34

9861

56592

Primary biliary cholangitis, wide definition

460

1128

7.18

196.64

3.3

2.3

2.39

2.34

g/l

0.98

439

1047

Dental caries, including avohilmo

8604

31443

1.49

196.38

2.7

2.5

2.30

2.31

g/l

1.28

7869

29086

Myalgia

2849

16291

1.96

196.19

2.7

2.4

2.40

2.38

g/l

1.28

2636

15059

Autoimmune hepatitis, wide definition

711

2299

4.26

194.81

2.9

2.3

2.38

2.36

g/l

0.42

678

2125

Disorders of adult personality and behaviour

3098

18144

1.89

194.33

2.4

2.5

2.47

2.42

g/l

6.04

2774

16936

Symptoms and signs involving the skin and subcutaneous tissue

8490

58323

1.47

193.74

3.0

2.6

2.35

g/l

0.22

7940

53799

Diseases of pulp and periapical tissues and dental caries

7781

28046

1.52

193.37

2.7

2.5

2.29

2.31

g/l

1.88

7110

25942

Pleural effusion

2167

11645

2.23

192.54

3.7

2.6

2.12

2.25

g/l

21.40

2028

10694

Asthma/COPD (KELA code 203)

10964

54980

1.40

191.41

2.6

2.39

2.35

g/l

15.46

10184

50718

Later onset COPD, excluding more controls

2715

11718

2.03

190.66

3.0

2.3

2.23

2.29

g/l

5.09

2502

10612

Other inflammatory liver diseases

965

3756

3.41

190.32

3.0

2.6

2.34

2.32

g/l

0.27

920

3467

Diseases of oral cavity, salivary glands and jaws

6752

23863

1.56

190.24

2.7

2.4

2.28

2.30

g/l

3.06

6211

22008

Disorder of lipoprotein metabolism, unspecified

1717

8499

2.42

189.99

3.6

2.4

2.27

g/l

0.07

1605

7748

Coxarthrosis

5784

25100

1.60

189.91

2.7

2.5

2.30

g/l

0.11

5340

23095

Shoulder lesions

8609

37250

1.47

189.67

2.7

2.5

2.35

2.33

g/l

3.28

7967

34392

Diseases of pulp and periapical tissues, including avohilmo

12049

47178

1.39

189.52

2.8

2.5

2.35

2.34

g/l

1.57

11066

43677

Other necrotizing vasculopathies (FG)

907

3440

3.55

188.76

4.1

2.5

2.17

2.30

g/l

9.81

854

3157

Fungal Sepsis

716

2403

4.32

188.65

4.9

2.3

2.15

2.32

g/l

10.01

678

2218

Ischaemic Stroke, excluding all haemorrhages

6837

35376

1.54

187.93

3.3

2.6

2.25

2.28

g/l

4.74

6300

32514

Stroke, excluding SAH

7194

36812

1.53

187.48

3.3

2.6

2.25

2.29

g/l

7.16

6644

33847

Cytomegalovirus infection, IBD co-morbidity

462

1189

7.04

187.42

9.1

2.5

2.06

2.35

g/l

23.18

451

1112

Osteomyelitis

1005

4045

3.34

187.38

6.4

2.6

2.08

2.28

g/l

24.14

956

3757

Crohn's disease of large intestine

764

2636

3.91

187.34

3.4

2.5

2.41

2.37

g/l

1.13

734

2449

ILD, hospital admission 2, with pulmonary infections

1399

6468

2.69

186.94

3.2

2.5

2.20

2.29

g/l

6.26

1307

5910

Osteoporosis with pathological fracture (FG)

1068

4403

3.15

186.80

2.9

2.3

2.31

2.33

g/l

0.47

974

3972

Nonorganic sleeping disorders

2560

14454

2.00

185.25

2.6

2.42

2.39

g/l

1.64

2389

13438

Unspecified fall

6181

42177

1.55

185.20

2.9

2.6

2.29

2.33

g/l

7.73

5634

38963

Mental and behavioural disorders due to alcohol, excluding acute intoxication

5077

33653

1.63

185.16

2.6

2.8

2.27

2.31

g/l

4.69

4626

31312

Myelodysplastic syndrome, including Hilmo

577

1737

5.36

185.09

3.3

2.5

2.00

2.23

g/l

18.62

562

1587

Charcot foot

356

738

8.76

185.01

7.9

2.1

2.04

2.29

g/l

12.70

337

677

Stroke, including SAH

7479

38374

1.51

184.98

3.3

2.6

2.25

2.29

g/l

7.67

6914

35307

Periodontitis

11460

55497

1.39

184.34

3.2

2.5

2.31

2.35

g/l

8.66

10588

51331

Crohn disease (strict definition, all UC cases excluded)

766

2672

3.86

184.30

2.9

2.5

2.45

2.37

g/l

3.49

742

2484

Other/unspecified cytomegaloviral diseases

418

1019

8.01

183.76

9.6

2.5

2.04

2.35

g/l

25.02

412

955

Symptoms and signs involving the nervous and musculoskeletal systems

6891

48982

1.51

183.43

2.8

2.6

2.35

2.33

g/l

2.84

6384

45216

Chronic periodontitis, including avohilmo

11438

55489

1.39

183.21

3.3

2.5

2.31

2.35

g/l

8.41

10567

51326

Fracture of lumbar spine and pelvis

2981

17741

1.92

182.68

3.0

2.6

2.21

2.30

g/l

13.94

2726

16218

Hyperkinetic disorders, excluding more controls

1289

5221

2.58

182.38

2.4

2.3

2.54

2.53

g/l

0.21

1178

4917

Gonarthrosis

7120

28209

1.52

182.30

2.5

2.4

2.34

2.32

g/l

2.41

6539

26003

Artificial opening status

835

3095

3.69

182.25

3.6

2.4

2.24

2.29

g/l

1.87

806

2873

Cytomegaloviral disease

467

1233

6.64

182.18

9.0

2.6

2.06

2.34

g/l

22.28

456

1152

Exclusions for E4_PCOS_BROAD

2110

11318

2.15

182.08

3.1

2.7

2.38

2.36

g/l

0.46

1979

10529

Implicit fungal Sepsis

669

2210

4.44

181.54

5.0

2.3

2.16

2.32

g/l

9.90

636

2039

Other ulcerative colitis

835

3073

3.58

181.48

3.3

2.5

2.43

2.35

g/l

3.84

807

2862

Cytomegaloviral disease, including avohilmo

469

1246

6.52

181.06

9.0

2.5

2.07

2.34

g/l

21.98

458

1164

Diseases of peritoneum

1401

6581

2.65

180.61

7.8

2.5

2.11

2.30

g/l

26.35

1336

6081

Disorders of eyelid, lacrimal system and orbit

10202

56225

1.41

180.49

2.7

2.6

2.34

g/l

0.09

9415

51908

Mental and behavioural disorders due to alcohol

5815

38163

1.56

180.33

2.7

2.28

2.32

g/l

4.59

5289

35501

Dental operations

7130

25695

1.52

180.27

2.7

2.4

2.29

2.30

g/l

0.99

6541

23743

COPD

5473

30311

1.60

179.83

3.0

2.7

2.27

2.26

g/l

0.70

5062

27836

Hepatic failure, not elsewhere classified

647

2123

4.60

179.08

3.5

2.6

2.10

2.29

g/l

9.39

606

1968

Multiple myeloma, including Hilmo

740

2629

4.05

177.33

3.5

2.7

2.10

2.26

g/l

12.53

713

2396

Arthropathies in other diseases classified elsewhere

598

1865

4.68

176.75

6.8

2.5

2.15

2.31

g/l

10.05

560

1739

Fibromyalgia

1171

5081

2.77

176.22

2.3

2.51

2.42

g/l

7.15

1093

4667

Early onset COPD, excluding more controls

2253

12383

2.05

176.08

3.2

2.4

2.33

2.32

g/l

0.45

2086

11413

Other disorders of skin and subcutaneous tissue, not elsewhere classified

1873

9829

2.25

175.89

4.2

2.5

2.25

2.32

g/l

5.54

1732

9072

Abnormal results of function studies

1228

5507

2.77

175.66

3.2

2.6

2.38

2.34

g/l

1.64

1126

5115

Gingivitis and periodontal diseases

11435

44913

1.38

174.75

2.9

2.5

2.33

2.34

g/l

1.55

10557

41534

Alcohol use disorder, ICD-based

4691

31255

1.63

174.72

2.6

2.8

2.27

2.31

g/l

3.58

4271

29093

Fracture of femur

3590

20338

1.78

174.71

3.1

2.6

2.16

2.27

g/l

21.73

3277

18540

Acquired haemolytic anaemia

489

1386

6.26

174.61

5.3

2.6

2.17

2.30

g/l

6.06

466

1294

Insulin, fast-acting (human)

1667

8336

2.31

174.57

6.1

2.4

2.06

2.36

g/l

98.92

1571

7730

Viral infections characterized by skin and mucous membrane lesions

4901

32949

1.62

174.23

3.6

2.6

2.32

2.35

g/l

4.04

4624

30459

Myocarditis

563

1637

4.26

173.82

3.2

1.7

2.32

2.36

g/l

0.81

542

1493

Collagenous colitis

1275

5866

2.71

172.74

3.3

2.5

2.31

2.33

g/l

0.50

1186

5418

Other headache syndromes

4577

30212

1.63

172.22

2.5

2.43

2.36

g/l

14.03

4243

27963

Chronic ulcer of skin, not elsewhere classified

1041

4438

3.07

170.91

5.0

2.5

2.14

2.29

g/l

12.28

975

4104

Injuries to the thorax

5540

38356

1.56

170.60

3.0

2.6

2.28

2.30

g/l

2.50

5089

35448

Acute upper respiratory infections

12049

55711

1.36

170.18

2.9

2.5

2.36

2.34

g/l

5.54

11118

51378

Decubitus ulcer and pressure area

995

4175

3.17

170.15

5.1

2.5

2.01

2.25

g/l

30.96

920

3833

Total colectomy operation

664

2262

4.19

169.91

3.7

2.6

2.40

2.32

g/l

2.56

640

2112

Total colectomy

664

2262

4.19

169.91

3.7

2.6

2.40

2.32

g/l

2.56

640

2112

Other necrotizing vasculopathies

1059

4591

3.03

168.49

4.5

2.7

2.16

2.29

g/l

11.99

1000

4233

Diabetic retinopathy, excluding more controls

3639

12851

1.83

168.39

5.2

2.4

2.20

2.45

g/l

114.17

3367

11804

Specific personality disorders

2529

14589

1.93

167.87

2.4

2.5

2.48

2.42

g/l

6.33

2274

13615

Intestinal adhesions without obstruction

1168

5225

2.76

167.59

3.3

2.5

2.32

2.26

g/l

2.37

1082

4810

Congenital malformations, deformations and chromosomal abnormalities

6254

41860

1.51

167.45

3.7

2.5

2.37

2.39

g/l

3.02

5839

38829

Hernia of abdominal wall

5351

37011

1.57

167.21

3.3

2.6

2.33

2.31

g/l

1.60

4962

34251

Undetermined asthma

1562

7728

2.32

167.07

2.6

2.2

2.39

2.37

g/l

0.59

1457

7101

Generalized anxiety disorder

1791

9246

2.17

166.91

2.2

2.4

2.48

2.45

g/l

1.77

1632

8599

Other disorders of glucose regulation and pancreatic internal secretion

1151

5137

2.78

166.28

4.8

2.6

2.20

2.32

g/l

9.15

1086

4754

Sciatica+with lumbago

5838

36084

1.53

166.26

2.6

2.39

2.34

g/l

11.58

5461

33334

Weight loss

1420

6995

2.50

162.54

2.7

2.24

2.31

g/l

3.59

1301

6458

Cholecystectomy

8201

51734

1.43

162.42

2.8

2.6

2.39

2.32

g/l

21.63

7610

47635

KRA_PSY_EATING, excluding more controls

912

3577

2.94

162.00

2.5

2.1

2.53

2.54

g/l

0.14

826

3330

Other chronic obstructive pulmonary disease

5207

29390

1.58

161.70

3.0

2.7

2.27

2.26

g/l

0.91

4807

26990

Behavioural syndromes associated with physiological disturbances and physical factors

10514

54413

1.37

161.53

2.4

2.6

2.41

2.35

g/l

22.21

9703

50341

Failure and rejection of transplanted organs and tissues

298

609

10.00

160.46

11.7

2.3

2.07

2.36

g/l

13.97

293

562

Adalimumab

1228

5674

2.59

160.24

2.6

2.41

2.40

g/l

0.25

1181

5289

Congenital malformations, deformations and chromosomal abnormalities, including avohilmo

6884

45341

1.47

159.76

3.6

2.5

2.37

2.39

g/l

3.05

6420

42042

Poisoning by drugs, medicaments and biological substances

2570

15128

1.88

159.07

2.5

2.6

2.42

2.40

g/l

1.06

2325

14108

Other diseases of hard tissues of teeth

6459

23572

1.51

158.89

2.7

2.4

2.30

2.31

g/l

0.58

5927

21770

Other diseases of biliary tract

1235

5821

2.64

158.20

2.9

2.6

2.25

2.28

g/l

0.69

1168

5347

Seronegative rheumatoid arthritis

1416

6959

2.40

157.89

2.6

2.5

2.26

2.33

g/l

4.86

1320

6386

Left ventricular outflow tract obstruction (LVOTO), broad definition

1249

5890

2.57

157.09

3.9

2.8

2.39

2.34

g/l

2.62

1201

5533

Elevated blood glucose level

1143

5218

2.71

156.99

3.7

2.6

2.27

2.32

g/l

1.72

1060

4825

Extrapyramidal and movement disorders

4686

32073

1.60

156.26

2.4

2.7

2.34

2.30

g/l

6.19

4231

29553

Other diseases of arteries and capillaries

1220

5737

2.61

155.63

7.0

2.4

2.22

2.30

g/l

4.36

1156

5272

Ventral hernia

2884

17756

1.82

154.69

3.3

2.5

2.35

2.30

g/l

3.56

2679

16353

Other diseases of stomach and duodenum

920

3862

3.05

154.15

4.0

2.5

2.32

2.26

g/l

2.22

870

3568

Sulfonylureas

4076

21476

1.66

153.08

3.8

2.5

2.26

2.20

g/l

9.17

3743

19608

Abnormal weight loss

1313

6440

2.53

152.68

2.7

2.24

2.30

g/l

3.06

1207

5955

Injury, poisoning and certain other consequences of external causes

5736

19903

1.52

150.49

2.7

2.3

2.35

2.38

g/l

3.44

5319

18426

Non-allergic asthma (mode), excluding more controls

1915

10358

2.02

150.04

2.7

2.1

2.39

2.37

g/l

1.11

1791

9467

Haemorrhage, not elsewhere classified

619

2166

3.93

149.53

5.5

2.4

2.22

2.30

g/l

2.78

583

2000

Other symptoms and signs involving the digestive system and abdomen

1955

10848

2.03

149.41

3.0

2.4

2.37

2.36

g/l

0.48

1797

9977

Agranulocytosis

1411

7131

2.38

148.74

3.1

2.6

2.17

2.33

g/l

19.34

1340

6596

Visual disturbances and blindness

6077

43829

1.48

147.99

2.9

2.6

2.34

2.33

g/l

0.65

5575

40441

Candidiasis, including avohilmo

3500

22725

1.69

147.93

2.9

2.5

2.37

g/l

0.18

3218

20975

ILD, hospital admissions 3, with pneumonia sepsis

1190

5675

2.60

147.93

3.3

2.5

2.17

2.28

g/l

8.26

1112

5191

Secondary right heart disease

686

2592

3.78

147.75

4.4

2.6

2.39

2.25

g/l

9.82

666

2384

Cholangitis (primary sclerosing, PSC), with reimbursement 202

365

935

6.75

147.52

3.7

2.6

2.41

2.37

g/l

0.66

356

872

Poisoning by medicine

2320

13561

1.90

147.46

2.5

2.43

2.40

g/l

1.15

2096

12641

Primary biliary cholangitis (PBC)

397

1074

5.99

147.43

3.1

2.3

2.42

2.35

g/l

1.16

377

995

Superficial injury of head

2917

18149

1.78

147.38

2.6

2.29

2.33

g/l

2.54

2687

16738

Acute pancreatitis

2325

13692

1.92

147.31

3.3

2.6

2.24

2.29

g/l

3.64

2157

12645

Complications of internal orthopaedic prosthetic devices, implants and grafts

2749

16977

1.83

146.88

3.0

2.4

2.26

2.29

g/l

2.36

2511

15521

Acute sinusitis

5613

36144

1.50

146.56

3.0

2.5

2.38

g/l

0.18

5189

33532

Other chronic obstructive pulmonary disease, including avohilmo

6312

37693

1.48

145.10

2.9

2.7

2.29

2.27

g/l

0.92

5804

34745

Other pulmonary heart/vessel disease

733

2887

3.52

144.69

4.4

2.7

2.40

2.25

g/l

10.47

712

2659

Other malignant neoplasms of skin (=non-melanoma skin cancer), including Hilmo

5183

24393

1.54

143.32

3.0

2.7

2.26

2.32

g/l

9.69

4753

22256

Fracture of rib(s), sternum and thoracic spine

3719

24714

1.66

143.12

3.0

2.7

2.25

2.29

g/l

3.92

3408

22822

Other coagulation defects

1008

4538

2.76

143.10

4.1

2.5

2.34

2.35

g/l

0.43

955

4212

Other respiratory diseases principally affecting the interstitium

2328

13932

1.93

143.00

3.5

2.7

2.22

2.26

g/l

1.99

2176

12768

Viral and other specified intestinal infections, including avohilmo

2949

17679

1.73

142.93

3.6

2.3

2.37

2.42

g/l

4.90

2745

16362

Bipolar affective disorders

1959

10978

1.98

142.91

2.5

2.44

2.40

g/l

2.32

1752

10284

Other and unspecified diseases of blood and blood-forming organs

473

1482

5.05

142.61

3.6

2.5

2.30

g/l

0.04

453

1379

Malignant neoplasm of skin, including Hilmo

5635

26730

1.51

142.37

3.0

2.7

2.27

2.33

g/l

12.70

5192

24437

Other viral diseases, including avohilmo

3991

26459

1.61

142.33

3.8

2.5

2.36

2.41

g/l

6.85

3734

24602

Haemorrhoids and perianal venous thrombosis

3779

24897

1.63

142.10

2.9

2.4

2.39

2.30

g/l

19.90

3465

22821

Sleep disorders

9976

53116

1.35

141.86

2.4

2.6

2.41

2.35

g/l

21.59

9227

49128

Mycoses, including avohilmo

10333

61290

1.34

140.98

2.6

2.36

2.35

g/l

0.50

9532

56693

Developmental endpoint to exclude non autoimmune-cases from E4_HYTHY_AI_STRICT

3780

25221

1.64

140.87

2.9

2.5

2.38

2.36

g/l

0.85

3546

23312

Aortic valve malfunction, age under 60 years

1144

5452

2.54

140.19

4.0

2.8

2.38

2.33

g/l

2.16

1101

5117

COPD related to multimorbidity

4811

28480

1.56

139.95

3.1

2.7

2.28

2.25

g/l

2.77

4452

26163

Substance use, excluding alcohol

2125

12298

1.92

139.95

2.6

2.7

2.41

2.37

g/l

1.90

1924

11499

Other (seronegative) rheumatoid arthritis, wide

2261

13451

1.92

139.84

2.7

2.5

2.25

2.32

g/l

8.00

2103

12375

Other viral diseases

3081

19552

1.71

139.11

4.3

2.5

2.33

2.40

g/l

7.82

2877

18205

Other malignant neoplasms of skin (=non-melanoma skin cancer)

4993

23635

1.54

138.46

2.9

2.7

2.26

2.31

g/l

10.11

4562

21544

Chronic periodontitis, complicated

6334

45390

1.45

137.62

3.5

2.6

2.28

2.32

g/l

6.14

5871

42006

Misadventures to patients during surgical and medical care

1775

9898

2.08

137.32

4.0

2.5

2.29

2.32

g/l

1.71

1667

9144

Malignant neoplasm of skin

5366

25687

1.51

137.08

2.9

2.7

2.26

2.32

g/l

13.11

4930

23466

Other disorders of veins

4581

31419

1.55

135.92

2.8

2.5

2.34

2.35

g/l

0.38

4209

28999

Rheumatism, unspecified

1539

8199

2.16

135.56

2.4

2.46

2.37

g/l

7.87

1426

7552

Rotator cuff syndrome

6816

34630

1.44

135.30

2.7

2.5

2.36

2.32

g/l

6.89

6311

31984

Adrenocortical insufficiency

566

2004

3.96

135.25

3.5

2.4

2.30

2.33

g/l

0.48

528

1873

Exclusions for E4_PCOS_CONSORTIUM

7563

35259

1.41

135.11

2.5

2.43

2.41

g/l

2.64

6937

32614

Menorrhagia

3510

12635

1.68

134.95

2.5

2.4

2.48

2.40

g/l

12.28

3223

11619

Degeneration of macula and posterior pole

5785

32367

1.49

134.76

3.0

2.5

2.25

2.27

g/l

2.17

5218

29675

Zoster [herpes zoster], including avohilmo

6014

42470

1.46

134.74

2.9

2.6

2.31

2.32

g/l

1.75

5595

39059

Mycoses

3228

21053

1.69

134.62

3.4

2.6

2.31

2.33

g/l

1.53

3018

19452

Allergic asthma (mode), excluding more controls

2173

12341

1.85

134.62

2.4

2.0

2.45

2.44

g/l

0.86

2042

11391

Hypoglycaemia, other or unspecified

912

4036

2.81

134.59

4.8

2.6

2.21

2.32

g/l

6.40

858

3740

Any operation in hilmo

317

278

6.33

133.58

2.3

1.2

2.37

2.58

g/l

5.86

293

261

Multiple myeloma and malignant plasma cell neoplasms

751

3136

3.31

132.52

3.6

2.6

2.10

2.26

g/l

13.50

725

2886

Other metabolic disorders

1469

7740

2.16

132.00

3.1

2.2

2.38

2.39

g/l

0.55

1381

7131

Polycystic ovarian syndrome, consortium definition

7407

31689

1.41

131.76

2.5

2.3

2.47

2.43

g/l

7.88

6743

29175

Other blood glucose lowering drugs, excl. Insulins

1881

10814

2.00

131.43

3.4

2.6

2.39

2.23

g/l

27.40

1755

9906

Other diseases of pancreas

1111

5402

2.53

131.21

3.6

2.7

2.25

2.28

g/l

1.20

1051

4997

L04AC Interleukin inhibitors

827

3530

2.89

131.05

2.9

2.5

2.40

2.39

g/l

0.41

794

3297

Problems related to lifestyle

1170

5692

2.36

130.96

2.8

2.3

2.39

2.37

g/l

0.41

1069

5299

Visual disturbances

5535

40185

1.47

130.46

2.8

2.6

2.36

2.34

g/l

1.44

5099

37117

Drugs, medicaments and biological substances causing adverse effects in therapeutic use

1141

5583

2.45

130.14

3.4

2.5

2.34

2.35

g/l

0.17

1065

5147

Somatoform disorder

1800

10193

1.99

128.97

2.5

2.43

2.36

g/l

5.61

1665

9433

Transient ischemic attack

6032

35307

1.46

128.93

2.9

2.6

2.28

2.29

g/l

0.15

5595

32420

Colitis, primary sclerosing

278

638

7.76

128.92

3.4

2.5

2.43

2.37

g/l

0.80

267

594

Spondyloarthritis

1990

11592

1.91

128.74

3.0

2.5

2.32

2.33

g/l

0.48

1848

10721

Non-Hodgkin lymphoma, all, including Hilmo

1549

8443

2.13

128.71

2.6

2.7

2.17

2.29

g/l

12.27

1464

7701

Psoriatic and enteropathic arthropathies

1303

6657

2.25

128.71

2.6

2.5

2.39

2.35

g/l

1.58

1226

6167

Seropositive rheumatoid arthritis, wide

2998

19474

1.71

128.36

2.6

2.25

2.33

g/l

12.75

2810

17901

Phobic anxiety disorders

1361

6993

2.16

127.72

2.7

2.4

2.48

2.45

g/l

1.18

1248

6509

Other disorders of lacrimal gland

4136

28663

1.56

127.40

2.8

2.5

2.36

2.35

g/l

0.39

3818

26422

Thoracic aortic aneurysm

1768

10115

2.04

127.27

3.0

2.5

2.26

g/l

0.07

1641

9346

Malignant neoplasm of urinary organs, including Hilmo

1404

7456

2.21

127.05

3.9

2.8

2.14

2.27

g/l

14.59

1321

6809

Insomnia

9678

52609

1.34

126.95

2.3

2.6

2.42

2.36

g/l

19.83

8961

48637

Basal cell carcinoma, including Hilmo

4959

23764

1.51

126.74

3.0

2.7

2.26

2.32

g/l

10.33

4529

21664

ICD-8 DM (Sub-endpoint used for defining DM endpoints)

511

1746

3.86

126.34

7.6

2.3

2.01

2.43

g/l

64.18

482

1654

Intestinal malabsorption

659

2602

3.31

125.95

4.1

2.5

2.27

2.33

g/l

1.74

621

2417

Amputation of foot

477

1635

4.64

125.87

7.6

2.6

1.97

2.23

g/l

20.52

457

1515

Excessive, frequent and irregular menstruation

3871

13794

1.60

125.54

2.6

2.3

2.47

2.42

g/l

6.14

3541

12690

Aortic aneurysm

2793

17611

1.73

125.15

3.1

2.5

2.23

g/l

0.17

2588

16151

Injuries to the knee and lower leg

13276

58005

1.28

125.11

2.8

2.6

2.35

g/l

0.26

12269

53592

Other/unspecified seropositive rheumatoid arthritis (ICD-10)

2909

18896

1.71

124.66

2.5

2.6

2.25

2.33

g/l

12.94

2724

17366

Delirium, not induced by alcohol and other psychoactive substances

1705

9707

2.06

124.63

2.9

2.7

2.17

2.25

g/l

5.88

1531

8918

Other disorders of adrenal gland

650

2567

3.33

124.60

3.5

2.4

2.30

2.35

g/l

1.10

608

2383

Phlebitis and thrombophlebitis (not including DVT)

2572

16230

1.76

124.11

3.4

2.6

2.30

2.32

g/l

1.09

2389

14997

Other/unspecified seropositive rheumatoid arthritis

2952

19260

1.70

123.90

2.5

2.6

2.25

2.33

g/l

12.76

2765

17701

Pericarditis

484

1617

3.92

123.84

4.4

2.2

2.16

2.30

g/l

6.18

458

1485

Acute posthaemorrhagic anaemia

528

1876

3.81

123.78

4.8

2.2

2.27

2.28

g/l

0.12

492

1711

SLE (Finngen)

489

1658

3.95

123.25

3.7

2.2

2.20

2.38

g/l

10.29

469

1538

Methotrexate

1542

8453

2.07

123.23

2.6

2.4

2.29

2.34

g/l

2.64

1446

7761

Disorders of lacrimal system

4944

34963

1.49

123.06

2.8

2.5

2.36

2.35

g/l

0.64

4571

32219

Persons with potential health hazards related to communicable diseases

3726

25101

1.57

122.74

3.6

2.5

2.38

2.43

g/l

4.59

3452

23400

Speech therapy

2969

19459

1.69

122.31

3.1

2.6

2.32

g/l

0.12

2879

17887

Basal cell carcinoma

4790

23142

1.51

121.90

2.9

2.7

2.25

2.31

g/l

11.05

4368

21084

Other and unspecified local infections of skin and subcutaneous tissue

1216

6239

2.30

121.55

4.3

2.6

2.27

2.33

g/l

2.40

1139

5769

Extreme obesity with alveolar hypoventilation

598

2307

3.51

121.35

3.1

2.5

2.50

2.30

g/l

10.79

521

2142

Secondary and unspecified malignant neoplasm of lymph nodes, including Hilmo

1766

10181

1.98

121.18

2.3

2.7

2.21

2.31

g/l

10.03

1669

9305

Other respiratory disorders and diseases

2492

15790

1.77

120.04

3.5

2.6

2.29

2.26

g/l

1.71

2303

14466

Other diseases of the respiratory system

2492

15790

1.77

120.04

3.5

2.6

2.29

2.26

g/l

1.71

2303

14466

Other and unspecified coagulation defects

688

2837

3.10

119.50

4.3

2.4

2.34

2.38

g/l

0.94

658

2647

Lumbar disc prolapse

6850

38204

1.40

119.33

2.5

2.6

2.39

2.33

g/l

15.06

6339

35302

Polymyalgia rheumatica

1727

10026

2.01

119.18

2.7

2.6

2.22

2.27

g/l

3.22

1588

9158

All influenza (not pneumonia)

1622

9104

2.00

119.16

3.9

2.4

2.32

2.36

g/l

1.85

1510

8421

Acute pancreatitis (for exclusion)

2325

14492

1.80

119.08

3.3

2.6

2.24

2.29

g/l

3.79

2157

13409

Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, including Hilmo

872

3993

2.70

119.07

2.7

2.28

2.26

g/l

0.50

829

3620

Abnormal findings on diagnostic imaging of other body structures

1719

9904

1.99

119.04

3.0

2.6

2.32

2.33

g/l

0.15

1621

9160

Polyuria

2661

17137

1.73

119.02

2.9

2.6

2.28

g/l

0.06

2417

15790

ILD, hospital admissions

1926

11537

1.94

118.73

3.0

2.7

2.23

2.26

g/l

1.07

1798

10602

Other local infections of skin and subcutaneous tissue

1268

6649

2.23

118.69

4.3

2.6

2.28

2.32

g/l

1.89

1187

6156

Deforming dorsopathies

3005

19752

1.65

118.38

2.6

2.5

2.41

2.35

g/l

7.31

2791

18212

Supplementary factors related to causes of morbidity and mortality classified elsewhere

3493

23748

1.59

118.32

3.2

2.6

2.35

2.34

g/l

0.13

3208

21986

Unspecified privation

1308

6948

2.21

118.30

3.7

2.6

2.25

2.32

g/l

4.64

1243

6445

Other sleep disorders

1341

7144

2.16

118.13

2.9

2.6

2.38

2.30

g/l

6.09

1260

6637

Polycythaemia vera

517

1881

3.85

118.11

2.8

2.5

2.54

2.28

g/l

18.30

493

1723

Ulcerative ileocolitis

542

1992

3.55

117.98

3.5

2.5

2.38

2.35

g/l

0.57

519

1859

Need for other prophylactic measures

763

3322

2.90

117.80

4.1

2.7

2.29

2.33

g/l

1.17

738

3093

Disorders of skin appendages

5247

38069

1.45

117.71

3.2

2.5

2.37

2.38

g/l

0.66

4889

35327

Behavioural and emotional disorders with onset usually occurring in childhood and adolescence

2026

10441

1.83

117.54

2.7

2.4

2.52

2.50

g/l

0.88

1850

9728

Persistent mood disorders

2069

12487

1.83

117.37

2.6

2.5

2.39

2.35

g/l

2.74

1869

11565

Zoster [herpes zoster]

2238

13895

1.81

117.17

3.4

2.6

2.28

2.30

g/l

1.18

2099

12744

Fitting and adjustment of other devices

3999

24504

1.54

117.14

2.7

2.1

2.31

g/l

0.20

3681

22203

Other pleural conditions

1346

7285

2.20

116.88

4.0

2.6

2.10

2.25

g/l

15.73

1262

6701

Panic disorder

1500

8225

2.02

116.82

2.4

2.49

2.44

g/l

2.97

1368

7633

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperium or nerve system disorders

2941

19268

1.65

116.72

2.5

2.46

2.41

g/l

3.58

2656

17942

Injuries to the shoulder and upper arm

9519

58037

1.32

116.31

2.7

2.6

2.31

2.34

g/l

6.59

8732

53675

Other interstitial pulmonary diseases

1943

11727

1.91

116.19

3.0

2.7

2.23

2.25

g/l

1.10

1814

10774

Immunodeficiencies

648

2643

3.19

116.11

4.1

2.6

2.34

g/l

0.07

619

2452

Other and unspecified drugs and medicaments

1070

5352

2.40

115.84

3.4

2.6

2.33

g/l

0.07

999

4931

Malignant neoplasm of kidney, except renal pelvis, including Hilmo

1214

6335

2.26

115.83

4.0

2.8

2.14

2.27

g/l

13.38

1149

5784

COPD, early/later onset

5264

32420

1.47

115.58

3.0

2.7

2.27

2.26

g/l

0.54

4860

29832

Other complications of surgical and medical care, not elsewhere classified

1162

5955

2.28

115.53

3.3

2.4

2.34

2.35

g/l

0.07

1094

5499

Benign neoplasm: Stomach

1231

6510

2.28

115.44

3.4

2.6

2.41

2.30

g/l

9.37

1152

6007

Interstitial lung disease endpoints

1943

11749

1.91

115.39

3.0

2.7

2.23

2.25

g/l

1.12

1814

10794

Interstitial lung disease

1943

11749

1.91

115.39

3.0

2.7

2.23

2.25

g/l

1.12

1814

10794

COPD, hospital admissions

5214

32211

1.47

115.00

3.0

2.7

2.27

2.26

g/l

0.65

4813

29632

Artrosis, including avohilmo

8904

37963

1.34

114.88

2.5

2.7

2.35

2.32

g/l

5.20

8193

35241

Viral and other specified intestinal infections

2124

12591

1.78

114.06

4.1

2.3

2.34

2.43

g/l

8.88

1976

11616

Open wound of lower leg

1805

10639

1.92

114.03

3.5

2.6

2.27

2.33

g/l

4.46

1672

9810

Schizophrenia or delusion, excluding more controls

2888

18683

1.64

113.03

2.3

2.6

2.39

2.37

g/l

0.90

2589

17493

Benign neoplasm: Ascending colon

1753

10375

1.97

113.01

3.4

2.7

2.34

2.27

g/l

5.86

1660

9560

Nonalcoholic steatohepatitis

219

474

10.49

112.98

2.8

2.4

2.54

2.36

g/l

3.55

213

439

Other general symptoms and signs

631

2495

3.02

112.90

2.5

2.2

2.44

2.43

g/l

0.23

563

2318

Chronic sinusitis

4521

32402

1.48

112.47

2.5

2.6

2.38

2.35

g/l

4.17

4163

29977

Benign neoplasm: Sigmoid colon

2259

14242

1.79

112.29

3.2

2.7

2.35

2.28

g/l

7.30

2136

13130

Migraine with aura

2471

15665

1.70

112.09

2.3

2.4

2.46

2.42

g/l

3.52

2292

14538

Soft tissue disorders related to use, overuse and pressure

3008

20045

1.63

111.94

2.9

2.5

2.34

2.33

g/l

0.61

2783

18530

Fissure and fistula of anal and rectal regions

2484

15834

1.71

111.91

2.6

2.4

2.37

2.32

g/l

4.79

2296

14655

Emotionally unstable personality disorder

1268

6702

2.13

111.83

2.3

2.4

2.51

2.46

g/l

1.92

1137

6248

Isolated proteinuria

443

1533

4.14

111.01

7.5

2.6

2.15

2.31

g/l

9.04

429

1427

COPD, hospital admission 2, with asthma infections

3840

23186

1.56

110.86

3.1

2.7

2.25

2.24

g/l

0.26

3547

21295

Sequelae of cerebrovascular disease

4318

26390

1.51

110.72

3.3

2.6

2.21

2.27

g/l

7.57

3948

24219

Chronic tubulo-interstitial nephritis

509

1872

3.54

110.46

7.3

1.9

2.12

2.37

g/l

20.61

484

1710

ILD, hospital admissions 1, main diag only

1715

10185

1.96

109.45

3.0

2.7

2.23

2.26

g/l

0.84

1602

9368

Abnormal findings on examination of urine, without diagnosis

628

2608

3.17

109.35

6.2

2.7

2.19

2.30

g/l

5.38

607

2418

Other disorders of white blood cells

729

3229

2.87

109.12

3.4

2.7

2.31

2.30

g/l

0.10

686

2991

Special screening examination for other diseases and disorders

1283

6847

2.09

109.00

3.5

2.3

2.38

2.31

g/l

4.06

1239

6223

Malignant neoplasm of urinary organs

1177

6205

2.23

108.86

3.9

2.8

2.12

2.27

g/l

14.67

1112

5656

Thiazolidinediones

1345

7432

2.12

108.64

3.5

2.6

2.38

2.21

g/l

19.45

1252

6860

Postprocedural endocrine and metabolic disorders, not elsewhere classified

1314

7118

2.08

108.35

3.0

2.2

2.38

2.40

g/l

0.37

1237

6549

Diseases of the ear and mastoid process

12403

50552

1.27

108.07

2.7

2.6

2.38

2.35

g/l

6.91

11427

46859

Vitreous haemorrhage

1261

6842

2.18

108.03

6.3

2.7

2.09

2.29

g/l

32.02

1189

6325

Malignant neoplasm of rectum, including Hilmo

1417

7936

2.06

107.97

2.3

2.8

2.34

2.28

g/l

3.13

1341

7242

Abnormalities of gait and mobility

1539

8898

2.02

107.73

2.9

2.7

2.25

2.27

g/l

1.11

1414

8210

Other viral diseases, not elsewhere classified, including avohilmo

2769

18117

1.64

107.71

3.5

2.5

2.38

2.40

g/l

1.49

2589

16871

Respiratory insufficiency

998

4946

2.36

107.69

3.4

2.4

2.34

2.27

g/l

3.17

919

4506

Migraine without aura

1963

11873

1.79

107.57

2.5

2.4

2.48

2.45

g/l

2.05

1826

11034

Vitamin deficiency

648

2733

2.99

106.82

3.3

2.5

2.30

2.29

g/l

0.07

623

2524

Vitamin deficiency, wide

648

2733

2.99

106.82

3.3

2.5

2.30

2.29

g/l

0.07

623

2524

Invasive ventilation

935

4600

2.48

106.79

4.1

2.6

2.20

2.29

g/l

3.89

866

4265

Meniscus derangement

5664

27901

1.42

106.64

2.6

2.5

2.35

2.32

g/l

2.23

5207

25751

Irregular menses

4671

25311

1.46

106.57

2.6

2.3

2.50

2.45

g/l

6.55

4297

23447

Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1209

6500

2.20

106.41

4.1

2.7

2.24

2.31

g/l

4.08

1148

6024

Familial hypercholesterolemia

1690

9977

1.91

106.31

3.5

2.4

2.29

2.26

g/l

0.98

1565

9065

Colitis, primary sclerosing, strict definition

215

469

8.42

106.23

3.4

2.4

2.43

2.40

g/l

0.35

206

439

Heart failure and hypertrophic cardiomyopathy

350

1112

5.39

106.05

4.9

2.6

2.31

2.26

g/l

1.02

333

1025

Malignant neoplasm of liver and intrahepatic bile ducts, including Hilmo

673

2905

2.93

106.04

3.0

2.7

2.30

2.24

g/l

1.31

636

2651

Diagnoses used for exclusion with ILD

2880

19313

1.63

105.87

3.1

2.7

2.28

g/l

0.34

2676

17798

Multiple myeloma, Monoclonal gammopathy of undetermined significance (MGUS)

447

1607

3.96

104.98

3.5

2.6

2.08

2.25

g/l

8.12

429

1473

Multiple myeloma

447

1607

3.96

104.98

3.5

2.6

2.08

2.25

g/l

8.12

429

1473

Allergic asthma (mode)

2173

13192

1.72

104.88

2.4

2.1

2.45

2.43

g/l

1.52

2042

12202

Non-allergic asthma (mode)

1915

11507

1.80

104.58

2.7

2.2

2.39

2.37

g/l

1.29

1791

10552

Other disorders of ear

10036

52046

1.30

104.55

2.7

2.6

2.35

2.33

g/l

1.32

9161

48234

Postprocedural disorders of digestive system, not elsewhere classified

486

1823

3.62

103.98

3.2

2.5

2.37

2.30

g/l

1.72

455

1697

Other viral diseases, not elsewhere classified

1954

11955

1.80

103.98

4.0

2.6

2.35

2.38

g/l

1.17

1822

11139

Spondylopathies (FG)

1406

7866

1.99

103.92

2.5

2.38

2.37

g/l

0.37

1297

7309

Disorders of synovium and tendon

5611

35609

1.41

103.91

2.8

2.5

2.38

2.35

g/l

2.28

5187

32952

Ulcerative rectosigmoiditis

944

4664

2.38

103.70

3.0

2.5

2.40

2.35

g/l

2.45

904

4347

Type of accident

3213

22064

1.58

103.57

3.1

2.6

2.35

2.34

g/l

0.18

2957

20419

Malignant neoplasm of kidney, except renal pelvis

1074

5587

2.27

103.50

4.1

2.8

2.13

2.27

g/l

13.33

1016

5108

COPD-related respiratory insufficiency

1475

8518

2.02

103.23

3.8

2.7

2.30

2.23

g/l

5.61

1364

7810

Fracture of shoulder and upper arm

3992

28485

1.50

103.22

2.9

2.6

2.27

2.33

g/l

9.64

3644

26291

Immunodeficiency with predominantly antibody defects

399

1355

4.17

102.71

4.2

2.5

2.34

2.37

g/l

0.58

389

1264

IBD (strict) with PSC

199

418

8.76

102.48

3.6

2.5

2.46

2.38

g/l

0.99

193

391

Other infectious diseases, including avohilmo

1125

5983

2.22

102.03

4.7

2.6

2.17

2.29

g/l

9.97

1070

5517

Osteonecrosis

808

3831

2.61

102.00

3.4

2.6

2.24

2.31

g/l

3.18

761

3550

3693

22462

1.54

101.90

2.9

2.6

2.25

2.24

g/l

0.53

3300

20527

DVT of lower extremities

2139

13574

1.75

101.30

3.2

2.6

2.28

2.30

g/l

0.96

1983

12516

Post-traumatic stress disorder

882

4230

2.36

101.25

2.3

2.2

2.52

2.48

g/l

1.00

799

3934

Candidiasis

1627

9640

1.91

101.07

3.4

2.5

2.32

2.35

g/l

1.56

1514

8910

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

1658

9808

1.87

100.98

2.6

2.44

2.41

g/l

1.24

1489

9149

In situ neoplasms

4564

33575

1.46

100.46

3.1

2.5

2.29

2.32

g/l

2.88

4180

30833

Other embolism and thrombosis

1482

8592

1.96

100.04

3.7

2.5

2.26

2.31

g/l

2.12

1380

7927

Hypopituitarism

834

3987

2.48

99.99

2.9

2.5

2.42

2.35

g/l

3.13

790

3735

Ulcerative enterocolitis

431

1539

3.72

99.53

3.3

2.4

2.43

2.34

g/l

2.41

409

1430

Coeliac disease

1338

7543

2.02

98.66

2.8

2.5

2.37

2.36

g/l

0.17

1239

6976

Diabetic retinopathy

4628

21285

1.50

98.51

4.9

2.8

2.20

2.40

g/l

99.39

4277

19748

Drug-induced adrenocortical insufficiency

321

995

5.06

98.27

3.5

2.6

2.38

2.33

g/l

0.76

304

926

Other or ill-defined heart diseases

602

2506

2.84

98.14

4.1

2.2

2.25

2.32

g/l

2.35

564

2292

Diseases of the myoneural junction and muscle

1459

8494

1.97

98.13

2.9

2.7

2.24

2.29

g/l

1.88

1313

7853

Acidosis

344

1104

4.58

98.01

4.3

2.3

2.13

2.28

g/l

4.23

320

1022

Ulcerative proctitis

735

3379

2.61

97.61

2.7

2.5

2.41

2.36

g/l

1.65

697

3150

Hepatocellular carcinoma, including Hilmo

447

1666

3.69

97.34

2.9

2.7

2.34

2.23

g/l

3.47

424

1530

Chronic rhinitis, nasopharyngitis and pharyngitis

3394

23766

1.53

97.32

2.6

2.39

2.35

g/l

3.53

3134

22061

Disturbance of activity and attention

1255

6708

2.00

96.92

2.5

2.54

2.52

g/l

0.70

1147

6258

Chronic myeloproliferative disease

277

809

6.41

96.60

3.6

2.5

2.22

2.26

g/l

0.67

266

745

Barrett oesophagus

669

3013

2.81

96.46

3.0

2.6

2.35

2.24

g/l

4.46

626

2798

Gonarthrosis,primary

9759

47521

1.29

96.23

2.5

2.7

2.34

2.30

g/l

7.95

8953

43945

Other and unspecified effects of external causes

2807

18995

1.59

96.17

2.8

2.6

2.39

g/l

0.31

2557

17676

Malignant neoplasm of stomach, including Hilmo

756

3549

2.57

96.11

2.5

2.7

2.39

2.25

g/l

7.44

707

3228

Systemic lupus erythematosus

489

1913

3.35

95.49

3.7

2.4

2.20

2.37

g/l

8.93

469

1774

Diabetic retinopathy, strict definition

2286

13456

1.76

95.39

6.5

2.8

2.08

2.40

g/l

138.51

2120

12525

Hypocalcemia

381

1329

4.22

95.35

6.2

2.5

2.13

2.34

g/l

9.08

366

1234

Disturbances of skin sensation

2867

19546

1.58

95.04

2.6

2.5

2.40

2.38

g/l

1.27

2658

18122

Traumatic subdural haemorrhage

1608

9007

1.87

94.62

3.0

2.6

2.20

2.24

g/l

2.42

1453

8346

Hyperkinetic disorders

1312

7157

1.96

94.60

2.5

2.54

2.52

g/l

0.96

1201

6672

Benign neoplasm: Rectum, anus and anal canal

2314

15238

1.69

94.58

3.1

2.7

2.35

2.28

g/l

8.11

2179

14022

Viral pneumonia (unknown virus, not influenza)

815

3963

2.45

94.26

4.3

2.6

2.24

2.32

g/l

3.69

773

3686

Hypertrophic cardiomyopathy

581

2507

3.04

93.69

4.0

2.8

2.33

2.28

g/l

1.72

552

2319

Unspecified acute lower respiratory infection

1715

10489

1.82

93.60

3.6

2.6

2.28

2.32

g/l

1.53

1615

9728

Suicide or other Intentional self-harm

2395

15776

1.64

93.28

2.6

2.43

2.38

g/l

2.55

2160

14708

Attention to artificial openings

551

2311

3.03

92.44

3.1

2.1

2.28

2.29

g/l

0.12

523

2124

Carpal tunnel syndrome

6499

43810

1.35

92.27

2.8

2.5

2.40

2.34

g/l

13.97

5975

40466

Mixed and other personality disorders

848

4191

2.34

92.10

2.6

2.5

2.46

2.40

g/l

2.35

744

3919

Eating disorder

916

4626

2.24

91.90

2.5

2.3

2.53

g/l

0.06

830

4275

Alcohol dependence

2764

18878

1.58

91.44

2.6

2.8

2.28

2.29

g/l

0.51

2520

17593

Follow-up examination after treatment for malignant neoplasms

1149

6319

2.07

91.32

2.5

2.4

2.35

2.26

g/l

5.27

1074

5709

Pruritus

1329

7657

1.97

91.09

3.9

2.4

2.35

g/l

0.18

1246

7062

Subjective visual disturbances

2763

18917

1.59

91.00

2.7

2.6

2.37

2.35

g/l

1.64

2555

17452

Papulosquamous disorders

4136

30376

1.45

90.79

2.7

2.6

2.36

2.33

g/l

2.40

3857

28105

Transport accidents

4708

29087

1.41

90.67

2.6

2.5

2.36

2.38

g/l

1.71

4367

27113

Adenocarcinoma, papilloma adenocarcinoma and mucinous carcinomas of rectum

1175

6560

2.07

90.65

2.3

2.8

2.34

2.28

g/l

3.39

1110

5982

Pyogenic arthritis

786

3819

2.43

90.52

4.4

2.6

2.21

2.28

g/l

2.64

736

3540

Urticaria and erythema

3722

26827

1.48

90.51

2.8

2.5

2.40

2.38

g/l

1.35

3426

24867

Benign neoplasm: Transverse colon

1314

7664

2.00

89.48

3.5

2.7

2.37

2.27

g/l

8.21

1254

7090

Superficial injury of lower leg

2779

19058

1.57

89.38

3.0

2.5

2.38

2.37

g/l

0.74

2566

17610

COPD, hospital admissions 3, with asthma pneumonia sepsis

3209

19422

1.54

89.32

3.2

2.7

2.22

2.23

g/l

0.22

2973

17811

Benign neoplasm: Rectum

2073

13511

1.72

89.30

3.1

2.7

2.36

2.28

g/l

8.33

1958

12453

Other diseases of lip and oral mucosa

4418

32876

1.43

88.86

2.6

2.37

2.35

g/l

1.57

4077

30439

Benign neoplasm: Caecum

1314

7687

2.00

88.82

3.2

2.7

2.38

2.27

g/l

9.77

1234

7093

Pain and other conditions associated with female genital organs and menstrual cycle

1950

10256

1.71

88.73

2.3

2.50

2.46

g/l

2.25

1778

9497

SLE, ICD10

462

1827

3.33

88.69

3.7

2.4

2.19

2.37

g/l

9.13

444

1693

SLE, strict definition

462

1827

3.33

88.69

3.7

2.4

2.19

2.37

g/l

9.13

444

1693

Injuries to the ankle and foot

7422

50267

1.31

88.63

3.0

2.6

2.37

2.38

g/l

0.85

6905

46633

Adenocarcinoma and papilloma adenocarcinoma of rectum

1130

6277

2.08

88.62

2.3

2.8

2.34

2.27

g/l

3.12

1066

5727

Thyrotoxicosis, other and/or unspecified

2090

13562

1.68

88.23

2.8

2.5

2.38

2.36

g/l

0.95

1921

12535

Squamous cell neoplasms and carcinomas of the skin, including Hilmo

1506

8995

1.88

88.04

3.4

2.7

2.19

2.24

g/l

2.67

1392

8114

Hypercalcemia

608

2752

2.86

88.02

4.3

2.6

2.15

2.30

g/l

7.45

565

2544

Disease of hard tissues of teeth, NOS

5693

22651

1.38

87.78

2.6

2.4

2.35

2.31

g/l

7.08

5211

20965

Duodenal ulcer

1261

7251

1.98

87.46

3.9

2.6

2.24

2.22

g/l

0.67

1162

6671

Other diseases of upper respiratory tract

11995

51827

1.25

87.36

2.6

2.36

2.33

g/l

8.27

11104

47760

Enteropathic arthropathies

326

1069

4.11

87.11

2.9

2.5

2.40

2.35

g/l

0.89

317

997

Myelodysplastic syndrome

245

692

5.93

87.01

2.9

2.5

1.94

2.21

g/l

13.00

240

633

Secondary polycythaemia

364

1292

3.95

86.90

2.5

2.7

2.55

2.29

g/l

15.44

338

1202

Folate deficiency anaemia

215

559

7.08

86.80

3.0

2.5

1.96

2.21

g/l

7.57

207

522

Fentanyl

1160

6474

2.01

86.79

3.4

2.4

2.18

2.27

g/l

5.05

1068

5912

Other specified and unspecified personality disorders

940

4919

2.18

86.79

2.6

2.5

2.47

2.39

g/l

4.14

856

4576

Exposure to other specified factors

8518

59083

1.29

86.71

2.8

2.6

2.36

g/l

0.37

7821

54761

Acute myeloid leukaemia and myelodysplastic syndromes

368

1316

3.90

86.60

2.6

2.5

1.97

2.25

g/l

20.55

359

1209

Congenital malformations of the circulatory system

1489

8692

1.85

86.40

3.3

2.7

2.41

2.37

g/l

2.14

1401

8101

Familial hypercholesterolemia, with ischemic heart disease

1093

6094

2.10

86.00

3.6

2.5

2.28

2.23

g/l

2.29

1015

5532

Unspecified jaundice

633

2897

2.66

85.92

2.7

2.6

2.20

2.27

g/l

2.06

586

2666

Other infectious diseases

926

4893

2.24

85.86

5.1

2.6

2.16

2.28

g/l

9.17

877

4506

Vascular diseases of the intestine

552

2411

2.94

85.75

4.6

2.4

2.20

2.25

g/l

1.05

518

2200

Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

2758

11755

1.57

85.64

2.2

2.54

2.53

g/l

0.50

2535

10913

Fracture of lower leg, including ankle

5782

43994

1.35

85.60

3.0

2.6

2.32

2.35

g/l

2.30

5333

40658

Sicca syndrome [Sjögren]

961

5141

2.19

85.32

2.6

2.4

2.35

2.36

g/l

0.38

894

4745

Injuries to the elbow and forearm

7534

51585

1.30

85.05

2.8

2.6

2.34

2.37

g/l

2.65

6907

47675

Other viral hepatitis

676

3165

2.51

84.91

2.6

2.40

2.39

g/l

0.26

623

2959

Disorders of sclera, cornea, iris and ciliary body

5775

44860

1.35

84.80

3.0

2.6

2.32

2.35

g/l

3.95

5342

41505

4777

32664

1.41

84.36

3.0

2.6

2.24

2.27

g/l

2.01

4380

29914

Isolated proteinuria with specified morphological lesion

218

582

6.58

84.28

7.7

2.2

2.15

2.33

g/l

4.11

211

539

Unspecified mental disorder

3924

28831

1.44

84.10

2.4

2.6

2.41

2.37

g/l

4.16

3526

26783

Malignant neoplasm of stomach

655

3064

2.58

84.06

2.5

2.7

2.39

2.25

g/l

6.65

614

2799

Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder

650

3046

2.60

83.64

2.7

2.25

g/l

0.10

617

2776

Amputation of ankle bones

356

1285

3.99

83.59

9.0

2.6

1.92

2.24

g/l

22.52

338

1191

Heartburn

1202

6865

1.96

83.50

2.8

2.5

2.37

2.34

g/l

1.08

1106

6341

Other viral hepatitis, including avohilmo

707

3390

2.43

83.42

2.6

2.41

2.38

g/l

0.54

652

3165

Other symptoms and signs involving the nervous and musculoskeletal systems

4385

32913

1.41

82.97

2.7

2.6

2.40

2.34

g/l

9.55

4073

30419

Other and unspecified disorders of white blood cells

531

2321

2.93

82.23

3.4

2.6

2.32

2.31

g/l

0.25

502

2150

Arterial embolism and thrombosis

730

3603

2.43

81.98

4.6

2.4

2.19

2.24

g/l

1.91

682

3301

Other eating disorders

551

2389

2.70

81.95

2.6

2.3

2.57

2.52

g/l

1.19

498

2205

Congenital malformations of heart and great arteries

1320

7565

1.89

81.77

3.3

2.7

2.43

2.38

g/l

3.33

1246

7057

Psoriasis

2945

20800

1.52

81.77

2.7

2.36

2.33

g/l

1.69

2741

19264

Autoimmune hepatitis

178

413

7.56

81.48

2.3

2.0

2.43

2.37

g/l

0.70

173

383

Other obstetric conditions, not elsewhere classified

2791

12066

1.54

81.44

2.2

2.53

2.52

g/l

0.40

2561

11211

Neuromuscular dysfunction of bladder

1032

5718

2.08

81.39

3.1

2.6

2.25

2.31

g/l

2.49

951

5301

Postmenopausal osteoporosis with pathological fracture

848

4477

2.32

81.18

2.8

2.4

2.33

g/l

0.00

765

4062

Eating disorders

1052

5818

2.01

80.20

2.7

2.4

2.50

2.48

g/l

0.41

959

5389

Right hemicolectomy

750

3811

2.41

79.62

3.3

2.6

2.36

2.26

g/l

4.88

710

3506

Sarcoidosis

1404

8534

1.85

79.57

3.3

2.6

2.33

2.32

g/l

0.12

1336

7932

Speech and linguistic disorders, excluding more controls

752

3462

2.26

79.56

3.2

2.5

2.46

2.43

g/l

0.49

694

3242

Secondary and unspecified malignant neoplasm of lymph nodes

941

5101

2.13

79.55

2.5

2.7

2.20

2.30

g/l

5.99

885

4663

Alcohol abuse, main dg, excluding more controls

1443

8755

1.80

79.52

2.6

2.7

2.32

2.33

g/l

0.42

1314

8233

Paracetamol or NSAID medication

1633

4937

1.77

79.30

2.5

2.8

2.33

2.35

g/l

0.57

1501

4580

Other skin changes

2262

15364

1.62

79.00

3.8

2.6

2.30

g/l

0.14

2137

14132

Other and unspecified myopathies

1064

6038

2.05

78.98

2.9

2.7

2.21

2.27

g/l

2.13

945

5571

Emotional disorders starting during childhood or adolecense, excluding more controls

419

1553

2.99

78.86

2.7

2.3

2.61

2.59

g/l

0.30

381

1447

Viral hepatitis, including avohilmo

799

4094

2.25

78.74

2.5

2.6

2.41

2.37

g/l

0.84

734

3829

Viral hepatitis

764

3857

2.29

78.65

2.6

2.40

2.37

g/l

0.68

701

3607

Other diseases of oesophagus

1070

6049

2.02

78.64

3.1

2.6

2.32

2.25

g/l

3.50

974

5585

Other crystal arthropathies

316

1104

4.16

78.62

3.3

2.6

2.17

2.25

g/l

1.64

293

1015

Chronic lymphocytic leukaemia and small lyphocytis leukaemia, including Hilmo

418

1680

3.30

78.18

3.0

2.7

2.25

g/l

0.10

401

1540

Chronic lymphocytic leukaemia, helper endpoint

418

1680

3.30

78.18

3.0

2.7

2.25

g/l

0.10

401

1540

Chronic lymphocytic leukaemia

418

1680

3.30

78.18

3.0

2.7

2.25

g/l

0.10

401

1540

Other symptoms and signs involving the circulatory and respiratory systems

730

3629

2.32

77.96

3.3

2.4

2.35

2.30

g/l

1.37

684

3339

Covid-19 suspected case

2112

14081

1.62

77.75

3.1

2.4

2.42

2.40

g/l

0.72

2006

13034

Tubulo-interstitial nephritis, not specified as acute or chronic

750

3778

2.29

77.59

4.3

1.9

2.22

2.35

g/l

8.85

705

3444

Other abnormalities of plasma proteins

272

884

4.75

77.41

4.0

2.6

2.12

2.29

g/l

4.54

263

817

Injuries to unspecified part of trunk, limb or body region

1164

6788

1.95

77.17

3.7

2.6

2.28

2.32

g/l

1.97

1078

6286

Primary gonarthrosis, bilateral

5661

37158

1.35

76.96

2.5

2.7

2.34

2.29

g/l

9.31

5135

34278

Cervicalgia

2158

14511

1.61

76.89

2.5

2.39

2.32

g/l

5.79

1999

13360

Squamous cell neoplasms and carcinomas of the skin

1207

7128

1.93

76.77

3.5

2.7

2.18

2.23

g/l

2.40

1120

6432

Infliximab

286

931

4.03

76.61

2.2

2.4

2.43

2.42

g/l

0.08

276

868

Crystal arthropathies, rheuma endpoint

316

1123

4.08

76.39

3.3

2.5

2.17

2.25

g/l

1.95

293

1023

Skin changes due to chronic exposure to nonionizing radiation

4516

31292

1.40

76.27

3.1

2.6

2.24

2.26

g/l

2.21

4131

28635

Cardiomyopathy, Hypertrophic obstructive

260

809

4.45

76.13

4.5

2.2

2.33

2.31

g/l

0.19

248

745

Superficial injury of hip and thigh

1727

11133

1.71

76.12

3.0

2.6

2.25

2.31

g/l

4.01

1582

10200

Malignant neoplasm of rectum

1103

6360

1.98

76.11

2.3

2.8

2.34

2.27

g/l

3.26

1038

5801

Actinic keratosis

4412

30653

1.40

75.86

3.1

2.6

2.24

2.26

g/l

2.14

4035

28046

Thyrotoxicosis

2597

18189

1.54

75.66

2.8

2.5

2.37

2.36

g/l

0.57

2387

16765

Pneumocystosis

313

1125

4.22

75.58

4.3

2.6

2.10

2.27

g/l

5.70

300

1044

Pneumocystosis, including avohilmo

313

1125

4.22

75.58

4.3

2.6

2.10

2.27

g/l

5.70

300

1044

Asthma and allergy, excluding more controls

1111

6225

1.90

75.45

2.4

2.0

2.51

2.47

g/l

1.52

1049

5754

Malignant neoplasm of small intestine, including Hilmo

412

1671

3.23

75.26

2.9

2.7

2.38

2.28

g/l

2.08

397

1536

Need for immunization against other single viral diseases

295

1014

4.20

75.19

11.1

2.6

2.11

2.32

g/l

8.02

284

948

Psoriatic arthropathies

1018

5726

1.99

74.58

2.5

2.39

2.34

g/l

2.25

950

5318

Other autoimmune haemolytic anaemias

235

726

5.56

74.39

3.6

2.5

2.13

2.30

g/l

4.85

222

679

Diseases of spleen

289

992

4.26

74.19

4.3

2.6

2.23

2.29

g/l

1.02

275

925

Adverse effects, not elsewhere classified

1968

13087

1.63

74.09

2.9

2.6

2.41

2.39

g/l

0.81

1784

12146

Umbilical hernia

2810

20040

1.51

73.97

3.5

2.7

2.31

g/l

0.11

2613

18584

Thyroiditis, ILD-related definition

1169

6867

1.90

73.91

2.9

2.4

2.39

g/l

0.05

1079

6332

Migraine with aura and triptan purchases

1531

9592

1.73

73.90

2.2

2.4

2.48

2.46

g/l

0.74

1421

8894

2612

17248

1.54

73.47

2.8

2.5

2.27

2.25

g/l

0.89

2306

15726

Gingival hyperplasia

479

2103

2.89

73.30

7.8

2.6

2.24

2.34

g/l

3.97

463

1957

Anosmia

180

398

5.00

73.30

2.4

1.5

2.35

2.33

g/l

0.24

166

362

Stomatitis and related lesions

2057

13857

1.61

73.29

2.7

2.6

2.36

g/l

0.05

1902

12823

Endometriosis

3131

12997

1.48

73.02

2.3

2.44

2.41

g/l

2.27

2861

11957

Complications of cardiac and vascular prosthetic devices, implants and grafts

328

1221

3.81

72.75

8.0

2.4

2.13

2.24

g/l

2.83

316

1129

Viral pneumonia (known virus, not influenza)

407

1677

3.22

72.60

4.8

2.7

2.18

2.29

g/l

3.13

388

1551

Pneumonia due to other infectious organisms, not elsewhere classified

430

1799

3.02

72.54

4.1

2.5

2.14

2.32

g/l

8.60

407

1661

Internal derangement of knee

3614

26533

1.42

72.50

2.5

2.37

2.34

g/l

2.61

3300

24526

Sensorineural hearing loss

8076

43993

1.27

72.38

2.7

2.6

2.33

2.30

g/l

4.32

7302

40690

Other/unspecified rheumatoid arthritis

1363

8447

1.82

72.37

2.9

2.5

2.22

2.30

g/l

5.74

1261

7735

Non-follicular lymphoma

1105

6514

1.96

72.18

2.6

2.7

2.15

2.26

g/l

8.03

1041

6025

Urticaria

2932

21103

1.48

71.90

2.8

2.5

2.42

2.39

g/l

1.50

2706

19585

Conductive and sensorineural hearing loss

8413

45855

1.26

71.74

2.7

2.6

2.33

2.31

g/l

3.18

7621

42425

Disorders of continuity of bone

1047

6025

1.95

71.56

3.2

2.5

2.36

2.37

g/l

0.21

993

5582

Systemic lupus erythematosus, unspecified

390

1583

3.21

70.99

3.5

2.4

2.20

2.38

g/l

7.98

374

1464

Disorders of magnesium metabolism

166

416

7.75

70.94

4.0

2.4

2.16

2.31

g/l

1.91

161

386

Other and unspecified mood [affective] disorders

707

3576

2.22

70.74

2.6

2.3

2.48

2.43

g/l

1.21

638

3347

Other disorders of bladder

1326

8196

1.82

70.74

3.0

2.7

2.22

2.27

g/l

2.26

1177

7562

Malnutrition

332

1261

3.67

70.55

3.3

2.7

2.13

2.32

g/l

5.57

318

1175

Early onset COPD

2253

15609

1.57

70.34

3.2

2.7

2.33

2.29

g/l

3.33

2086

14490

Malignant neoplasm of small intestine

329

1241

3.63

70.21

3.0

2.5

2.39

2.27

g/l

2.49

318

1148

Right bundle-branch block

434

1833

2.86

69.97

3.1

2.1

2.29

2.27

g/l

0.31

403

1671

Drug-induced cataract

332

1260

3.59

69.93

6.8

2.5

2.22

2.33

g/l

2.81

317

1170

Cholecystitis

1558

10017

1.72

69.79

3.0

2.6

2.28

2.27

g/l

0.27

1452

9178

Malignant neoplasm of liver and intrahepatic bile ducts

419

1772

3.01

69.43

3.0

2.7

2.27

2.22

g/l

0.76

397

1622

Open wound of ankle and foot

1121

6642

1.89

69.41

4.5

2.6

2.25

2.33

g/l

4.41

1047

6161

Lymphoid leukaemia

691

3579

2.35

69.39

3.0

2.8

2.25

2.27

g/l

0.37

665

3312

Other postsurgical states

702

3606

2.26

69.27

3.2

2.3

2.46

2.34

g/l

5.71

657

3351

Diabetic neuropathy

1555

10191

1.79

69.05

5.4

3.1

2.13

2.34

g/l

40.99

1462

9451

Carcinoma in situ of skin of other and unspecified parts of face

1107

6648

1.95

68.95

3.3

2.6

2.19

2.24

g/l

2.90

1003

6068

Other degenerative diseases of the nervous system

2907

15222

1.48

68.81

2.3

2.5

2.24

2.29

g/l

5.79

2619

14087

Ovarian cyst

3198

13235

1.46

68.65

2.6

2.3

2.42

2.41

g/l

0.49

2933

12176

Other symptoms and signs involving the urinary system

1153

6926

1.88

68.59

3.2

2.6

2.30

2.29

g/l

0.21

1085

6406

Abscess of anal and rectal regions

842

4579

2.06

68.48

3.2

2.5

2.37

2.32

g/l

1.43

798

4256

Faecal incontinence

999

5777

1.95

67.73

2.8

2.3

2.34

g/l

0.06

921

5300

Etanercept

697

3598

2.24

67.72

2.3

2.5

2.38

2.39

g/l

0.21

659

3352

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

5267

40074

1.32

67.35

2.6

2.7

2.37

2.33

g/l

5.99

4853

37136

Social phobias

778

4116

2.08

67.35

2.5

2.3

2.50

2.47

g/l

1.01

707

3824

Coxarthrosis, primary

6485

43582

1.29

66.86

2.7

2.30

2.29

g/l

1.31

5972

40065

Other specified/unspecified systemic involvement of connective tissue

638

3227

2.34

66.68

2.8

2.4

2.31

2.36

g/l

1.45

609

2991

Migraine without aura and triptan purchases

1537

9872

1.68

66.56

2.4

2.49

2.47

g/l

0.83

1427

9153

Secondary uncertain malignant neoplasm

1394

8823

1.74

66.42

2.4

2.7

2.17

2.29

g/l

11.64

1306

8036

Drug-induced neutropenia

797

4371

2.14

66.10

2.6

2.7

2.14

2.32

g/l

12.99

759

4049

Inflammatory diseases of female pelvic organs

6036

32994

1.30

66.10

2.5

2.3

2.45

2.43

g/l

2.24

5501

30371

Carcinoma in situ of other and unspecified digestive organs

566

2792

2.53

65.76

3.2

2.7

2.34

2.27

g/l

1.79

545

2591

Benign neoplasm: Descending colon

841

4718

2.11

65.74

3.6

2.7

2.36

2.27

g/l

4.24

807

4374

Clear cell adenocarcinoma of kidney

561

2742

2.49

65.51

3.4

2.7

2.16

2.28

g/l

4.73

537

2509

Artificial joint operation, meniscal resection

9588

51401

1.23

65.42

2.5

2.7

2.33

2.31

g/l

2.57

8785

47541

Symptoms and signs involving speech and voice

3477

26184

1.41

65.34

2.7

2.6

2.34

2.33

g/l

0.24

3206

24132

Pain in thoracic spine

1525

9851

1.68

65.25

2.5

2.42

2.34

g/l

6.30

1436

9080

Amyloidosis

322

1244

3.46

65.21

4.8

2.4

2.15

2.27

g/l

3.52

308

1137

Protozoal diseases

404

1748

3.03

64.99

4.0

2.6

2.16

2.29

g/l

4.76

381

1631

Alcohol-induced chronic pancreatitis

708

3761

2.22

64.63

3.3

2.8

2.21

2.28

g/l

2.08

669

3544

Sleep disorders, other/unspecified

419

1804

2.79

64.59

2.7

2.5

2.41

2.40

g/l

0.09

384

1667

Suppurative and necrotic conditions of lower respiratory tract

670

3505

2.28

64.58

3.6

2.7

2.09

2.25

g/l

9.37

631

3257

Asthma and allergy

1111

6517

1.80

64.23

2.4

2.1

2.51

2.46

g/l

2.05

1049

6038

Benign neoplasm: Small intestine

517

2493

2.63

64.13

4.1

2.6

2.37

2.28

g/l

2.61

487

2314

Acute gastritis

808

4463

2.07

64.13

3.3

2.5

2.39

2.27

g/l

7.73

753

4129

Protozoal diseases, including avohilmo

414

1819

2.95

64.12

4.0

2.6

2.16

2.29

g/l

5.00

390

1701

Chronic viral hepatitis

532

2530

2.44

64.06

2.8

2.5

2.39

g/l

0.05

485

2358

Cyst of kidney

846

4800

2.07

63.52

4.3

2.5

2.25

2.28

g/l

0.87

797

4448

Other abnormal uterine and vaginal bleeding

2200

10967

1.54

63.18

2.5

2.4

2.42

2.38

g/l

3.38

1976

10069

Spondylolisthesis/Spondylolysis

1815

12280

1.60

63.10

2.6

2.41

2.32

g/l

8.25

1682

11323

Other disorders of the musculoskeletal system and connective tissue

1559

10269

1.67

63.08

2.7

2.34

2.31

g/l

1.28

1461

9494

Gonarthrosis, primary, with knee surgery

6214

39187

1.29

63.00

2.5

2.7

2.34

2.28

g/l

10.48

5629

36156

Benign neoplasm of other and unspecified endocrine glands

1387

8913

1.73

62.79

2.8

2.6

2.34

2.32

g/l

0.75

1302

8286

Obsessive-compulsive disorder

639

3249

2.19

62.49

2.4

2.3

2.53

2.46

g/l

2.07

566

3023

Leisure time condition

1885

12898

1.58

62.45

2.8

2.6

2.34

g/l

0.23

1704

11949

Other and unspecified acquired haemolytic anaemias

182

533

5.87

62.15

5.3

2.5

2.21

2.29

g/l

0.96

174

494

Trochanteric bursitis

1487

9683

1.68

62.14

2.8

2.4

2.39

2.35

g/l

2.06

1362

8906

Disorders of conjunctiva

8584

55523

1.24

62.13

2.7

2.6

2.39

2.37

g/l

2.71

7971

51309

Other hearing loss

3199

23243

1.42

61.93

2.9

2.6

2.27

2.26

g/l

0.67

2890

21390

Hepatocellular carcinoma

319

1258

3.36

61.90

2.8

2.6

2.29

2.22

g/l

1.33

300

1155

Late syphilis, including avohilmo

252

886

4.05

61.76

6.4

2.4

2.17

2.31

g/l

3.15

235

823

Diabetic maculopathy

1595

10167

1.71

61.69

6.5

2.8

2.09

2.40

g/l

95.40

1480

9462

Mental disorders, not otherwise specified

810

4508

2.01

61.56

2.5

2.45

2.41

g/l

1.25

746

4189

Mental and behavioural disorders due to sedatives or hypnotics

686

3630

2.15

61.49

2.4

2.5

2.40

2.36

g/l

0.82

604

3384

Other specified/unspecified bacterial intestinal infections

743

4071

2.12

61.39

3.3

2.6

2.32

2.31

g/l

0.21

691

3774

Unspecified nephritic syndrome

307

1199

3.43

61.05

8.0

2.3

2.07

2.32

g/l

12.92

300

1109

Drug-induced osteoporosis with pathological fracture

263

968

4.00

60.49

3.7

2.4

2.24

2.30

g/l

1.05

247

897

Amyloidosis, other/unspecified

275

1024

3.71

60.40

4.9

2.4

2.12

2.27

g/l

4.02

266

940

Mouth breathing

3831

29483

1.37

60.32

2.8

2.38

2.32

g/l

7.56

3541

27452

Portal vein thrombosis

247

870

4.03

60.24

4.1

2.7

2.24

2.30

g/l

0.70

235

804

Other enthesopathies

2832

20844

1.43

60.12

2.4

2.5

2.40

2.36

g/l

4.46

2632

19291

Organic, including symptomatic, mental disorders

5728

32514

1.30

60.01

2.5

2.7

2.23

2.27

g/l

7.59

5109

29965

L01XE Protein kinase inhibitors

623

3286

2.30

59.63

2.8

2.7

2.21

2.29

g/l

2.42

601

3049

Abnormal involuntary movements

1427

9336

1.68

59.35

2.8

2.6

2.34

2.32

g/l

0.89

1311

8646

Injury of unspecified body region

849

4884

1.99

59.34

3.6

2.6

2.28

2.32

g/l

1.12

787

4514

Diseases of male genital organs

4900

19345

1.33

59.33

3.1

2.8

2.27

g/l

0.02

4575

18068

Discitis, unspecified

261

957

3.83

59.28

4.3

2.6

2.16

2.25

g/l

1.26

249

892

Epilepsy

3019

22439

1.41

59.14

2.7

2.6

2.29

2.30

g/l

0.62

2784

20741

Primary hyperparathyroidism

1186

7476

1.79

59.10

3.5

2.5

2.34

2.32

g/l

0.43

1081

6880

Malignant neoplasm of bladder, including Hilmo

1265

7957

1.74

58.86

3.0

2.8

2.21

2.22

g/l

0.15

1157

7248

Persons with potential health hazards related to socioeconomic and psychosocial circumstances

2514

17988

1.46

58.84

3.0

2.4

2.44

g/l

0.02

2325

16724

Other and unspecified nonorganic psychotic disorders

1717

11605

1.58

58.71

2.2

2.6

2.41

2.40

g/l

0.30

1537

10843

Other disorders of eyelid

4758

35687

1.32

58.65

2.7

2.6

2.30

g/l

0.27

4364

32794

Disorders of psychological development

1063

5944

1.79

58.59

3.0

2.6

2.49

2.46

g/l

1.03

978

5534

Late syphilis

216

720

4.45

58.52

6.8

2.4

2.15

2.30

g/l

3.02

205

666

Disorders of oesophagus in diseases classified elsewhere

303

1203

3.38

58.51

4.2

2.5

2.19

2.25

g/l

0.98

288

1109

Kela-code for severe mental illness

3375

25630

1.38

58.28

2.3

2.6

2.41

2.36

g/l

4.51

3013

23815

Deficiency of other B group vitamins

294

1146

3.37

58.15

3.3

2.4

2.36

2.27

g/l

1.68

283

1060

Other and unspecified aplastic anaemias

178

523

5.06

58.11

4.2

2.3

2.05

2.31

g/l

7.68

173

484

Paralytic ileus

445

2072

2.59

57.93

3.2

2.5

2.23

2.24

g/l

0.15

412

1905

Ulcer of oesophagus

763

4304

2.05

57.49

3.7

2.6

2.34

2.22

g/l

6.41

716

3980

Left ventricular outflow tract obstruction, narrow definition

545

2749

2.34

57.49

3.0

2.8

2.43

2.35

g/l

2.80

521

2569

Myocardial infarction, with ST-elevation

1902

13292

1.56

57.47

3.4

2.7

2.23

g/l

0.10

1785

12195

Oesophagitis

606

3171

2.23

57.39

3.6

2.6

2.31

2.26

g/l

1.16

563

2941

Personal history of other diseases and conditions

1006

6024

1.81

56.95

3.3

2.0

2.41

2.49

g/l

3.88

928

5581

Congenital malformations of cardiac chambers and connections

117

259

8.16

56.92

4.7

3.3

2.48

g/l

0.04

117

251

Colonic or urogenital fistula

2662

19650

1.44

56.92

2.7

2.36

2.33

g/l

2.82

2466

18200

Reactive arthropathies, FINNGEN

690

3750

2.07

56.72

2.8

2.5

2.30

2.34

g/l

1.39

651

3462

Vasculitis limited to skin, not elsewhere classified

346

1478

3.01

56.65

3.5

2.4

2.25

2.31

g/l

0.91

319

1366

Schizophrenia or delusion

2888

21532

1.41

56.55

2.3

2.6

2.39

2.36

g/l

1.48

2589

20039

Other and unspecified immunodeficiencies with predominantly antibody defects

194

623

4.62

55.68

4.3

2.3

2.37

g/l

0.01

194

573

Ankylosing spondylitis

868

5087

1.90

55.47

2.6

2.35

2.31

g/l

1.22

799

4747

Fracture of foot, except ankle

2360

17116

1.46

55.39

3.2

2.6

2.33

2.37

g/l

3.83

2197

15886

Coxibs

2961

11474

1.42

55.25

2.2

3.3

2.32

2.27

g/l

4.00

2719

10651

Wegener granulomatosis

230

821

4.00

55.08

4.7

2.4

2.12

2.30

g/l

5.28

224

764

Schizophrenia, schizotypal and delusional disorders

2894

21675

1.40

54.99

2.3

2.6

2.39

2.36

g/l

1.36

2595

20165

Other and unspecified injuries of head

825

4806

1.95

54.98

2.8

2.6

2.30

2.32

g/l

0.38

760

4421

Mixed hyperlipidaemia

455

2182

2.49

54.94

3.9

2.4

2.35

2.28

g/l

1.99

426

2020

Recurrent aphthous stomatitis , including avohilmo

1472

9842

1.63

54.94

2.7

2.6

2.37

2.35

g/l

0.72

1364

9079

Mental and behavioural disorders due to opioids

387

1721

2.63

54.80

2.7

2.4

2.43

2.40

g/l

0.41

351

1592

Mental and behavioural disorders due to multiple drug use and use of multiple drugs and use of other psychoactive substances

635

3383

2.09

54.72

2.3

2.6

2.48

2.39

g/l

2.68

568

3151

Hepatomegaly and splenomegaly, not elsewhere classified

162

468

5.30

54.67

3.8

2.4

2.36

2.32

g/l

0.38

153

444

Other obstructive and reflux uropathy

449

2130

2.46

54.60

5.4

1.9

2.20

2.38

g/l

8.68

423

1950

Fall on and from stairs and steps

2671

19860

1.43

54.55

2.7

2.6

2.33

2.34

g/l

0.25

2462

18324

Cervical disc disorders

3501

27003

1.36

54.46

2.6

2.39

2.31

g/l

16.67

3249

24974

Bronchiectasis

881

5267

1.92

54.43

2.7

2.6

2.24

2.26

g/l

0.44

814

4843

Special screening examination for infectious and parasitic diseases

1920

9654

1.51

54.39

2.2

2.1

2.42

g/l

0.23

1786

8911

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

684

3765

2.06

54.38

2.6

2.5

2.44

2.38

g/l

1.44

628

3484

Varicose veins

6211

38509

1.26

54.31

2.7

2.5

2.34

2.31

g/l

2.34

5691

35459

Unintentional cut, puncture, perforation or haemorrhage during surgical and medical care

837

4926

1.94

54.29

4.3

2.6

2.27

2.32

g/l

1.82

787

4556

Psychotic depression

571

2943

2.17

54.27

2.4

2.6

2.38

2.36

g/l

0.31

509

2766

Psoriasis vulgaris

1824

12755

1.54

53.84

2.9

2.7

2.34

2.33

g/l

0.64

1702

11862

Other shoulder lesions

938

5651

1.83

53.83

2.8

2.5

2.40

2.35

g/l

1.77

855

5213

Open wound of forearm

1009

6217

1.80

53.81

3.1

2.5

2.28

2.32

g/l

1.07

914

5749

Other problems related to primary support group, including family circumstances

1030

6161

1.77

53.77

3.7

2.4

2.47

g/l

0.12

971

5730

Disorders of muscles

1030

6365

1.78

53.73

3.0

2.5

2.31

2.33

g/l

0.62

974

5882

Lesion of ulnar nerve

1372

9070

1.65

53.69

2.8

2.6

2.39

2.32

g/l

5.64

1272

8483

Infection of intervertebral disc (pyogenic)

221

787

4.11

53.69

4.7

2.5

2.11

2.23

g/l

2.01

210

728

Viral warts

996

6115

1.80

53.68

5.1

2.5

2.32

2.37

g/l

2.61

951

5653

Superficial injury of abdomen, lower back and pelvis

1579

10732

1.59

53.66

2.8

2.6

2.33

2.36

g/l

0.99

1438

9943

Other bursopathies

1316

8627

1.66

53.60

3.1

2.6

2.30

g/l

0.15

1212

7953

Reactive arthropathies

839

4913

1.89

53.55

2.9

2.5

2.29

2.34

g/l

1.44

790

4570

Diseases of salivary glands

3209

24545

1.38

53.50

2.7

2.6

2.39

2.35

g/l

3.55

2994

22696

Carcinoma in situ of colon

387

1793

2.79

53.47

3.2

2.6

2.38

2.28

g/l

2.62

370

1667

Erosion of teeth , including avohilmo

2513

18511

1.43

53.45

3.3

2.5

2.39

g/l

0.33

2347

17237

Dronedarone medication

330

1406

2.92

53.35

2.3

2.1

2.39

2.27

g/l

3.54

303

1282

Giant cell arteritis

520

2683

2.37

53.27

2.8

2.6

2.22

2.28

g/l

1.49

474

2457

Lichen simplex chronicus and prurigo

691

3864

2.06

53.27

3.8

2.5

2.31

2.32

g/l

0.03

640

3582

Injuries to the neck

2229

16162

1.47

52.70

2.5

2.6

2.37

2.36

g/l

0.05

2066

15021

Other renal tubulo-interstitial diseases

285

1135

3.12

52.69

6.8

1.8

2.21

2.40

g/l

6.50

277

1049

Seropositive rheumatoid arthritis, strict definition

1485

10050

1.61

52.55

2.3

2.6

2.25

2.33

g/l

7.31

1399

9286

Type 1 diabetes, definitions combined

802

4616

1.88

52.46

4.2

2.4

2.20

2.43

g/l

25.28

750

4323

Postviral fatigue syndrome

132

334

5.76

52.29

3.0

2.3

2.45

2.46

g/l

0.07

127

306

Eosinophilic disease (BM)

205

693

3.94

52.24

3.6

2.3

2.25

2.33

g/l

1.11

191

641

Fibrosis of liver

146

417

6.27

52.17

3.5

2.4

2.42

2.30

g/l

1.33

137

388

Convalescence

538

2781

2.22

51.89

3.0

1.9

2.41

2.38

g/l

0.77

495

2558

Sequelae of injuries, of poisoning and of other consequences of external causes

2235

16270

1.46

51.75

2.7

2.35

2.34

g/l

0.53

2073

15142

Iridocyclitis

2213

16115

1.47

51.55

3.1

2.6

2.30

2.34

g/l

2.63

2043

14908

Atopic dermatitis, strict definition with reimbursement

2666

19086

1.40

51.32

2.6

2.4

2.43

2.44

g/l

0.18

2479

17742

Necrosis of pulp, including avohilmo

5605

45355

1.26

51.31

2.7

2.6

2.42

2.37

g/l

9.40

5156

42217

Type 1 diabetes, strict (exclude DM2)

796

4603

1.87

51.27

4.2

2.4

2.20

2.43

g/l

24.66

744

4309

Monoamine oxidase A inhibitors

1094

6937

1.72

51.27

2.4

2.7

2.37

2.31

g/l

2.86

983

6486

Unspecified misadventure during surgical and medical care

649

3620

2.09

51.25

3.7

2.6

2.29

2.30

g/l

0.24

611

3364

Childhood asthma (age<16), excluding more controls

966

4524

1.76

51.20

2.6

1.9

2.50

2.53

g/l

0.82

896

4194

Other and unspecified vasculitis limited to skin

309

1313

3.02

51.19

3.5

2.4

2.26

2.31

g/l

0.67

284

1216

Other follicular disorders

748

4305

1.94

51.15

3.7

2.5

2.36

2.37

g/l

0.20

695

4007

Other aneurysm

620

3405

2.12

51.12

4.2

2.4

2.17

2.24

g/l

2.08

586

3140

Adhesive capsulitis of shoulder

1606

11060

1.56

51.11

3.2

2.6

2.30

2.32

g/l

0.83

1484

10223

Conjunctivitis

7502

50722

1.23

51.04

2.6

2.40

2.38

g/l

1.46

6970

46882

Other endocrine disorders

536

2665

2.22

51.03

3.9

2.6

2.46

2.43

g/l

0.49

495

2485

Kela reimbursement Agammaglobulinemia (D80-84)

147

420

5.53

50.85

3.6

2.5

2.46

2.35

g/l

1.45

147

390

Drug-induced osteoporosis

206

728

4.12

50.62

3.7

2.4

2.27

2.32

g/l

0.69

195

674

Presbycusis

1678

11597

1.56

50.58

2.8

2.6

2.24

2.22

g/l

0.67

1471

10577

Benign neoplasm: Adrenal gland

838

5047

1.90

50.36

2.7

2.37

2.30

g/l

3.16

791

4673

Hypoparathyroidism

434

2135

2.49

50.18

3.6

2.3

2.32

2.33

g/l

0.14

405

1976

Other condition

1417

9567

1.61

50.13

3.5

2.7

2.35

2.34

g/l

0.04

1337

8885

Diffuse large B-cell lymphoma

540

2857

2.23

50.11

2.6

2.7

2.11

2.27

g/l

7.68

501

2622

Diffuse large B-cell lymphoma, helper endpoint

540

2857

2.23

50.11

2.6

2.7

2.11

2.27

g/l

7.68

501

2622

Diffuse large B-cell lymphoma, including Hilmo

540

2857

2.23

50.11

2.6

2.7

2.11

2.27

g/l

7.68

501

2622

Excessive attrition of teeth

5890

48139

1.25

49.63

2.9

2.6

2.40

2.38

g/l

3.67

5455

44716

Pain associated with micturition

1217

7993

1.67

49.44

3.0

2.5

2.36

2.34

g/l

0.36

1114

7391

Other disorders of bone

1801

12735

1.51

49.25

2.8

2.5

2.37

g/l

0.27

1665

11831

UC patients in KELA-register (code 208), prior to 1994

471

2398

2.34

48.96

3.5

2.7

2.42

2.30

g/l

5.20

447

2239

Arterial embolism and thrombosis of lower extremity artery

426

2092

2.46

48.93

3.8

2.4

2.22

2.24

g/l

0.26

397

1908

Temporomandibular joint disorders, including avohilmo

4130

31833

1.31

48.90

2.3

2.5

2.46

2.42

g/l

5.50

3828

29508

Chronic hepatitis NAS

193

668

4.14

48.75

2.8

2.3

2.32

2.33

g/l

0.14

178

618

ILD-related respiratory insufficiency

436

2192

2.49

48.68

3.7

2.7

2.27

2.24

g/l

0.59

412

2028

Oter anti-inflammatory and antirheumatic agents, non-steroids

2410

9707

1.45

48.63

2.4

3.4

2.28

2.23

g/l

3.69

2211

9007

Acquired absence of limb

160

496

4.78

48.44

7.5

2.4

2.06

2.26

g/l

3.93

154

460

Pyothorax

509

2683

2.26

48.26

3.5

2.7

2.09

2.26

g/l

7.35

483

2497

Hypertension, portal

173

13.90

48.25

4.5

2.4

2.19

2.27

g/l

0.42

162

Sequelae of other external causes

610

3381

2.06

48.14

3.8

2.5

2.27

2.32

g/l

1.42

580

3139

Hyperplasia of prostate

3642

16002

1.35

48.10

3.0

2.8

2.23

g/l

0.13

3372

14892

Herpesviral [herpes simplex] infections

1159

7573

1.67

48.07

3.3

2.5

2.32

2.36

g/l

1.20

1095

6998

Procreative management

2924

18320

1.37

48.06

3.0

2.7

2.41

g/l

0.12

2761

17113

Idiopathic thrombocytopenic purpura

367

1719

2.63

48.03

3.4

2.6

2.38

2.32

g/l

1.39

353

1600

Disorder of the sleep-wake schedule

232

877

3.38

48.02

2.6

2.5

2.40

2.38

g/l

0.19

218

808

Other hammer toe(s) (acquired)

1622

10274

1.54

48.00

2.6

2.5

2.32

g/l

0.03

1467

9366

Cardiac murmurs and other cardiac sounds

870

5213

1.79

47.97

3.2

2.4

2.41

2.39

g/l

0.55

805

4806

Diseases of external ear

3592

28306

1.33

47.85

3.0

2.6

2.36

2.32

g/l

3.38

3254

26197

Rash and other nonspecific skin eruption

977

6158

1.76

47.85

3.1

2.6

2.32

2.33

g/l

0.14

920

5703

Other disorders of eye and adnexa

1392

9468

1.59

47.47

2.8

2.6

2.36

2.37

g/l

0.23

1285

8768

Keratitis

3489

27389

1.33

47.44

3.1

2.6

2.33

2.35

g/l

1.20

3228

25337

Triptan medication for migraine, min. 3 purchases

4989

30271

1.27

47.31

2.2

2.5

2.49

2.43

g/l

9.37

4631

28149

Spontaneous rupture of synovium and tendon

838

5101

1.83

47.07

2.7

2.6

2.33

2.30

g/l

0.94

762

4703

malignant neoplasm of male genital organs, including Hilmo

2804

12739

1.39

46.83

2.6

2.9

2.19

2.24

g/l

4.45

2568

11724

Nail disorders

837

5097

1.82

46.77

4.0

2.6

2.32

2.35

g/l

0.54

781

4723

Acute alcohol intoxication, ICD10

1893

13639

1.48

46.73

2.6

2.7

2.32

2.33

g/l

0.44

1713

12745

Childhood asthma (age<16)

967

4644

1.71

46.65

2.6

2.0

2.50

2.53

g/l

0.65

897

4311

Fracture of forearm

5484

40639

1.25

46.41

2.8

2.5

2.34

2.37

g/l

3.55

5042

37495

Malignant neoplasm of rectosigmoid junction, including Hilmo

347

1612

2.65

46.31

2.4

2.6

2.32

2.26

g/l

1.05

337

1482

Arthropathic psoriasis

1088

7077

1.69

46.27

2.6

2.37

2.33

g/l

1.37

1016

6587

Other disorders starting during childhood or adolecense, excluding more controls

376

1662

2.38

46.07

4.0

2.4

2.54

g/l

0.00

356

1563

Agoraphobia

318

1397

2.63

46.01

2.4

2.2

2.51

2.44

g/l

1.32

286

1294

Congenital malformations of aortic and mitral valves

450

2296

2.30

46.01

3.0

2.8

2.42

2.35

g/l

2.39

430

2147

Superficial injury of thorax

1509

10492

1.55

45.95

3.0

2.7

2.32

g/l

0.03

1384

9714

malignant neoplasm of male genital organs

2754

12552

1.39

45.86

2.6

2.9

2.18

2.24

g/l

4.94

2515

11552

Vasomotor and allergic rhinitis

3447

26442

1.32

45.68

2.4

2.6

2.45

2.39

g/l

10.07

3212

24560

Chronic Coagulation defects

286

1228

2.90

45.60

4.2

2.5

2.45

2.40

g/l

1.07

274

1132

Radiculopathy

1593

11207

1.53

45.47

2.6

2.35

2.29

g/l

4.32

1440

10310

Other juvenile arthritis

381

1813

2.40

45.44

3.1

2.4

2.40

2.47

g/l

1.66

365

1671

Dermatitis due to substances taken internally

574

3176

2.06

45.43

3.2

2.5

2.32

2.35

g/l

0.57

535

2938

Other chondrocalcinosis

208

792

3.87

45.34

3.2

2.5

2.16

2.25

g/l

1.53

194

728

Atopic dermatitis

5487

36012

1.25

45.30

2.5

2.42

2.40

g/l

1.87

5071

33454

Amenorrhoea

600

3327

1.98

45.26

2.8

2.3

2.48

2.50

g/l

0.39

558

3068

Malignant neoplasm of pancreas, including Hilmo

883

5507

1.78

45.23

2.3

2.7

2.21

2.27

g/l

2.43

839

4996

Voice disturbances

2628

20051

1.39

45.20

2.6

2.35

2.34

g/l

0.84

2436

18503

Juvenile arthritis (FINNGEN)

426

2119

2.27

45.08

3.1

2.4

2.38

2.47

g/l

2.21

407

1954

Disorders of vitreous body and globe

5246

40996

1.26

44.97

3.4

2.6

2.29

2.32

g/l

3.30

4853

37825

Retinal vascular occlusion

1293

8817

1.61

44.97

3.7

2.6

2.23

2.25

g/l

0.83

1202

8076

Dental pulpitis, including avohilmo

8899

48935

1.19

44.88

2.5

2.6

2.44

2.36

g/l

32.48

8166

45580

Wet age-related macular degeneration

1996

14171

1.47

44.83

2.9

2.6

2.24

g/l

0.22

1789

12851

malignant neoplasm of female genital organs, including Hilmo

1578

10569

1.52

44.74

2.4

2.5

2.24

2.40

g/l

20.42

1446

9569

Shock, not elsewhere classified

142

424

4.71

44.65

4.7

2.4

2.15

2.30

g/l

1.98

136

392

severe traumatic brain injury, does not include concussion

2354

17742

1.41

44.59

3.0

2.7

2.24

2.26

g/l

1.17

2150

16313

Speech and linguistic disorders

786

4529

1.81

44.58

3.2

2.6

2.47

2.45

g/l

0.28

728

4230

Amputation of thigh

386

1903

2.48

44.48

6.0

2.6

2.02

2.21

g/l

8.10

361

1740

Redundant prepuce, phimosis and paraphimosis

1875

13346

1.46

44.46

3.2

2.8

2.29

2.28

g/l

0.22

1759

12495

Disorders of vitreous body

5103

40071

1.26

44.33

3.4

2.6

2.29

2.32

g/l

3.27

4721

36988

Fibroblastic disorders

2296

17207

1.41

44.32

2.8

2.6

2.29

2.28

g/l

0.15

2137

15883

Vitamin D deficiency

231

907

3.19

44.19

3.4

2.4

2.28

2.34

g/l

0.66

223

845

Fall on same level involving ice and snow

5821

48590

1.24

44.15

2.7

2.6

2.34

2.35

g/l

0.29

5379

44870

Small fibre neuropathy

367

1788

2.54

43.96

4.4

2.6

2.26

2.28

g/l

0.34

341

1654

Corns and callosities

685

4039

1.92

43.85

4.7

2.5

2.24

2.32

g/l

3.37

649

3725

Fracture of skull and facial bones

2018

14832

1.44

43.82

2.9

2.7

2.31

2.33

g/l

0.80

1839

13814

Other disorders of nervous system

703

4187

1.90

43.70

3.3

2.7

2.28

2.30

g/l

0.53

644

3868

Dermatophytosis, including avohilmo

6570

54362

1.22

43.56

2.5

2.6

2.36

2.34

g/l

1.24

6066

50344

Other symptoms and signs involving general sensations and perceptions

470

2483

2.21

43.50

2.4

2.5

2.36

2.31

g/l

0.93

421

2276

Emotional disorders and disorders of social functioning with onset specific to childhood

449

2246

2.17

43.38

2.8

2.5

2.60

2.57

g/l

0.51

408

2090

Unspecified/other endometriosis

801

4771

1.78

43.34

2.4

2.3

2.49

2.47

g/l

0.50

737

4407

Malignant neoplasm of mesothelium and soft tissue, including Hilmo

671

3949

1.92

43.18

2.5

2.7

2.20

2.29

g/l

3.30

639

3595

Scoliosis

810

4976

1.78

43.14

2.7

2.5

2.43

2.38

g/l

1.49

749

4558

Neuroendocrine tumor and carcinoma of small intestine

196

729

3.67

43.10

2.9

2.3

2.42

2.27

g/l

2.53

190

667

Temporal arteritis

442

2322

2.31

43.08

2.7

2.5

2.24

2.28

g/l

0.93

403

2134

Cerebral palsy and other paralytic syndromes

1088

7189

1.65

42.95

2.9

2.6

2.34

2.32

g/l

0.57

1016

6657

Benign neoplasm: Duodenum

332

1581

2.68

42.92

4.1

2.6

2.37

2.29

g/l

1.52

308

1474

Acute and subacute iridocyclitis

1801

13072

1.47

42.90

3.1

2.6

2.29

2.33

g/l

2.36

1665

12121

Retinal vascular disorders

1303

8979

1.59

42.85

3.7

2.6

2.23

2.25

g/l

0.85

1212

8221

Syphilis, including avohilmo

302

1365

2.72

42.80

5.5

2.6

2.18

2.31

g/l

3.30

287

1269

Syphilis

302

1365

2.72

42.80

5.5

2.6

2.18

2.31

g/l

3.30

287

1269

Alcohol abuse, main dg

1443

10080

1.53

42.61

2.6

2.7

2.32

2.33

g/l

0.36

1314

9418

Other specified/unspecified inflammatory spondylopathies

454

2364

2.17

42.51

2.5

2.4

2.41

2.38

g/l

0.47

424

2205

Psoriatic arthropathies, ICD10

995

6472

1.69

42.42

2.6

2.39

2.34

g/l

2.63

928

6020

Cardiomyopathy in other diseases

104

265

6.59

42.42

3.6

1.9

2.33

2.23

g/l

0.90

234

Anterior Iridocyclitis

1911

14051

1.45

42.09

3.0

2.6

2.30

2.33

g/l

1.86

1767

13026

Other specified disorders of kidney and ureter

370

1827

2.44

42.06

6.7

2.5

2.20

2.32

g/l

3.43

350

1694

Other psoriatic arthropathies

970

6286

1.69

42.05

2.5

2.6

2.40

2.34

g/l

2.90

904

5845

Conjunctivitis (acute, non atopic), including avohilmo

10385

54708

1.17

42.03

2.7

2.6

2.38

2.34

g/l

6.56

9632

50517

Ankylosing spondylitis, ICD10

825

5152

1.77

41.77

2.6

2.36

2.34

g/l

0.41

762

4806

COPD, hospital admissions 1, only main diagnosis

3613

24891

1.31

41.56

3.1

2.7

2.27

2.24

g/l

2.04

3324

22853

Diplopia

1306

9031

1.57

41.51

2.7

2.6

2.34

2.31

g/l

1.14

1211

8354

Golimumab

361

1755

2.39

41.50

2.1

2.5

2.40

g/l

0.07

338

1640

Fall involving bed

429

2261

2.31

41.46

3.4

2.7

2.23

2.27

g/l

0.69

394

2067

Disorders of tooth development and eruption

1438

8119

1.52

41.43

2.9

2.2

2.40

2.38

g/l

0.88

1340

7571

Asthma and opportunity respiratory infection

518

2888

2.11

41.35

2.6

2.28

2.26

g/l

0.29

487

2654

Postprocedural musculoskeletal disorders, not elsewhere classified

758

4685

1.83

41.28

2.7

2.32

2.29

g/l

0.62

713

4339

Enthesopathies of lower limb, excluding foot

2082

15512

1.41

41.20

2.7

2.6

2.39

2.34

g/l

3.92

1928

14346

Toxic liver disease

203

783

3.41

41.15

3.4

2.4

2.35

2.34

g/l

0.06

192

732

Acute suppurative otitis media

2202

15358

1.39

41.03

3.2

2.4

2.45

g/l

0.04

2035

14324

Viral warts, including avohilmo

2008

14915

1.42

40.72

3.7

2.5

2.37

2.38

g/l

0.30

1897

13845

Malignant neoplasm of prostate

2677

12151

1.37

40.67

2.6

2.9

2.18

2.23

g/l

4.41

2441

11173

Retinal detachments and breaks

3560

28601

1.30

40.59

3.4

2.5

2.25

2.29

g/l

5.58

3300

26400

Malignant neoplasm of prostate, including Hilmo

2714

12308

1.37

40.56

2.6

2.9

2.19

2.23

g/l

3.82

2483

11320

Other specified/unspecified necrotizing vasculopathies

193

739

3.56

40.35

5.4

2.5

2.14

2.29

g/l

3.72

188

680

Other and unspecified nerve root and plexus disorders, also in other diseases

1923

14236

1.43

40.15

2.5

2.6

2.42

2.33

g/l

9.83

1764

13236

Emphysema

775

4831

1.79

40.13

2.7

2.24

2.22

g/l

0.35

730

4452

Congenital malformations of cardiac septa

636

3632

1.89

40.02

3.4

2.8

2.44

2.40

g/l

1.34

595

3398

Other arterial embolism and thrombosis

332

1602

2.50

40.01

5.7

2.3

2.13

2.24

g/l

2.99

308

1463

Giant cell arteritis with polymyalgia rheumatica

442

2383

2.24

40.00

2.7

2.6

2.24

2.28

g/l

0.98

403

2191

Dermatophytosis

1371

9637

1.54

39.96

3.4

2.7

2.31

2.30

g/l

0.34

1285

8947

Polyarthritis, unspecified

378

1902

2.31

39.86

2.8

2.5

2.24

2.32

g/l

1.95

362

1755

Bulimia nervosa (incl. atypical)

329

1559

2.41

39.80

2.5

2.2

2.48

2.51

g/l

0.51

297

1433

Other and unspecified psoriasis

687

4166

1.85

39.69

2.8

2.7

2.32

2.31

g/l

0.28

642

3870

Unspecified urinary incontinence

901

5832

1.71

39.67

2.5

2.4

2.34

g/l

0.00

775

5344

Arthropathy in ulcerative colitis

178

655

3.65

39.66

2.8

2.4

2.42

2.36

g/l

0.69

172

610

Injuries to the wrist and hand

10385

60372

1.17

39.60

2.6

2.37

2.35

g/l

1.81

9569

55880

Herpesviral [herpes simplex] infections, including avohilmo

2358

18001

1.38

39.58

2.8

2.4

2.38

2.40

g/l

0.70

2216

16655

Acetic acid derivatives and related substances

2843

11327

1.35

39.57

2.3

3.3

2.32

2.27

g/l

4.46

2600

10514

Hypogonadotropic hypogonadism

312

1462

2.51

39.53

2.4

2.7

2.54

2.32

g/l

10.92

297

1381

Chronic laryngitis and laryngotracheitis

1363

9574

1.53

39.52

2.7

2.41

2.31

g/l

8.96

1243

8842

Noninflammatory disorders of female genital tract

3492

13846

1.31

39.51

2.4

2.3

2.44

2.42

g/l

0.78

3203

12738

Mental and behavioural disorders due to tobacco

840

5346

1.73

39.47

3.1

2.6

2.35

2.32

g/l

0.57

777

4988

Acquired absence of organs, not elsewhere classified

170

612

3.75

39.42

6.2

2.4

2.21

2.28

g/l

0.77

160

568

Osteonecrosis due to drugs

217

905

3.31

38.94

3.1

2.5

2.21

2.29

g/l

1.21

207

843

Periapical abscess

4399

36222

1.26

38.90

2.8

2.7

2.38

2.34

g/l

3.68

4070

33703

Pneumonia derived septicemia

386

1986

2.29

38.89

4.0

2.7

2.18

2.30

g/l

3.45

359

1838

Pure hyperglyceridaemia

260

1148

2.76

38.65

3.7

2.4

2.41

2.29

g/l

2.22

241

1067

Other and unspecified urticaria

1776

13064

1.44

38.59

2.9

2.6

2.40

2.38

g/l

0.82

1643

12120

Hypermobility syndrome

486

2673

2.03

38.50

2.5

2.3

2.51

2.48

g/l

0.96

460

2474

Conjunctivitis (acute, non atopic)

2627

20333

1.35

38.49

3.0

2.6

2.38

g/l

0.12

2445

18876

Hallux valgus (acquired)

2969

16650

1.33

38.43

2.4

2.37

2.35

g/l

0.63

2736

15272

Alcohol withdrawal state with delirium

676

4120

1.84

38.40

2.6

2.9

2.16

2.26

g/l

4.08

617

3871

Drug-induced hypoglycaemia without coma

211

858

3.16

38.35

5.4

2.5

2.08

2.29

g/l

5.77

198

795

Visual impairment including blindness (binocular or monocular)

736

4584

1.79

38.29

3.9

2.6

2.26

2.29

g/l

0.88

655

4210

Smoking dependency

840

5389

1.72

38.18

3.1

2.6

2.35

2.33

g/l

0.45

777

5028

Ocular pain

821

5233

1.72

38.12

2.8

2.5

2.40

2.38

g/l

0.50

757

4846

Ingrowing nail

526

2986

1.98

38.10

4.2

2.5

2.31

2.35

g/l

0.93

491

2764

Olecranon bursitis

634

3803

1.87

38.10

3.3

2.7

2.26

g/l

0.03

583

3537

Other peripheral vascular diseases

779

4909

1.75

38.02

3.0

2.3

2.36

2.34

g/l

0.41

730

4532

Neuralgia and neuritis, unspecified

509

2863

2.00

37.91

2.9

2.5

2.36

2.32

g/l

0.69

476

2645

Acute alcohol intoxication

2379

18306

1.36

37.89

2.7

2.31

2.30

g/l

0.10

2165

17032

Cervicobrachial syndrome

1978

14830

1.40

37.58

2.5

2.42

2.35

g/l

7.68

1854

13700

Acute pharyngitis

1282

8829

1.52

37.57

2.8

2.4

2.43

g/l

0.17

1196

8253

Background retinopathy and retinal vascular changes

260

1173

2.76

37.42

6.0

2.5

2.22

2.28

g/l

0.92

245

1088

Testicular dysfunction

396

2068

2.19

37.34

3.2

2.6

2.40

2.31

g/l

2.68

360

1948

Other/unspecified synovitis and tenosynovitis

1058

7139

1.60

37.31

3.0

2.5

2.34

2.33

g/l

0.07

986

6573

Other enthesopathy of foot (+metatarsalgia)

946

6233

1.64

37.28

2.7

2.5

2.39

2.36

g/l

0.92

872

5743

Suppurative and unspecified otitis media

3143

22111

1.30

37.27

3.0

2.5

2.43

2.41

g/l

1.18

2905

20538

Trigger finger

1320

9290

1.52

37.24

3.3

2.5

2.33

2.34

g/l

0.29

1211

8592

Testicular hypofunction

358

1810

2.29

37.13

3.3

2.6

2.40

2.31

g/l

2.64

326

1699

Cerebral cysts

556

3232

1.92

36.98

3.4

2.6

2.34

g/l

0.02

517

2986

Prurigo nodularis

296

1417

2.57

36.93

4.1

2.5

2.30

2.31

g/l

0.10

271

1308

Anankastic personality disorder

373

1911

2.22

36.90

2.0

2.4

2.50

2.40

g/l

3.11

335

1778

Corticotropin deficiency

138

468

4.39

36.69

3.1

2.5

2.32

2.33

g/l

0.06

128

434

Metatarsalgia

879

5722

1.66

36.68

2.7

2.5

2.38

2.36

g/l

0.72

811

5269

Embolic stroke with flimmer

290

1364

2.52

36.67

3.2

2.4

2.25

2.19

g/l

1.14

274

1240

Endometriosis of pelvic peritoneum

1312

8362

1.51

36.64

2.2

2.4

2.48

2.42

g/l

3.03

1198

7750

Systemic sclerosis (FG)

259

1170

2.68

36.50

3.6

2.4

2.35

g/l

0.04

249

1082

Other specified/unspecified soft tissue disorders

490

2763

2.00

36.37

2.7

2.4

2.37

2.30

g/l

1.96

452

2524

Gangrene, not elsewhere classified

122

383

4.70

36.35

6.9

2.4

2.01

2.21

g/l

3.66

114

350

D07AA Corticosteroids, weak (group I)

1368

9711

1.49

36.29

2.6

2.42

2.40

g/l

0.81

1260

9026

Emotional disorders starting during childhood or adolescence

422

2230

2.08

36.21

2.7

2.6

2.61

2.57

g/l

0.81

384

2071

Infections with a predominantly sexual mode of transmission

2551

19829

1.34

36.20

3.1

2.4

2.37

2.44

g/l

8.40

2333

18434

Progressive vascular leukoencephalopathy

503

2917

2.05

36.09

2.5

2.6

2.15

2.24

g/l

2.95

479

2662

Atopic dermatitis, strict definition

2492

18925

1.34

36.05

2.6

2.5

2.44

2.45

g/l

0.42

2322

17612

Striking against or struck by other objects

3052

24317

1.30

35.88

2.7

2.36

g/l

0.16

2817

22644

Dentofacial anomalies [including malocclusion]

6471

43277

1.20

35.64

2.4

2.6

2.45

2.40

g/l

12.11

5942

40223

Assault

1099

7515

1.55

35.61

2.7

2.6

2.38

2.39

g/l

0.20

1005

7051

Myeloid leukaemia

318

1588

2.44

35.54

2.7

2.12

2.28

g/l

6.16

305

1480

Pneumonia due to Streptococcus pneumoniae

406

2171

2.12

35.50

3.3

2.5

2.20

2.32

g/l

3.65

371

2003

Other surgical follow-up care

339

1704

2.28

35.48

3.3

2.0

2.36

2.38

g/l

0.22

321

1566

Benign neoplasm: Rectosigmoid junction

457

2576

2.09

35.47

2.7

2.36

2.27

g/l

2.33

433

2392

Synovial cyst of popliteal space [Baker]

718

4518

1.75

35.41

2.9

2.5

2.31

2.30

g/l

0.08

663

4142

Dislocation, sprain and strain of joints and ligaments at ankle and foot level

3366

26803

1.28

35.40

2.6

2.5

2.43

2.42

g/l

0.51

3133

24957

Seborrhoeic dermatitis

970

6529

1.62

35.31

3.1

2.6

2.32

2.30

g/l

0.49

904

6068

Other/unspecified reactive arthropathies

618

3753

1.83

35.22

2.9

2.6

2.29

2.35

g/l

1.57

584

3469

Other epidermal thickening

477

2707

2.01

35.20

3.9

2.5

2.29

2.32

g/l

0.36

453

2501

Adenocarcinoma and papillary adenocarcinoma of stomach

315

1556

2.37

35.16

2.5

2.45

2.24

g/l

6.60

293

1421

Artificial joint re-operation

732

4681

1.77

35.00

2.9

2.7

2.30

2.28

g/l

0.26

692

4292

Inflammatory disease of uterus

1198

8375

1.52

34.95

2.3

2.48

2.45

g/l

0.75

1085

7733

Lung diseases due to external agents

1411

10208

1.49

34.91

2.9

2.7

2.22

2.24

g/l

0.64

1279

9394

Maternal care for other conditions predominantly related to pregnancy

1659

11911

1.42

34.84

2.3

2.53

2.49

g/l

2.45

1510

11112

Cervicocranial syndrome

1002

6789

1.59

34.74

2.5

2.6

2.40

2.33

g/l

3.76

939

6241

malignant neoplasm of female genital organs

1362

9556

1.49

34.73

2.4

2.22

2.39

g/l

20.47

1243

8644

Glaucoma

5827

42209

1.21

34.63

2.9

2.6

2.29

g/l

0.01

5280

38823

Disorders of ocular muscles, binocular movement, accommodation and refraction

4460

36817

1.24

34.62

2.9

2.6

2.39

2.38

g/l

0.76

4127

34168

Use of eye-antiallergens (taken as indicator of allergic/atopic conjunctivitis)

5039

40612

1.22

34.46

2.4

2.5

2.41

2.40

g/l

0.41

4673

37543

Adenomyosis (Endometriosis of uterus)

1193

8358

1.52

34.42

2.4

2.40

2.37

g/l

0.99

1089

7695

Morphin

263

1225

2.57

34.42

2.9

2.4

2.27

2.26

g/l

0.16

245

1126

Carcinoma in situ of skin of trunk

413

2297

2.18

34.34

3.8

2.7

2.24

2.22

g/l

0.24

381

2103

Marginal zone B-cell lymphoma, including Hilmo

203

858

3.05

34.29

2.3

2.5

2.22

2.28

g/l

0.67

191

789

Von Willebrand disease

162

610

3.44

34.19

4.6

2.3

2.48

2.43

g/l

0.61

157

562

Other and unspecified injuries of lower leg

722

4576

1.72

34.06

2.9

2.5

2.41

2.38

g/l

0.69

676

4246

Anorexia (incl.atypical)

524

3050

1.88

33.93

2.8

2.4

2.49

2.45

g/l

0.60

480

2825

Calculus of kidney and ureter

2916

23395

1.31

33.80

3.0

2.7

2.30

2.28

g/l

0.92

2705

21637

Eosinophilia

206

884

3.00

33.74

3.6

2.6

2.25

2.30

g/l

0.46

192

820

Explicit fungal Sepsis

111

346

4.79

33.58

5.5

2.3

2.03

2.28

g/l

3.90

104

322

Parkinson's disease, excluding more controls

1296

8517

1.49

33.50

2.2

2.6

2.23

2.25

g/l

0.62

1169

7924

Otitis externa

2135

16492

1.36

33.34

3.1

2.6

2.37

2.34

g/l

1.39

1960

15273

Generalized skin eruption due to drugs and medicaments

407

2243

2.09

33.17

3.2

2.5

2.30

2.32

g/l

0.34

382

2078

Carcinoma in situ of skin

911

6183

1.64

33.12

3.5

2.6

2.24

2.26

g/l

0.56

853

5672

Benign thyroid growths and nodules

3044

22791

1.29

33.12

2.7

2.5

2.36

2.34

g/l

1.66

2834

20956

Acute generalized exanthematous pustulosis

458

2617

2.00

33.04

3.1

2.5

2.31

2.33

g/l

0.34

427

2423

Bullous disorders

604

3734

1.83

32.93

3.3

2.6

2.25

2.27

g/l

0.41

568

3444

Lung cancer and mesothelioma

1780

11349

1.40

32.90

2.4

2.16

2.30

g/l

17.94

1680

10336

Urolithiasis

3155

25610

1.29

32.87

3.0

2.7

2.29

2.27

g/l

0.94

2915

23692

Other and unspecified disorders of skin and subcutaneous tissue

615

3804

1.80

32.87

3.5

2.5

2.35

2.33

g/l

0.36

550

3513

Explicit fungal Sepsis, including avohilmo

111

351

4.68

32.81

5.5

2.3

2.03

2.28

g/l

3.89

104

326

Symptoms and signs involving emotional state

313

1578

2.29

32.78

2.8

2.4

2.40

2.36

g/l

0.53

290

1465

Pneumococcal septicemia

365

1958

2.18

32.69

3.7

2.7

2.19

2.30

g/l

3.17

339

1813

Other nutritional anaemias

137

485

3.76

32.53

4.1

2.4

2.17

2.23

g/l

0.44

128

452

Other orthopaedic follow-up care

512

3011

1.88

32.43

2.6

2.0

2.32

2.36

g/l

0.84

474

2766

Allergic conjunctivitis

5247

42869

1.21

32.33

2.5

2.41

2.40

g/l

0.50

4869

39651

Other inflammation of eyelid, including avohilmo

4143

34505

1.24

32.20

2.4

2.5

2.40

2.39

g/l

0.12

3838

31980

Carcinoma in situ of skin of scalp and neck

363

1988

2.26

32.18

4.3

2.7

2.19

2.20

g/l

0.12

334

1828

Dissociative [conversion] disorders

352

1849

2.14

32.15

2.2

2.51

2.42

g/l

2.34

317

1715

Other inflammation of eyelid

1362

9919

1.47

32.13

2.6

2.34

2.33

g/l

0.36

1261

9158

Other noninflammatory disorders of vulva and perineum

842

5585

1.62

32.06

2.7

2.4

2.40

g/l

0.06

775

5167

Diseases of tongue

583

3565

1.80

32.05

2.7

2.4

2.34

2.32

g/l

0.22

537

3280

Bicuspidal aortic valve syndrome

371

2005

2.13

32.03

2.6

2.7

2.39

2.33

g/l

1.30

352

1874

Other and unspecified visual disturbances

1016

7040

1.56

31.99

3.0

2.6

2.34

g/l

0.10

933

6515

Other congenital malformations

747

4837

1.67

31.97

3.2

2.6

2.40

2.42

g/l

0.55

700

4501

Localized swelling, mass and lump of skin and subcutaneous tissue

3048

24691

1.29

31.96

2.9

2.6

2.33

g/l

0.02

2848

22792

Carbimazole or st.post thyroidectomy, condition for graves disease

1873

14301

1.38

31.91

2.7

2.5

2.39

2.38

g/l

0.34

1739

13219

Malignant neoplasm of oesophagus, including Hilmo

375

2040

2.13

31.91

2.4

2.8

2.28

2.24

g/l

0.40

358

1875

Disorders of vestibular function (Vertigo)

4667

38380

1.23

31.88

2.6

2.36

2.32

g/l

6.04

4254

35318

Malignant neoplasm of bladder

682

4349

1.72

31.67

2.9

2.7

2.18

2.21

g/l

0.72

635

3942

Pulmonary oedema

234

1087

2.68

31.67

7.1

2.5

2.16

2.23

g/l

0.93

220

996

Car occupant injured in other and unspecified transport accidents

1651

12389

1.40

31.41

2.8

2.6

2.39

2.38

g/l

0.51

1527

11512

Seborrhoeic keratosis

2429

19249

1.33

31.40

3.4

2.5

2.29

2.31

g/l

1.67

2258

17725

Other acute viral hepatitis

158

614

3.30

31.38

2.5

2.7

2.46

2.33

g/l

1.73

153

572

Parkinson's disease, strict definition, excluding more controls

1213

8092

1.49

31.32

2.2

2.6

2.23

2.25

g/l

0.57

1092

7525

Malignant neoplasm of rectosigmoid junction

202

884

2.86

31.28

2.2

2.4

2.30

2.24

g/l

0.73

197

809

Malignant neoplasm of breast, including Hilmo

3483

18205

1.27

31.27

2.0

2.4

2.38

2.43

g/l

5.97

3210

16611

Cramp and spasm

465

2707

1.94

31.26

2.8

2.6

2.35

2.33

g/l

0.39

433

2515

Acne

852

5642

1.59

31.21

3.4

2.3

2.42

2.51

g/l

4.49

797

5231

Malignant neoplasm of breast, HER2-negative, including Hilmo

3482

18208

1.27

31.16

2.0

2.4

2.38

2.43

g/l

5.99

3209

16614

Rare circulating lymphoid malignancy, including Hilmo

303

1545

2.29

31.15

2.8

2.7

2.16

2.29

g/l

3.74

292

1429

Hidradenitis suppurativa

349

1855

2.12

30.99

3.3

2.4

2.38

2.41

g/l

0.53

327

1728

Secondary thrombocytopenia

166

673

3.26

30.92

4.1

2.5

2.00

2.33

g/l

9.99

159

629

Type 1 diabetes, strict definition, subgroup 1

553

3327

1.78

30.88

4.0

2.3

2.24

2.48

g/l

18.17

514

3112

Gastrointestinal stromal tumor and sarcoma

160

638

3.35

30.88

2.6

2.33

2.25

g/l

1.05

154

588

Other noninfective disorders of lymphatic vessels and lymph nodes

375

2059

2.09

30.83

3.8

2.4

2.26

2.34

g/l

1.93

354

1911

Fenamates

1461

7295

1.44

30.70

2.3

3.4

2.40

2.29

g/l

10.16

1359

6804

Oesophageal obstruction

380

2106

2.09

30.68

2.8

2.5

2.28

2.24

g/l

0.62

347

1942

Use of disulfiram, acamprosate or naltrexone

760

4998

1.65

30.63

2.2

2.8

2.38

2.34

g/l

0.93

685

4714

Pneumonitis due to solids and liquids

847

5723

1.62

30.60

2.9

2.7

2.18

2.24

g/l

2.22

762

5281

Diseases of middle ear and mastoid

5307

36946

1.20

30.58

2.9

2.5

2.40

2.38

g/l

2.20

4899

34250

conjunctival haemorrhage

770

5115

1.66

30.58

3.4

2.7

2.34

2.28

g/l

2.30

714

4715

Volvulus

293

1485

2.30

30.54

3.5

2.5

2.22

2.25

g/l

0.35

279

1376

Infections with a predominantly sexual mode of transmission, including avohilmo

3314

24773

1.26

30.51

2.9

2.4

2.39

2.45

g/l

7.04

3040

23041

Thyrotoxicosis with diffuse goitre

1207

8672

1.48

30.34

2.6

2.4

2.42

2.39

g/l

1.09

1105

8036

Coxarthrosis, primary, with hip surgery

4767

37582

1.22

30.27

2.6

2.7

2.30

2.28

g/l

1.34

4383

34475

Malignant neoplasm of other connective and soft tissue, including Hilmo

410

2328

2.00

30.15

2.5

2.6

2.20

2.29

g/l

2.14

389

2143

Infective dermatitis

1060

7485

1.52

30.01

3.2

2.6

2.32

2.31

g/l

0.21

977

6947

Postmenopausal bleeding

2342

9588

1.34

30.00

2.4

2.5

2.39

2.35

g/l

2.62

2117

8812

Unknown and unspecified causes of morbidity

582

3604

1.74

29.77

3.3

2.3

2.36

2.35

g/l

0.08

554

3325

Somnolence, stupor and coma

427

2456

1.95

29.76

3.5

2.6

2.31

2.29

g/l

0.27

398

2259

Type 1 diabetes, strict definition

577

3545

1.74

29.66

4.0

2.3

2.23

2.47

g/l

18.96

538

3316

Malignant neoplasm of breast, HER2-negative

3403

17974

1.26

29.59

2.0

2.4

2.38

2.43

g/l

5.46

3126

16399

Molar incisor enamel hypoplasia

341

1741

2.10

29.48

7.0

2.4

2.42

2.57

g/l

5.05

328

1635

Nonsuppurative otitis media

1932

12903

1.35

29.47

3.1

2.5

2.41

2.42

g/l

0.36

1811

11947

Malignant neoplasm of breast

3405

17990

1.26

29.46

2.0

2.4

2.38

2.43

g/l

5.34

3128

16415

Respiratory disorders in diseases classified elsewhere

180

780

3.00

29.13

3.5

2.5

2.20

2.30

g/l

1.42

175

722

Benign paroxysmal vertigo

2851

23210

1.28

29.05

2.7

2.6

2.36

2.32

g/l

3.47

2584

21369

Nonsuppurative otitis media, including avohilmo

2713

18859

1.29

29.05

3.0

2.5

2.41

g/l

0.01

2544

17491

Diabetes mellitus in pregnancy

2501

12583

1.31

29.03

2.6

2.2

2.55

2.51

g/l

3.41

2284

11756

Specific development disorders of scholastic skills

367

1973

2.01

28.89

3.5

2.6

2.52

2.51

g/l

0.20

345

1841

Other and unspecified follicular disorders

396

2248

1.98

28.88

4.2

2.6

2.34

2.32

g/l

0.37

365

2081

Other localized connective tissue disorders

219

1025

2.59

28.68

4.7

2.3

2.28

2.35

g/l

1.06

198

944

Congenital iodine-deficiency syndrome/hypothyroidism

307

1624

2.21

28.64

2.8

2.4

2.40

2.32

g/l

1.60

281

1496

Systemic sclerosis

259

1293

2.39

28.63

3.6

2.3

2.35

g/l

0.01

249

1194

Myositis

273

1386

2.32

28.58

3.3

2.5

2.20

2.29

g/l

1.71

263

1277

Fracture at wrist and hand level

3129

25594

1.26

28.53

2.7

2.34

2.35

g/l

0.75

2886

23786

Neovascular glaucoma

426

2494

1.94

28.41

5.0

2.6

2.13

2.27

g/l

5.18

404

2290

Special screening examination for neoplasms

574

3593

1.73

28.31

3.3

2.3

2.27

g/l

0.02

537

3288

Brachial plexus disorders

775

5201

1.60

28.04

2.5

2.4

2.48

2.39

g/l

3.97

730

4855

Nummular dermatitis

801

5447

1.60

28.02

3.0

2.6

2.30

2.29

g/l

0.30

743

5054

Superficial injury of ankle and foot

1076

7685

1.48

27.89

3.1

2.5

2.39

2.40

g/l

0.13

996

7134

Malignant neoplasm of breast, ER-positive, including Hilmo

2666

15970

1.29

27.87

2.0

2.4

2.39

2.42

g/l

1.83

2435

14536

Other specified congenital malformation syndromes affecting multiple systems

178

769

2.81

27.81

4.6

2.8

2.36

2.42

g/l

0.84

172

728

Other and unspecified tonsillitis

2702

18102

1.28

27.79

2.9

2.5

2.44

2.42

g/l

0.99

2503

16949

Disorders of phosphorus metabolism and phosphatases

233

5.32

27.73

6.5

2.3

2.14

2.34

g/l

1.85

217

Malignant neoplasm of other and unspecified parts of biliary tract, including Hilmo

237

1160

2.45

27.69

2.3

2.5

2.22

2.27

g/l

0.60

228

1070

Malignant neoplasm of breast, HER-positive

2656

15937

1.29

27.65

2.0

2.4

2.39

2.42

g/l

1.82

2425

14504

Lack of expected normal physiological development

177

647

2.70

27.61

4.8

2.1

2.54

2.61

g/l

1.08

169

600

Other congenital malformations of the digestive system, including avohilmo

478

2872

1.83

27.60

4.5

2.8

2.37

2.39

g/l

0.26

456

2687

Congenital malformations of great arteries

223

1044

2.51

27.60

3.5

3.1

2.49

2.44

g/l

0.70

214

989

!Aliquae complicationes praecoces traumatis

432

2553

1.90

27.52

3.3

2.7

2.28

2.31

g/l

0.37

401

2374

Early complications of trauma

432

2553

1.90

27.52

3.3

2.7

2.28

2.31

g/l

0.37

401

2374

Alcohol-induced acute pancreatitis

355

1989

2.04

27.49

3.2

2.7

2.14

2.29

g/l

3.44

324

1857

Later onset COPD

3050

20187

1.27

27.49

2.9

2.7

2.21

2.22

g/l

0.07

2809

18420

Wide developmental disorders, excluding more controls

243

1142

2.27

27.37

2.2

2.5

2.61

2.51

g/l

2.02

217

1071

Glaucoma secondary to other eye disorders

429

2544

1.91

27.37

4.9

2.7

2.13

2.27

g/l

4.90

406

2346

Other and unspecified vascular occlusions

944

6669

1.54

27.37

3.7

2.6

2.23

2.25

g/l

0.62

874

6117

Hypoplasia of dental enamel , including avohilmo

320

1651

2.09

27.36

7.3

2.4

2.41

2.56

g/l

5.30

308

1551

Mixed connective tissue disease

200

921

2.65

27.34

3.1

2.5

2.32

2.35

g/l

0.28

187

859

Systemic sclerosis, icd10

258

1311

2.34

27.27

3.6

2.4

2.35

g/l

0.05

248

1213

Malignant neoplasm of pancreas

668

4396

1.66

27.23

2.1

2.7

2.18

2.26

g/l

3.12

633

3988

Carcinoma in situ of skin of upper limb, including shoulder

327

1828

2.19

27.23

4.1

2.7

2.17

2.23

g/l

1.28

302

1685

Excessive vomiting in pregnancy

662

4324

1.65

27.19

2.4

2.3

2.49

2.47

g/l

0.45

615

4027

Biomechanical lesions, not elsewhere classified

508

3154

1.81

27.16

2.7

2.6

2.33

2.31

g/l

0.27

473

2918

Superficial injury of wrist and hand

1811

14040

1.35

27.14

2.6

2.43

2.39

g/l

2.40

1658

13070

Autoimmune hyperthyroidism

514

3166

1.76

27.10

2.7

2.3

2.43

2.40

g/l

0.80

476

2944

Presence of other devices

2318

18263

1.30

27.01

2.7

2.3

2.31

2.27

g/l

4.34

2166

16768

Sacroiliitis, not elsewhere classified

403

2326

1.90

27.01

2.2

2.4

2.44

2.41

g/l

0.73

381

2159

Alzheimer disease, excluding more controls

1742

8648

1.37

26.94

2.2

2.5

2.20

2.25

g/l

3.47

1550

8013

Dislocation, sprain and strain of joints and ligaments at neck level

1298

9616

1.42

26.93

2.3

2.5

2.43

2.40

g/l

0.97

1207

8938

Other disorders of conjunctiva

1349

10109

1.42

26.89

3.1

2.6

2.34

2.29

g/l

2.79

1249

9331

Primary adrenocortical insufficiency

138

544

3.28

26.87

3.2

2.5

2.21

2.35

g/l

2.28

127

502

Polyp of the female genital tract

2551

11572

1.30

26.86

2.4

2.42

2.38

g/l

2.97

2337

10649

Allergic rhinitis

2574

20547

1.28

26.76

2.4

2.5

2.48

2.42

g/l

6.45

2403

19150

Non-Hodgkin lymphoma, all

441

2646

1.87

26.72

2.5

2.6

2.04

2.25

g/l

10.15

420

2409

Hypotension due to drugs

193

897

2.75

26.67

3.2

2.6

2.28

2.23

g/l

0.59

176

831

Otalgia

769

5228

1.59

26.64

2.7

2.6

2.43

2.37

g/l

1.89

702

4850

Migraine, single triptan purchase ok & required. ICD-code if available is included

6703

39702

1.17

26.63

2.3

2.6

2.46

2.40

g/l

18.47

6223

36849

Triptan medication for migraine, single purchase ok

6703

39702

1.17

26.63

2.3

2.6

2.46

2.40

g/l

18.47

6223

36849

Other and unspecified types of non-Hodgkin lymphoma, hilmo

429

2572

1.91

26.62

2.9

2.7

2.19

2.26

g/l

1.79

406

2370

Other congenital malformations, including avohilmo

1083

7822

1.47

26.41

2.9

2.6

2.37

2.41

g/l

1.46

1013

7275

Abnormal blood-pressure reading, without diagnosis

410

2400

1.88

26.40

2.8

2.4

2.43

2.34

g/l

2.77

381

2211

Speech disturbances, not elsewhere classified

893

6281

1.54

26.39

2.9

2.7

2.27

2.28

g/l

0.06

808

5781

Other misadventures during surgical and medical care

267

1392

2.28

26.37

4.2

2.6

2.34

2.30

g/l

0.36

249

1299

Carcinoma in situ of skin of ear and external auricular canal

216

1061

2.62

26.37

3.7

2.8

2.14

2.19

g/l

0.60

194

976

Left hemicolectomy

262

1364

2.32

26.35

3.2

2.6

2.24

2.26

g/l

0.25

246

1264

Benign neoplasm: Other and unspecified parts of small intestine

197

926

2.69

26.33

4.0

2.4

2.36

2.30

g/l

0.67

189

859

Other congenital malformations of the digestive system

413

2421

1.89

26.26

4.8

2.8

2.38

2.39

g/l

0.23

397

2273

Other other unspecified disorders of the circulatory system

372

2148

1.98

26.25

3.6

2.7

2.29

2.30

g/l

0.08

347

1998

Degenerative macular diseases

1180

8710

1.46

26.24

3.2

2.6

2.23

2.27

g/l

1.49

1054

7980

Carrier of infectious disease

258

1323

2.28

26.22

3.7

2.4

2.26

2.37

g/l

1.96

236

1225

Diseases of inner ear

5347

44331

1.19

26.21

2.6

2.35

2.32

g/l

5.14

4888

40875

Idiopathic pulmonary fibrosis

804

5578

1.59

26.14

2.6

2.7

2.23

g/l

0.04

751

5118

Dermatographic urticaria

594

3833

1.68

26.14

2.3

2.4

2.49

2.40

g/l

4.18

531

3557

Abdominal aortic aneurysm (AAA)

978

6925

1.50

26.06

3.7

2.5

2.15

2.18

g/l

0.92

904

6284

Malignant neoplasm of mesothelium and soft tissue

392

2296

1.93

25.97

2.4

2.6

2.11

2.27

g/l

6.28

377

2106

Congenital malformations and deformations of the musculoskeletal system, including avohilmo

913

6380

1.51

25.91

2.8

2.6

2.46

2.43

g/l

0.58

853

5925

Ehlers-Danlos syndrome, including avohilmo

140

559

3.08

25.91

3.1

2.2

2.45

2.46

g/l

0.07

130

512

Ovarian dysfunction

621

4036

1.65

25.91

2.2

2.1

2.60

2.52

g/l

3.08

569

3729

Contact with and exposure to communicable diseases

2433

19521

1.28

25.90

2.7

2.5

2.46

2.45

g/l

0.41

2216

18223

Operations for atrial fibrillation

190

893

2.77

25.88

3.0

2.7

2.34

2.25

g/l

1.35

179

830

Primary coxarthrosis, bilateral

2857

23576

1.27

25.85

2.5

2.7

2.32

2.28

g/l

3.15

2638

21625

Assault by bodily force

625

4073

1.64

25.79

2.6

2.39

2.40

g/l

0.07

568

3806

Other noninflammatory disorders of uterus, except cervix

1859

9669

1.34

25.61

2.5

2.40

2.35

g/l

2.84

1699

8875

Other secondary gonarthrosis

507

3188

1.77

25.59

2.9

2.8

2.29

g/l

0.07

474

2969

Protein-energy malnutrition of moderate and mild degree

137

561

3.35

25.58

3.2

2.8

2.11

2.30

g/l

2.38

128

520

Unspecified behavioural syndromes associated with physiological disturbances and physical factors +Physiological and behavioural factors associated with disorders of diseases classified elsewhere

172

760

2.72

25.55

4.6

2.6

2.31

2.41

g/l

1.41

159

703

Benign neoplasm: Pancreas

307

1702

2.14

25.42

3.5

2.6

2.34

2.28

g/l

0.99

292

1580

Fracture of neck

609

4008

1.68

25.38

2.9

2.7

2.20

2.26

g/l

1.44

558

3706

Suggestive for eosinophilic asthma

828

5772

1.55

25.34

2.4

2.7

2.35

2.28

g/l

3.28

780

5363

Other and unspecified glaucoma

723

4937

1.61

25.34

3.1

2.6

2.21

2.26

g/l

1.56

660

4523

Intentional self-harm by unspecified means

138

551

3.01

25.24

2.2

2.4

2.40

g/l

0.00

125

505

Septal defects

553

3473

1.71

25.13

3.2

2.9

2.44

2.41

g/l

0.84

512

3249

Autism spe, excluding more controls

181

801

2.49

25.12

2.1

2.3

2.61

2.50

g/l

1.66

162

747

Asthma mixed form (mode), excluding more controls

391

2274

1.85

25.10

2.8

2.1

2.45

2.34

g/l

3.50

372

2079

Allergic urticaria

719

4877

1.59

25.02

2.7

2.5

2.38

2.39

g/l

0.18

662

4527

Exclusion endpoint for clefts

199

938

2.49

25.01

4.5

2.8

2.35

2.41

g/l

0.82

193

879

Urethral stricture

576

3754

1.70

25.01

3.0

2.7

2.22

2.24

g/l

0.21

528

3485

Excessive earwax

6354

50640

1.17

24.88

2.6

2.7

2.34

2.32

g/l

3.94

5768

46834

Algoneurodystrophy

293

1585

2.08

24.87

3.1

2.3

2.44

2.40

g/l

0.59

272

1469

Malignant neoplasm of head and neck, including Hilmo

856

6012

1.52

24.85

2.5

2.8

2.20

2.27

g/l

3.19

799

5488

Other disorders of patella

1349

10162

1.39

24.77

2.5

2.4

2.41

2.39

g/l

0.94

1239

9430

Traumatic subarachnoid haemorrhage

370

2156

1.92

24.74

2.9

2.5

2.24

2.25

g/l

0.06

341

2009

Abnormality of white blood cells, not elsewhere classified

119

457

3.47

24.72

3.3

2.4

2.27

2.35

g/l

0.75

112

427

Appendectomy

5887

49006

1.17

24.65

2.6

2.38

2.37

g/l

0.44

5466

45446

Caries of enamel

9270

54383

1.14

24.60

2.8

2.6

2.39

2.36

g/l

4.73

8623

50400

Acute laryngitis and tracheitis

920

6414

1.48

24.44

2.9

2.4

2.50

2.44

g/l

2.22

873

5991

L02BX Other hormone antagonists and related agents

623

4193

1.68

24.43

2.3

3.0

2.06

2.20

g/l

9.27

577

3889

Ptosis of eyelid

1081

7967

1.46

24.32

2.7

2.6

2.28

2.29

g/l

0.13

999

7330

Melanocytic naevi

2798

23108

1.25

24.31

3.6

2.6

2.34

2.37

g/l

1.41

2661

21390

therapeutic use

329

1883

2.02

24.23

3.4

2.4

2.28

2.29

g/l

0.16

295

1734

Monoarthritis, not elsewhere classified

371

2170

1.89

24.14

3.1

2.5

2.27

2.33

g/l

1.14

349

2011

Other and unspecified abdominal hernia

407

2463

1.86

24.11

3.2

2.5

2.35

2.28

g/l

1.53

378

2282

Impotence

555

3619

1.70

24.06

4.1

2.8

2.27

2.24

g/l

0.66

522

3399

Adenocarcinoma and ductal carcinoma of pancreas

358

2092

1.94

24.03

2.0

2.6

2.19

2.28

g/l

2.00

351

1916

Personal history of malignant neoplasm

698

4742

1.58

23.97

2.3

2.1

2.34

2.39

g/l

1.66

656

4392

Ankylosing spondylitis, strict definition

372

2185

1.88

23.90

2.3

2.6

2.37

2.38

g/l

0.06

350

2041

Moderate visual impairment, binocular

332

1908

2.00

23.89

4.0

2.5

2.22

2.28

g/l

0.85

275

1734

Superficial injury of forearm

881

6256

1.50

23.87

2.7

2.5

2.39

2.37

g/l

0.61

797

5797

Abnormal findings in nipple discharge synovial fluid wound secretions

173

797

2.67

23.84

4.3

2.4

2.28

2.36

g/l

0.96

163

740

Bacterial, viral and other infectious agents

709

4844

1.57

23.77

3.6

2.7

2.32

2.35

g/l

0.54

665

4533

Other and unspecified rosacea

815

5735

1.53

23.67

3.0

2.5

2.36

2.35

g/l

0.35

757

5325

Other diseases of gallbladder

435

2685

1.81

23.66

2.8

2.5

2.38

2.30

g/l

2.22

412

2481

Other female pelvic inflammatory diseases

1321

10028

1.39

23.63

2.5

2.4

2.48

2.41

g/l

4.51

1191

9230

Atypical facial pain

466

2920

1.76

23.57

2.4

2.5

2.43

2.35

g/l

2.39

435

2709

Melanocytic naevi of trunk

1084

8003

1.44

23.53

4.0

2.6

2.29

2.35

g/l

2.73

1018

7429

Disorders of plasma-protein metabolism, not elsewhere classified

308

3.97

23.53

2.2

2.1

2.34

2.37

g/l

0.16

288

Cluster headache, strict

311

1738

1.98

23.53

2.7

2.4

2.38

2.36

g/l

0.34

295

1632

Exposure to other and unspecified inanimate mechanical forces

674

4574

1.59

23.50

3.2

2.6

2.33

2.35

g/l

0.46

635

4257

Congenital malformations of the musculoskeletal system, not elsewhere classified, including avohilmo

179

831

2.53

23.47

3.1

2.2

2.45

2.43

g/l

0.21

168

768

Vaginitis/vulvovaginitis/vulvitis/abscess of vulva

1529

11823

1.35

23.44

2.6

2.3

2.47

2.46

g/l

0.53

1408

10885

Endometriosis of ovary

1360

9738

1.38

23.38

2.4

2.46

2.40

g/l

4.23

1240

9009

Other/unspecified enthesopathies of lower limb, excluding foot

619

4126

1.61

23.32

2.5

2.40

2.35

g/l

1.68

570

3825

Hyperfunction of pituitary gland

424

2596

1.79

23.28

3.0

2.3

2.43

2.40

g/l

0.34

387

2423

Blepharochalasis

2757

22893

1.25

23.22

2.6

2.33

2.31

g/l

1.01

2512

21061

Disorders of optic nerve and visual pathways

820

5795

1.52

23.15

3.2

2.6

2.32

2.36

g/l

1.23

771

5386

Postzoster neuralgia

195

957

2.50

23.13

3.3

2.3

2.33

2.29

g/l

0.56

186

893

Other immunodeficiencies

132

547

3.05

23.13

3.9

2.6

2.36

2.39

g/l

0.22

125

499

Congenital malformations and deformations of the musculoskeletal system

705

4802

1.56

23.05

3.0

2.6

2.47

2.45

g/l

0.44

661

4480

Cluster headache, wide

332

1904

1.92

23.03

2.7

2.5

2.38

2.35

g/l

0.42

314

1783

Post-traumatic wound infection, not elsewhere classified

280

1543

2.08

22.97

3.4

2.5

2.27

2.31

g/l

0.52

259

1435

Other and unspecified haemorrhagic conditions

178

841

2.56

22.91

3.9

2.6

2.27

2.32

g/l

0.59

170

784

Atrophic disorders of skin

1369

10493

1.37

22.86

2.6

2.4

2.39

2.38

g/l

0.08

1242

9648

Endocrine disorders, other/unspecified

203

1008

2.39

22.81

3.2

2.3

2.38

2.35

g/l

0.24

175

934

Erythema intertrigo

266

1450

2.13

22.79

3.5

2.6

2.30

g/l

0.10

248

1343

Autonomic disorders

250

1333

2.17

22.74

2.8

2.5

2.35

2.32

g/l

0.37

235

1243

Otitis media, unspecified

897

5908

1.47

22.68

3.1

2.4

2.49

2.45

g/l

1.48

836

5511

Bacterial, viral and other infectious agents, including avohilmo

756

5278

1.53

22.63

3.5

2.7

2.32

2.35

g/l

0.73

708

4951

Hydrocele

1101

8206

1.42

22.58

3.8

2.8

2.21

2.22

g/l

0.09

1027

7610

Juvenile rheumatoid arthirtis

192

924

2.36

22.52

2.6

2.4

2.34

2.43

g/l

1.27

181

861

Other behavioural and emotional disorders with onset usually occurring in childhood and adolescence

425

2555

1.75

22.43

4.0

2.6

2.53

2.52

g/l

0.16

404

2387

Specific development disorders of speech and language

492

3025

1.69

22.42

3.2

2.7

2.44

2.41

g/l

0.56

451

2827

Other abnormal immunological findings in serum

209

1052

2.32

22.40

2.6

2.5

2.39

2.37

g/l

0.14

194

977

Overexertion and strenuous or repetitive movements

848

6066

1.49

22.33

2.6

2.30

2.34

g/l

1.58

804

5643

Abnormality of red blood cells

262

4.36

22.30

2.1

2.2

2.40

2.29

g/l

0.77

241

Raynaud syndrome

776

5471

1.52

22.28

2.4

2.5

2.40

2.38

g/l

0.64

720

5076

Personal history of risk-factors, not elsewhere classified

141

604

2.76

22.25

2.5

2.0

2.29

2.38

g/l

0.92

129

559

Ehlers-Danlos syndrome

113

439

3.19

22.20

3.3

2.2

2.43

2.46

g/l

0.19

103

403

Abscess of lung

179

861

2.52

22.15

4.0

2.6

2.11

2.27

g/l

2.71

164

808

Female genital prolapse

2426

10982

1.27

22.11

2.1

2.4

2.45

2.37

g/l

9.33

2211

10104

Uterine polyps

2354

11175

1.27

22.09

2.5

2.4

2.44

2.37

g/l

6.72

2156

10294

Complications following infusion, transfusion and therapeutic injection

167

781

2.60

22.09

4.4

2.3

2.31

2.33

g/l

0.11

156

717

Xerosis cutis

204

1035

2.39

22.09

3.6

2.3

2.31

g/l

0.02

194

950

Benign neoplasm of mouth and pharynx

971

7133

1.45

22.08

2.8

2.6

2.31

g/l

0.06

891

6607

Disorders of porphyrin and bilirubin metabolism

129

538

2.96

22.05

3.6

2.3

2.36

2.32

g/l

0.43

123

502

Adenocarcinoma and Papillary adenocarcinoma of kidney

138

601

2.91

21.95

6.8

2.5

2.16

2.22

g/l

0.51

128

556

Psoriasis (vulgaris), strict definition

315

1816

1.94

21.91

2.3

2.6

2.44

2.34

g/l

2.12

292

1692

Event of undetermined intent

553

3656

1.63

21.87

2.8

2.6

2.37

2.35

g/l

0.26

520

3408

Other and unspecified malignant neoplasms of lymphoid, haematopoietic and related tissue

127

540

3.15

21.86

2.5

2.11

2.26

g/l

2.35

119

503

Inguinal hernia

5515

32097

1.17

21.82

2.9

2.7

2.27

2.29

g/l

2.81

5112

29687

Other disorders of optic [2nd] nerve and visual pathways

579

3883

1.63

21.81

3.6

2.6

2.29

2.33

g/l

0.80

546

3600

Mental and behavioural disorders due to cannabinoids

228

1175

2.13

21.78

1.7

2.5

2.46

2.41

g/l

0.55

199

1095

Lactose intolerance

274

1514

2.02

21.71

3.0

2.2

2.43

2.37

g/l

1.11

248

1400

Memory loss

890

6497

1.48

21.61

2.4

2.7

2.22

2.27

g/l

2.15

831

5986

Corneal ulcer

1595

12553

1.33

21.60

3.2

2.6

2.33

2.35

g/l

0.53

1475

11668

Acute and transient psychotic disorders

932

6798

1.45

21.56

2.5

2.6

2.34

2.37

g/l

0.56

826

6335

Open wound of wrist and hand

4085

33984

1.19

21.53

2.7

2.36

2.34

g/l

0.90

3771

31614

Orchitis and epididymitis

833

5985

1.49

21.43

3.4

2.8

2.25

2.24

g/l

0.28

781

5587

Impingement syndrome of shoulder

2005

16224

1.28

21.34

2.7

2.6

2.36

2.31

g/l

4.09

1875

15043

Oxicams

2270

10469

1.27

21.31

2.3

3.4

2.33

2.25

g/l

8.19

2084

9714

Acne, including avohilmo

1690

10771

1.31

21.31

2.8

2.3

2.47

2.50

g/l

1.09

1553

9992

Disorders of refraction and accommodation

2404

19723

1.25

21.26

3.0

2.5

2.41

2.40

g/l

0.63

2211

18375

Benign neoplasm: Liver/bile ducts

261

1442

2.07

21.23

3.1

2.4

2.47

2.36

g/l

1.85

246

1337

Allergic contact dermatitis

1107

8314

1.40

21.16

2.3

2.4

2.44

2.40

g/l

1.67

1019

7699

Atrial septal defect

343

2034

1.87

21.15

3.5

2.8

2.43

2.40

g/l

0.46

321

1912

Other/unspecified enthesopathies, not elsewhere classified

735

5175

1.52

21.14

2.7

2.5

2.33

2.30

g/l

0.93

687

4770

Meralgia paraesthetica

319

1869

1.92

21.10

2.5

2.6

2.42

2.33

g/l

2.28

290

1745

Allergic purpura

281

1587

2.00

21.07

4.1

2.5

2.34

2.35

g/l

0.11

265

1470

Senility

124

511

2.84

21.00

2.2

2.3

2.09

2.25

g/l

2.40

118

464

Postprocedural disorders of nervous system

569

3810

1.60

20.96

2.2

2.4

2.50

2.44

g/l

1.75

518

3535

Malignant neoplasm of endocrine gland, including Hilmo

670

4643

1.54

20.93

2.9

2.6

2.35

2.37

g/l

0.54

630

4275

Complications of other internal prosthetic devices, implants and grafts

403

2520

1.78

20.89

3.8

2.4

2.18

2.30

g/l

3.57

376

2314

Tobacco use

479

3109

1.68

20.89

3.2

2.6

2.41

2.34

g/l

1.39

446

2892

Macular pucker

1525

12062

1.34

20.81

3.1

2.6

2.24

2.27

g/l

0.95

1384

11102

Lesion of lateral popliteal nerve

443

2833

1.72

20.69

3.1

2.6

2.34

2.29

g/l

0.86

420

2640

Additional codes for the location of defect, injury or illness

528

3516

1.64

20.61

2.8

2.6

2.38

2.33

g/l

1.21

515

3256

Acne vulgaris

625

4253

1.55

20.60

3.3

2.3

2.42

2.51

g/l

4.17

586

3936

Gastrojejunal ulcer

143

645

2.70

20.59

5.3

2.5

2.40

2.25

g/l

1.80

134

604

Cutaneous lupus erythematosus

239

1300

2.13

20.59

2.7

2.4

2.29

2.35

g/l

0.73

219

1204

Manic episode

266

1481

2.00

20.59

2.3

2.5

2.40

2.35

g/l

0.59

238

1384

Disorders of purine and pyrimidine metabolism

299

3.95

20.44

4.6

2.2

2.20

2.27

g/l

0.54

284

Hyperuricaemia without signs of inflammatory arthritis and tophaceous disease

251

4.37

20.43

4.8

2.2

2.24

g/l

0.02

236

Flat foot [pes planus] (acquired)

780

5572

1.48

20.43

2.5

2.4

2.43

2.35

g/l

3.75

710

5124

Status epilepticus

338

2027

1.85

20.42

3.5

2.6

2.26

2.27

g/l

0.15

313

1884

Salpingitis and oophoritis

1394

10872

1.34

20.41

2.7

2.4

2.41

2.40

g/l

0.09

1279

10038

Palmar fascial fibromatosis [Dupuytren]

1414

11079

1.34

20.28

2.9

2.7

2.23

g/l

0.06

1313

10208

Sequelae of injuries of lower limb

777

5566

1.49

20.27

2.8

2.6

2.34

2.35

g/l

0.20

726

5173

Hypertrophy of breast in women and men

1597

12666

1.31

20.25

2.4

2.5

2.48

2.40

g/l

5.90

1471

11719

Hyperhidrosis

261

1445

1.98

20.21

2.1

2.48

2.43

g/l

0.81

234

1331

Rosacea

1109

8405

1.39

20.21

2.9

2.5

2.38

2.36

g/l

0.46

1022

7798

Campylobacter enteritis

262

1470

2.02

20.21

3.4

2.6

2.29

2.32

g/l

0.40

247

1368

Thalassaemia

180

5.12

20.20

2.8

2.5

2.31

2.35

g/l

0.23

168

Alcoholic gastritis

155

729

2.55

20.13

3.0

2.6

2.23

2.26

g/l

0.16

143

681

Benign neoplasm: Liver

233

1264

2.12

20.10

3.0

2.3

2.50

2.37

g/l

2.28

219

1173

Bronchitis, not specified as acute or chronic

734

5212

1.50

20.07

3.2

2.6

2.35

2.30

g/l

1.67

667

4813

Pollen allergy

1450

11189

1.33

20.04

2.4

2.5

2.49

2.46

g/l

1.36

1355

10435

Serous carcinoma of ovary, including Hilmo

297

1733

1.93

20.04

2.2

2.5

2.18

2.37

g/l

6.36

277

1576

Hodgkin lymphoma, hilmo

272

1550

2.00

20.03

2.8

2.5

2.30

2.32

g/l

0.33

257

1443

Hypothyroidism due to medicaments and other exogenous substances

141

644

2.71

19.99

2.9

2.4

2.36

2.31

g/l

0.41

135

595

Hyperosmolality and hypernatraemia

157

746

2.54

19.96

2.6

2.3

2.19

2.28

g/l

0.89

144

680

Otitis externa, unspecified

981

7316

1.42

19.94

3.3

2.6

2.36

g/l

0.11

899

6784

Other predominantly sexually transmitted diseases, not elsewhere classified, including avohilmo

1568

12404

1.31

19.90

2.7

2.4

2.40

2.46

g/l

3.79

1426

11528

Dislocation, sprain and strain of joints and ligaments of shoulder girdle

2628

21992

1.23

19.88

2.5

2.7

2.33

2.34

g/l

0.16

2406

20409

Other specified/unspecified hearing loss

838

6121

1.47

19.84

2.8

2.6

2.27

g/l

0.10

802

5665

Follicular cysts of skin and subcutaneous tissue

1601

12751

1.31

19.83

3.2

2.6

2.34

2.33

g/l

0.37

1502

11843

Polyarteritis nodosa and related conditions

151

708

2.57

19.81

3.9

2.4

2.24

2.33

g/l

0.96

142

659

Schizophrenia

1257

9700

1.35

19.76

2.2

2.7

2.40

2.35

g/l

2.13

1136

9080

Intentional self-harm by sharp object

220

1167

2.10

19.73

2.4

2.51

2.44

g/l

0.88

199

1071

Astigmatism

545

3670

1.60

19.70

3.1

2.6

2.39

2.38

g/l

0.21

498

3404

Malignant neoplasm of other and unspecified parts of biliary tract

167

816

2.44

19.70

2.3

2.5

2.21

2.25

g/l

0.38

161

754

Marginal zone B-cell lymphoma

118

503

2.98

19.68

2.4

2.3

2.25

2.27

g/l

0.20

110

461

Other disorders of penis

860

6297

1.45

19.65

3.3

2.8

2.27

2.26

g/l

0.22

797

5900

Malignant neoplasm of ovary, including Hilmo

518

3464

1.62

19.61

2.4

2.5

2.20

2.39

g/l

10.17

488

3157

Congenital malformations of the musculoskeletal system, not elsewhere classified

149

693

2.53

19.57

3.2

2.3

2.44

2.43

g/l

0.09

138

644

Lactose intolerance, other/unspecified

241

1323

2.04

19.56

2.9

2.2

2.43

2.36

g/l

1.01

218

1224

Viral infections of the central nervous system, including avohilmo

648

4528

1.53

19.51

2.8

2.6

2.37

2.35

g/l

0.28

594

4204

Secondary parkinsonism, excluding more controls

237

1299

2.05

19.48

2.3

2.5

2.29

2.25

g/l

0.62

204

1215

Cushing syndrome

128

567

2.78

19.34

3.1

2.2

2.34

g/l

0.02

118

527

Complications of genitourinary prosthetic devices, implants and grafts

250

1404

2.03

19.30

4.0

2.3

2.24

2.32

g/l

1.54

234

1293

Vulvovaginal ulceration/inflammation in other diseases

556

3773

1.57

19.23

2.6

2.3

2.47

g/l

0.02

514

3482

Viral infections of the central nervous system

600

4145

1.55

19.22

2.9

2.5

2.37

2.35

g/l

0.31

552

3854

Ganglion

1721

13832

1.29

19.22

2.5

2.4

2.43

2.38

g/l

3.74

1592

12803

Plantar fascial fibromatosis

810

5889

1.45

19.19

2.5

2.41

2.35

g/l

1.99

748

5435

Family history of malignant neoplasm

867

6365

1.43

19.15

2.2

2.1

2.44

2.43

g/l

0.15

807

5899

Viral meningitis, including avohilmo

316

1889

1.84

19.14

2.9

2.5

2.42

2.39

g/l

0.48

292

1762

Visual field defects

769

5577

1.48

19.10

3.1

2.7

2.32

2.29

g/l

0.85

703

5158

Polycystic ovarian syndrome

446

2887

1.65

19.09

2.1

2.64

2.53

g/l

4.04

410

2661

Other primary thrombocytopenia

209

4.70

19.06

3.6

2.4

2.45

2.32

g/l

0.92

189

Chondrocostal junction syndrome [Tietze]

347

2138

1.80

19.06

2.3

2.5

2.40

2.36

g/l

0.67

314

1977

Motor disorders, excluding more controls

119

467

2.72

19.05

4.1

3.0

2.62

2.53

g/l

0.99

109

448

Mental and behavioural disorders due to use of other stimulants, including caffeine

222

1191

2.05

19.02

2.5

2.39

2.41

g/l

0.13

199

1111

Malignant melanoma, including Hilmo

1498

11906

1.32

18.96

2.9

2.7

2.26

2.30

g/l

2.56

1392

10871

Other predominantly sexually transmitted diseases, not elsewhere classified

1305

10169

1.33

18.88

2.8

2.4

2.39

2.45

g/l

2.72

1181

9451

Encephalopathy

123

546

2.85

18.85

4.1

2.5

2.09

2.27

g/l

2.34

117

508

Acute myeloid leukaemia

143

670

2.58

18.85

1.9

2.5

2.01

2.25

g/l

6.26

137

614

Acute myeloid leukaemia, including Hilmo

143

670

2.58

18.85

1.9

2.5

2.01

2.25

g/l

6.26

137

614

Acute myeloid leukaemia, helper endpoint

143

670

2.58

18.85

1.9

2.5

2.01

2.25

g/l

6.26

137

614

Malignant neoplasm of anus and anal canal, including Hilmo

138

638

2.63

18.85

2.8

2.4

2.23

2.28

g/l

0.40

133

592

Lesion of radial nerve

335

2048

1.81

18.84

3.1

2.5

2.37

2.32

g/l

0.81

314

1910

Chronic iridocyclitis

436

2841

1.68

18.81

2.6

2.5

2.36

2.34

g/l

0.40

397

2634

Sequelae of injuries of neck and trunk

276

1606

1.93

18.79

2.3

2.5

2.35

2.31

g/l

0.51

258

1506

Vascular dementia (mixed)

242

1373

2.08

18.77

2.3

2.7

2.22

2.21

g/l

0.12

223

1268

Malignant neoplasm of head and neck

696

4964

1.50

18.74

2.5

2.8

2.18

2.27

g/l

3.17

647

4539

Personal history of certain other diseases

167

819

2.30

18.73

2.8

2.0

2.51

2.47

g/l

0.27

148

752

Other retinal artery occlusion

248

1415

2.03

18.60

3.4

2.7

2.22

2.24

g/l

0.20

234

1302

Malignant neoplasm of other and unspecified female genital organs, including Hilmo

251

1431

2.00

18.53

2.4

2.5

2.11

2.38

g/l

11.00

242

1298

Other and unspecified mononeuropathies, also in other diseases

277

1623

1.92

18.49

3.5

2.6

2.31

2.30

g/l

0.11

262

1508

Other bacterial agents as the cause of diseases classified to other chapters

123

549

2.80

18.49

5.2

2.4

2.12

2.32

g/l

3.11

112

505

Strabismus

2249

18633

1.24

18.47

2.9

2.6

2.38

2.37

g/l

0.54

2084

17302

Toxic effect of other and unspecified substances

128

573

2.63

18.40

2.0

2.3

2.46

2.39

g/l

0.68

117

535

Drug-induced polyneuropathy

114

499

2.98

18.33

3.0

2.7

2.33

2.31

g/l

0.13

107

460

Other benign neoplasms of skin

3496

30206

1.19

18.29

3.0

2.6

2.33

2.32

g/l

0.30

3186

27841

Other factor of the environment

141

666

2.56

18.29

5.3

2.5

2.31

2.34

g/l

0.21

131

622

Renal cell carcinoma of kidney

302

1817

1.85

18.21

4.2

2.5

2.08

2.25

g/l

6.52

283

1664

Mental retardation, excluding more controls

286

1618

1.86

18.18

3.4

2.7

2.42

2.41

g/l

0.11

266

1532

Panniculitis affecting regions of neck and back

315

1909

1.81

18.17

2.7

2.5

2.37

2.33

g/l

0.68

297

1770

Poisoning by narcotics and psychodysleptics [hallucinogens]

143

670

2.44

18.14

2.3

2.4

2.40

2.37

g/l

0.19

131

616

Open wound of abdomen, lower back and pelvis

279

1640

1.89

18.12

2.8

2.6

2.36

2.34

g/l

0.17

254

1527

Scar conditions and fibrosis of skin

352

2197

1.75

18.08

2.7

2.3

2.38

2.39

g/l

0.14

323

2044

183

937

2.17

18.06

2.8

2.0

2.41

2.47

g/l

0.83

166

864

Retinal haemorrhage

263

1537

1.96

18.04

4.3

2.5

2.22

2.27

g/l

0.79

247

1406

Coarctation of the aorta

114

495

2.83

17.97

2.7

2.9

2.52

2.42

g/l

1.37

108

466

Other otitis externa (chronic)

586

4092

1.54

17.93

3.1

2.6

2.39

2.32

g/l

2.26

522

3781

Other noninflammatory disorders of vagina

644

4558

1.50

17.92

2.7

2.4

2.36

2.39

g/l

0.70

589

4200

Sequelae of injuries of head

456

3029

1.63

17.91

2.6

2.7

2.32

2.31

g/l

0.15

416

2831

Scleritis and episcleritis

507

3438

1.59

17.88

2.7

2.4

2.34

2.37

g/l

0.77

478

3208

Sacrococcygeal disorders, not elsewhere classified

269

1569

1.89

17.85

2.3

2.4

2.48

2.36

g/l

2.98

249

1458

Malignant melanoma

1328

10486

1.33

17.83

2.9

2.7

2.25

2.30

g/l

3.00

1238

9564

Entropion and trichiasis of eyelid

834

6208

1.44

17.82

2.9

2.7

2.23

2.24

g/l

0.15

763

5689

Myocardial infarction, unclassifiable

2192

16306

1.25

17.79

3.6

2.6

2.23

2.22

g/l

0.67

2041

14825

Dislocation, sprain and strain of joints and ligaments at wrist and hand level

2451

20577

1.23

17.76

2.5

2.6

2.40

2.38

g/l

0.95

2260

19162

Acute bronchiolitis

440

2593

1.63

17.75

3.7

2.6

2.48

2.51

g/l

0.56

414

2413

Focal brain injury

543

3728

1.55

17.74

3.1

2.6

2.27

2.26

g/l

0.11

498

3486

Other disorders starting during childhood or adolescence

383

2409

1.68

17.71

4.0

2.6

2.54

2.53

g/l

0.14

363

2243

Schizoaffective disorder

589

4111

1.53

17.70

2.0

2.5

2.43

2.38

g/l

0.97

536

3831

Dissection of aorta

314

1932

1.82

17.62

3.3

2.5

2.20

2.24

g/l

0.69

290

1773

Hyperaldosteronism

271

1607

1.91

17.56

4.2

2.5

2.30

2.29

g/l

0.05

252

1498

Necrobiosis lipoidica, not elsewhere classified

264

3.71

17.56

4.8

2.0

2.29

2.41

g/l

0.93

243

Mixed disorders of conduct and emotions, excluding more controls

151

722

2.28

17.53

2.7

2.4

2.57

2.51

g/l

0.76

141

675

Lifestyle-related condition

132

619

2.60

17.53

5.3

2.4

2.29

2.34

g/l

0.37

122

573

Drug-induced obesity

101

421

2.97

17.43

3.3

2.6

2.53

2.34

g/l

2.14

396

Ventricular septal defect, a heart condition

205

1113

2.09

17.40

3.6

2.8

2.45

g/l

0.04

196

1039

Somnolence

135

637

2.53

17.39

4.1

2.4

2.45

2.31

g/l

2.17

130

591

CR(E)ST syndrome

163

830

2.34

17.36

3.8

2.3

2.35

2.36

g/l

0.11

158

772

Keratitis and keratoconjunctivitis in other diseases classified elsewhere

345

2178

1.76

17.35

3.5

2.5

2.32

g/l

0.02

325

2021

Deviated nasal septum

2883

24595

1.21

17.31

2.5

2.8

2.34

2.30

g/l

3.50

2662

22839

Vascular dementia

1005

7429

1.38

17.26

2.4

2.6

2.19

2.21

g/l

0.63

911

6775

Striae atrophicae

116

514

2.70

17.25

2.8

2.2

2.45

2.41

g/l

0.30

104

471

Other specified/unspecified dorsopathies

308

1885

1.80

17.24

2.5

2.36

2.31

g/l

0.75

292

1739

Viral meningitis

299

1813

1.81

17.24

2.9

2.4

2.42

2.38

g/l

0.55

277

1688

Other bacterial agents as the cause of diseases classified to other chapters, including avohilmo

140

676

2.49

17.20

5.0

2.4

2.14

2.32

g/l

3.17

129

622

Bell's palsy

1003

7674

1.38

17.19

2.8

2.6

2.38

2.31

g/l

3.44

921

7122

Osteopathy in diseases classified elsewhere

412

3.12

17.18

5.0

2.4

2.09

2.32

g/l

3.82

380

Superficial injury of shoulder and upper arm

1041

8004

1.37

17.14

2.5

2.6

2.36

2.34

g/l

0.62

942

7422

Maltreatment syndromes

399

2587

1.65

17.08

2.2

2.5

2.42

g/l

0.06

364

2408

Other keratitis

945

7172

1.39

17.04

3.3

2.6

2.32

2.35

g/l

0.96

887

6657

L02BB Anti-androgens

930

7102

1.40

16.94

2.3

2.9

2.12

2.18

g/l

3.36

867

6517

Anxious personality disorder

165

837

2.22

16.93

2.4

2.3

2.47

2.43

g/l

0.36

146

781

Embolic stroke

459

3100

1.62

16.93

3.2

2.6

2.25

2.23

g/l

0.37

427

2832

Anorexia

149

737

2.36

16.85

2.7

2.4

2.25

2.38

g/l

1.54

131

680

Alzheimer’s disease (Atypical or mixed), excluding more controls

903

5078

1.41

16.82

2.3

2.5

2.18

2.22

g/l

1.19

779

4683

Alcohol abuse counselling and surveillance

158

799

2.30

16.82

2.4

2.7

2.34

g/l

0.04

151

748

Malignant neoplasm of endocrine gland

570

3998

1.52

16.81

3.0

2.6

2.34

2.38

g/l

0.93

537

3686

Other prurigo

130

617

2.57

16.81

4.0

2.4

2.34

2.30

g/l

0.29

121

566

Other and unspecified injuries of wrist and hand

338

2127

1.73

16.80

2.9

2.6

2.43

2.37

g/l

1.16

309

1978

Benign neoplasm: Pituitary gland, craniopharyngeal duct

449

3019

1.61

16.78

2.4

2.6

2.30

2.34

g/l

0.71

419

2802

Vitamin B12 deficiency anemia due to intrinsic factor deficiency

200

1107

2.12

16.74

3.3

2.6

2.30

2.25

g/l

0.52

189

1030

Other and specified injuries of hip and thigh

231

1327

1.98

16.71

3.3

2.5

2.23

2.30

g/l

1.01

213

1228

Focal epilepsy

1854

15283

1.26

16.69

2.7

2.29

2.32

g/l

2.05

1706

14143

Sequelae of injuries of upper limb

802

5967

1.42

16.67

2.6

2.38

2.34

g/l

1.08

748

5558

Collapsed vertebra, not elsewhere classified

103

449

2.94

16.60

3.9

2.3

2.20

2.26

g/l

0.43

404

Myopia

1015

7796

1.36

16.55

2.9

2.5

2.45

2.42

g/l

0.97

931

7250

Female infertility

2088

10335

1.24

16.55

2.2

2.3

2.50

2.44

g/l

5.21

1921

9571

Hemiplegia

435

2911

1.62

16.52

3.1

2.6

2.33

2.30

g/l

0.46

397

2701

Anogenital herpesviral [herpes simplex] infection, including avohilmo

853

6392

1.40

16.50

2.4

2.3

2.44

2.46

g/l

0.71

795

5916

Respiratory conditions due to other external agents

213

1210

2.04

16.30

2.8

2.5

2.30

2.29

g/l

0.13

195

1115

Malignant neoplasm of retroperitoneum and peritoneum, including Hilmo

170

897

2.22

16.30

2.6

2.3

2.19

2.33

g/l

2.30

163

826

Other infective otitis externa

527

3677

1.54

16.28

2.9

2.6

2.34

2.32

g/l

0.26

491

3397

Gestational diabetes (for exclusion)

2718

15872

1.21

16.27

2.2

2.3

2.58

2.50

g/l

13.24

2475

14766

Complications peculiar to reattachment and amputation

353

3.19

16.27

6.2

2.2

2.02

2.26

g/l

2.67

317

Heterophoria

651

4701

1.47

16.25

2.8

2.5

2.44

2.39

g/l

1.34

598

4359

Other specified and unspecified disorders of eye and adnexa

332

2105

1.74

16.24

3.1

2.5

2.23

2.32

g/l

2.52

314

1958

Cluster headache, strict, including avohilmo

402

2651

1.64

16.21

2.5

2.40

2.39

g/l

0.10

380

2479

Sequelae of infectious and parasitic diseases, including avohilmo

628

4514

1.48

16.20

3.1

2.5

2.32

2.31

g/l

0.03

581

4176

Pneumothorax

613

4399

1.49

16.19

3.0

2.6

2.20

2.26

g/l

1.96

565

4077

Cluster headache, wide,, including avohilmo

423

2823

1.61

16.13

2.5

2.39

2.38

g/l

0.15

399

2643

Glucosamine medication

4492

31760

1.16

16.08

2.4

2.7

2.32

2.29

g/l

3.73

4047

29142

Malignant neoplasm of other connective and soft tissue

234

1363

1.94

16.06

2.6

2.14

2.28

g/l

3.05

224

1258

Tongue abnormality

541

3816

1.53

15.99

2.6

2.34

2.32

g/l

0.33

498

3517

Malignant neoplasm of oesophagus

250

1485

1.89

15.98

2.4

2.7

2.25

2.23

g/l

0.09

239

1364

Oligomenorrhoea

285

1736

1.78

15.96

2.6

2.4

2.52

2.46

g/l

0.90

263

1594

Infection due to other mycobacteria, including avohilmo

165

864

2.20

15.92

3.8

2.2

2.22

2.31

g/l

1.16

150

781

Benign neoplasm of urinary organs

436

2957

1.61

15.90

3.7

2.6

2.32

2.28

g/l

0.67

413

2735

Sequelae of infectious and parasitic diseases

612

4394

1.48

15.90

3.1

2.5

2.32

2.31

g/l

0.11

568

4065

Any dementia, excluding more controls

3687

22136

1.18

15.84

2.3

2.7

2.19

2.25

g/l

7.91

3283

20324

Other secondary coxarthrosis

311

1959

1.76

15.81

3.2

2.5

2.23

2.31

g/l

1.65

293

1813

Use of antiglaucoma preparations and miotics

752

5614

1.43

15.80

3.4

2.6

2.19

2.26

g/l

3.02

688

5124

Hypersomnia

141

702

2.36

15.80

2.3

2.4

2.46

2.35

g/l

1.53

129

649

Short stature, not elsewhere classified

187

938

2.07

15.80

4.7

2.9

2.55

2.58

g/l

0.27

180

884

Infection due to other mycobacteria

156

806

2.24

15.71

3.9

2.2

2.20

2.31

g/l

1.56

142

731

Asthma mixed form (mode)

391

2568

1.62

15.71

2.8

2.3

2.45

2.33

g/l

4.03

372

2357

Lichen simplex chronicus

303

1897

1.76

15.69

3.6

2.5

2.31

2.32

g/l

0.05

285

1757

Inflammatory diseases of the central nervous system

692

5088

1.44

15.66

3.0

2.6

2.30

2.33

g/l

0.90

658

4712

Pemphigoid

289

1807

1.82

15.65

3.1

2.6

2.22

2.24

g/l

0.31

272

1661

Other maternal disorders predominantly related to pregnancy

4423

24402

1.16

15.64

2.4

2.3

2.49

2.45

g/l

6.73

4059

22636

Carcinoid syndrome

112

522

2.71

15.49

2.6

2.4

2.38

2.26

g/l

1.05

106

485

Endometriosis ASRM stages 1,2

1342

10770

1.29

15.46

2.2

2.4

2.48

2.45

g/l

0.95

1225

9958

Single spontaneous delivery

2723

16785

0.83

15.44

2.2

2.6

2.42

2.41

g/l

0.31

2489

15394

Behavioural disorders, excluding more controls

141

690

2.22

15.42

2.8

2.5

2.48

2.46

g/l

0.14

125

645

Other disorders of electrolyte and fluid balance, not elsewhere classified

103

459

2.74

15.42

2.7

2.1

2.19

2.27

g/l

0.62

417

Implicit parasitic Sepsis

239

3.70

15.41

3.8

2.3

2.19

2.30

g/l

0.65

218

Malignant neoplasm of oral cavity, including Hilmo

370

2433

1.65

15.31

2.5

2.6

2.21

2.29

g/l

1.47

345

2234

Congenital malformation of biliary tract

143

5.31

15.29

7.8

3.0

2.60

2.45

g/l

0.96

134

Kyphosis

141

713

2.33

15.27

3.2

2.5

2.33

2.30

g/l

0.19

133

658

Dislocation, sprain and strain of joint and ligaments of hip

350

2286

1.69

15.24

2.9

2.6

2.26

2.30

g/l

0.57

325

2116

Implicit parasitic Sepsis, including avohilmo

285

3.34

15.23

3.9

2.1

2.20

2.33

g/l

0.93

262

Clefts and syndromes for tooth agenesis exclusion, including avohilmo

261

1575

1.81

15.20

4.1

2.7

2.36

2.43

g/l

1.12

254

1469

Inflammatory diseases of prostate (prostatitis)

1124

8883

1.33

15.20

2.6

2.8

2.30

2.23

g/l

3.96

1018

8277

Sequelae of other and unspecified infectious and parasitic diseases, including avohilmo

426

2884

1.59

15.20

3.1

2.5

2.34

2.37

g/l

0.34

393

2699

Dependent personality disorder

180

985

2.08

15.18

3.3

2.4

2.49

2.34

g/l

2.25

160

923

Pre-eclampsia or poor fetal growth

2267

19081

1.21

15.17

2.9

2.3

2.48

2.47

g/l

0.34

2090

17687

Other disorders of iris and ciliary body

268

1647

1.82

15.14

4.4

2.6

2.17

2.29

g/l

3.40

247

1532

Sequelae of other and unspecified infectious and parasitic diseases

423

2863

1.59

15.11

3.1

2.5

2.35

2.37

g/l

0.32

390

2679

Disorders of speech understanding and production

362

2326

1.65

15.11

3.3

2.7

2.43

2.40

g/l

0.51

333

2177

Previous suicide attempt

108

491

2.59

15.10

2.2

2.31

2.39

g/l

0.62

451

Other abnormal findings in urine

172

938

2.15

15.09

3.1

2.5

2.27

g/l

0.04

165

864

Lateral epicondylitis

1014

7888

1.34

15.08

2.2

2.5

2.47

2.36

g/l

8.28

950

7341

Other strabismus

1760

14511

1.25

15.06

2.8

2.6

2.43

2.39

g/l

2.39

1624

13478

Oral leukoplakia and other epithelial disorders of tongue and oral cavity , including avohilmo

771

5818

1.41

14.92

2.6

2.32

2.31

g/l

0.21

709

5395

Burns and corrosions of external body surface, specified by site

878

6728

1.37

14.85

2.8

2.7

2.34

2.35

g/l

0.13

814

6271

Other viral infections characterized by skin and mucous membrane lesions, not elsewhere classified

295

1851

1.73

14.81

4.1

2.4

2.44

2.46

g/l

0.14

280

1720

Certolizumab pegol

167

897

2.10

14.77

1.9

2.3

2.40

2.45

g/l

0.57

157

831

Panniculitis, unspecified

110

512

2.56

14.71

2.7

2.4

2.41

2.33

g/l

0.81

104

472

Malignant melanoma of skin, including Hilmo

1207

9648

1.31

14.69

2.8

2.7

2.26

2.30

g/l

2.06

1127

8814

Nontoxic multinodular goitre

1644

13585

1.26

14.66

2.8

2.4

2.37

2.33

g/l

2.02

1539

12496

Other or unspecified immunodeficiency

198

4.10

14.62

4.0

2.5

2.25

2.42

g/l

1.23

179

Traction detachment of retina

426

2.78

14.62

7.3

2.5

2.01

2.29

g/l

5.37

389

Arthropod-borne viral fevers and viral haemorrhagic fevers, including avohilmo

1500

12282

1.27

14.60

2.9

2.7

2.31

2.33

g/l

0.93

1440

11407

Other bursitis of hip

199

1137

1.98

14.60

3.2

2.3

2.33

2.32

g/l

0.16

188

1050

Granulomatous disorders of skin and subcutaneous tissue

232

1381

1.87

14.58

3.8

2.3

2.35

2.38

g/l

0.31

217

1274

Liver disorders in diseases classified elsewhere

135

4.92

14.56

4.4

2.2

2.42

2.37

g/l

0.19

123

Chronic myeloid leukaemia

236

3.64

14.52

4.0

2.4

2.30

2.27

g/l

0.19

217

Glaucoma suspect

3415

29972

1.17

14.46

2.9

2.6

2.32

2.30

g/l

0.93

3104

27610

Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium

3535

26867

1.16

14.44

2.8

2.3

2.48

2.45

g/l

3.16

3291

24798

Pregnancy hypertension

3160

24571

1.17

14.43

2.8

2.3

2.48

2.45

g/l

2.24

2941

22720

Mantle cell lymphoma, including Hilmo

141

728

2.27

14.43

3.0

2.6

2.06

2.23

g/l

3.27

133

669

Thyroiditis

572

4133

1.47

14.42

2.6

2.4

2.43

2.38

g/l

1.11

524

3830

Focal epilepsy, strict definition

1704

14145

1.25

14.41

2.7

2.28

2.32

g/l

1.77

1565

13076

Cystic fibrosis, other manifestations/unspecified

7.94

14.39

5.1

2.5

2.46

2.42

g/l

0.11

Impetigo

359

2369

1.63

14.38

3.1

2.6

2.36

2.42

g/l

1.22

341

2204

Seronegative juvenile rheumatoid arthritis

155

818

2.13

14.36

2.5

2.4

2.42

2.49

g/l

0.70

150

756

Burns and corrosions

1101

8723

1.31

14.30

2.7

2.34

2.35

g/l

0.24

1023

8135

Hyphaema and other vascular disorders of iris and ciliary body

212

1249

1.94

14.24

4.9

2.5

2.12

2.28

g/l

4.16

194

1154

Other bullous disorders

251

1542

1.82

14.23

3.0

2.6

2.33

2.31

g/l

0.20

235

1442

Diffuse brain injury

287

1802

1.72

14.23

2.4

2.31

2.28

g/l

0.35

265

1685

Ectropion of eyelid

414

2849

1.59

14.23

2.9

2.7

2.18

2.20

g/l

0.47

377

2593

Other diseases of spinal cord

267

1662

1.78

14.23

2.8

2.6

2.28

2.30

g/l

0.20

250

1549

Colitis due to radiation

124

622

2.46

14.22

3.1

2.6

2.21

2.20

g/l

0.04

119

569

Bruxism

164

887

2.09

14.22

3.0

2.3

2.50

2.41

g/l

1.72

154

824

Tinnitus

2045

17285

1.22

14.22

2.5

2.6

2.34

2.32

g/l

1.08

1844

16061

Contusion of other and unspecified parts of foot

419

2861

1.56

14.20

3.2

2.4

2.42

2.41

g/l

0.12

391

2654

Viral haemorrhagic fevers, not elsewhere classified/unspecified, including avohilmo

1326

10752

1.29

14.20

2.9

2.7

2.30

2.33

g/l

1.66

1278

9989

Hypertrophy of breast

1332

10789

1.28

14.20

2.2

2.4

2.51

2.43

g/l

5.82

1220

9968

Diabetes insipidus

450

2.67

14.15

2.7

2.2

2.39

2.34

g/l

0.32

418

Other specified/unspecified spondylopathies

235

1422

1.85

14.10

3.0

2.5

2.22

2.27

g/l

0.54

214

1304

Pre-existing hypertension complicating pregnancy, childbirth and the puerperium

556

4002

1.47

14.09

3.1

2.3

2.52

2.49

g/l

0.69

524

3719

Malignant neoplasm of other and ill-defined digestive organs, including Hilmo

164

896

2.10

14.03

2.4

2.18

2.25

g/l

0.78

156

828

Car occupant injured in noncollision transport accident

296

1887

1.71

14.03

2.9

2.5

2.38

2.36

g/l

0.16

273

1744

Recurrent dislocation of patella

362

2402

1.60

13.86

2.6

2.3

2.47

2.48

g/l

0.15

328

2223

Neuroendocrine tumor and carcinoma of stomach

236

3.53

13.84

2.5

2.3

2.42

2.26

g/l

1.08

215

Degeneration of nervous system due to alcohol

220

1323

1.90

13.83

2.4

2.9

2.12

2.24

g/l

1.59

198

1236

Chorioretinal inflammation

249

1533

1.80

13.83

3.1

2.4

2.28

2.33

g/l

0.67

226

1426

Other disorders of cornea

827

6365

1.37

13.80

3.0

2.6

2.32

g/l

0.02

764

5891

Degeneration of the brain due to alcohol

220

1324

1.90

13.79

2.4

2.8

2.12

2.24

g/l

1.62

198

1236

Corneal scars and opacities

261

1632

1.78

13.79

4.3

2.5

2.26

2.30

g/l

0.62

238

1520

Drug-induced thyroiditis

126

5.15

13.78

3.6

2.7

2.46

2.35

g/l

0.52

112

Intracranial and intraspinal abscess and granuloma

128

653

2.35

13.77

3.4

2.3

2.20

2.29

g/l

0.81

122

608

Follow-up care involving plastic surgery

303

1950

1.68

13.74

2.4

2.0

2.37

2.38

g/l

0.10

255

1794

Toxic effects of substances chiefly nonmedicinal as to source

904

7030

1.34

13.72

2.6

2.7

2.36

2.35

g/l

0.14

843

6536

Lesion of plantar nerve

497

3547

1.50

13.67

2.4

2.5

2.38

2.34

g/l

1.21

466

3286

Dementia, including avohilmo

4746

29035

1.14

13.58

2.3

2.7

2.22

2.26

g/l

4.03

4178

26717

Malignant neoplasm of thyroid gland, including Hilmo

563

4094

1.46

13.57

2.9

2.5

2.35

2.38

g/l

0.51

527

3769

Trigeminal neuralgia

480

3402

1.50

13.55

2.4

2.5

2.36

2.33

g/l

0.59

441

3152

Other diseases of peritoneum

384

2621

1.59

13.55

3.1

2.4

2.39

2.33

g/l

1.31

352

2426

Malignant neoplasm of breast, ER-negative, including Hilmo

1636

12705

1.24

13.53

2.2

2.4

2.35

2.40

g/l

3.34

1489

11528

Bullous pemphigoid

229

1405

1.87

13.51

3.0

2.6

2.21

2.23

g/l

0.23

214

1289

Other and unspecified epidermal thickening

239

1468

1.81

13.45

4.5

2.4

2.28

2.34

g/l

0.81

228

1358

Achalasia of cardia

166

923

2.05

13.41

2.3

2.7

2.38

2.26

g/l

1.66

155

862

Pre-eclampsia or eclampsia

1599

13267

1.24

13.41

3.1

2.3

2.46

2.45

g/l

0.36

1473

12273

Chondropathies

1210

9771

1.29

13.38

2.5

2.6

2.39

2.36

g/l

0.89

1107

9094

Acute lymphadenitis

446

3122

1.52

13.35

3.0

2.5

2.37

2.38

g/l

0.17

418

2901

Malignant neoplasm of renal pelvis, including Hilmo

123

624

2.33

13.30

3.4

2.4

2.09

2.20

g/l

1.26

115

572

Localized scleroderma [morphea]

140

740

2.19

13.29

2.4

2.2

2.38

2.37

g/l

0.02

126

682

Female infertility, cervical, vaginal, other or unspecified origin

1886

10093

1.22

13.26

2.2

2.3

2.50

2.44

g/l

4.95

1734

9346

Blood alcohol or alcohol intoxication level

197

1149

1.89

13.23

2.8

2.6

2.38

2.35

g/l

0.40

178

1069

Carcinoma in situ of skin of lower limb, including hip

237

1480

1.85

13.21

4.0

2.5

2.21

2.28

g/l

1.02

217

1349

Other mental disorders due to brain damage and dysfunction and to physical disease

1125

9072

1.30

13.13

2.7

2.27

g/l

0.20

1030

8352

Thyrotoxicosis with toxic multinodular goitre

526

3826

1.48

13.11

2.6

2.5

2.32

g/l

0.03

484

3509

Leiomyoma of uterus

5368

27149

1.13

13.06

2.4

2.43

2.40

g/l

3.70

4900

25017

Anogenital herpesviral [herpes simplex] infection

483

3440

1.48

13.06

2.7

2.3

2.42

2.45

g/l

0.57

448

3192

Other ill-defined and unspecified causes of mortality

861

6736

1.35

13.03

3.4

2.6

2.20

2.24

g/l

0.88

777

6206

Panhypopituitarism

171

972

2.01

13.01

2.5

2.6

2.24

2.31

g/l

0.73

161

905

Secondary systemic amyloidosis

152

4.46

12.95

5.4

2.1

1.95

2.24

g/l

2.87

135

Erythema nodosum

256

1615

1.75

12.94

3.3

2.4

2.36

2.35

g/l

0.18

236

1494

Hyperprolactinaemia

268

1701

1.71

12.89

2.8

2.2

2.48

2.43

g/l

0.69

239

1588

Injury of intra-abdominal organs

215

1297

1.83

12.87

3.1

2.6

2.28

2.34

g/l

0.77

198

1204

Malignant neoplasm of respiratory system and intrathoracic organs, including Hilmo

2048

14330

1.21

12.84

2.4

2.7

2.16

2.27

g/l

14.20

1941

13029

Injuries involving multiple body regions

318

2106

1.63

12.81

3.1

2.5

2.38

2.34

g/l

0.48

295

1950

Malignant neoplasm of ovary

377

2586

1.57

12.79

2.1

2.5

2.19

2.39

g/l

8.41

353

2351

Non-small cell lung cancer, adenocarcinoma

533

3893

1.46

12.79

2.3

2.7

2.17

2.26

g/l

2.82

504

3538

Pyoderma

169

957

1.99

12.77

3.2

2.5

2.34

2.32

g/l

0.16

150

892

Ethmoidectomy

1027

8193

1.31

12.75

2.4

2.6

2.41

2.34

g/l

3.61

926

7633

Disorders of breast

4197

33008

1.14

12.75

2.3

2.4

2.44

2.42

g/l

1.19

3881

30319

Impacted cerumen

1040

8335

1.31

12.74

2.9

2.7

2.33

2.28

g/l

1.87

901

7693

Central retinal artery occlusion

223

1375

1.83

12.73

4.2

2.7

2.23

2.21

g/l

0.22

210

1256

Type1 diabetes, definitions combined, early onset

449

3152

1.49

12.72

4.4

2.7

2.25

2.49

g/l

15.40

424

2949

Malignant melanoma of skin

988

7854

1.31

12.72

2.9

2.7

2.24

2.30

g/l

2.97

924

7178

Unspecified event, undetermined intent

215

1303

1.82

12.65

3.1

2.6

2.31

2.35

g/l

0.47

205

1215

Abnormal findings on examination of other body fluids, substances and tissues, without diagnosis

5172

36291

1.13

12.61

2.6

2.5

2.38

2.39

g/l

0.22

4739

33594

Oral lichen planus or lichen planus, and hypothyroidism or thyroxine medication

502

3649

1.48

12.59

2.2

2.6

2.41

2.34

g/l

1.97

453

3368

Other specified and unspecified retinal disorders

317

2116

1.64

12.57

4.0

2.6

2.29

g/l

0.02

290

1959

Delivery

2784

16828

0.85

12.55

2.2

2.6

2.42

2.41

g/l

0.35

2547

15432

Atrial septal defect, secundum type

238

1481

1.76

12.53

3.4

2.9

2.47

2.42

g/l

0.67

223

1397

Certain conditions originating in the perinatal period

570

3708

1.42

12.52

3.6

2.5

2.51

2.53

g/l

0.43

533

3458

Helminthiases, including avohilmo

335

2253

1.60

12.48

2.9

2.6

2.44

2.40

g/l

0.68

322

2090

Need for immunization against other single infectious diseases

8.00

12.46

17.1

2.3

2.01

2.31

g/l

1.39

Episcleritis

414

2902

1.52

12.45

2.8

2.4

2.35

2.38

g/l

0.49

388

2716

Gluteal tendinitis

356

2426

1.58

12.44

2.5

2.46

2.33

g/l

4.57

316

2245

Papillary adenocarcinoma of thyroid gland

392

2722

1.54

12.39

3.0

2.6

2.38

2.37

g/l

0.08

368

2513

202

1209

1.83

12.37

3.3

2.5

2.52

2.38

g/l

2.71

182

1125

Familial erythrocytosis

238

3.31

12.37

2.3

2.5

2.60

2.26

g/l

4.03

221

Peptic ulcer

103

502

2.42

12.35

3.6

2.5

2.37

2.25

g/l

1.09

467

Isolated patent ductus arteriosus

100

475

2.45

12.33

3.7

3.4

2.50

2.51

g/l

0.05

444

Malignant neoplasm of thyroid gland

508

3694

1.46

12.31

2.9

2.5

2.35

2.37

g/l

0.39

477

3405

Other and unspecified nail disorders

208

1264

1.83

12.26

4.0

2.4

2.36

2.33

g/l

0.34

192

1180

Vascular dementia (subcortical)

370

2574

1.58

12.25

2.3

2.7

2.20

2.21

g/l

0.21

343

2356

Alzheimer’s disease (Late onset), excluding more controls

1389

7427

1.26

12.21

2.2

2.5

2.17

2.24

g/l

4.43

1239

6864

Benign neoplasm: Skin of trunk

358

2459

1.57

12.20

3.7

2.6

2.33

2.32

g/l

0.14

327

2280

Combined immunodeficiencies

109

547

2.36

12.20

3.0

2.4

2.36

2.30

g/l

0.51

506

Neuroendocrine tumor and carcinoma of pancreas

305

2.93

12.19

2.8

2.3

2.44

2.29

g/l

1.29

278

Malignant neoplasm of corpus uteri, including Hilmo

726

5588

1.37

12.17

2.4

2.5

2.29

2.38

g/l

3.16

652

5023

Thyrotropin deficiency

107

531

2.35

12.16

3.0

2.3

2.42

2.38

g/l

0.24

490

Pleural plaque

904

7189

1.33

12.15

2.7

2.21

2.20

g/l

0.36

791

6598

Other and unspecified injuries of ankle and foot

337

2280

1.58

12.10

2.8

2.4

2.39

2.40

g/l

0.06

310

2113

Other salmonella infections

298

1972

1.64

12.10

2.9

2.3

2.29

2.33

g/l

0.61

272

1828

Female infertility, associated with anovulation

511

3711

1.43

12.00

2.0

2.2

2.57

2.52

g/l

1.26

470

3423

Melanocytic naevi, other sites/unspecified

674

5143

1.38

11.97

4.5

2.6

2.33

2.36

g/l

0.51

645

4785

Iridocyclitis in diseases classified elsewhere

177

1039

1.92

11.97

3.0

2.5

2.31

2.34

g/l

0.29

162

974

Malignant neoplasm of bone and articular cartilage, including Hilmo

162

925

1.96

11.92

3.3

2.5

2.24

2.29

g/l

0.52

153

855

Other viral infections characterized by skin and mucous membrane lesions, not elsewhere classified, including avohilmo

541

3916

1.42

11.91

3.3

2.5

2.49

2.46

g/l

0.43

509

3642

Hallux rigidus

1079

8723

1.28

11.88

2.3

2.5

2.32

g/l

0.04

969

8040

Poisoning by and exposure to other and unspecified chemicals and noxious substances, undetermined intent

119

617

2.20

11.83

2.5

2.50

2.36

g/l

2.06

113

572

Other neurotic disorders

384

2685

1.53

11.83

2.7

2.5

2.38

2.30

g/l

2.16

357

2479

Other specified cerebrovascular diseases, other cerebrovascular disorders in diseases classified elsewhere

603

4539

1.41

11.80

3.1

2.6

2.26

g/l

0.11

562

4158

Hyperkinetic disorders (excl. ADHD)

155

857

1.96

11.79

2.9

2.8

2.56

2.47

g/l

1.10

149

806

Injury of other and unspecified intrathoracic organs

538

3989

1.43

11.77

2.8

2.7

2.26

2.28

g/l

0.44

500

3703

Factitial dermatitis

250

3.16

11.77

3.9

2.1

2.41

2.35

g/l

0.36

227

Follicular lymphoma, hilmo

371

2596

1.56

11.75

2.1

2.7

2.25

2.28

g/l

0.40

350

2409

Other and unspecified iridocyclitis

392

2756

1.52

11.74

3.1

2.5

2.26

2.33

g/l

1.89

368

2550

Bicipital tendinitis

387

2712

1.53

11.74

2.8

2.6

2.36

2.30

g/l

1.26

361

2528

Use of donepezil

1569

17698

0.82

11.71

2.0

2.6

2.22

2.23

g/l

0.34

1339

16095

Other nonthrombocytopenic purpura

104

523

2.38

11.70

3.6

2.5

2.43

2.28

g/l

1.63

480

Papilloedema, unspecified

202

1234

1.81

11.67

3.8

2.4

2.29

2.36

g/l

0.98

191

1147

Other salmonella infections, including avohilmo

341

2334

1.56

11.65

2.8

2.3

2.31

2.35

g/l

0.65

310

2155

Examination and encounter for administrative purposes

655

4995

1.38

11.61

3.0

2.4

2.34

2.25

g/l

4.22

634

4543

Carcinoma in situ of other and unspecified sites

385

2728

1.55

11.61

3.0

2.8

2.30

2.21

g/l

2.11

351

2530

Tooth eruption problems

1019

7892

1.28

11.61

3.1

2.4

2.50

g/l

0.04

969

7333

Infective bursitis

248

1595

1.71

11.60

3.8

2.7

2.24

2.28

g/l

0.50

232

1487

Lichen planus

1088

8850

1.28

11.57

2.6

2.37

2.32

g/l

2.20

1017

8151

Abnormal findings on diagnostic imaging of central nervous system

400

2827

1.51

11.57

2.8

2.5

2.32

2.35

g/l

0.57

375

2621

Other superficial mycoses, including avohilmo

829

6517

1.32

11.53

2.5

2.38

2.39

g/l

0.29

762

6062

Muscle strain

265

1726

1.65

11.44

3.0

2.5

2.39

2.35

g/l

0.61

252

1595

Unspecified visual impairment (binocular)

150

853

2.00

11.41

3.4

2.6

2.26

2.32

g/l

0.72

142

790

Other acute skin changes due to ultraviolet radiation

291

1947

1.63

11.38

2.9

2.5

2.33

2.30

g/l

0.42

276

1806

Rheumatic fever incl heart disease

268

1762

1.66

11.34

4.6

2.5

2.30

2.26

g/l

0.64

248

1629

Paraplegia, diplegia of upper limbs

198

1217

1.82

11.31

3.0

2.6

2.22

2.28

g/l

0.75

184

1140

Dislocation, sprain and strain of joints and ligaments of thorax

292

1953

1.62

11.30

2.9

2.6

2.34

2.33

g/l

0.19

269

1817

Erythema multiforme

200

1230

1.80

11.30

2.7

2.6

2.31

2.32

g/l

0.09

184

1148

Persistent delusional disorders

605

4589

1.39

11.28

2.4

2.6

2.35

2.32

g/l

0.61

537

4240

Other/unspecified disorders of vestibular function

366

2570

1.54

11.27

2.5

2.6

2.32

2.30

g/l

0.43

343

2372

Cauda equina syndrome

131

719

2.10

11.26

2.1

2.4

2.39

2.34

g/l

0.54

125

670

Ill-defined and unknown causes of mortality

920

7388

1.31

11.23

3.3

2.6

2.21

2.24

g/l

0.85

830

6807

Haemophagocytic lymphohistiocytosis

7.06

11.22

3.6

3.3

1.85

2.33

g/l

2.56

Malignant neoplasm, without specification of site, including Hilmo

386

2724

1.51

11.17

2.4

2.5

2.11

2.26

g/l

4.84

356

2482

FESS (DNB20)

978

7882

1.29

11.17

2.4

2.6

2.41

2.34

g/l

4.23

881

7348

Herpesviral keratitis and keratoconjunctivitis

361

2529

1.54

11.14

3.3

2.5

2.34

2.30

g/l

0.72

337

2338

Propionic acid derivatives

2708

11880

1.17

11.14

2.4

3.4

2.32

2.28

g/l

3.27

2484

11044

Varicose veins of other sites

505

3735

1.43

11.12

3.1

2.6

2.37

2.31

g/l

1.69

462

3473

Chronic diseases of tonsils and adenoids

6893

39977

1.10

11.10

2.5

2.6

2.44

2.37

g/l

22.67

6459

37063

Benign neoplasm: Kidney

314

2153

1.59

11.05

3.9

2.6

2.33

2.29

g/l

0.55

296

1995

Malignant neoplasm of oral cavity

280

1869

1.62

11.00

2.5

2.6

2.16

2.29

g/l

3.19

258

1719

Lichen planus, including avohilmo

1606

13616

1.22

10.99

2.5

2.6

2.38

2.33

g/l

3.36

1497

12586

Appendicitis, broad definition

6664

55052

1.10

10.98

2.7

2.6

2.38

2.35

g/l

4.30

6208

51030

Malignant neoplasm of breast, HER-negative

1488

12006

1.23

10.97

2.2

2.4

2.35

2.40

g/l

2.90

1346

10880

Other injuries of lower limb, level unspecified

498

2.33

10.97

3.8

2.3

2.16

2.32

g/l

1.65

464

Pre-eclampsia

1452

12175

1.23

10.96

3.0

2.3

2.45

g/l

0.12

1336

11265

Foreign body in alimentary tract

453

3310

1.46

10.95

2.4

2.7

2.37

2.30

g/l

1.36

410

3070

Acute appendicitis, no complications

4730

42665

1.12

10.92

2.6

2.40

2.37

g/l

3.62

4403

39669

Colorectal neuroendocrine tumor and carcinoma

124

672

2.09

10.88

2.5

2.4

2.49

2.34

g/l

1.78

118

621

Acute appendicitis

6220

53030

1.10

10.86

2.6

2.38

2.35

g/l

4.10

5803

49183

Anti-inflammatory and antirheumatic products, non-steroids

2703

11881

1.17

10.82

2.5

3.4

2.32

2.28

g/l

2.16

2481

11045

Other disorders of pigmentation

378

2684

1.51

10.82

3.0

2.4

2.37

2.34

g/l

0.51

346

2467

Inflammatory disorders of male genital organs, not elsewhere classified

127

696

2.07

10.81

3.5

2.9

2.23

g/l

0.00

119

654

Autism

186

1122

1.78

10.80

2.1

2.4

2.60

2.50

g/l

1.77

167

1041

Family history of certain disabilities and chronic diseases leading to disablement

349

2426

1.52

10.78

2.9

2.0

2.52

2.46

g/l

1.46

329

2241

Mantle cell lymphoma

483

2.37

10.76

2.6

2.5

2.08

2.22

g/l

1.81

446

Other disorders of bone density and structure

212

1335

1.73

10.75

2.6

2.3

2.40

2.36

g/l

0.52

203

1237

Malignant neoplasm of tongue, including Hilmo

218

1388

1.72

10.68

2.5

2.6

2.24

2.29

g/l

0.58

203

1283

Hordeolum and other deep inflammation of eyelid

479

3537

1.43

10.68

3.0

2.5

2.32

2.36

g/l

0.81

451

3270

Congenital malformations of the respiratory system, including avohilmo

172

1035

1.86

10.65

3.2

2.6

2.39

2.38

g/l

0.09

155

965

Disorder of external ear, unspecified

283

1909

1.61

10.65

3.2

2.6

2.41

2.30

g/l

2.09

255

1772

Open wound of shoulder and upper arm

174

1047

1.83

10.61

3.6

2.5

2.29

2.31

g/l

0.18

163

974

Dysplasia of cervi uteri

1693

10091

1.21

10.59

2.5

2.3

2.43

g/l

0.03

1544

9331

Lichen ruber planus, wide definition including periferal and oral lichen planus

1895

16329

1.20

10.58

2.4

2.6

2.39

2.34

g/l

3.78

1755

15117

Diseases of appendix

6717

55398

1.10

10.58

2.7

2.6

2.38

2.35

g/l

4.22

6256

51341

Other mycoses, not elsewhere classified/unspecified, including avohilmo

165

984

1.88

10.57

3.5

2.5

2.25

2.34

g/l

1.18

156

916

Intussusception

174

1048

1.82

10.51

2.3

2.4

2.44

2.34

g/l

1.50

162

971

Erectile dysfunction

713

5617

1.35

10.46

4.4

2.9

2.22

2.20

g/l

0.41

670

5209

Other specified/unspecified disorders of bone/cartilage

227

1466

1.69

10.44

3.1

2.4

2.28

2.34

g/l

0.93

216

1374

Disorders of parathyroid gland, other and/or unspecified

398

2.56

10.38

6.0

2.2

2.25

2.31

g/l

0.38

358

Medial epicondylitis

285

1926

1.58

10.38

2.3

2.5

2.44

2.35

g/l

2.18

260

1796

Benign intracranial hypertension

442

2.32

10.37

3.2

2.3

2.44

2.48

g/l

0.26

405

232

1522

1.70

10.31

2.7

2.13

2.23

g/l

1.74

212

1396

Alzheimer’s disease (Early onset)

191

3009

0.60

10.31

2.1

2.6

2.23

2.25

g/l

0.22

162

2754

Other and unspecified trigeminal disorders

138

787

1.97

10.30

2.5

2.2

2.38

2.36

g/l

0.15

123

733

Haemorrhagic disorder due to circulating anticoagulants

151

895

1.96

10.29

3.8

2.6

2.23

2.22

g/l

0.05

134

828

Radial styloid tenosynovitis [de Quervain]

414

2996

1.45

10.29

2.7

2.4

2.46

2.40

g/l

1.60

375

2783

Hypertrophic disorders of skin

431

3145

1.45

10.28

2.7

2.3

2.44

2.41

g/l

0.44

406

2909

Disorders of myoneural junction and muscle in diseases classified elsewhere

417

2.46

10.27

4.2

2.4

2.14

2.36

g/l

2.41

385

Embedded teeth, including avohilmo

637

4913

1.35

10.21

3.1

2.4

2.46

2.47

g/l

0.14

607

4550

Malignant neoplasm of corpus uteri

654

5089

1.35

10.20

2.3

2.5

2.28

2.37

g/l

3.65

588

4580

Malignant neoplasm of other and unspecified parts of tongue, including Hilmo

179

1100

1.80

10.19

2.7

2.4

2.22

2.29

g/l

0.76

166

1015

Hypothermia

172

1050

1.84

10.19

3.3

2.6

2.21

2.26

g/l

0.39

156

974

Common variable immunodeficiency with predominant abnormalities of B-cell numbers and function

107

4.45

10.18

4.2

2.1

2.44

2.37

g/l

0.21

Human immunodeficiency virus [HIV] disease, including avohilmo

151

885

1.89

10.15

1.9

2.6

2.49

2.33

g/l

2.47

146

836

Pilonidal cyst

590

4509

1.36

10.14

3.2

2.5

2.40

2.39

g/l

0.09

553

4221

Anomalies of dental arch relationship, including avohilmo

1479

11293

1.21

10.13

2.7

2.5

2.51

2.43

g/l

6.86

1363

10516

Contusion of ankle

320

2224

1.53

10.13

3.0

2.4

2.35

2.39

g/l

0.64

298

2066

Retinal detachment with retinal break

1089

8989

1.26

10.11

3.5

2.6

2.21

2.28

g/l

3.47

1014

8320

Wide developmental disorders

244

1593

1.62

10.10

2.2

2.8

2.61

2.51

g/l

2.03

217

1484

Carcinoma in situ, bladder

351

2512

1.53

10.09

3.0

2.8

2.29

2.21

g/l

1.65

318

2325

Specific developmental disorder of motor function

119

630

2.03

10.05

4.1

3.2

2.62

2.53

g/l

1.00

109

606

Nephropathy induced by other drugs, medicaments and biological substances

5.28

9.98

11.3

2.5

2.06

2.27

g/l

1.63

Achilles tendinitis

807

6446

1.30

9.98

2.9

2.6

2.37

2.31

g/l

2.64

755

5997

Human immunodeficiency virus [HIV] disease

148

867

1.89

9.97

1.9

2.6

2.49

2.33

g/l

2.54

143

818

Syndrome of inappropriate secretion of antidiuretic hormone

312

2.76

9.95

3.1

2.3

2.39

2.25

g/l

1.25

288

Other congenital malformations of skin

304

2104

1.55

9.92

2.5

2.6

2.40

2.38

g/l

0.23

285

1951

Disorders of orbit

347

2465

1.50

9.90

2.6

2.5

2.37

2.35

g/l

0.27

323

2289

Malignant neoplasm of cervix uteri, including Hilmo

198

1255

1.72

9.84

3.2

2.3

2.22

2.42

g/l

4.34

180

1153

Localized skin eruption due to drugs and medicaments

114

626

2.10

9.83

2.9

2.3

2.42

2.36

g/l

0.55

104

579

Encephalitis

245

1632

1.63

9.82

3.0

2.6

2.28

2.32

g/l

0.40

231

1514

Causalgia

132

752

1.95

9.80

3.2

2.4

2.53

2.39

g/l

1.98

123

708

Bitten or struck by other mammals

878

7095

1.28

9.76

2.9

2.5

2.41

2.40

g/l

0.25

807

6587

Problems related to social environment

245

1631

1.62

9.76

2.8

2.4

2.32

g/l

0.02

228

1502

Streptococcus and staphylococcus as the cause of diseases classified to other chapters, including avohilmo

447

2.36

9.73

4.2

2.4

2.21

2.33

g/l

0.98

416

Pediculosis, acariasis and other infestations

456

3391

1.42

9.73

3.4

2.6

2.34

g/l

0.04

428

3168

Congenital malformations of the respiratory system

157

947

1.86

9.72

3.3

2.7

2.39

2.38

g/l

0.04

143

883

Other and unspecified paralytic syndromes

133

767

1.96

9.70

2.5

2.4

2.35

2.34

g/l

0.07

128

706

Other disorders of the genitourinary system

1048

8660

1.26

9.70

2.9

2.5

2.37

2.32

g/l

2.38

978

7949

Perforation of tympanic membrane

797

6392

1.30

9.66

3.0

2.6

2.39

2.33

g/l

2.37

738

5926

Dislocation, sprain and strain of joints and ligaments of knee

5202

43088

1.11

9.65

2.4

2.6

2.42

2.38

g/l

5.93

4853

40042

Drug-induced acute pancreatitis

5.28

9.62

3.9

2.1

2.39

2.30

g/l

0.30

Delivery, wide proxy

2374

14325

0.86

9.60

2.2

2.5

2.42

2.41

g/l

0.28

2163

13123

Other encephalitis

231

1528

1.65

9.60

3.1

2.6

2.27

2.32

g/l

0.68

219

1418

Spinal instabilities

221

1445

1.66

9.58

2.6

2.5

2.44

2.33

g/l

2.29

204

1349

Aspergillosis

492

2.28

9.58

3.8

2.7

2.14

2.27

g/l

1.43

454

Other injuries of spine and trunk, level unspecified

468

2.27

9.55

4.8

2.5

2.28

2.33

g/l

0.27

435

All dysplastic lesions of the vulva

330

2340

1.51

9.53

3.8

2.3

2.32

2.42

g/l

2.62

303

2167

Single delivery by forceps and vacuum extractor

760

5693

0.77

9.52

1.8

2.6

2.56

2.51

g/l

1.90

696

5312

Pathological/recurrent dislocation and subluxation of joint, not elsewhere classified

530

4027

1.37

9.51

2.5

2.4

2.44

2.39

g/l

1.13

493

3743

Other/unspecified soft tissue disorders related to use, overuse and pressure

228

1501

1.63

9.49

2.7

2.4

2.40

2.35

g/l

0.67

216

1386

Hypertrichosis

168

1028

1.77

9.49

2.6

2.2

2.53

2.47

g/l

0.82

147

943

Other inflammation of vagina/vulva

281

1929

1.55

9.49

2.2

2.3

2.51

2.46

g/l

0.77

260

1790

Cryoglobulinemia

5.37

9.47

10.3

2.4

2.09

2.32

g/l

1.56

Anaphylactic shock due to adverse effect of correct drug or medication properly administered

111

610

2.07

9.45

3.8

2.3

2.36

2.34

g/l

0.08

104

570

Disorders of synovium and tendon in diseases classified elsewhere

180

1128

1.75

9.44

3.6

2.6

2.32

2.30

g/l

0.21

163

1044

Other fall from one level to another

1857

16096

1.18

9.42

2.7

2.34

2.35

g/l

0.21

1729

14958

Ankylosing hyperostosis [Forestier]

128

738

1.97

9.41

3.0

2.4

2.37

2.25

g/l

1.78

118

682

Benign neoplasm of other and unspecified intrathoracic organs

107

586

2.12

9.40

3.2

2.4

2.29

2.31

g/l

0.17

545

Pedestrian injured in transport accident

550

4227

1.37

9.39

2.6

2.37

2.34

g/l

0.71

507

3923

Nasal polyp

1589

13635

1.20

9.38

2.4

2.8

2.32

2.28

g/l

2.15

1482

12661

Dissocial personality disorder

122

687

1.96

9.37

2.4

2.7

2.35

2.33

g/l

0.13

115

649

Viral agents as the cause of diseases classified to other chapters

191

1221

1.72

9.34

3.2

2.6

2.36

2.35

g/l

0.07

179

1133

Autism spe

181

1129

1.71

9.33

2.1

2.6

2.61

2.50

g/l

1.95

162

1048

Benign neoplasm: Tongue

235

1574

1.63

9.32

2.8

2.5

2.33

2.30

g/l

0.36

216

1469

Other and unspecified disorders of vitreous body

3773

33439

1.13

9.32

2.6

2.34

2.32

g/l

1.60

3470

30856

Aspergillosis, including avohilmo

504

2.23

9.29

3.8

2.7

2.14

2.27

g/l

1.40

466

Benign neoplasm: Appendix

114

642

2.07

9.27

2.6

2.40

2.29

g/l

1.17

107

591

Other congenital malformations of peripheral vascular system

122

693

1.97

9.26

4.0

2.6

2.46

2.39

g/l

0.81

114

641

Other superficial mycoses

186

1179

1.72

9.24

3.6

2.5

2.35

2.36

g/l

0.16

176

1104

Bursitis of shoulder

205

1330

1.67

9.23

2.5

2.4

2.36

2.33

g/l

0.40

193

1233

Cerebral aneurysm, nonruptured

686

5443

1.32

9.20

3.1

2.6

2.35

2.32

g/l

0.47

644

5046

Contact with heat and hot substances

407

3005

1.43

9.13

3.4

2.7

2.30

2.36

g/l

1.14

370

2806

Cerebral palsy

127

729

1.92

9.13

3.4

2.6

2.44

2.42

g/l

0.16

119

681

Maze procedure for atrial fibrillation

267

2.91

9.13

3.0

2.5

2.28

2.27

g/l

0.03

246

Malignant neoplasm of other and unspecified female genital organs

141

842

1.88

9.12

2.4

2.3

2.08

2.39

g/l

9.03

135

767

Malignant neoplasm of tongue

164

1015

1.78

9.11

2.5

2.6

2.22

2.29

g/l

0.64

151

936

Other specified disorders of muscle

233

1558

1.61

9.11

3.2

2.6

2.31

2.32

g/l

0.16

219

1437

Dislocation of lens

146

879

1.86

9.11

3.6

2.4

2.13

2.23

g/l

1.26

131

810

Other erythematous conditions

293

2056

1.53

9.07

2.9

2.5

2.38

2.31

g/l

1.26

275

1915

Diastasis of muscle

439

2.24

9.07

2.4

2.2

2.39

2.36

g/l

0.19

410

Allergic contact dermatitis due to drugs in contact with skin

187

1198

1.72

9.06

2.6

2.4

2.37

2.32

g/l

0.51

173

1116

Malignant neoplasm of ureter, including Hilmo

466

2.27

9.06

3.4

2.7

2.12

2.19

g/l

0.49

429

Benign neoplasm of middle ear and respiratory system

633

4990

1.33

9.02

2.7

2.31

2.28

g/l

0.50

593

4631

Endometriosis ASRM stages 3,4

1753

15196

1.18

9.00

2.3

2.4

2.47

2.42

g/l

3.10

1596

13995

Paralytic strabismus

575

4483

1.35

8.99

3.4

2.7

2.22

2.28

g/l

1.56

534

4140

Macular hole

501

3847

1.39

8.97

3.0

2.7

2.26

2.27

g/l

0.11

458

3543

Benign neoplasm: Anus and anal canal

246

1679

1.60

8.96

2.8

2.7

2.29

2.28

g/l

0.06

226

1555

Haemorrhage in early pregnancy

1999

16963

1.17

8.95

2.3

2.50

2.45

g/l

4.16

1837

15770

Hypertrophic scar

387

2842

1.43

8.94

2.7

2.3

2.44

2.41

g/l

0.56

365

2627

Use of biperiden

394

2909

1.43

8.93

2.3

2.6

2.41

2.32

g/l

1.95

357

2710

Other protozoal intestinal diseases

125

723

1.93

8.92

2.8

2.3

2.33

2.39

g/l

0.55

115

666

Other disorders of male genital organs

300

2114

1.51

8.88

2.8

2.30

2.27

g/l

0.43

287

1993

Alcohol induced polyneuropathy

104

577

2.10

8.86

2.8

2.6

2.08

2.26

g/l

1.94

534

Other disorders of choroid

132

781

1.90

8.81

3.4

2.4

2.22

2.29

g/l

0.75

124

715

Residual foreign body in soft tissue

384

2827

1.43

8.74

2.3

2.5

2.34

g/l

0.12

359

2614

Habit and impulse disorders

122

700

1.90

8.74

2.0

2.4

2.50

2.35

g/l

1.96

108

658

Haemangioma, any site

663

5271

1.31

8.73

2.7

2.6

2.41

2.34

g/l

2.51

622

4885

Focal epilepsy, mode (most common among epilepsy diagnosis)

1549

13341

1.19

8.72

2.6

2.7

2.27

2.32

g/l

2.68

1426

12344

Viral agents as the cause of diseases classified to other chapters, including avohilmo

209

1383

1.64

8.71

3.1

2.6

2.36

2.35

g/l

0.03

194

1287

Endometriosis of rectovaginal septum and vagina

573

4471

1.34

8.71

2.0

2.4

2.48

2.37

g/l

4.41

515

4119

Pediculosis, acariasis and other infestations, including avohilmo

1319

11201

1.21

8.70

2.8

2.6

2.40

g/l

0.03

1233

10436

Other contact dermatitis

609

4786

1.33

8.69

2.9

2.5

2.37

2.36

g/l

0.23

572

4438

Complications associated with artificial fertilization

127

737

1.86

8.66

2.4

2.3

2.61

2.50

g/l

1.38

119

685

Other congenital malformations of skin, including avohilmo

599

4702

1.33

8.66

2.4

2.6

2.37

2.39

g/l

0.24

561

4363

Injury of muscle and tendon at hip and thigh level

795

6453

1.28

8.65

2.8

2.6

2.36

2.34

g/l

0.74

739

6026

Unspecified chronic bronchitis

287

2019

1.51

8.63

3.2

2.5

2.29

2.24

g/l

0.79

265

1846

Other papulosquamous disorders

109

615

2.02

8.63

3.4

2.4

2.29

2.32

g/l

0.20

103

568

Other and unspecified intracranial injuries

255

1760

1.56

8.62

2.6

2.29

2.27

g/l

0.26

234

1629

Injury of muscle and tendon at forearm level

150

919

1.79

8.61

2.4

2.6

2.40

2.32

g/l

1.03

139

859

Open wound of hip and thigh

254

1747

1.55

8.60

2.8

2.5

2.25

2.34

g/l

1.38

223

1613

Atlantoaxial subluxation

349

2.44

8.60

2.3

2.2

2.34

2.33

g/l

0.05

325

Porphyria cutanea tarda

7.78

8.59

7.4

2.8

2.26

g/l

0.02

Carcinoma in situ of skin, other sites/unspecified

165

1053

1.79

8.59

4.8

2.6

2.16

2.23

g/l

1.18

150

966

Assault by unspecified means

153

939

1.76

8.58

2.5

2.34

2.38

g/l

0.34

141

877

Other and unspecified erythematous conditions

264

1838

1.55

8.57

2.9

2.5

2.38

2.31

g/l

1.47

247

1712

Routine general health check-up of defined subpopulation

144

865

1.78

8.56

2.1

1.9

2.48

2.42

g/l

0.64

139

772

Allergic colitis

159

983

1.74

8.55

3.8

2.6

2.56

2.54

g/l

0.20

149

913

Other leukaemias of specified cell type

132

3.82

8.54

6.0

2.4

2.10

2.32

g/l

1.02

123

Varicella [chickenpox]

332

2398

1.46

8.53

4.8

2.6

2.34

2.38

g/l

0.56

315

2252

Normotensive glaucoma

773

6295

1.29

8.53

2.6

2.31

2.27

g/l

1.01

670

5766

Other specific arthropathies, wide

167

1053

1.72

8.51

2.5

2.4

2.34

g/l

0.08

159

976

Malignant neoplasm of other and unspecified parts of tongue

125

735

1.90

8.49

2.6

2.3

2.20

2.28

g/l

0.81

115

677

Lichen sclerosus et atrophicus

889

7317

1.26

8.48

2.4

2.39

2.37

g/l

0.51

804

6723

Accidental poisoning by and exposure to other and unspecified chemicals and noxious substances

272

1902

1.53

8.48

2.8

2.5

2.40

2.38

g/l

0.21

260

1769

Open bite

377

2778

1.42

8.48

3.1

2.5

2.54

2.49

g/l

0.88

353

2582

Graves disease, strict definition

759

6141

1.28

8.47

2.3

2.5

2.43

2.40

g/l

0.70

695

5701

Simple and mucopurulent chronic bronchitis

334

2424

1.46

8.44

3.0

2.6

2.29

2.25

g/l

0.76

304

2222

Alopecia areata

210

1397

1.62

8.44

2.5

2.4

2.44

2.39

g/l

0.59

199

1299

Dislocation, sprain and strain of joints and ligaments of lumbar spine and pelvis

265

1845

1.53

8.43

2.5

2.39

g/l

0.05

247

1716

Scabies

345

2514

1.45

8.42

3.3

2.5

2.39

2.36

g/l

0.46

319

2349

Adenocarcinoma of pancreas

242

1664

1.57

8.39

2.0

2.6

2.15

2.27

g/l

2.55

236

1526

Sexual dysfunction

152

941

1.77

8.38

3.5

2.7

2.32

2.33

g/l

0.08

141

881

Viral encephalitis, not elsewhere classified/unspecified

172

1102

1.72

8.37

3.3

2.6

2.25

2.29

g/l

0.38

153

1023

Viral encephalitis, not elsewhere classified/unspecified, including avohilmo

176

1134

1.71

8.37

3.3

2.6

2.25

2.29

g/l

0.30

157

1051

Separation of retinal layers (serosa)

319

2305

1.47

8.30

4.1

2.6

2.31

g/l

0.00

303

2159

Ulcer of vagina/vulva

220

1484

1.59

8.29

2.5

2.3

2.40

2.41

g/l

0.10

199

1367

Childhood allergy (age < 16)

901

6088

1.25

8.28

2.7

2.4

2.55

2.56

g/l

0.27

840

5625

Marasmic kwashiorkor

142

3.79

8.26

4.4

2.9

2.13

2.35

g/l

0.97

129

Congenital malformations of trachea and bronchus

531

2.10

8.26

2.9

2.6

2.35

2.34

g/l

0.08

491

Malignant neoplasm of testis, including Hilmo

131

780

1.82

8.25

3.5

2.6

2.26

g/l

0.01

122

724

Polycystic ovarian syndrome, broad definition

755

6107

1.27

8.25

2.1

2.2

2.60

2.52

g/l

3.28

694

5636

Other drug-induced secondary parkinsonism

554

2.08

8.22

2.2

2.4

2.34

2.32

g/l

0.14

513

Perineal laceration during delivery

861

8451

0.80

8.19

1.6

2.3

2.58

2.51

g/l

3.65

790

7832

Crossbite

498

3531

1.35

8.16

3.4

2.7

2.51

2.48

g/l

0.85

469

3303

Disorders of optic nerve, not elsewhere classified

187

1233

1.68

8.16

4.1

2.6

2.24

2.30

g/l

0.83

178

1153

Tic and related disorders

463

2.06

8.15

2.6

2.4

2.49

2.45

g/l

0.34

432

Schizotypal disorder

167

1062

1.70

8.15

2.0

2.6

2.50

2.37

g/l

2.10

148

992

Injury of nerves at lower leg level

493

2.10

8.13

2.7

2.4

2.43

2.34

g/l

1.01

455

Evidence of alcohol involvement determined by blood alcohol level

122

720

1.88

8.12

2.6

2.41

2.34

g/l

0.71

110

671

Haemangioma and lymphangioma, any site

704

5685

1.29

8.11

2.8

2.6

2.41

2.34

g/l

2.56

659

5275

Nonspecific lymphadenitis

418

3154

1.39

8.11

2.6

2.5

2.35

2.38

g/l

0.44

384

2938

Isolated growth hormone deficiency

307

2.45

8.10

4.7

4.0

2.51

2.54

g/l

0.20

295

Disorders of adrenal gland, other and/or unspecified

277

2.61

8.09

3.3

2.2

2.28

2.31

g/l

0.13

254

Pedal cyclist injured in other and unspecified transport accidents

870

7177

1.25

8.08

2.5

2.6

2.35

g/l

0.10

799

6663

Idiopathic urticaria

173

1114

1.68

8.08

2.3

2.42

2.39

g/l

0.31

168

1029

Malignant neoplasm of oropharynx, including Hilmo

164

1047

1.72

8.07

2.4

2.6

2.20

2.28

g/l

1.14

154

968

Foreign body or object entering through skin

456

3490

1.37

8.06

2.6

2.7

2.39

2.33

g/l

1.38

415

3252

Dystonia

415

3140

1.39

8.05

2.3

2.6

2.39

2.34

g/l

0.97

375

2902

Motor disorders

119

692

1.87

8.04

4.1

3.3

2.62

2.54

g/l

0.95

109

667

Intercostal neuropathy

398

2.26

8.04

2.7

2.3

2.32

2.30

g/l

0.08

365

Non-small cell lung cancer

850

6918

1.26

8.04

2.2

2.7

2.15

2.25

g/l

5.08

803

6280

Complications of labour and delivery

4182

25391

0.90

8.04

2.3

2.4

2.46

2.44

g/l

2.55

3857

23408

Urethritis and urethral syndrome

173

1116

1.68

8.01

2.7

2.3

2.38

2.35

g/l

0.27

161

1030

Other and unspecified disorders of pigmentation

356

2.32

8.01

2.7

2.2

2.32

2.42

g/l

0.68

329

Female infertility, tubal origin

319

2307

1.45

8.01

2.5

2.4

2.47

2.45

g/l

0.21

294

2150

Secondary parkinsonism+Parkinsonism in other disease

242

1684

1.56

8.00

2.3

2.7

2.29

2.26

g/l

0.41

209

1574

Delayed milestone in childhood

138

756

1.80

7.96

5.3

3.6

2.50

2.58

g/l

1.07

131

729

Secondary parkinsonism

237

1645

1.56

7.96

2.3

2.7

2.29

2.26

g/l

0.46

204

1537

Dislocation, sprain and strain of joints and ligaments of head

300

2157

1.47

7.94

2.7

2.5

2.39

2.40

g/l

0.09

273

2008

Orthopaedic devices associated with adverse incidents

176

1158

1.71

7.94

2.6

2.5

2.32

2.30

g/l

0.15

147

1072

Sudden idiopathic hearing loss

827

6818

1.26

7.92

3.4

2.7

2.33

2.29

g/l

1.28

752

6324

Dermatitis herpetiformis

149

938

1.76

7.86

2.3

2.6

2.31

g/l

0.02

135

875

Other haemoglobinopathies

110

4.04

7.85

3.1

2.2

2.35

2.30

g/l

0.18

101

Hypermetropia

548

4308

1.33

7.84

3.4

2.6

2.42

2.38

g/l

0.83

510

3987

Other and unspecified injuries of shoulder and upper arm

255

1792

1.52

7.81

3.0

2.6

2.27

2.32

g/l

0.69

236

1666

Chronic crepitant synovitis/bursitis of hand and wrist/periarthritis of wrist

121

722

1.86

7.80

2.5

2.4

2.37

2.32

g/l

0.50

114

673

Scabies, including avohilmo

1090

9197

1.22

7.79

2.7

2.5

2.43

2.42

g/l

0.10

1013

8556

Oral lichen planus

225

1553

1.57

7.78

2.2

2.5

2.45

2.35

g/l

1.74

207

1446

Superficial injuries involving multiple body regions

213

1449

1.58

7.76

3.2

2.4

2.39

2.35

g/l

0.37

198

1341

Inguinal or femoral hernia, bilateral

922

7702

1.24

7.76

3.1

2.8

2.23

2.24

g/l

0.24

858

7154

Blindness, monocular

534

2.05

7.74

4.4

2.4

2.21

2.31

g/l

0.78

492

Hirsutism in women

145

903

1.74

7.73

2.2

2.52

2.47

g/l

0.45

125

829

Prepatellar bursitis

350

2601

1.42

7.68

2.8

2.7

2.28

g/l

0.06

325

2427

Malignant neoplasm of testis

115

675

1.85

7.66

3.4

2.6

2.26

2.27

g/l

0.05

106

627

Non-small cell lung cancer, including Hilmo

1235

9905

1.20

7.66

2.4

2.7

2.18

2.26

g/l

4.75

1166

9001

Nontoxic goitre/thyroid nodule

2471

22162

1.14

7.64

2.7

2.5

2.37

2.34

g/l

1.74

2311

20332

Prolonged pregnancy

759

7911

0.80

7.63

1.7

2.4

2.57

2.51

g/l

2.69

686

7376

Thyroiditis, unspecified

121

725

1.84

7.63

2.6

2.2

2.38

2.34

g/l

0.30

105

675

Hypothalamic dysfunction, including iatrogenic, not elsewhere classified

4.38

7.57

4.5

2.3

2.17

2.39

g/l

1.14

Other maltreatment syndromes

210

1426

1.56

7.56

2.5

2.6

2.35

2.38

g/l

0.19

199

1332

Pleural plaque without asbestos

340

2544

1.44

7.54

2.8

2.7

2.21

2.20

g/l

0.22

296

2342

Whooping cough, including avohilmo

128

778

1.78

7.53

3.3

2.1

2.37

2.46

g/l

0.92

117

718

Flatulence and related conditions

498

2.02

7.49

2.3

2.26

2.32

g/l

0.51

461

Perioral dermatitis

180

1190

1.63

7.48

2.7

2.2

2.42

g/l

0.04

160

1098

Dementia

4350

27393

1.11

7.47

2.2

2.7

2.22

2.26

g/l

3.41

3813

25188

Inguinal hernia, bilateral

903

7559

1.24

7.45

3.1

2.8

2.23

2.24

g/l

0.23

841

7019

Deep bite

802

5795

1.25

7.44

3.3

2.6

2.50

2.44

g/l

2.36

739

5405

Rheumatic valve diseases

189

1269

1.61

7.43

4.7

2.5

2.26

2.24

g/l

0.21

171

1173

Alzheimer’s disease (undefined)

561

0.26

7.40

1.9

2.4

2.23

2.16

g/l

—

508

Injury of eye and orbit

1059

8961

1.21

7.39

2.7

2.33

2.35

g/l

0.59

970

8373

Paranoid personality disorder

144

910

1.73

7.37

2.2

2.4

2.39

2.34

g/l

0.44

123

854

Biological medicines for asthma

168

1099

1.65

7.37

2.2

2.4

2.53

2.39

g/l

2.67

157

1016

Vertigo of central origin

145

924

1.74

7.36

2.3

2.5

2.35

2.29

g/l

0.67

127

853

Malignant neoplasm of tonsil and base of tongue

158

1022

1.68

7.36

2.1

2.7

2.22

2.28

g/l

0.62

150

944

Benign neoplasm of ovary

1303

11239

1.19

7.35

2.6

2.4

2.42

2.38

g/l

1.50

1190

10323

Benign neoplasm: Skin of eyelid, including canthus

1283

11064

1.20

7.34

2.6

2.35

2.30

g/l

2.30

1176

10202

Other congenital malformations, not elsewhere classified

373

2.19

7.34

3.7

2.9

2.54

2.42

g/l

0.87

347

Abnormal spermatozoa

1086

9267

1.22

7.32

2.7

3.0

2.21

2.22

g/l

0.08

937

8634

Acute drug-induced interstitial lung disorder

444

2.16

7.32

3.4

2.6

2.23

2.26

g/l

0.24

414

Pustulosis palmaris et plantaris

319

2358

1.43

7.30

2.2

2.5

2.45

2.36

g/l

2.04

296

2185

Melanocytic naevi of lower limb, including hip

343

2566

1.41

7.26

3.9

2.5

2.32

2.35

g/l

0.50

329

2386

Pustular psoriasis

353

2653

1.41

7.25

2.3

2.5

2.44

2.35

g/l

2.15

328

2458

Contusion of toe(s) without damage to nail

200

1360

1.57

7.24

2.9

2.4

2.46

2.40

g/l

0.69

185

1262

Disorders of pituitary gland, other and/or unspecified

303

2.40

7.22

3.1

2.2

2.21

2.32

g/l

0.81

281

Other, unspecified and serous retinal detachments

261

1875

1.49

7.22

3.7

2.7

2.18

2.28

g/l

2.28

247

1734

Contracture of joint

562

1.92

7.18

2.7

2.4

2.31

2.26

g/l

0.44

526

Other protozoal intestinal diseases, including avohilmo

167

1097

1.64

7.15

2.9

2.2

2.31

2.38

g/l

0.95

155

1009

Other acquired deformities of ankle and foot

377

2.17

7.15

2.7

2.5

2.33

2.37

g/l

0.22

353

Assault by other specified means

439

2.05

7.14

2.6

2.4

2.55

2.37

g/l

1.56

408

Mental retardation

287

2072

1.45

7.13

3.4

3.0

2.42

2.41

g/l

0.07

267

1948

Pedestrian injured in collision with pedal cycle

239

1691

1.51

7.13

2.1

2.6

2.38

2.31

g/l

0.98

224

1575

Malignant neoplasm of tonsil

119

725

1.81

7.13

2.1

2.7

2.20

2.28

g/l

0.80

114

671

Respiratory tuberculosis, confirmed, including avohilmo

161

1056

1.66

7.12

3.4

2.6

2.15

2.24

g/l

1.16

150

972

Spinal osteochondrosis

499

1.98

7.09

2.4

2.41

2.35

g/l

0.43

465

Respiratory tuberculosis, confirmed

158

1034

1.67

7.06

3.4

2.6

2.15

2.24

g/l

1.08

147

950

Tonsillectomy and adenotomy

4379

28068

1.10

7.05

2.5

2.6

2.48

2.43

g/l

8.73

4102

26170

150

935

1.68

7.03

5.2

3.3

2.64

2.60

g/l

0.38

143

896

Toxic effect of ethanol

277

2009

1.45

7.02

2.8

2.6

2.37

g/l

0.07

252

1873

Respiratory tuberculosis, bacteriologically and histologically confirmed

162

1067

1.65

7.02

3.4

2.6

2.16

2.23

g/l

0.96

151

980

Unspecified threat to breathing

481

2.01

7.01

2.9

2.4

2.41

2.37

g/l

0.33

446

Poisoning by medicine, drug-induced

108

645

1.86

7.00

2.3

2.4

2.36

2.39

g/l

0.19

601

Dementia in Alzheimer disease

1409

13502

0.85

7.00

2.2

2.7

2.19

2.22

g/l

1.29

1166

12321

Other congenital malformations of nervous system

421

2.06

6.98

2.9

2.4

2.59

2.44

g/l

1.83

389

Pulmonary eosinophilia, not elsewhere classified

110

665

1.87

6.97

3.2

2.4

2.27

2.28

g/l

0.10

104

610

Malignant neoplasm of oropharynx

131

823

1.75

6.96

2.1

2.7

2.19

2.28

g/l

1.05

125

762

Intermittent heterotropia

414

3186

1.35

6.95

3.1

2.5

2.46

2.43

g/l

0.56

380

2966

Vasomotor rhinitis (mode)

551

4414

1.30

6.93

2.7

2.6

2.38

2.33

g/l

1.29

501

4088

Other and/or unspecified nontoxic goitre

616

4997

1.28

6.90

2.7

2.5

2.37

2.34

g/l

1.01

589

4596

Tuberculosis, IBD comorbidity

566

4551

1.30

6.90

3.2

2.5

2.21

2.25

g/l

0.92

527

4151

Malignant neoplasm of tonsil and base of tongue, including Hilmo

183

1240

1.59

6.90

2.2

2.7

2.22

2.29

g/l

0.71

175

1152

N06DA Anticholinesterases

2991

25293

0.89

6.87

2.1

2.7

2.22

2.24

g/l

0.76

2603

23110

Use of anticholinesterases

2991

25293

0.89

6.87

2.1

2.7

2.22

2.24

g/l

0.76

2603

23110

Injury of muscle and tendon at wrist and hand level

1025

8723

1.21

6.82

2.6

2.8

2.35

2.32

g/l

1.26

950

8164

Benign neoplasm of major salivary glands

772

6422

1.25

6.82

2.7

2.6

2.29

g/l

0.09

709

5937

Other deformities of toe(s)

262

1897

1.46

6.80

3.2

2.5

2.36

2.32

g/l

0.55

237

1753

Other and unspecified mononeuropathies of upper limb

222

1565

1.51

6.73

2.9

2.6

2.32

2.33

g/l

0.10

206

1460

Other and unspecified acute skin changes due to ultraviolet radiation

203

1414

1.55

6.73

3.4

2.5

2.29

2.27

g/l

0.13

195

1308

Other disorders of Eustachian tube

238

1703

1.49

6.71

3.1

2.5

2.37

2.34

g/l

0.49

216

1583

Varicella [chickenpox], including avohilmo

372

2842

1.37

6.68

4.6

2.6

2.34

2.40

g/l

1.25

353

2667

Assault by blunt object

111

673

1.80

6.68

2.5

2.6

2.24

2.35

g/l

0.84

100

629

Early lumbar disc prolapse, operated

615

4982

1.27

6.67

2.3

2.5

2.53

2.42

g/l

4.78

574

4671

Malignant neoplasm of bone and articular cartilage of other and unspecified sites, including Hilmo

100

594

1.87

6.63

3.5

2.5

2.22

2.30

g/l

0.72

549

Other puerperal infections

519

4137

1.30

6.62

2.1

2.2

2.51

g/l

0.01

470

3816

Benign lipomatous neoplasm

2443

22073

1.13

6.61

2.5

2.6

2.37

2.32

g/l

3.93

2277

20408

Use of levodopa decarboxylase inhibitor

1243

10803

1.19

6.58

2.3

2.7

2.23

2.24

g/l

0.37

1118

9911

Sixth [abducent] nerve palsy

275

2028

1.45

6.58

3.0

2.7

2.16

2.28

g/l

2.85

254

1883

Amblyopia ex anopsia

308

2303

1.41

6.55

3.4

2.6

2.44

2.41

g/l

0.41

280

2141

Oral lichen planus and hypothyroidism or thyroxine medication

158

1055

1.64

6.53

1.8

2.3

2.40

2.37

g/l

0.27

140

982

Aphakia

117

722

1.75

6.51

3.3

2.4

2.21

2.27

g/l

0.46

103

665

167

1066

1.59

6.51

5.1

3.3

2.63

2.61

g/l

0.16

160

1015

Primary open-angle glaucoma

2973

26125

1.12

6.51

2.7

2.6

2.27

2.26

g/l

0.28

2662

23929

LSIL lesion of the vulva

208

1460

1.52

6.50

3.7

2.3

2.36

2.42

g/l

1.00

195

1367

Acute epiglottitis

120

749

1.75

6.50

3.0

2.4

2.32

2.33

g/l

0.08

110

705

Malignant neoplasm of tonsil, including Hilmo

133

853

1.70

6.50

2.2

2.7

2.22

2.29

g/l

0.77

127

787

Other and unspecified noninflammatory disorders of ovary, fallopian tube and broad ligament

196

1356

1.53

6.49

2.8

2.5

2.48

2.42

g/l

0.61

186

1265

Other and unspecified mononeuropathies of lower limb

215

1522

1.51

6.48

2.7

2.4

2.35

2.33

g/l

0.18

204

1416

Any dementia

3957

25274

1.10

6.44

2.3

2.7

2.19

2.25

g/l

9.20

3527

23132

Use of rotigotine

104

635

1.86

6.44

4.5

2.4

2.23

2.32

g/l

0.86

585

Injury of urinary and pelvic organs

165

1112

1.60

6.42

3.3

2.6

2.24

2.30

g/l

0.67

148

1031

Other intracranial haemorrhages

282

2099

1.44

6.41

2.9

2.7

2.20

2.22

g/l

0.28

257

1931

Acute nasopharyngitis (common cold)

804

6673

1.23

6.40

3.1

2.6

2.35

2.36

g/l

0.21

769

6273

Donors of organs and tissues

105

634

1.79

6.38

2.5

1.9

2.27

2.39

g/l

1.52

586

Schizoid personality disorder

132

849

1.69

6.34

2.1

2.5

2.48

2.32

g/l

1.87

119

799

Burn and corrosion of trunk

227

1628

1.48

6.32

2.6

2.7

2.38

2.32

g/l

0.74

211

1520

Monoplegia

131

846

1.70

6.31

2.6

2.4

2.41

2.31

g/l

1.20

125

780

Traumatic ischaemia of muscle

110

679

1.78

6.31

3.2

2.7

2.35

2.31

g/l

0.18

100

631

Universal erythroderma, KELA reimbursement

116

727

1.76

6.31

2.8

2.4

2.42

2.29

g/l

1.23

100

677

Nutritional marasmus

100

3.68

6.30

2.2

2.3

2.29

2.37

g/l

0.24

Hereditary corneal dystrophies

282

2104

1.43

6.29

2.7

2.5

2.32

2.31

g/l

0.14

257

1950

Evidence of alcohol involvement determined by level of intoxication

458

1.95

6.29

3.0

2.4

2.37

g/l

0.00

425

Mixed disorders of conduct and emotions

151

995

1.61

6.28

2.7

2.5

2.57

2.52

g/l

0.53

141

913

Malignant neoplasm of other and ill-defined sites, including Hilmo

130

836

1.69

6.28

2.9

2.3

2.06

2.24

g/l

2.97

119

768

Injury of nerves and spinal cord at thorax level

257

2.39

6.25

2.6

2.5

2.09

2.31

g/l

1.56

239

Recurrent dislocation and subluxation of joint

437

3435

1.31

6.24

2.5

2.4

2.42

2.40

g/l

0.34

404

3196

Mandibular retrognathia

436

3423

1.32

6.23

2.6

2.53

2.46

g/l

2.28

402

3203

Chronic suppurative otitis media, including avohilmo

592

4837

1.27

6.23

2.8

2.6

2.35

2.34

g/l

0.35

545

4479

Primary open-angle glaucoma, strict

2420

21897

1.13

6.22

2.7

2.6

2.27

2.26

g/l

0.20

2155

20042

Alzheimer’s disease (undefined), excluding more controls

491

0.29

6.18

1.9

2.4

2.23

2.20

g/l

—

440

Femoral hernia

344

2642

1.37

6.18

2.7

2.5

2.36

2.28

g/l

1.89

319

2443

Other and unspecified pemphigoid

576

1.90

6.17

3.6

2.5

2.29

2.25

g/l

0.22

530

Whooping cough

241

2.34

6.16

5.2

2.1

2.45

2.44

g/l

0.02

219

Calcific tendinitis of shoulder

405

3169

1.33

6.15

2.5

2.44

2.34

g/l

2.90

371

2950

Abscess of Bartholin gland

189

1314

1.53

6.15

3.0

2.2

2.50

2.45

g/l

0.55

177

1222

Benign neoplasm of meninges

825

6977

1.22

6.14

2.7

2.6

2.32

g/l

0.02

747

6417

Intrahepatic Cholestasis of Pregnancy (ICP) , excluding more controls

445

3518

1.31

6.12

2.1

2.2

2.50

2.51

g/l

0.11

410

3248

Pyogenic granuloma

139

913

1.65

6.09

2.7

2.4

2.41

2.33

g/l

0.71

134

843

Cerebral atherosclerosis

124

796

1.71

6.09

3.0

2.5

2.20

2.22

g/l

0.12

109

739

Demyelinating diseases of the central nervous system

585

4778

1.27

6.09

2.4

2.5

2.41

g/l

0.05

543

4444

Chronic conjunctivitis

226

1631

1.47

6.08

2.3

2.4

2.40

2.37

g/l

0.34

218

1518

Intrahepatic Cholestasis of Pregnancy (ICP) , incl. ICD-8, excluding more controls

554

4499

1.27

6.05

2.2

2.47

g/l

0.07

508

4153

Other lack of coordination

145

968

1.64

6.04

2.2

2.6

2.28

2.30

g/l

0.16

135

903

Tuberculosis, wide, including avohilmo

587

4813

1.27

6.03

3.2

2.6

2.22

2.24

g/l

0.52

546

4392

Other vitreous opacities

330

2531

1.38

6.03

2.7

2.6

2.35

2.31

g/l

0.83

301

2341

Epiphora

186

1304

1.54

6.02

2.2

2.5

2.34

2.33

g/l

0.08

175

1202

Injury of nerves and spinal cord at neck level

182

1271

1.55

6.01

2.8

2.7

2.31

2.28

g/l

0.22

168

1178

Malignant neoplasm of bronchus and lung, including Hilmo

1737

12895

1.15

6.01

2.4

2.7

2.16

2.26

g/l

11.10

1639

11731

Primary ovarian failure

135

881

1.64

6.01

2.4

2.2

2.50

2.45

g/l

0.41

124

810

Effects of heat and light

410

2.03

6.01

2.1

2.7

2.27

2.28

g/l

0.06

378

Eustachian salpingitis and obstruction

539

4368

1.27

6.00

2.8

2.5

2.43

2.41

g/l

0.24

501

4076

Abnormal findings in secretions and smears from cervix uteri vagina vulva

3841

26111

1.10

5.97

2.5

2.3

2.44

2.45

g/l

1.23

3571

24118

Benign neoplasm: Parotid gland

611

5043

1.26

5.93

2.6

2.7

2.29

g/l

0.02

561

4673

Mental and behabioural disorders of puerperum, not classified elsewhere, excluding more controls

420

1.94

5.93

2.7

2.0

2.63

2.51

g/l

0.85

386

Medical abortion

5298

26789

1.08

5.92

2.4

2.43

g/l

0.28

4853

24623

Injury of nerves at wrist and hand level

270

2011

1.41

5.91

2.5

2.7

2.37

2.34

g/l

0.37

248

1884

Juvenile Open Angle Glaucoma

269

2.29

5.89

5.0

2.2

2.11

2.35

g/l

2.51

245

Torticollis

119

758

1.69

5.88

2.8

2.4

2.45

2.36

g/l

1.02

111

704

Injury of muscle and tendon at lower leg level

1157

10064

1.18

5.88

2.9

2.7

2.32

2.31

g/l

0.18

1077

9396

Aneurysms, operations, SAH

1309

11494

1.17

5.86

3.1

2.6

2.29

2.31

g/l

0.28

1211

10579

Benign neoplasm: salivary glands, exclude unknown (D119)

676

5644

1.24

5.82

2.7

2.6

2.29

g/l

0.04

624

5227

Maternal care for other known or suspected fetal problems

1640

9105

1.15

5.82

2.3

2.56

2.51

g/l

2.36

1501

8484

Other disorders of binocular movement

163

1116

1.56

5.82

2.4

2.3

2.47

2.39

g/l

0.95

157

1029

Benign neoplasm: Skin of other and unspecified parts of face

843

7175

1.21

5.80

2.9

2.6

2.30

g/l

0.03

756

6611

Infectious mononucleosis

524

4243

1.27

5.80

2.5

2.3

2.49

2.48

g/l

0.18

481

3944

Infectious mononucleosis, including avohilmo

524

4243

1.27

5.80

2.5

2.3

2.49

2.48

g/l

0.18

481

3944

Pre-eclampsia superimposed on chronic hypertension

228

2.36

5.79

3.4

2.1

2.45

2.47

g/l

0.09

215

120

766

1.66

5.79

3.1

2.1

2.62

2.59

g/l

0.20

106

695

Other osteochondropathies

483

3892

1.29

5.77

2.6

2.38

2.35

g/l

0.44

442

3630

Personality and behavioural disorders due to brain disease, damage and dysfunction

121

782

1.69

5.77

2.3

2.7

2.42

2.28

g/l

1.78

111

732

Malignant neoplasm of floor of mouth, including Hilmo

392

2.01

5.76

2.7

2.4

2.19

2.25

g/l

0.27

363

Tuberculosis, wide

577

4748

1.26

5.75

3.2

2.6

2.22

2.24

g/l

0.42

536

4335

Assault by sharp object

121

779

1.67

5.73

3.0

2.6

2.36

2.34

g/l

0.16

108

728

Autoimmune thyroiditis

137

908

1.62

5.73

2.4

2.3

2.48

2.39

g/l

1.17

122

844

Congenital deformities of hip

129

842

1.64

5.72

3.1

2.5

2.47

2.49

g/l

0.11

119

786

Lagophthalmos

117

758

1.72

5.71

3.6

2.4

2.15

2.28

g/l

1.71

108

699

Injury of muscle and tendon at shoulder and upper arm level

3085

28400

1.10

5.69

2.6

2.8

2.32

2.29

g/l

1.55

2868

26394

Other peripheral vertigo

735

6198

1.23

5.69

2.4

2.6

2.39

2.31

g/l

3.97

672

5727

Benign leiomyoma with endometriosis

1177

10290

1.17

5.67

2.4

2.41

2.38

g/l

1.22

1072

9451

Other acquired deformities of musculoskeletal system and connective tissue

328

2532

1.36

5.66

2.5

2.6

2.39

2.32

g/l

1.37

306

2360

Conduct disorder

141

939

1.59

5.66

2.9

2.7

2.46

2.44

g/l

0.11

126

865

Embedded and impacted teeth

1856

13478

1.13

5.65

2.9

2.4

2.48

2.47

g/l

0.25

1753

12496

Benign neoplasm: Other and unspecified parts of mouth

258

1931

1.42

5.65

2.9

2.5

2.29

2.31

g/l

0.17

237

1791

L02BG Aromatase inhibitors

2384

21430

1.12

5.62

2.1

2.5

2.38

g/l

0.09

2180

19648

Behavioural disorders

141

941

1.59

5.61

2.8

2.7

2.48

2.46

g/l

0.12

125

865

Other demyelinating diseases of the central nervous system

255

1898

1.41

5.61

2.6

2.3

2.40

2.41

g/l

0.10

241

1773

Congenital deformities of hip, including avohilmo

144

967

1.59

5.60

3.0

2.6

2.44

2.46

g/l

0.20

134

904

Optic neuritis

293

2229

1.38

5.59

2.5

2.3

2.40

g/l

0.03

272

2085

Benign neoplasm: Middle ear, nasal cavity and accessory sinuses

304

2332

1.38

5.58

2.6

2.7

2.27

2.29

g/l

0.21

279

2176

Malignant neoplasm of vulva, including Hilmo

113

728

1.71

5.56

2.8

2.3

2.23

2.38

g/l

1.78

665

Premenstrual syndrome

100

618

1.73

5.55

2.5

2.3

2.47

2.50

g/l

0.22

570

Pleural plaque with presence of asbestos

646

5417

1.25

5.55

2.6

2.9

2.20

2.18

g/l

0.52

564

4995

Conductive hearing loss, unspecified

617

5126

1.24

5.54

2.9

2.6

2.35

2.32

g/l

0.66

562

4748

Atypical mycobacterium lung infection

105

667

1.75

5.53

3.4

2.6

2.25

g/l

0.03

620

Carcinoma in situ of oral cavity, oesophagus and stomach

344

2.13

5.52

2.9

2.6

2.46

2.23

g/l

2.08

311

Benign neoplasm: Cerebral meninges

744

6300

1.22

5.51

2.7

2.5

2.32

g/l

0.04

677

5800

Helminthiases

134

895

1.62

5.51

3.5

2.4

2.45

2.34

g/l

1.38

127

831

Disorders of puberty

604

1.74

5.50

3.7

2.6

2.53

g/l

0.00

555

Severe visual impairment, binocular

292

2.20

5.49

6.9

2.7

2.12

2.28

g/l

1.40

266

Chronic suppurative otitis media

491

3990

1.28

5.48

2.8

2.6

2.33

g/l

0.11

452

3691

Personal history of allergy to drugs, medicaments and biological substances

531

1.81

5.48

2.2

2.1

2.47

2.36

g/l

0.94

492

Asymptomatic human immunodeficiency virus [HIV] infection status

255

2.25

5.47

1.8

2.5

2.54

2.34

g/l

1.36

243

Postmenopausal atrophic vaginitis

1971

9651

1.13

5.46

2.4

2.5

2.40

2.35

g/l

3.60

1813

8888

Disorders of branched-chain amino-acid metabolism and fatty-acid metabolism

3.85

5.46

4.5

1.7

2.53

2.40

g/l

0.39

Adult respiratory distress syndrome

112

725

1.70

5.43

5.1

2.5

2.12

2.26

g/l

1.66

104

674

Other specified/unspecified nutritional deficiencies

349

2.05

5.42

3.2

2.6

2.37

2.30

g/l

0.39

327

Endometriosis of intestine

108

685

1.68

5.41

2.3

2.65

2.49

g/l

1.98

102

634

False labour

2037

11384

1.13

5.37

1.9

2.4

2.57

2.50

g/l

6.41

1856

10625

Enteritis due to Yersinia enterocolitica

243

2.27

5.37

3.2

2.3

2.32

2.37

g/l

0.21

223

Mental retardation, wide definition

295

2242

1.37

5.35

3.3

3.0

2.41

2.40

g/l

0.07

274

2103

Other benign neoplasms of connective and other soft tissue

725

6134

1.22

5.34

2.7

2.6

2.40

2.33

g/l

2.75

675

5679

Symptoms and signs involving appearance and behaviour

401

1.94

5.33

2.3

2.2

2.39

2.35

g/l

0.26

370

Fall on and from ladder

597

4976

1.25

5.32

2.4

2.8

2.26

g/l

0.03

553

4649

Arnold-Chiari syndrome

378

1.95

5.29

2.7

2.3

2.60

2.45

g/l

1.50

349

Blindness or visual impairment, binocular

253

2.27

5.28

4.9

2.6

2.15

2.32

g/l

1.27

233

Stenosis and insufficiency of lacrimal passages

734

6227

1.22

5.28

2.5

2.38

2.32

g/l

2.05

674

5730

Disturbances of smell and taste

312

2419

1.35

5.27

2.5

2.6

2.38

2.33

g/l

0.95

288

2230

Malignant neoplasm of renal pelvis

317

2.10

5.27

2.4

2.05

2.20

g/l

1.19

292

Benign neoplasm: Larynx

241

1805

1.42

5.26

2.5

2.7

2.35

2.25

g/l

1.66

233

1686

Other and unspecified injuries of thorax

139

944

1.58

5.25

2.9

2.6

2.30

2.31

g/l

0.09

127

881

Unspecified severe protein-energy malnutrition

111

3.27

5.25

2.1

2.8

2.14

2.37

g/l

0.77

103

Malignant neoplasm of other and unspecified urinary organs, including Hilmo

391

1.97

5.23

3.3

2.6

2.13

2.20

g/l

0.48

362

Tic disorders

544

1.76

5.22

2.6

2.7

2.49

2.45

g/l

0.34

508

Other and unspecified injuries of abdomen, lower back and pelvis

121

800

1.63

5.21

2.6

2.3

2.35

g/l

0.02

108

729

Malignant neoplasm of other and ill-defined digestive organs

436

1.90

5.18

2.1

2.5

2.14

2.25

g/l

0.95

403

Effects of foreign body entering through natural orifice

1887

17047

1.13

5.18

2.6

2.8

2.35

2.33

g/l

0.37

1737

15913

Common variable immunodeficiency with predominant abnormalities of T-cell numbers and function

4.11

5.17

8.2

2.0

2.18

2.35

g/l

0.57

Calculus of lower urinary tract

436

3536

1.29

5.17

2.9

2.8

2.20

2.21

g/l

0.26

394

3278

Other bursitis, not elsewhere classified

473

1.84

5.16

2.2

2.6

2.35

2.29

g/l

0.32

440

Inflammatory disorders of breast

443

3582

1.28

5.15

2.6

2.3

2.42

2.45

g/l

0.45

410

3292

Mixed specific developmental disorders

140

878

1.56

5.12

3.6

3.2

2.61

2.54

g/l

0.68

134

834

Cysts of oral region, not elsewhere classified

432

3495

1.29

5.11

3.7

2.6

2.31

g/l

0.00

401

3247

Family history of other specific disorders

603

1.71

5.10

3.0

2.0

2.54

2.42

g/l

1.19

557

Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs

591

4938

1.24

5.09

2.7

2.6

2.39

2.32

g/l

2.19

549

4587

Paroxysmal nocturnal haemoglobinuria [Marchiafava-Micheli]

5.87

5.07

5.9

2.2

2.35

2.32

g/l

0.08

Chromosomal abnormalities, not elsewhere classified

145

996

1.55

5.07

3.1

2.9

2.46

g/l

0.03

138

933

Benign neoplasm: Nasopharynx

495

1.84

5.05

2.2

2.3

2.28

2.30

g/l

0.19

451

Burn and corrosion of hip and lower limb, except ankle and foot

175

1252

1.49

5.03

2.5

2.32

2.33

g/l

0.10

163

1159

Other congenital malformations of circulatory system

193

1406

1.46

5.03

2.5

2.6

2.25

2.34

g/l

1.25

177

1316

Benign neoplasm of bone and articular cartilage

593

4957

1.23

5.01

2.4

2.6

2.40

2.36

g/l

1.13

551

4627

Malignant neoplasm of eye and adnexa, including Hilmo

121

809

1.62

4.99

3.0

2.5

2.26

2.25

g/l

0.07

115

746

Pseudomembranous colitis

403

1.91

4.98

3.8

2.4

2.31

g/l

0.01

370

Congenital malformations of eye, ear, face and neck

434

3516

1.28

4.97

3.2

2.6

2.41

g/l

0.06

405

3267

Infections of genitourinary tract in pregnancy

629

5285

1.22

4.96

2.5

2.3

2.48

2.44

g/l

0.90

569

4904

Burn and corrosion of wrist and hand

263

2007

1.37

4.94

2.6

2.36

2.37

g/l

0.02

240

1869

603

5044

1.23

4.94

2.2

2.48

2.52

g/l

1.02

548

4676

Malignant neoplasm of cervix uteri

127

858

1.59

4.93

2.7

2.2

2.21

2.43

g/l

3.07

115

789

Mild mental retardation

175

1255

1.48

4.93

3.6

2.8

2.39

g/l

0.02

162

1172

Habitual aborter

129

869

1.56

4.92

2.3

2.2

2.51

2.53

g/l

0.12

118

805

Granuloma annulare

116

772

1.62

4.89

2.8

2.3

2.40

2.38

g/l

0.13

111

714

Contact with other hot fluids

219

1631

1.41

4.89

2.9

2.6

2.36

2.38

g/l

0.19

194

1526

Gestational [pregnancy-induced] oedema and proteinuria without hypertension

590

4942

1.23

4.89

3.6

2.3

2.44

2.41

g/l

0.49

549

4546

Liposarcoma

361

1.96

4.88

3.0

2.5

2.23

2.26

g/l

0.18

331

Oral lichen planus, including avohilmo , including avohilmo

518

4293

1.25

4.88

2.2

2.6

2.42

2.35

g/l

2.10

472

3984

Horner syndrome

102

663

1.69

4.88

2.7

2.3

2.39

2.31

g/l

0.74

615

Maternal care for known or suspected abnormality of pelvic organs

1754

10655

1.13

4.85

2.1

2.4

2.53

2.48

g/l

3.02

1613

9933

Gestational [pregnancy-induced] hypertension

1774

15988

1.12

4.85

2.4

2.3

2.52

2.47

g/l

3.66

1653

14797

Exposure to smoke, fire and flames

183

1330

1.46

4.82

2.2

2.7

2.37

2.30

g/l

0.90

171

1240

Exposure to other and unspecified animate mechanical forces

220

1643

1.40

4.80

3.0

2.5

2.34

2.40

g/l

0.81

197

1527

Peritonsillar abscess

1518

13602

1.13

4.80

2.7

2.6

2.40

2.37

g/l

1.56

1415

12671

Bacterial agents resistant to antibiotics

4.57

4.78

4.0

3.8

2.37

2.24

g/l

0.29

Sequelae of hyperalimentation

3.40

4.75

2.7

2.5

2.58

2.34

g/l

1.25

Contact with sharp object, undetermined intent

173

1247

1.47

4.75

2.4

2.6

2.35

2.34

g/l

0.08

161

1163

Motor- or nonmotor-vehicle accident, type of vehicle unspecified

105

687

1.64

4.73

2.8

2.5

2.27

2.34

g/l

0.57

632

Malignant neoplasm of respiratory system and intrathoracic organs

1720

12879

1.13

4.73

2.3

2.7

2.16

2.26

g/l

11.05

1623

11726

Other facial nerve disorders

206

1530

1.42

4.73

2.3

2.4

2.43

2.33

g/l

1.84

192

1414

Intrahepatic Cholestasis of Pregnancy (ICP)

445

3634

1.26

4.72

2.1

2.3

2.50

2.49

g/l

0.15

410

3373

Disorders of puberty, all

111

734

1.61

4.70

3.7

2.8

2.55

g/l

0.03

101

679

Non-neuropathic heredofamilial amyloidosis

4.01

4.70

5.1

2.0

2.20

2.35

g/l

0.42

Benign neoplasm: Short bones of upper limb

120

814

1.59

4.66

2.2

2.4

2.38

2.36

g/l

0.15

110

756

Other specified/unspecified deforming dorsopathies

127

868

1.56

4.66

2.7

2.3

2.40

2.33

g/l

0.87

117

804

Nontoxic single thyroid nodule

515

4283

1.24

4.66

2.7

2.5

2.40

2.34

g/l

1.93

478

3964

Contact with sharp glass

258

1980

1.36

4.64

2.6

2.5

2.39

2.38

g/l

0.12

233

1844

Foreign body in respiratory tract

367

2951

1.29

4.62

2.3

2.6

2.37

2.34

g/l

0.40

338

2748

Glaucoma-related operations

473

3921

1.26

4.61

2.5

2.7

2.25

2.27

g/l

0.31

435

3592

606

1.69

4.61

2.8

2.5

2.28

2.29

g/l

0.06

563

Viral conjunctivitis, including avohilmo

270

2090

1.35

4.60

3.2

2.4

2.37

2.38

g/l

0.10

256

1939

Brain meningioma, including Hilmo

353

2826

1.30

4.60

2.6

2.30

2.33

g/l

0.41

316

2589

ILD medications: pirfenidone

612

1.71

4.60

1.9

2.6

2.33

2.20

g/l

1.68

561

Subacute thyroiditis

257

1979

1.36

4.59

2.5

2.3

2.41

2.35

g/l

0.99

240

1843

Ebstein's anomaly

3.65

4.58

4.4

3.4

2.59

2.53

g/l

0.16

Retinoschisis and retinal cysts

189

1400

1.44

4.57

2.7

2.6

2.29

2.28

g/l

0.16

171

1295

Superficial injury of neck

142

995

1.51

4.56

2.0

2.4

2.46

2.38

g/l

0.97

135

918

Other disorders of prostate

279

2179

1.35

4.56

3.2

2.7

2.16

2.20

g/l

0.60

260

2033

Benign neoplasm: Skin, unspecified

294

2310

1.33

4.54

3.7

2.5

2.31

2.32

g/l

0.12

266

2150

Lumbosacral root disorders, not elsewhere classified

635

1.67

4.52

2.4

2.31

g/l

0.04

587

Generalized epilepsy

282

2201

1.33

4.50

2.5

2.6

2.36

2.40

g/l

0.52

264

2056

Glaucoma secondary to eye inflammation

431

1.82

4.48

2.3

2.2

2.35

2.32

g/l

0.18

400

Disorders of eyelid in diseases classified elsewhere

237

1815

1.37

4.45

3.1

2.5

2.34

2.33

g/l

0.13

222

1674

Other cranial nerve disorders in other disorders

125

2.74

4.44

2.8

2.3

2.36

g/l

0.01

114

Other congenital malformations of intestine

425

1.82

4.43

3.0

2.4

2.46

2.37

g/l

0.62

390

Small cell lung cancer, helper endpoint

108

1584

0.65

4.43

2.1

2.7

2.18

2.21

g/l

0.20

1471

Kissing spine

101

3.08

4.42

2.2

2.4

2.22

2.29

g/l

0.25

Other abnormal auditory perceptions

581

1.68

4.40

2.2

2.3

2.36

2.38

g/l

0.12

543

Medicines for HER+ breast cancer

2910

25157

1.09

4.39

2.1

2.5

2.39

g/l

0.17

2666

23059

Ovarian hyperstimulation (induction)

118

804

1.56

4.39

2.4

2.1

2.62

2.50

g/l

1.38

111

746

Benign neoplasm: Skin of ear and external auricular canal

309

2458

1.32

4.39

2.9

2.7

2.28

2.27

g/l

0.12

272

2269

Oral leukoplakia, including avohilmo

209

1579

1.40

4.39

2.7

2.6

2.33

2.30

g/l

0.43

195

1469

Seminoma of testis, including Hilmo

385

1.83

4.39

4.4

2.5

2.23

g/l

0.04

359

Open wound of thorax

113

766

1.58

4.38

3.3

2.6

2.36

2.31

g/l

0.42

106

716

Pathological resorption of teeth

269

2100

1.34

4.38

3.2

2.6

2.32

2.33

g/l

0.14

246

1945

Other conjunctival vascular disorders and cysts

179

1322

1.44

4.38

2.7

2.5

2.35

2.31

g/l

0.45

169

1225

Other and unspecified skin changes due to chronic exposure to nonionizing radiation

117

806

1.59

4.37

4.0

2.5

2.29

2.27

g/l

0.13

105

747

Intrahepatic Cholestasis of Pregnancy (ICP) , incl. ICD-8

554

4662

1.22

4.36

2.2

2.3

2.47

2.46

g/l

0.08

508

4314

Endometriosis diagnosis and infertility diagnosis occurring together

696

5970

1.19

4.34

2.2

2.3

2.49

2.47

g/l

0.48

642

5528

Disorders of fatty-acid metabolism

4.18

4.34

5.4

1.6

2.48

2.44

g/l

0.07

Procedures for purposes other than remedying health state

161

1165

1.46

4.33

2.8

1.9

2.42

2.40

g/l

0.14

152

1080

Certain zoonotic bacterial diseases, including avohilmo

223

1703

1.38

4.31

2.8

2.5

2.29

2.31

g/l

0.18

204

1583

Acute inflammation of orbit

299

1.97

4.31

4.0

2.5

2.36

2.41

g/l

0.25

275

Inguinal hernia, unilateral

208

1575

1.40

4.30

2.8

2.5

2.33

2.27

g/l

0.71

193

1459

Femoral hernia, unilateral

208

1575

1.40

4.30

2.8

2.5

2.33

2.27

g/l

0.71

193

1459

Inguinal of femoral hernia, unilateral

208

1575

1.40

4.30

2.8

2.5

2.33

2.27

g/l

0.71

193

1459

Burns and corrosions of multiple and unspecified body regions

164

1195

1.45

4.29

3.0

2.7

2.30

2.31

g/l

0.07

152

1113

Mixed conductive and sensorineural hearing loss

978

8624

1.16

4.29

2.8

2.7

2.33

2.27

g/l

2.57

890

7978

Spirochaetal infections, other/unspecified, including avohilmo

2382

25806

0.91

4.28

2.3

2.6

2.37

2.34

g/l

1.27

2208

23913

Use of rasagiline

206

1566

1.41

4.28

1.8

2.7

2.34

2.27

g/l

1.15

176

1454

All dysplastic lesions of the vagina

190

1418

1.41

4.28

3.1

2.3

2.32

2.41

g/l

1.31

180

1317

Lyme disease, including avohilmo

2366

25635

0.91

4.27

2.2

2.6

2.37

2.35

g/l

1.30

2193

23759

Lyme disease

2366

25635

0.91

4.27

2.2

2.6

2.37

2.35

g/l

1.30

2193

23759

Parkinson's disease, including avohilmo

1367

12311

1.14

4.25

2.2

2.7

2.23

2.25

g/l

0.52

1232

11285

Congenital malformations of the nervous system

152

1094

1.47

4.24

3.2

2.6

2.53

2.43

g/l

1.54

141

1018

HSIL lesion of the vulva

134

948

1.52

4.24

4.0

2.3

2.25

2.40

g/l

2.63

119

881

Brain meningioma

339

2730

1.29

4.23

2.6

2.30

2.33

g/l

0.51

304

2498

Malignant neoplasm of vulva

550

1.70

4.23

3.0

2.3

2.21

2.39

g/l

1.67

505

Benign lipomatous neoplasm of other sites/unspecified

657

5641

1.20

4.21

2.6

2.7

2.33

2.29

g/l

1.18

610

5203

Other noninflammatory disorders of cervix uteri

343

2769

1.29

4.21

2.6

2.5

2.38

2.35

g/l

0.42

313

2547

Spasmodic torticollis

225

1728

1.37

4.17

2.3

2.4

2.41

2.36

g/l

0.71

203

1608

Atopic conjunctivitis

307

2449

1.30

4.14

2.9

2.4

2.45

2.39

g/l

0.83

288

2274

Melanocytic naevi of upper limb, including shoulder

179

1334

1.42

4.12

3.7

2.5

2.30

2.34

g/l

0.46

174

1237

Polymorphous light eruption

372

1.84

4.11

1.5

2.1

2.35

2.40

g/l

0.26

348

Aggressive periodontitis

170

1259

1.44

4.11

2.9

2.6

2.25

2.31

g/l

0.85

158

1168

Complications of the puerperium, not elsewhere classified

263

2059

1.32

4.11

2.4

2.3

2.55

2.50

g/l

0.86

247

1922

Guillain-Barre syndrome

123

862

1.53

4.10

2.6

2.5

2.31

2.29

g/l

0.12

117

803

Tuberculosis

475

3976

1.24

4.10

3.1

2.6

2.21

2.23

g/l

0.29

446

3635

Mild or no visual impairment, binocular

233

2.10

4.05

2.4

2.3

2.40

2.36

g/l

0.16

215

Male infertility

251

1952

1.32

4.04

4.3

2.8

2.32

2.34

g/l

0.27

237

1850

Disorders of endocrine glands in diseases classified elsewhere

3.06

4.04

16.0

2.3

2.50

2.35

g/l

0.68

Combined immunodeficiency, unspecified

4.24

4.02

2.2

3.0

2.46

2.26

g/l

0.59

Vascular dementia (other)

473

1.76

4.00

2.0

2.6

2.30

2.22

g/l

0.53

439

Iliotibial band syndrome

529

1.67

4.00

2.9

2.2

2.38

2.36

g/l

0.09

495

Dementia due to Parkinsons disease, excluding more controls

190

1437

1.40

4.00

1.8

2.6

2.13

2.23

g/l

1.30

156

1333

Congenital malformations of genital organs

605

5135

1.20

4.00

2.6

2.4

2.50

2.46

g/l

1.06

559

4767

Other specified/unspecified disorders of synovium and tendon +Other specified/unspecified bursopathies

299

2387

1.29

3.98

2.7

2.4

2.46

2.37

g/l

2.01

283

2221

Mature T/NK-cell lymphomas, hilmo

114

796

1.56

3.98

2.7

2.6

2.20

2.25

g/l

0.30

108

740

Myasthenia gravis

136

979

1.49

3.97

2.5

2.6

2.35

2.30

g/l

0.40

129

913

Major anomalies of jaw size

176

1313

1.41

3.96

2.3

2.6

2.43

2.39

g/l

0.58

160

1219

Other specified and unspecified disorders of eyelid

113

787

1.55

3.93

2.6

2.5

2.35

2.31

g/l

0.31

107

727

Pervasive developmental disorders excl. Autism + Asperger

562

1.63

3.93

2.1

3.1

2.58

2.48

g/l

0.76

533

Complications predominantly related to the puerperium

1784

16311

1.11

3.90

2.2

2.3

2.49

2.46

g/l

1.79

1648

15107

Pregnancy examination and test

1025

5617

1.15

3.88

2.1

2.3

2.54

2.53

g/l

0.10

952

5220

Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk

996

8850

1.15

3.87

2.4

2.6

2.38

2.33

g/l

1.66

918

8235

Effects of other external causes

188

1420

1.38

3.86

2.3

2.5

2.43

2.36

g/l

0.87

180

1318

Other lesions of median nerve

207

1593

1.37

3.86

3.4

2.4

2.33

2.31

g/l

0.26

175

1463

Suppurative otitis media, unspecified

178

1336

1.40

3.85

3.5

2.3

2.35

2.36

g/l

0.06

166

1238

Crushed, pushed or stepped on by crowd or human stampede

483

4062

1.22

3.85

2.7

2.6

2.39

g/l

0.12

446

3787

Bitten or stung by nonvenomous insect and other nonvenomous arthropods

243

1907

1.33

3.84

2.3

2.6

2.37

2.35

g/l

0.29

219

1765

Other spirochaetal diseases

2398

25845

0.92

3.83

2.2

2.6

2.37

2.35

g/l

1.18

2221

23950

Guttate psoriasis

107

740

1.55

3.83

2.6

2.4

2.52

2.36

g/l

1.59

681

All dysplastic lesions of the cervix uteri, vagina or vulva

2073

18619

1.10

3.82

2.6

2.3

2.42

2.47

g/l

4.13

1896

17253

Tooth agenesis EXCLUDE clefts and syndromes

245

1918

1.32

3.80

3.8

2.5

2.53

g/l

0.05

227

1784

Seminoma of testis

325

1.84

3.79

4.7

2.4

2.18

2.25

g/l

0.37

305

Supervision of high-risk pregnancy

1333

7204

1.13

3.78

2.1

2.4

2.54

2.50

g/l

1.34

1212

6731

Non-small cell lung cancer, adenocarcinoma, helper endpoint

533

4552

1.21

3.78

2.3

2.7

2.17

2.25

g/l

2.25

504

4198

Benign neoplasm of eye and adnexa

818

7198

1.17

3.77

2.8

2.6

2.31

g/l

0.04

751

6660

Pedal cyclist injured in transport accident

1701

15553

1.11

3.77

2.4

2.7

2.37

2.36

g/l

0.26

1583

14467

Severe combined immunodeficiency [SCID] with reticular dysgenesis

156

2.38

3.73

4.9

2.8

2.23

2.29

g/l

0.20

141

Poor fetal growth

783

6854

1.16

3.73

2.6

2.2

2.52

g/l

0.00

724

6340

Malignant neoplasm of lip, including Hilmo

556

1.63

3.73

2.9

2.5

2.15

2.18

g/l

0.20

514

Other and unspecified injuries of forearm

366

1.78

3.72

3.0

2.4

2.36

2.37

g/l

0.06

338

415

3446

1.23

3.70

3.0

2.4

2.35

2.26

g/l

2.62

384

3093

Labour and delivery complicated by intrapartum haemorrhage, not elsewhere classified

207

2662

0.75

3.70

2.0

2.5

2.38

2.41

g/l

0.26

194

2466

Spinal enthesopathy

201

1538

1.35

3.69

2.5

2.4

2.22

g/l

0.01

188

1377

Other spirochaetal diseases, including avohilmo

2432

26149

0.92

3.67

2.3

2.6

2.37

2.35

g/l

1.15

2254

24235

Other congenital malformations of intestine, including avohilmo

576

1.62

3.66

3.2

2.5

2.48

2.35

g/l

1.18

529

Parkinson's disease, strict definition

1214

10965

1.13

3.65

2.2

2.7

2.23

2.24

g/l

0.48

1093

10064

Foreign body entering into or through eye or natural orifice

561

4811

1.20

3.65

2.8

2.7

2.32

2.33

g/l

0.09

515

4474

Contact with nonpowered hand tool

291

2349

1.29

3.64

2.7

2.8

2.32

2.30

g/l

0.26

266

2202

Respiratory tuberculosis, confirmed and not-confirmed

403

3365

1.24

3.63

3.0

2.6

2.21

2.24

g/l

0.43

377

3076

Respiratory tuberculosis

403

3365

1.24

3.63

3.0

2.6

2.21

2.24

g/l

0.44

377

3077

Polypectomy (DHB20)

483

4101

1.22

3.61

2.5

2.8

2.28

g/l

0.12

455

3819

Obstructed labour due to malposition and malpresentation of fetus

1230

12622

0.89

3.60

2.1

2.4

2.51

2.48

g/l

0.86

1149

11751

Meningitis

335

2747

1.26

3.60

2.9

2.6

2.32

2.33

g/l

0.17

321

2562

Trichomoniasis

404

1.75

3.58

3.1

2.2

2.18

2.37

g/l

1.52

370

Other and unspecified hypertrophic disorders of skin

317

1.84

3.58

2.5

2.1

2.37

2.38

g/l

0.05

286

Sunburn

2.81

3.57

3.9

2.2

2.31

2.37

g/l

0.16

Cervical polyps

653

5673

1.18

3.54

2.3

2.5

2.40

2.37

g/l

0.59

603

5256

Loose body in joint

158

1182

1.40

3.54

1.9

2.6

2.35

2.28

g/l

0.86

142

1104

Unspecified lump in breast

1148

10340

1.13

3.53

2.4

2.39

g/l

0.06

1076

9476

Other appendicitis

590

5093

1.19

3.53

3.0

2.6

2.36

2.33

g/l

0.47

539

4739

Nutritional and metabolic disorders in diseases classified elsewhere

8.74

3.53

15.1

3.2

2.27

2.69

g/l

—

Malignant neoplasm, without specification of site

238

1884

1.32

3.53

2.5

2.14

2.23

g/l

1.53

218

1707

Tic and related disorders

593

1.57

3.53

2.6

2.8

2.49

2.46

g/l

0.26

555

Patent foramen ovale

154

1151

1.41

3.52

3.1

3.0

2.48

2.37

g/l

1.72

136

1089

Alzheimer’s disease, strict definition

2184

18980

0.91

3.51

2.1

2.7

2.17

2.23

g/l

4.97

1939

17265

Patellar tendinitis

108

758

1.50

3.49

2.1

2.4

2.40

2.35

g/l

0.46

707

Phakomatoses, not elsewhere classified

540

1.61

3.49

3.7

2.6

2.26

2.38

g/l

1.28

509

Periodontal disease, other/unspecified

193

1491

1.36

3.49

2.5

2.3

2.31

2.33

g/l

0.27

178

1371

Enterobiasis, including avohilmo

148

1098

1.41

3.48

2.6

2.5

2.49

2.47

g/l

0.18

141

1014

Other and unspecified corneal deformities and disorders

229

1810

1.32

3.47

3.0

2.5

2.31

2.34

g/l

0.29

212

1689

Cellulitis of external ear

657

1.55

3.46

3.1

2.4

2.45

2.35

g/l

0.84

608

Deep endometriosis

666

5813

1.17

3.45

2.0

2.4

2.50

2.41

g/l

3.73

601

5334

Glycosuria

3.05

3.45

2.5

2.4

2.50

2.44

g/l

0.22

Malignant neoplasm of gum, including Hilmo

470

1.66

3.45

2.0

2.3

2.15

2.26

g/l

0.73

434

Migraine, unspecified, drug-induced

337

1.80

3.44

2.3

2.42

2.40

g/l

0.07

315

Parkinson's disease

1297

11791

1.12

3.44

2.2

2.7

2.23

2.25

g/l

0.46

1170

10813

Primary angle-closure glaucoma

339

2806

1.26

3.44

2.9

2.6

2.26

2.28

g/l

0.24

297

2569

Benign neoplasm of breast

848

7524

1.15

3.43

2.3

2.4

2.40

2.39

g/l

0.30

776

6896

Acute otitis externa, noninfective

126

918

1.46

3.42

3.9

2.4

2.43

2.33

g/l

1.09

118

857

Mental and behavioural disorders associated with the puerperium

493

1.63

3.41

2.7

2.3

2.63

2.48

g/l

1.17

454

Frostbite

527

1.61

3.40

2.8

2.6

2.29

2.30

g/l

0.04

489

Lumbosacral plexus disorders

161

2.24

3.40

1.9

2.2

2.41

2.36

g/l

0.23

146

Crowding of teeth, including avohilmo

560

3982

1.19

3.40

3.5

2.5

2.54

2.53

g/l

0.15

513

3695

Knuckle pads

2.93

3.39

5.1

2.4

2.41

2.34

g/l

0.22

Other bursitis of knee

104

733

1.51

3.39

2.8

2.5

2.31

2.32

g/l

0.05

677

Erosion and ectropion of cervix uteri

194

1506

1.35

3.39

2.6

2.5

2.38

2.35

g/l

0.30

174

1379

Fourth [trochlear] nerve palsy

170

1301

1.38

3.39

3.2

2.6

2.32

2.28

g/l

0.48

159

1207

Contusion of toe(s) with damage to nail

568

1.58

3.38

3.5

2.4

2.40

2.35

g/l

0.27

528

Acute appendicitis, with complications

1490

13628

1.11

3.37

2.8

2.7

2.34

2.31

g/l

1.10

1400

12661

Benign neoplasm: Parathyroid gland

622

1.57

3.37

5.4

2.5

2.26

2.34

g/l

0.73

576

Nocardiosis, including avohilmo

3.68

3.33

10.0

1.8

2.36

g/l

0.00

Nocardiosis

3.68

3.33

10.0

1.8

2.36

g/l

0.00

Other specified disorders of external ear

289

2365

1.28

3.31

2.7

2.8

2.27

2.25

g/l

0.22

262

2196

Nystagmus and other irregular eye movements

106

755

1.50

3.30

3.2

2.6

2.37

g/l

0.02

703

Acquired clawhand, clubhand, clawfoot and clubfoot

226

1.95

3.29

3.0

2.2

2.25

2.32

g/l

0.40

211

Polyhydramnios

291

2372

1.26

3.29

2.8

2.5

2.56

2.48

g/l

1.14

268

2235

Benign neoplasm: Pharynx, unspecified

446

1.67

3.26

2.3

2.2

2.26

2.33

g/l

0.33

409

Inflammatory disease of cervix uteri

426

3614

1.22

3.25

2.2

2.4

2.42

2.37

g/l

1.16

373

3322

Use of ropinirole

269

2193

1.29

3.24

2.3

2.7

2.31

2.26

g/l

0.67

240

2035

Narcolepsy and cataplexy

287

1.82

3.23

3.4

2.3

2.47

2.36

g/l

0.67

267

Other meningitis

113

816

1.47

3.22

3.0

2.4

2.32

2.34

g/l

0.19

107

753

Other osteochondrodysplasias, including avohilmo

592

1.56

3.21

2.3

2.5

2.51

2.38

g/l

0.97

551

Failure in dosage during surgical and medical care

2.97

3.20

5.2

2.3

2.43

2.30

g/l

0.40

Trichomoniasis, including avohilmo

455

1.65

3.20

2.9

2.2

2.21

2.37

g/l

1.26

416

Acute thyroiditis

208

2.02

3.19

2.7

1.7

2.43

2.35

g/l

0.34

191

Pityriasis lichenoides et varioliformis acuta

3.02

3.19

1.9

2.9

2.15

2.30

g/l

0.52

Overjet

160

1213

1.37

3.17

4.6

2.8

2.58

2.51

g/l

0.58

148

1145

Dementia in other diseases classified elsewhere

372

3133

1.23

3.17

2.3

2.7

2.18

2.24

g/l

1.11

307

2894

Thoracic root disorders

2.84

3.16

1.8

2.4

2.39

2.33

g/l

0.13

Other deformity of hallux (acquired)

409

1.68

3.15

2.4

2.43

2.32

g/l

0.68

384

Benign neoplasm: Tonsil

663

1.52

3.14

2.4

2.3

2.41

2.35

g/l

0.50

615

Multiple delivery

431

5046

0.83

3.13

2.3

2.7

2.48

2.43

g/l

1.05

395

4694

Convergent concomitant strabismus

361

3023

1.23

3.13

2.4

2.44

2.40

g/l

0.47

332

2812

Other corneal oedema

493

1.63

3.11

3.1

2.5

2.36

2.29

g/l

0.57

453

Contact with other hot metals

112

815

1.46

3.09

3.8

2.6

2.22

2.31

g/l

0.90

107

754

Lesion of femoral nerve

387

1.69

3.09

2.3

2.1

2.31

2.36

g/l

0.28

361

hereditary angioödema type 3

3.98

3.08

4.3

3.1

2.60

g/l

0.01

Malignant neoplasm of larynx, including Hilmo

141

1064

1.39

3.07

2.4

2.6

2.18

2.20

g/l

0.14

135

969

Malignant neoplasm of other endocrine glands and related structures

2.78

3.07

7.2

2.4

2.26

2.32

g/l

0.15

Other and unspecified mental retardation

113

816

1.45

3.07

2.9

3.2

2.46

2.44

g/l

0.15

107

779

Increased secretion of glucagon

7.41

3.06

3.8

1.8

1.99

2.32

g/l

—

Other acute disseminated demyelination

450

1.62

3.06

3.0

2.2

2.51

2.40

g/l

0.81

419

Injury of nerves at shoulder and upper arm level

549

1.56

3.05

2.8

2.6

2.32

2.33

g/l

0.03

512

Intracerebral haemorrhage

1053

9530

1.13

3.05

3.2

2.6

2.18

2.25

g/l

3.14

955

8699

Urticaria due to cold and heat

403

1.66

3.05

2.6

2.2

2.38

2.40

g/l

0.13

377

Maternal care for cervical incompetence

256

2083

1.27

3.05

2.2

2.4

2.48

2.41

g/l

1.12

228

1921

Eclampsia

111

2.41

3.04

4.3

2.1

2.51

2.44

g/l

0.20

103

Burn and corrosion of shoulder and upper limb, except wrist and hand

145

1100

1.38

3.03

2.8

2.6

2.22

2.33

g/l

1.49

139

1025

Tuberculosis of other organs

159

1227

1.37

3.02

3.5

2.5

2.23

2.27

g/l

0.44

145

1132

Bus occupant injured in other and unspecified transport accidents

358

1.72

3.01

3.9

2.3

2.31

2.34

g/l

0.14

333

Histrionic personality disorder

250

1.89

3.01

2.1

2.2

2.38

2.33

g/l

0.24

235

Benign neoplasm: Mediastinum

192

2.06

2.98

3.0

2.5

2.18

2.35

g/l

1.08

176

Lethal midline granuloma

6.10

2.98

11.4

1.6

2.30

2.27

g/l

—

Toxic effect of alcohol

137

1034

1.39

2.97

3.4

2.7

2.34

2.32

g/l

0.11

127

967

Struck by thrown, projected or falling objec

352

2960

1.22

2.96

2.7

2.38

2.34

g/l

0.89

325

2762

Corneal degeneration

134

1014

1.40

2.95

3.5

2.4

2.29

2.33

g/l

0.28

125

944

Pregnancy, childbirth and the puerperium

2245

12552

0.92

2.95

2.2

2.5

2.41

g/l

0.02

2025

11467

Chalazion

825

7379

1.14

2.95

2.7

2.6

2.36

2.34

g/l

0.36

768

6831

Labour and delivery complicated by fetal stress [distress]

1377

9781

0.91

2.95

2.1

2.3

2.53

2.51

g/l

0.60

1255

9087

Other disorders of breast

969

8745

1.13

2.93

2.3

2.4

2.43

2.41

g/l

0.39

894

8020

Benign neoplasm: other/unspecified salivary gland

194

1543

1.32

2.91

3.0

2.6

2.26

2.29

g/l

0.29

179

1431

Mesothelioma, including Hilmo

690

1.49

2.90

2.1

2.6

2.12

2.19

g/l

0.49

631

Optic atrophy

128

963

1.41

2.90

2.6

2.26

2.35

g/l

0.88

114

893

Spermatocele

582

5107

1.17

2.90

3.0

2.8

2.23

2.22

g/l

0.11

552

4746

Occupant of heavy transport vehicle injured in other and unspecified transport accidents

275

1.80

2.89

3.6

2.6

2.29

2.31

g/l

0.05

259

Caught, crushed, jammed or pinched in or between objects

353

2977

1.22

2.89

2.8

2.7

2.40

2.35

g/l

1.10

338

2769

LSIL lesion of the vagina

107

782

1.45

2.89

2.7

2.3

2.36

2.42

g/l

0.52

101

730

Impacted teeth

1276

9996

1.11

2.88

2.9

2.4

2.50

2.49

g/l

0.18

1202

9247

Fasciculation

606

1.51

2.88

2.3

2.5

2.42

2.35

g/l

0.58

563

Injury of nerves at forearm level

630

1.50

2.87

3.6

2.3

2.47

2.34

g/l

1.53

582

Prophylactic surgery

320

1.71

2.87

1.9

2.38

2.44

g/l

0.29

298

Carcinoma in situ of vulva

451

1.61

2.86

3.9

2.4

2.40

g/l

0.02

417

Hypertrophy of (infrapatellar) fat pad

441

1.60

2.85

3.6

2.3

2.38

2.34

g/l

0.29

411

Optic atrophy, wide definition

133

1009

1.39

2.85

2.6

2.27

2.35

g/l

0.76

119

939

Toxoplasmosis, including avohilmo

285

1.78

2.83

3.7

2.3

2.35

2.36

g/l

0.05

263

Macular cyst

244

2001

1.28

2.82

3.6

2.6

2.15

2.27

g/l

3.18

227

1844

Normal-pressure hydrocephalus

279

3344

0.81

2.82

2.3

2.7

2.23

2.24

g/l

0.05

251

3060

Injury of blood vessels at forearm level

165

2.07

2.81

3.8

2.8

2.11

2.30

g/l

1.10

154

Spirochaetal infections, other/unspecified

657

5825

1.15

2.80

2.6

2.7

2.35

2.32

g/l

0.67

606

5406

Disorders of aromatic amino-acid metabolism

143

2.15

2.80

3.9

2.6

2.37

2.36

g/l

0.02

134

Secondary malignant neoplasm of respiratory and digestive organs

130

987

1.39

2.79

1.8

2.4

2.12

2.25

g/l

1.63

121

912

Vascular dementia (undefined)

348

2917

1.22

2.78

2.4

2.6

2.13

2.20

g/l

1.19

306

2647

Exposure to unspecified smoke, fire and flames

495

1.56

2.77

2.4

2.5

2.39

2.32

g/l

0.45

463

Nontraumatic intracranial haemmorrhage

1672

15517

1.09

2.76

3.2

2.6

2.21

2.27

g/l

3.04

1524

14192

LSIL lesion of the cervix uteri, vagina or vulva

935

8449

1.12

2.76

2.8

2.3

2.41

2.46

g/l

2.02

869

7836

Dislocation, sprain and strain of joints and ligaments of elbow

415

3561

1.19

2.75

2.5

2.49

2.40

g/l

1.97

389

3309

Disorders of lacrimal system and orbit in diseases classified elsewhere

167

1312

1.33

2.74

2.5

2.4

2.44

2.36

g/l

0.93

156

1215

Benign neoplasm: Bronchus and lung

689

1.47

2.74

2.7

2.34

2.27

g/l

0.63

641

Mental and behavioural disorders of puerperium, not classified elsewhere

519

1.53

2.74

2.7

2.2

2.63

2.47

g/l

1.27

478

Toxoplasmosis

280

1.77

2.73

3.7

2.3

2.35

2.36

g/l

0.02

258

Benign neoplasm: Skin of upper limb, including shoulder

145

1121

1.36

2.73

3.1

2.4

2.31

2.33

g/l

0.18

135

1048

Osteomalacia

407

1.62

2.72

3.1

2.2

2.41

2.37

g/l

0.16

374

Vestibular neuronitis

643

5706

1.15

2.71

2.7

2.38

2.31

g/l

2.81

584

5284

Certain zoonotic bacterial diseases

130

993

1.38

2.67

2.7

2.4

2.33

2.31

g/l

0.18

119

927

Other specified and unspecified disorders of conjunctiva

524

1.53

2.66

3.9

2.3

2.25

2.35

g/l

0.82

487

Excessive and redundant skin and subcutaneous tissue

2.56

2.66

1.9

2.5

2.53

2.45

g/l

0.25

Other complications of labour and delivery, not elsewhere classified

611

6119

0.87

2.64

1.7

2.3

2.59

2.53

g/l

2.51

564

5665

Disorders of globe

187

1499

1.30

2.64

3.8

2.5

2.24

2.29

g/l

0.65

172

1387

Malignant neoplasm of other and unspecified male genital organs, including Hilmo

2.55

2.64

3.2

3.0

2.15

2.13

g/l

0.07

Atypical virus infections of central nervous system

493

1.55

2.63

2.8

2.3

2.30

2.37

g/l

0.49

450

Vascular syndromes of brain in cerebrovascular disorders

346

2950

1.21

2.63

3.3

2.7

2.29

2.24

g/l

0.97

334

2726

Chronic mastoiditis

188

1512

1.30

2.61

3.4

2.6

2.29

2.27

g/l

0.22

177

1409

Benign neoplasm: Connective and other soft tissue of lower limb, including hip

164

1298

1.32

2.59

2.9

2.5

2.42

2.32

g/l

1.46

149

1214

Alzheimer’s disease (Early onset), excluding more controls

190

2225

0.79

2.59

2.1

2.5

2.23

2.24

g/l

0.16

162

2048

Generalized epilepsy, mode (most common among epilepsy diagnosis)

193

1554

1.28

2.56

2.5

2.37

2.39

g/l

0.19

181

1444

Desensitization to allergens

320

2705

1.21

2.55

2.1

2.4

2.46

g/l

0.02

305

2515

Abnormal reflex

254

1.78

2.55

2.6

2.4

2.28

2.34

g/l

0.26

235

Long labour

1400

12834

0.91

2.54

1.9

2.4

2.53

2.48

g/l

2.83

1304

11922

Use of amantadine

118

897

1.39

2.53

1.9

2.4

2.43

2.31

g/l

1.29

103

834

Benign neoplasm: Skin of scalp and neck

184

1481

1.29

2.52

3.1

2.6

2.32

2.30

g/l

0.25

172

1377

Atypical virus infections of central nervous system, including avohilmo

507

1.53

2.50

2.8

2.3

2.30

2.37

g/l

0.46

464

Complications following abortion and ectopic and molar pregnancy

228

1879

1.26

2.50

2.2

2.4

2.39

2.38

g/l

0.10

200

1752

Toxic effect of contact with venomous animals

281

2361

1.23

2.49

2.2

2.6

2.36

2.34

g/l

0.26

262

2194

Ankyloglossia

704

1.42

2.47

3.1

3.0

2.49

2.53

g/l

0.35

656

Congenital deformities of feet

159

1258

1.31

2.46

3.7

2.5

2.38

2.40

g/l

0.14

148

1167

Melanocytic naevi of other and unspecified parts of face

404

3499

1.18

2.46

2.9

2.5

2.38

2.36

g/l

0.25

382

3244

Other congenital malformations of tongue, mouth and pharynx, including avohilmo

112

841

1.38

2.45

3.2

2.7

2.47

2.50

g/l

0.24

105

783

Graves ophthalmopathy

164

1308

1.31

2.43

2.5

2.4

2.43

2.36

g/l

0.89

153

1217

MS-disease / Multiple Sclerosis

455

3974

1.17

2.43

2.1

2.5

2.46

2.42

g/l

1.08

420

3697

Impacted maxillary molar

360

3087

1.19

2.41

3.0

2.2

2.50

2.52

g/l

0.33

341

2830

Dyshidrosis [pompholyx]

105

789

1.39

2.41

2.3

2.4

2.38

2.36

g/l

0.06

722

Ménière disease

695

6247

1.14

2.41

2.3

2.6

2.38

2.31

g/l

2.96

643

5758

Pedestrian injured in collision with car, pick-up truck or van

169

1354

1.30

2.40

2.8

2.5

2.32

2.33

g/l

0.00

151

1249

Malignant neoplasm of ureter

137

2.07

2.39

2.4

2.7

1.97

2.20

g/l

0.94

124

Pedal cyclist injured in noncollision transport accidents

795

7199

1.12

2.34

2.4

2.6

2.38

2.36

g/l

0.61

743

6693

Other and unspecified injuries of neck

387

1.56

2.34

2.1

2.3

2.54

2.39

g/l

1.23

355

Viral conjunctivitis

136

1066

1.33

2.31

3.3

2.3

2.31

2.37

g/l

0.77

129

994

Perichondritis of external ear

132

1036

1.34

2.30

2.7

2.5

2.46

2.28

g/l

3.25

122

966

Mandibular prognathia

743

1.39

2.30

2.8

2.49

2.41

g/l

0.78

693

Abnormal findings on antenatal screening of mother

492

4335

1.15

2.28

2.0

2.2

2.62

2.53

g/l

3.14

461

4040

Transient retinal artery occlusion

134

2.13

2.28

3.4

2.4

2.25

2.27

g/l

0.05

122

Pedestrian injured in other and unspecified transport accidents

661

1.42

2.27

2.8

2.4

2.38

2.33

g/l

0.39

611

Ectopic pregnancy

1143

10538

1.10

2.27

2.3

2.4

2.48

2.44

g/l

1.80

1047

9795

Congenital obstruction of the pelviureteric junction

408

1.55

2.26

5.1

2.3

2.33

2.37

g/l

0.20

381

Findings of drugs and other substances, not normally found in blood

224

1.78

2.25

4.5

2.6

2.35

2.26

g/l

0.37

209

Congenital deformities of feet, including avohilmo

244

2042

1.23

2.25

3.2

2.5

2.39

2.40

g/l

0.08

223

1893

Benign neoplasm: Other parts of oropharynx

484

1.50

2.25

3.6

2.4

2.34

2.29

g/l

0.36

450

Graves ophthalmopathy, strict

146

1161

1.31

2.25

2.6

2.4

2.42

2.36

g/l

0.63

136

1076

Other adrenocortical overactivity

262

1.69

2.24

4.0

2.6

2.41

2.50

g/l

0.43

240

Melanoma in situ

343

2968

1.19

2.23

3.3

2.7

2.23

2.27

g/l

0.65

313

2743

Carcinoma in situ of other and unspecified genital organs

138

1092

1.32

2.23

3.2

2.3

2.33

2.39

g/l

0.49

127

1006

Benign neoplasm of thyroid gland

223

1858

1.24

2.23

2.6

2.4

2.37

2.34

g/l

0.47

205

1713

Benign neoplasm: Long bones of lower limb

207

1711

1.25

2.21

2.6

2.4

2.44

2.37

g/l

1.02

195

1588

Abrasion of teeth

2863

27237

1.06

2.21

2.6

2.40

2.36

g/l

3.54

2653

25250

Tuberculosis of other organs, strict, including avohilmo

176

1435

1.28

2.20

3.5

2.5

2.26

g/l

0.03

160

1319

Contact with hypodermic needle

215

1.74

2.20

2.0

2.4

2.58

2.45

g/l

0.92

196

Merkel cell carcinoma of skin

2.52

2.20

2.3

2.5

2.30

2.19

g/l

0.33

Malignant neoplasm of lip

411

1.53

2.18

3.2

2.5

2.21

2.17

g/l

0.23

378

Malignant neoplasm of parotid gland

420

1.53

2.17

2.9

2.3

2.19

2.25

g/l

0.37

387

Caries in Clefts patients

443

1.50

2.17

3.0

2.6

2.38

2.40

g/l

0.11

413

Other bursal cyst

108

832

1.36

2.15

3.0

2.4

2.32

2.30

g/l

0.17

779

Use of galantamine

557

6211

0.88

2.15

2.0

2.6

2.26

2.23

g/l

0.47

481

5641

Dengue, including avohilmo

122

2.14

3.3

2.3

2.35

2.33

g/l

0.04

109

Anomalies of pupillary function

137

1088

1.31

2.13

2.0

2.5

2.46

2.39

g/l

0.75

124

1011

Androgenic alopecia

455

1.49

2.12

2.3

2.44

2.40

g/l

0.19

421

Malignant neoplasm of parotid gland, including Hilmo

489

1.48

2.12

2.8

2.5

2.19

2.24

g/l

0.32

450

Other rupture of muscle

306

1.61

2.12

2.7

2.5

2.31

2.29

g/l

0.06

285

Supervision of normal pregnancy

1194

7369

0.92

2.11

1.9

2.4

2.53

2.51

g/l

0.55

1096

6879

Contact with other sharp object(s)

425

3737

1.16

2.10

2.7

2.39

2.38

g/l

0.13

394

3486

Early lumbar disc prolapse operation

631

5677

1.13

2.10

2.3

2.5

2.53

2.44

g/l

4.14

590

5323

Synovial hypertrophy, not elsewhere classified

396

1.52

2.09

2.1

2.2

2.30

2.36

g/l

0.38

369

Pregnancy with abortive outcome

5398

27098

1.04

2.09

2.4

2.43

g/l

0.42

4931

24896

Other abnormal products of conception

2180

13499

1.07

2.08

2.2

2.3

2.51

2.49

g/l

0.82

2029

12544

Sequelae of tuberculosis, including avohilmo

137

1094

1.31

2.07

3.3

2.5

2.27

2.20

g/l

0.75

130

996

Hand

277

1.65

2.06

4.5

2.3

2.44

2.34

g/l

0.58

255

Sequelae of tuberculosis

135

1077

1.31

2.06

3.3

2.5

2.28

2.20

g/l

0.88

128

982

Glaucoma, exfoliation

904

8308

1.11

2.06

2.3

2.6

2.25

g/l

0.12

822

7535

Congenital malposition of the kidney

2.90

2.06

4.3

3.2

2.18

2.38

g/l

0.53

Tuberculosis of other organs, strict

172

1411

1.27

2.06

3.5

2.5

2.26

g/l

0.03

156

1295

Immunodeficiency with increased immunoglobulin M [IgM]

6.28

2.05

2.4

1.6

2.43

2.51

g/l

—

Non-small cell lung cancer, squamous, helper endpoint

286

3324

0.84

2.04

2.0

2.7

2.14

2.19

g/l

0.77

267

3040

Enterohaemorrhagic Escherichia coli infection

101

2.18

2.04

3.7

2.2

2.35

2.41

g/l

0.14

Maxillary retrognathism

107

828

1.34

2.03

2.5

2.50

2.44

g/l

0.71

100

769

HSIL lesion of the vagina

726

1.37

2.03

3.8

2.3

2.24

2.43

g/l

2.59

671

Other specified and unspecified strabismus

587

1.41

2.02

2.8

2.3

2.38

2.40

g/l

0.07

541

Deaf mutism, not elsewhere classified

238

1.69

2.01

3.8

2.4

2.43

2.28

g/l

0.71

217

Hypergammalglobulinemia, unspecified

2.91

2.00

8.4

2.0

2.10

2.35

g/l

1.18

Congenital malformations of breast

104

804

1.34

2.00

2.2

2.48

2.49

g/l

0.09

731

L02BA Anti-estrogens

1177

10936

1.09

2.00

2.0

2.4

2.38

g/l

0.06

1109

10064

Pityriasis rosea

368

1.53

1.99

2.0

2.2

2.54

2.38

g/l

1.36

345

Other combined immunodeficiencies

2.50

1.99

2.6

1.7

2.17

2.42

g/l

1.19

Hereditary retinal dystrophy

737

1.36

1.98

3.3

2.4

2.35

2.34

g/l

0.06

680

Syndactyly

2.22

1.98

2.1

2.6

2.56

2.40

g/l

0.71

Unspecified transport accident

215

1.71

1.98

2.5

2.4

2.15

2.34

g/l

1.06

200

Drug-induced aplastic anaemia

2.33

1.97

3.3

3.1

1.68

2.29

g/l

3.88

Congenital malformations of ovaries, fallopian tubes and broad ligaments

334

2904

1.17

1.97

2.4

2.3

2.51

2.47

g/l

0.78

308

2696

Anisometropia and aniseikonia

213

1791

1.23

1.95

3.1

2.5

2.41

2.34

g/l

1.00

191

1670

Divergent concomitant strabismus

486

4336

1.14

1.95

2.7

2.5

2.43

2.37

g/l

1.29

450

4044

Amoebiasis, including avohilmo

404

1.50

1.95

3.1

2.3

2.23

2.36

g/l

1.05

376

Retinoblastoma

3.70

1.95

6.7

2.8

2.31

2.42

g/l

—

Acute poliomyelitis

706

1.37

1.95

2.3

2.34

2.33

g/l

0.08

648

Vascular dementia (multiple infarctions)

783

0.69

1.94

3.4

2.7

2.22

2.17

g/l

0.33

720

Other/unspecified mastoiditis and related conditions

257

1.65

1.94

2.9

2.4

2.23

2.33

g/l

0.47

235

Muscular dystrophy

431

1.49

1.94

2.2

2.6

2.51

2.34

g/l

1.21

398

Acute poliomyelitis, including avohilmo

707

1.37

1.93

2.3

2.34

2.33

g/l

0.09

649

Chronic drug-induced interstitial lung disorders

2.30

1.92

3.5

2.4

2.40

2.26

g/l

0.56

Chronic thyroiditis

194

1.76

1.92

1.9

2.49

2.36

g/l

0.56

172

Other congenital malformations of respiratory system

104

2.14

1.92

3.8

2.3

2.28

2.41

g/l

0.38

Brain glioblastoma and astrocytoma

873

0.71

1.91

1.5

2.4

2.30

2.31

g/l

0.07

815

Birth trauma

249

1.63

1.88

3.8

3.0

2.36

2.47

g/l

0.52

230

Torsion of ovary, ovarian pedicle and fallopian tube

131

1050

1.29

1.88

2.0

2.4

2.48

2.45

g/l

0.25

122

972

Profound mental retardation

2.54

1.88

1.3

3.0

2.52

2.44

g/l

0.22

Contact with blunt object, undetermined intent

299

1.57

1.87

3.0

2.4

2.43

2.37

g/l

0.27

277

Occupant of pick-up truck or van injured in other and unspecified transport accidents

267

1.62

1.87

3.1

2.4

2.25

2.32

g/l

0.33

248

Other trisomies and partial trisomies of the autosomes, not elsewhere classified

2.57

1.85

4.6

3.1

2.43

2.44

g/l

0.03

Benign neoplasm: Conjunctiva

219

1858

1.22

1.85

3.1

2.5

2.34

2.31

g/l

0.33

208

1725

Dermatitis due to ingested food

195

1559

1.22

1.84

2.8

2.51

2.57

g/l

0.87

185

1459

Lipid storage disorder, other/unspecified

2.69

1.82

3.6

2.4

2.28

2.36

g/l

0.12

Alzheimer’s disease (Late onset)

2076

17981

0.94

1.82

2.1

2.7

2.17

2.23

g/l

4.50

1841

16341

Scarlet fever, including avohilmo

324

1.52

1.81

4.9

2.1

2.58

2.47

g/l

0.80

305

Asymmetry of jaw

667

1.36

1.81

2.1

2.5

2.51

2.41

g/l

0.88

620

Juvenile osteochondrosis

194

1629

1.22

1.80

3.1

2.5

2.36

2.40

g/l

0.46

179

1507

Bacterial meningitis

219

1862

1.21

1.80

2.8

2.6

2.34

2.33

g/l

0.04

211

1743

Short stature starting before birth

182

1.74

1.78

3.1

3.7

2.55

2.53

g/l

0.06

177

Superficial frostbite

319

1.53

1.78

3.4

2.5

2.23

2.27

g/l

0.19

292

Other degenerative diseases of the basal ganglia

146

1204

1.27

1.77

2.5

2.8

2.10

2.24

g/l

2.03

134

1127

Distal bite

223

1884

1.20

1.76

4.1

2.6

2.53

g/l

0.04

208

1768

Other superficial injuries of ankle and foot

320

1.53

1.76

4.2

2.5

2.32

2.35

g/l

0.11

298

Benign neoplasm of other and unspecified sites

221

1887

1.21

1.75

2.3

2.6

2.33

2.32

g/l

0.07

197

1764

Arthropod-borne viral fevers and viral haemorrhagic fevers

647

5907

1.11

1.74

2.9

2.7

2.36

2.31

g/l

1.35

612

5506

Retinal breaks without detachment

1188

11113

1.08

1.74

2.8

2.6

2.29

2.32

g/l

0.73

1089

10306

Secondary malignant neoplasm of other and unspecified sites

126

1022

1.28

1.73

1.7

2.5

2.08

2.26

g/l

2.69

119

939

Unspecified abortion

292

2544

1.17

1.73

2.9

2.4

2.45

2.43

g/l

0.17

267

2391

Congenital malformations of breast, including avohilmo

109

867

1.30

1.72

2.2

2.48

2.49

g/l

0.08

790

Other benign neoplasms of uterus

387

3449

1.15

1.71

2.3

2.4

2.37

2.34

g/l

0.58

332

3145

Cholinergic urticaria

232

1.62

1.70

2.0

2.3

2.26

2.40

g/l

0.81

215

Bullous keratopathy

504

1.42

1.70

2.3

2.6

2.32

2.29

g/l

0.20

461

Crystalline deposits in vitreous body

565

1.39

1.70

2.9

2.6

2.39

2.25

g/l

1.30

524

Benign neoplasm: Skin of lower limb, including hip

187

1580

1.22

1.69

3.8

2.5

2.31

2.33

g/l

0.28

175

1469

Vascular dementia (sudden onset)

208

0.45

1.68

3.1

2.6

2.07

2.18

g/l

—

198

Small cell lung cancer, including Hilmo

108

1346

0.78

1.67

2.1

2.5

2.18

2.23

g/l

0.37

1222

Small cell lung cancer

108

1346

0.78

1.67

2.1

2.5

2.18

2.23

g/l

0.37

1222

Agent resistant to multiple antibiotics

3.43

1.66

6.6

3.5

2.25

2.11

g/l

—

Early syphilis, including avohilmo

642

1.35

1.66

2.0

2.5

2.29

2.31

g/l

0.10

598

Other specified and unspecified disorders of lens

532

1.40

1.66

3.0

2.5

2.36

2.26

g/l

0.70

484

Sequelae of injuries involving multiple and unspecified body regions

2.02

1.66

1.9

2.2

2.35

2.28

g/l

0.15

Carcinoma in situ of anus and anal canal

2.31

1.65

3.9

2.0

2.16

2.32

g/l

0.54

Maternal infectious and parasitic diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

110

880

1.29

1.65

1.9

2.2

2.48

2.49

g/l

0.05

821

Other congenital malformations of brain

209

1.64

1.65

3.5

3.0

2.50

2.45

g/l

0.16

193

Non-seminoma of testis

2.08

1.64

3.8

2.4

2.43

2.20

g/l

1.08

Congenital malformations of uterus and cervix

123

998

1.27

1.64

2.6

2.3

2.46

2.48

g/l

0.18

112

914

Postpartum care and examination

871

5048

1.09

1.64

2.2

2.3

2.55

2.54

g/l

0.30

778

4684

Vertical strabismus

223

1917

1.19

1.63

2.6

2.5

2.39

2.32

g/l

0.96

210

1789

HSIL lesion of the cervix uteri, vagina or vulva

1327

12478

1.07

1.63

2.7

2.3

2.42

2.48

g/l

3.72

1199

11563

Kaposi sarcoma, including Hilmo

2.27

1.63

3.8

2.5

2.13

2.19

g/l

0.09

Benign neoplasm: Choroid

471

4258

1.13

1.60

2.7

2.31

2.30

g/l

0.16

424

3945

Non-allergic asthma

584

5327

1.11

1.59

2.7

2.38

2.32

g/l

1.52

541

4952

Glycogen storage disease

2.81

1.57

7.3

2.7

2.20

2.35

g/l

—

Malignant neoplasm of nasal cavity and middle ear, including Hilmo

345

1.47

1.57

1.8

2.3

2.23

2.25

g/l

0.09

319

Antenatal screening

1276

7606

0.93

1.56

2.1

2.4

2.52

2.51

g/l

0.17

1181

7106

Benign neoplasm of male genital organs

146

1218

1.24

1.56

2.7

3.0

2.16

2.20

g/l

0.34

132

1137

Scarlet fever

227

1.57

1.56

5.4

1.9

2.56

2.46

g/l

0.62

211

Idiopathic hypoparathyroidism

166

1.74

1.56

5.0

2.6

2.39

2.29

g/l

0.54

151

Chronic congestive splenomegaly

3.64

1.55

4.8

1.7

2.12

2.31

g/l

—

Malignant neoplasm of pyriform sinus, including Hilmo

2.26

1.55

3.8

2.5

2.40

2.15

g/l

0.79

Other disorders of breast and lactation associated with childbirth

103

826

1.29

1.55

1.8

2.2

2.53

2.50

g/l

0.25

756

Carcinoma in situ of cervix uteri

631

5784

1.10

1.55

2.6

2.3

2.44

2.48

g/l

1.04

565

5345

Contact with machinery

769

7118

1.10

1.55

3.0

2.8

2.31

2.27

g/l

1.21

712

6660

Acute alcohol intoxication ICD-9

220

1899

1.19

1.54

3.0

2.8

2.33

2.26

g/l

0.87

200

1773

Toxic effect of other noxious substances eaten as food

181

1.67

1.54

2.4

2.2

2.32

2.31

g/l

0.04

164

Malignant neoplasm of eye, brain and central nervous system, including Hilmo

437

3937

1.13

1.54

2.5

2.7

2.28

2.31

g/l

0.56

412

3622

Disorders of tyrosine metabolism

2.52

1.53

5.7

2.6

2.08

2.22

g/l

—

Use of levodopa decarbox-comt-inhibitor

235

2046

1.18

1.52

2.1

2.7

2.28

2.23

g/l

0.65

213

1892

Disorders of branched-chain amino-acid metabolism, other/unspecified

4.10

1.52

2.0

1.5

2.64

2.47

g/l

—

Migraine with aura, drug-induced

538

1.36

1.51

2.4

2.45

2.36

g/l

0.66

497

Benign neoplasm: Other/unspecified site

108

877

1.28

1.51

2.4

2.5

2.31

2.32

g/l

0.04

815

Hypotony of eye

2.13

1.51

3.0

2.0

2.11

2.29

g/l

0.48

Benign neoplasm: Lip

147

1232

1.24

1.50

2.7

2.5

2.35

2.30

g/l

0.49

130

1141

Other menopausal disorders

1885

9984

1.06

1.50

2.3

2.5

2.42

2.38

g/l

3.36

1724

9250

Use of rivastigmine

1274

13450

0.93

1.49

2.1

2.6

2.22

2.24

g/l

0.64

1137

12202

Third [oculomotor] nerve palsy

128

1060

1.25

1.49

4.6

2.7

2.19

2.26

g/l

0.75

118

986

Other eccrine sweat disorders

2.58

1.49

4.3

2.0

2.00

2.39

g/l

—

Transient global amnesia

576

6276

0.90

1.49

2.4

2.7

2.34

2.29

g/l

1.34

521

5801

Injury of nerves at ankle and foot level

349

1.45

1.48

2.4

2.42

2.34

g/l

0.31

330

Gonococcal infection

191

1635

1.20

1.48

2.7

2.4

2.34

2.36

g/l

0.26

175

1512

Failed induction of labour

359

3212

1.14

1.44

2.1

2.3

2.63

2.51

g/l

4.00

337

2962

All dysplastic lesions of the cervix uteri

1730

16197

1.06

1.44

2.6

2.3

2.43

2.48

g/l

3.32

1582

15033

Transient synovitis

324

1.45

1.44

2.9

2.4

2.46

2.40

g/l

0.29

296

Disorders of male genital organs in diseases classified elsewhere

309

1.47

1.43

3.4

2.8

2.28

2.27

g/l

0.03

291

Maxillary prognathism

245

0.54

1.42

2.6

2.8

2.60

2.44

g/l

0.69

225

Sequelae of poliomyelitis, including avohilmo

528

1.36

1.42

2.5

2.4

2.24

g/l

0.04

490

Eccrine sweat disorders

122

1.81

1.41

3.4

2.4

2.47

2.33

g/l

0.35

107

Malignant neoplasm of bronchus and lung

1441

11417

1.06

1.40

2.3

2.7

2.15

2.26

g/l

8.70

1352

10362

Soft tissue disorders in diseases classified elsewhere

2.70

1.38

1.8

2.1

2.32

2.29

g/l

—

Malignant otitis externa

2.03

1.38

8.1

1.8

2.22

2.39

g/l

0.56

Respiratory conditions due to inhalation of chemicals, gases, fumes and vapours

468

1.37

1.38

2.6

2.4

2.29

2.27

g/l

0.12

434

Defect, injury or illness of neck

295

1.47

1.37

2.2

2.5

2.42

2.33

g/l

0.43

273

Melanoma in situ, other sites/unspecified

205

1.61

1.37

4.2

2.6

2.24

2.26

g/l

0.07

190

Occupational exposure to risk-factors

227

1988

1.17

1.36

2.0

2.8

2.32

2.27

g/l

0.70

207

1842

Chronic postrheumatic arthropathy [Jaccoud]

2.18

1.36

1.4

2.2

2.38

2.35

g/l

0.10

Persistent hyperplasia of thymus

2.62

1.35

3.9

1.7

2.16

2.31

g/l

—

Lesion of sciatic nerve

305

2723

1.14

1.35

2.4

2.5

2.34

2.25

g/l

2.41

281

2501

Benign neoplasm: Endocrine gland, other/unspecified

172

1.65

1.35

2.0

2.7

2.44

2.29

g/l

0.37

160

Hypothyroidism, autoimmune, DX-based

179

1.61

1.35

2.2

2.4

2.56

2.39

g/l

0.88

164

Gonococcal infection, including avohilmo

205

1780

1.18

1.34

2.7

2.4

2.33

2.36

g/l

0.43

188

1644

Tularaemia

700

1.29

1.34

2.5

2.4

2.42

2.31

g/l

1.24

652

Keratoconus

147

1245

1.21

1.33

3.0

2.6

2.38

2.35

g/l

0.32

136

1164

Preterm labour and delivery

1670

15916

1.06

1.32

2.6

2.4

2.47

2.44

g/l

1.43

1529

14771

Hereditary ataxia

720

1.29

1.32

3.3

2.6

2.28

2.29

g/l

0.02

668

Other chromosome abnormalities, not elsewhere classified

222

1.54

1.31

1.9

3.6

2.46

2.52

g/l

0.35

216

Benign neoplasm of brain and other parts of central nervous system

429

3909

1.12

1.29

2.5

2.7

2.32

g/l

0.02

392

3632

Reduction defects of lower limb, including avohilmo

157

1.64

1.28

3.6

2.5

2.37

2.33

g/l

0.12

148

Acute myringitis

360

1.40

1.26

3.9

2.6

2.42

2.36

g/l

0.31

335

Other and unspecified disorders of refraction

2.39

1.26

2.5

3.1

1.99

2.18

g/l

—

Other benign neoplasm of uterus: Other parts/unspecified

296

2656

1.14

1.26

2.2

2.4

2.33

2.32

g/l

0.02

250

2414

Disorders of optic chiasm

2.37

1.24

1.4

2.7

2.18

2.34

g/l

—

Diaper [napkin] dermatitis

1.99

1.22

7.3

3.9

2.31

2.41

g/l

0.23

Benign neoplasm: Spinal cord

773

1.26

1.22

2.2

2.4

2.33

2.34

g/l

0.06

719

Benign neoplasm: Thymus

137

1.70

1.20

2.6

2.5

2.37

2.32

g/l

0.16

126

Generalized epilepsy, strict definition

132

1120

1.21

1.20

2.3

2.6

2.43

2.42

g/l

0.08

123

1040

Melanoma in situ of upper limb, including shoulder

444

1.35

1.20

3.6

2.4

2.19

2.27

g/l

0.58

404

Benign neoplasm: Rectum/anal canal icd-9

496

1.33

1.20

3.0

2.5

2.21

2.26

g/l

0.36

451

Congenital ovarian cysts

251

2231

1.14

1.19

2.2

2.3

2.51

2.48

g/l

0.49

231

2067

Obstructive hydrocephalus

811

1.25

1.19

2.6

2.25

2.31

g/l

0.54

756

Foreign body in ear

123

1039

1.22

1.19

3.6

2.5

2.43

2.38

g/l

0.53

111

974

Placental disorders

424

1.35

1.19

2.7

2.3

2.51

g/l

0.04

396

Hereditary lymphedema

1.97

1.18

1.6

2.8

2.58

2.29

g/l

0.78

Disorders of conjunctiva in diseases classified elsewhere

2.54

1.17

2.6

2.5

2.57

2.20

g/l

—

Abscess of spleen

2.34

1.17

9.7

2.0

2.11

2.44

g/l

—

Other congenital malformations of digestive system

121

1.72

1.17

2.5

2.4

2.32

2.41

g/l

0.25

110

Dysplastic lesion of unknown severity in the cervix uteri, vagina or vulva

640

1.28

1.17

2.6

2.2

2.44

2.43

g/l

0.06

587

Explosion and rupture of other specified pressurized devices

2.16

1.16

1.8

2.5

2.61

2.30

g/l

—

Persons encountering health services in circumstances related to reproduction

4265

27788

1.03

1.15

2.7

2.42

2.40

g/l

1.72

4002

25976

Cyst of Bartholin Gland

223

1975

1.15

1.14

2.0

2.3

2.52

2.44

g/l

1.51

205

1836

Forearm

2.25

1.14

2.3

1.9

2.34

2.30

g/l

—

Traumatic amputation of forearm

2.44

1.13

4.1

1.6

2.37

2.30

g/l

—

Abnormal findings on diagnostic imaging of breast

808

1.24

1.12

2.6

2.2

2.37

2.39

g/l

0.12

753

Other benign neoplasm of uterus: Corpus uteri

430

1.34

1.12

3.0

2.4

2.46

2.39

g/l

0.45

396

Digeorge syndrome

2.43

1.12

4.7

3.0

2.48

2.42

g/l

—

Cicatricial alopecia [scarring hair loss]

439

1.33

1.11

2.7

2.2

2.30

2.35

g/l

0.30

405

Benign neoplasm: Prostate

424

1.35

1.11

2.6

2.7

2.12

2.19

g/l

0.53

392

Airway disease due to specific organic dust

123

1.68

1.10

2.7

2.6

2.41

2.38

g/l

0.08

117

Complications of anaesthesia during pregnancy

1.87

1.10

2.3

2.2

2.41

g/l

0.01

Other changes in lacrimal passages

1.84

1.10

1.9

2.7

2.51

2.38

g/l

0.40

Burns and corrosions confined to eye and internal organs

156

1354

1.18

1.09

2.3

2.5

2.37

2.36

g/l

0.06

143

1264

LeFortI or BSSO operation

225

2002

1.14

1.08

1.8

2.3

2.55

2.42

g/l

2.98

202

1868

Other melanin hyperpigmentation

153

1331

1.18

1.08

3.5

2.4

2.38

2.30

g/l

0.98

139

1233

Compression of brain

2.07

1.07

4.7

3.0

1.88

2.32

g/l

—

Traumatic amputation of wrist and hand

275

2480

1.13

1.07

2.9

2.29

2.26

g/l

0.46

258

2315

Injury of muscle and tendon at ankle and foot level

153

1329

1.18

1.07

2.5

2.32

2.35

g/l

0.33

141

1232

Benign neoplasm: Connective and other soft tissue of head, face and neck

102

858

1.22

1.06

2.1

2.4

2.43

2.33

g/l

1.12

800

Von Hippel-Lindau syndrome

2.21

1.05

6.7

1.8

2.19

2.43

g/l

—

Carcinoma in situ of skin of eyelid, including canthus

134

1.65

1.05

3.7

3.1

2.23

2.20

g/l

0.10

122

Bilateral sagittal split ramus osteotomy operation

186

1640

1.15

1.04

1.7

2.3

2.55

2.41

g/l

2.84

170

1529

Obstructed labour due to maternal pelvic abnormality

855

9049

0.94

1.04

2.6

2.5

2.43

2.41

g/l

0.41

796

8399

Deficiency of other/unspecified vitamins

1.93

1.03

3.5

2.3

1.96

2.32

g/l

0.94

HSIL lesion of the cervix uteri

1165

11107

1.06

1.00

2.6

2.3

2.43

2.49

g/l

2.87

1055

10303

Unspecified renal colic

341

1.36

0.99

4.5

2.5

2.39

2.28

g/l

0.63

314

Erythrasma

110

1.67

0.99

5.0

2.3

2.40

2.33

g/l

0.16

101

Right side

352

1.36

0.99

3.2

2.5

2.52

2.27

g/l

2.35

322

Motorcycle rider injured in other and unspecified transport accidents

324

2957

1.11

0.98

2.5

2.6

2.38

2.37

g/l

0.18

303

2755

Viral haemorrhagic fevers, not elsewhere classified/unspecified

512

4769

1.09

0.98

2.9

2.7

2.34

2.31

g/l

0.63

489

4436

Subclinical iodine-deficiency hypothyroidism

1.88

0.98

2.6

2.1

2.25

2.32

g/l

0.14

Malignant neoplasms of independent (primary) multiple sites

2.44

0.98

3.5

1.9

1.71

2.28

g/l

—

Motorcycle rider injured in noncollision transport accidents

167

1470

1.16

0.97

2.4

2.6

2.35

2.37

g/l

0.19

158

1370

Disorders of acoustic nerve

178

1578

1.15

0.97

2.2

2.4

2.33

2.29

g/l

0.40

158

1464

Benign mammary dysplasia

987

9388

1.06

0.97

2.4

2.40

2.37

g/l

0.96

918

8582

Tularaemia, including avohilmo

121

1045

1.19

0.95

2.6

2.5

2.42

2.33

g/l

1.14

110

976

Schistosomiasis [bilharziasis], including avohilmo

178

1.50

0.95

2.1

2.5

2.39

2.37

g/l

0.06

163

Premature rupture of membranes

1263

9397

0.95

0.94

1.9

2.4

2.54

2.49

g/l

2.19

1135

8752

Contact with lifting and transmission devices, not elsewhere classified

112

963

1.19

0.94

2.0

2.7

2.33

2.31

g/l

0.21

103

899

Nontoxic diffuse goitre

196

1752

1.14

0.93

2.9

2.4

2.32

2.33

g/l

0.09

181

1621

Drug-induced dystonia

145

1.54

0.93

2.4

2.3

2.32

2.39

g/l

0.20

133

Sequelae of other accidents

101

863

1.20

0.92

2.6

2.5

2.27

2.28

g/l

0.11

811

Granuloma faciale [eosinophilic granuloma of skin]

2.22

0.91

1.2

1.7

2.46

2.29

g/l

—

LSIL lesion of the cervix uteri

699

6594

1.07

0.91

2.7

2.3

2.43

2.47

g/l

1.45

647

6118

Venous complications and haemorrhoids in pregnancy

798

1.20

0.90

1.9

2.3

2.46

2.51

g/l

0.38

757

Traumatic subcutaneous emphysema

1.80

0.89

1.8

2.8

2.04

2.09

g/l

0.14

Drug-induced fever

106

1.67

0.89

2.0

2.3

2.28

2.32

g/l

0.09

Malignant neoplasm of other and unspecified male genital organs

1.93

0.89

2.5

2.03

2.13

g/l

—

Benign neoplasm: Spinal meninges

591

1.25

0.89

2.9

2.4

2.26

2.32

g/l

0.31

552

Osteochondrodysplasia with defects of growth of tubular bones and spine

1.74

0.88

3.6

2.3

2.33

2.43

g/l

0.35

Cholesteatoma of middle ear

341

3145

1.10

0.88

3.1

2.6

2.32

2.27

g/l

0.79

317

2900

Alzheimer’s disease (Atypical or mixed)

974

9174

1.06

0.88

2.2

2.6

2.18

2.22

g/l

1.32

836

8339

Melanoma in situ of other and unspecified parts of face

815

1.21

0.88

4.0

2.6

2.18

2.25

g/l

0.75

752

Other and unspecified degenerative diseases of nervous system

200

1801

1.14

0.87

2.3

2.6

2.22

2.23

g/l

0.15

187

1668

Other disorders of amniotic fluid and membranes

838

7680

1.06

0.87

2.0

2.4

2.57

2.50

g/l

3.62

752

7155

conjunctival degenerations and deposits

139

1224

1.16

0.87

2.6

2.5

2.38

2.31

g/l

1.05

129

1136

Fetus and newborn affected by maternal factors and by complications of pregnancy, labour and delivery

657

1.22

0.86

4.0

2.62

2.55

g/l

0.48

625

Malignant neoplasm of nasal cavity and middle ear

225

1.40

0.85

1.8

2.5

2.35

2.22

g/l

0.65

206

Carcinoma in situ, other/unspecified

1.81

0.85

3.6

2.0

2.62

2.23

g/l

1.43

Otitis media in diseases classified elsewhere

1.97

0.85

1.6

2.6

2.51

2.33

g/l

—

Viral infections of central nervous system, not elsewhere classified/unspecified

529

1.25

0.84

2.7

2.2

2.37

2.35

g/l

0.11

494

Open bite that required surgery (Lefort1 or BSSO)

411

1.28

0.84

1.6

2.2

2.66

2.46

g/l

1.59

381

Spontaneous abortion

3320

21664

1.03

0.84

2.4

2.49

2.44

g/l

4.79

3053

19998

Disorders of glycosaminoglycan metabolism

2.58

0.83

4.6

3.4

2.32

2.17

g/l

—

Disorder of thyroid, unspecified

705

1.21

0.83

3.1

2.2

2.45

2.34

g/l

1.00

649

Prolapse and hernia of ovary and fallopian tube

260

2354

1.11

0.83

2.3

2.4

2.34

2.28

g/l

1.02

238

2114

404

1.28

0.83

3.6

2.6

2.43

2.22

g/l

1.31

364

Undefined dementia

886

8571

0.95

0.82

2.3

2.5

2.18

2.21

g/l

1.02

784

7721

Flatback syndrome

1.85

0.82

2.6

2.5

2.69

2.34

g/l

—

Other specified/unspecified diseases of inner ear

271

1.35

0.82

1.7

2.7

2.33

2.27

g/l

0.27

251

Effects of air pressure and water pressure

244

1.37

0.82

1.8

2.3

2.36

2.37

g/l

0.03

234

Foreign body in genitourinary tract

505

1.25

0.81

2.6

2.5

2.26

2.33

g/l

0.46

473

Noise effects on inner ear

221

2429

0.90

0.81

2.6

2.9

2.31

2.25

g/l

0.86

207

2275

Toxic effect of other gases, fumes and vapours

289

1.33

0.81

4.2

2.0

2.42

2.32

g/l

0.48

270

Myxoedema coma

2.39

0.80

2.8

1.9

2.00

2.44

g/l

—

Puerperal sepsis

779

7413

1.06

0.79

2.3

2.5

2.45

2.41

g/l

1.24

725

6863

Benign neoplasm: Connective and other soft tissue of pelvis

117

1.55

0.78

3.2

2.3

2.56

2.37

g/l

0.66

106

Antepartum haemorrhage, not elsewhere classified

501

4708

1.07

0.78

2.2

2.4

2.50

g/l

0.01

457

4391

Sequelae of inflammatory diseases of the central nervous system

160

1.46

0.77

3.0

2.5

2.44

2.32

g/l

0.48

143

Otorrhoea

143

1.49

0.77

6.1

2.8

2.28

2.37

g/l

0.40

132

Postpartum hemorraghe, parous women as controls

1580

12758

1.04

0.77

2.1

2.2

2.53

2.49

g/l

1.91

1433

11828

Environmental-pollution-related condition

1.73

0.77

4.2

2.6

2.56

2.44

g/l

—

Retained (old) intraocular foreign body

1.89

0.75

2.3

2.0

2.22

2.19

g/l

—

Hydrocephalus

479

5088

0.93

0.75

2.5

2.6

2.23

2.27

g/l

0.79

435

4656

Diphyllobothriasis and sparganosis, including avohilmo

1.87

0.75

2.0

1.9

2.51

2.32

g/l

—

Sexual assault by bodily force

1.59

0.74

1.4

2.2

2.88

2.50

g/l

1.48

Iodine-deficiency-related thyroid disorders and allied conditions

1.85

0.74

2.5

2.0

2.53

2.44

g/l

—

Severe visual impairment, monocular

585

1.22

0.74

4.2

2.4

2.25

2.31

g/l

0.48

539

Poikiloderma of Civatte

1.61

0.73

1.2

2.5

2.29

2.40

g/l

0.28

Mandibular retrognathia AND surgery (BSSO)

139

1239

1.14

0.73

1.6

2.4

2.57

2.41

g/l

3.41

127

1154

Circumscribed brain atrophy

121

1363

0.87

0.73

2.2

2.6

2.18

2.26

g/l

0.89

105

1265

Methaemoglobinaemia

2.01

0.71

2.6

2.4

2.60

2.14

g/l

—

Lymphocyte function antigen-1 [LFA-1] defect

1.74

0.70

2.0

3.5

2.43

2.22

g/l

—

Hereditary angioödema type 1

1.73

0.69

3.3

2.3

2.45

2.42

g/l

—

Cholera

1.71

0.69

2.2

3.0

2.19

2.29

g/l

0.22

Carcinoma in situ of breast, intraductal

546

5174

1.07

0.69

2.3

2.5

2.37

g/l

0.00

483

4775

Meningitis, viral

225

1.35

0.69

4.3

2.4

2.28

2.39

g/l

0.51

206

Burn and corrosion of head and neck

120

1066

1.15

0.68

2.1

2.6

2.42

2.33

g/l

0.80

107

997

Benign neoplasm: Vulva

125

1115

1.14

0.68

3.1

2.4

2.43

2.37

g/l

0.49

117

1031

Photocontact dermatitis [berloque dermatitis]

1.62

0.68

1.8

2.5

2.41

2.36

g/l

0.15

Exposure to other and unspecified man-made environmental factors

110

973

1.15

0.67

3.3

2.5

2.47

2.35

g/l

1.34

103

903

Congenital heart conduction disorder

1.72

0.67

2.7

2.47

2.49

g/l

—

Other injuries involving multiple body regions, not elsewhere classified

1.60

0.67

3.7

2.5

2.46

2.32

g/l

0.36

Animal-rider or occupant of animal-drawn vehicle injured in transport accident

516

1.21

0.67

2.0

2.1

2.43

2.47

g/l

0.35

468

Respiratory tuberculosis, not confirmed, including avohilmo

267

2475

1.09

0.67

2.7

2.6

2.23

g/l

0.00

252

2269

Beningn neoplasm: Meninges, unspecified

873

1.16

0.66

2.6

2.4

2.36

2.33

g/l

0.22

812

Myopathy due to other toxic agents

2.01

0.65

4.0

1.9

2.21

2.37

g/l

—

Clubfoot

444

1.22

0.65

3.4

2.5

2.39

2.38

g/l

0.06

415

Birth injury to peripheral nervous system

113

1.48

0.65

3.4

2.8

2.65

2.45

g/l

0.65

104

Arteriovenous malformation of cerebral vessels

584

1.20

0.65

2.5

2.4

2.28

2.31

g/l

0.13

539

Benign neoplasm: Urinary organ, other/unspecified

140

1.44

0.64

2.8

2.2

2.36

2.29

g/l

0.20

128

Respiratory tuberculosis, clinically confirmed

668

1.18

0.64

3.0

2.7

2.23

2.20

g/l

0.18

621

Cerebral oedema

114

0.58

0.64

4.6

2.8

2.27

2.35

g/l

—

104

General autosomal fish scale disease

1.65

0.63

2.9

1.9

2.46

2.36

g/l

—

Other congenital malformations of face and neck

164

1491

1.12

0.63

3.0

2.4

2.35

2.39

g/l

0.44

158

1386

Respiratory tuberculosis, not confirmed

263

2443

1.09

0.63

2.8

2.6

2.24

2.23

g/l

0.17

248

2242

Other infestations

159

1.42

0.63

2.0

2.4

2.40

2.28

g/l

0.61

147

Cleft palate

427

1.22

0.63

2.9

2.5

2.42

g/l

0.02

395

Peripheral retinal degeneration

188

1723

1.11

0.62

2.8

2.5

2.38

2.32

g/l

0.78

172

1595

Contact with venomous snakes and lizards

558

1.20

0.62

1.9

2.4

2.38

2.31

g/l

0.40

520

Rheumatic fever without mention of heart involvement

167

1.39

0.62

3.5

2.9

2.51

2.30

g/l

0.92

150

Alzheimer disease

3015

22001

0.97

0.62

2.2

2.7

2.18

2.24

g/l

7.13

2670

20052

Benign neoplasm: Cranial nerves

184

1688

1.11

0.61

2.2

2.5

2.32

2.31

g/l

0.10

163

1563

Subarachnoid haemorrhage

722

6920

1.05

0.60

3.1

2.6

2.27

2.28

g/l

0.38

661

6374

Benign neoplasm: Uterine tubes and ligaments

330

1.26

0.60

2.3

2.36

2.37

g/l

0.06

303

Ophthalmic devices associated with adverse incidents

100

1.56

0.60

3.5

2.4

2.08

2.19

g/l

0.42

Single delivery by caesarean section

1142

6745

0.96

0.60

2.2

2.7

2.52

2.49

g/l

1.08

1059

6302

Cleft lip, lip and palate or palate

690

1.17

0.60

3.1

2.5

2.39

2.42

g/l

0.19

640

Hydatidiform mole

672

1.17

0.60

2.2

2.3

2.46

2.44

g/l

0.11

627

Benign neoplasm of other and unspecified female genital organs

259

2418

1.08

0.57

2.6

2.4

2.42

2.38

g/l

0.48

234

2223

Viral infections of central nervous system, not elsewhere classified/unspecifie, including avohilmod

723

1.16

0.56

2.6

2.3

2.36

2.33

g/l

0.15

669

Degeneration of iris and ciliary body

1.64

0.56

5.5

1.7

2.42

2.29

g/l

—

Carcinoma in situ of breast

179

1.34

0.56

2.4

2.40

2.38

g/l

0.09

163

Multiple congenital exostoses

0.59

0.56

2.3

2.2

2.72

2.36

g/l

—

Dysplastic lesion of unknown severity of the cervix uteri

480

1.19

0.55

2.9

2.2

2.50

2.46

g/l

0.25

440

Primary amenorrhea

296

1.25

0.55

2.6

2.1

2.57

2.55

g/l

0.09

263

Melanoma in situ of trunk

109

983

1.13

0.54

2.8

2.7

2.27

2.26

g/l

0.05

104

910

Benign lipomatous neoplasm of skin and subcutaneous tissue of head, face and neck

427

4057

1.06

0.54

2.6

2.7

2.39

2.29

g/l

3.54

410

3778

Female pelvic inflammatory disorders in diseases classified elsewhere

144

1.37

0.54

2.2

2.0

2.48

2.51

g/l

0.08

134

Malignant neoplasm of brain

159

1732

0.91

0.54

1.8

2.6

2.25

2.32

g/l

0.96

149

1598

Palsy of conjugate gaze

1.71

0.54

2.6

2.8

2.50

2.30

g/l

—

Traumatic secondary and recurrent haemorrhage

102

1.48

0.53

3.9

1.9

2.34

2.20

g/l

0.40

Injury of heart

137

1.40

0.53

4.3

2.4

2.56

2.23

g/l

1.43

126

Other obstetric trauma

298

2804

1.07

0.52

2.0

2.4

2.53

2.49

g/l

0.62

276

2607

Prominent ears

372

1.21

0.51

2.8

2.3

2.55

2.49

g/l

0.31

337

Mandibular prognathia AND surgery (LeFortI or BSSO), including avohilmo

456

1.19

0.51

1.9

3.0

2.60

2.44

g/l

1.30

422

Trisomy 21 (Down syndrome) due to meiotic nondisjunction

1.49

0.50

1.4

3.0

2.46

2.55

g/l

0.17

Occupant of streetcar injured in transport accident

1.60

0.50

4.5

2.4

2.20

2.18

g/l

—

Exposure to excessive heat of man-made origin

477

1.18

0.50

3.6

2.5

2.29

2.27

g/l

0.09

441

Torsion of testis

757

1.14

0.50

2.5

2.9

2.40

2.36

g/l

0.31

723

Benign neoplasm: Connective and other soft tissue of upper limb, including shoulder

275

2589

1.07

0.49

2.7

2.5

2.43

2.32

g/l

2.63

256

2401

Dementia due to Parkinson's disease

190

1769

1.09

0.49

1.8

2.7

2.13

2.22

g/l

1.06

156

1624

Benign neoplasm: Brain, supratentorial

827

1.13

0.49

3.0

2.4

2.37

2.34

g/l

0.22

766

Other and unspecified hydrocephalus

112

1018

1.12

0.49

2.8

2.5

2.26

2.29

g/l

0.15

103

948

Postpartum haemorrhage due to anatomy

582

5585

1.05

0.49

2.0

2.1

2.55

2.54

g/l

0.15

522

5130

Other disorders of thyroid

771

1.14

0.48

3.3

2.3

2.44

2.36

g/l

0.66

715

Cholesteatoma of external ear

470

1.18

0.48

3.4

2.6

2.23

2.26

g/l

0.12

432

Crushing injury of wrist and hand

857

1.13

0.48

3.1

2.8

2.31

2.29

g/l

0.14

807

Benign neoplasm: Female genital organ, unspecified

157

1.33

0.47

2.1

2.4

2.53

2.40

g/l

0.27

143

Unspecified drowning and submersion

1.57

0.47

1.3

2.6

2.23

2.38

g/l

—

Benign neoplasm: Trachea

1.53

0.46

3.7

3.6

2.06

2.34

g/l

—

Pneumoconiosis due to asbestos and other mineral fibres

147

1359

1.10

0.46

3.1

2.8

2.25

2.14

g/l

1.79

132

1254

Endovascular or surgical operations to intracerebral aneurysms

381

3631

1.06

0.46

3.4

2.6

2.31

g/l

0.00

357

3365

Other sudden death, cause unknown

0.60

0.46

7.0

2.6

2.22

2.17

g/l

—

Hereditary spastic paraplegia

1.51

0.46

9.0

3.2

1.99

2.28

g/l

—

Epidermolysis bullosa

1.52

0.45

8.0

3.4

2.22

2.49

g/l

—

Benign neoplasm: Skin of lip

756

1.13

0.45

3.5

2.4

2.37

2.29

g/l

0.63

704

Injury of blood vessels at ankle and foot level

1.49

0.45

5.8

2.3

2.11

2.20

g/l

—

Benign neoplasm: Peripheral nerves and autonomic nervous system

870

1.12

0.45

2.4

2.5

2.36

2.32

g/l

0.31

806

Other mosquito-borne viral fevers

105

1.40

0.45

1.9

2.5

2.51

2.31

g/l

0.49

Cyst of iris, ciliary body and anterior chamber

1.45

0.44

2.9

2.1

2.35

2.45

g/l

0.20

Congenital malformations of larynx

141

1.33

0.43

6.4

3.5

2.60

2.54

g/l

0.14

133

Use of interferon beta-1a

112

1025

1.11

0.43

2.1

2.4

2.45

2.42

g/l

0.34

105

959

Abnormalities of ear ossicles

105

0.63

0.43

2.1

2.6

2.36

2.37

g/l

—

Degenerative diseases of the nervous system

3447

24417

1.02

0.43

2.2

2.7

2.18

2.24

g/l

9.01

3059

22322

Other mosquito-borne viral fevers, including avohilmo

343

1.19

0.43

2.2

2.4

2.34

2.35

g/l

0.02

312

Progressive external ophthalmoplegia

1.57

0.43

2.6

1.9

2.29

2.32

g/l

—

Exposure to ignition or melting of other clothing and apparel

133

1.34

0.42

2.2

2.8

2.19

2.23

g/l

0.08

120

Accessory breast

279

1.21

0.41

2.3

2.44

2.43

g/l

0.05

258

Placenta praevia

245

2315

1.07

0.41

2.1

2.4

2.54

2.48

g/l

0.98

224

2174

Multiple congenital exostoses, including avohilmo

136

0.71

0.40

1.8

2.3

2.80

2.32

g/l

—

126

Infections of breast associated with childbirth

194

1821

1.07

0.40

1.9

2.2

2.57

2.48

g/l

1.47

176

1675

Other zoonotic bacterial diseases, not elsewhere classified

1.36

0.40

3.1

2.3

2.11

2.38

g/l

—

Maternal care for known or suspected disproportion

227

2143

1.07

0.40

1.9

2.4

2.48

2.49

g/l

0.12

212

2016

Central nervous system disorder causing precocious puberty

107

1.36

0.40

3.9

2.9

2.68

2.57

g/l

0.21

Labour and delivery complicated by umbilical cord complications

248

2618

0.94

0.39

2.2

2.4

2.50

2.47

g/l

0.49

227

2437

Down's syndrome

152

1.29

0.39

3.0

2.6

2.38

2.49

g/l

0.29

140

Motor neuron disease (with DMD)

113

1041

1.10

0.39

1.7

2.6

2.23

2.25

g/l

0.15

981

Dengue fever [classical dengue]

1.43

0.39

2.1

2.4

2.44

2.36

g/l

0.17

Postprocedural disorders of eye and adnexa, not elsewhere classified

227

1.24

0.39

1.4

2.4

2.39

2.24

g/l

0.94

204

Melanoma in situ of eyelid, including canthus

1.47

0.38

1.0

2.8

2.58

2.33

g/l

—

Other congenital malformations of ear

537

1.13

0.36

2.5

2.4

2.50

2.49

g/l

0.06

493

Other sexually transmitted chlamydial diseases, including avohilmo

503

5213

0.96

0.36

2.5

2.3

2.48

2.52

g/l

0.83

448

4808

Need for immunization against combinations of infectious diseases

1.41

0.36

10.5

1.8

2.16

2.40

g/l

—

Medical treatment for female infertility

1283

12440

1.02

0.35

2.2

2.3

2.51

2.50

g/l

0.36

1186

11556

Constitutional tall stature

164

1.24

0.34

1.9

3.0

2.62

2.56

g/l

0.25

155

Other assisted single delivery

935

0.91

0.34

2.4

2.7

2.48

2.50

g/l

0.13

873

Pterygium

195

1850

1.07

0.33

2.7

2.31

2.25

g/l

0.74

175

1713

Other/unspecified postprocedural disorders of ear and mastoid process

176

1.24

0.32

4.1

2.4

2.19

2.25

g/l

0.20

161

Adhesive middle ear disease

803

1.10

0.31

2.3

2.4

2.46

2.34

g/l

1.19

750

Burn and corrosion confined to eye and adnexa

123

1151

1.08

0.31

2.2

2.5

2.40

2.37

g/l

0.28

113

1076

Unspecified dementia

878

8062

0.97

0.31

2.3

2.6

2.18

2.22

g/l

1.02

778

7343

Disorders of sexual preference

112

1.30

0.31

1.6

2.6

2.51

2.29

g/l

0.54

103

Outcome of delivery

932

5852

0.97

0.30

2.0

2.4

2.52

g/l

0.14

864

5456

Ankylosis of teeth

121

1.26

0.28

7.2

2.3

2.23

2.45

g/l

1.15

112

Pediculosis and phthiriasis

150

1.23

0.28

2.7

2.8

2.12

2.28

g/l

0.59

137

Dysplastic lesion of the vagina of unknown severity

1.32

0.28

2.0

2.7

2.18

2.41

g/l

—

Respiratory TBC, ICD-8 codes not specifying whether confirmed bacteriologically or histologically

184

1754

1.06

0.27

2.7

2.6

2.25

2.23

g/l

0.24

174

1621

Contraceptive management

2772

19141

1.01

0.26

2.5

2.6

2.45

2.42

g/l

2.65

2586

17906

Melanocytic naevi of eyelid, including canthus

503

1.11

0.26

2.0

2.4

2.39

2.31

g/l

0.46

464

Recurrent cholesteatoma of postmastoidectomy cavity

161

1.22

0.26

2.9

2.5

2.62

2.24

g/l

1.55

146

Other cestode infections

180

0.81

0.26

1.9

2.1

2.58

2.26

g/l

1.11

163

Vertiginous syndromes in diseases classified elsewhere

1.49

0.26

1.8

2.16

2.33

g/l

—

Degenerative myopia

360

0.87

0.26

3.4

2.4

2.46

2.32

g/l

0.80

330

Mumps

136

1289

1.06

0.25

2.3

2.5

2.39

2.35

g/l

0.31

119

1198

Freckles

1.36

0.25

1.2

1.7

2.20

2.41

g/l

—

Linear scleroderma

1.33

0.24

3.8

2.1

2.25

2.41

g/l

—

Toxic liver disease with cholestasis, drug-induced

0.00

0.24

0.0

2.0

—

2.16

—

Vibratory urticaria

1.30

0.24

3.2

2.1

2.53

2.54

g/l

—

Exposure to excessive natural cold

593

1.09

0.24

4.3

2.5

2.34

2.28

g/l

0.26

552

Monkeypox

0.00

0.23

0.0

1.8

—

2.12

—

Other sexually transmitted chlamydial diseases

306

3160

0.96

0.23

2.6

2.3

2.46

2.49

g/l

0.38

277

2915

Dengue fever [classical dengue], including avohilmo

1.27

0.23

2.0

2.7

2.43

2.36

g/l

0.16

Choroidal degeneration

1.38

0.22

1.3

2.1

1.99

2.26

g/l

—

Other or unspecified paralytic strabismus

344

1.12

0.22

2.5

2.1

2.24

2.32

g/l

0.41

314

Foreign body on external eye

942

9258

1.02

0.22

2.6

2.8

2.33

2.32

g/l

0.20

877

8694

Congenital absence of the vagina

1.22

0.22

3.2

2.7

2.08

2.45

g/l

—

Pityriasis lichenoides chronica

221

1.16

0.22

1.8

2.3

2.37

2.35

g/l

0.08

199

Pinta [carate], including avohilmo

1.27

0.21

1.3

3.2

2.05

2.37

g/l

—

Other and unspecified water transport accidents

193

1.17

0.21

2.2

2.3

2.46

2.30

g/l

0.72

177

Carcinoma in situ of bronchus and lung

1.30

0.21

1.7

3.0

2.34

2.26

g/l

—

Postpolio syndrome

118

1.23

0.21

2.6

2.4

2.47

2.22

g/l

1.20

106

Unspecified contact dermatitis due to drugs in contact with skin

1.21

0.21

3.7

1.9

2.45

2.24

g/l

—

Exposure to noise

1.29

0.20

2.6

2.7

2.06

2.24

g/l

—

Chronic bullous disease of childhood

1.21

0.20

2.2

2.5

2.53

2.38

g/l

—

Hypertrophy of bone

156

1.18

0.20

1.8

2.3

2.43

2.32

g/l

0.31

138

Use of other anti-dementia drugs

2565

20827

0.99

0.20

2.0

2.7

2.21

2.23

g/l

0.89

2215

18994

Use of memantine

2565

20827

0.99

0.20

2.0

2.7

2.21

2.23

g/l

0.89

2215

18994

Postpartum haemorrhage due to retained placenta

691

6783

1.02

0.20

1.8

2.1

2.57

2.51

g/l

2.25

630

6281

Motor neuron disease ALS

106

1008

1.06

0.20

1.7

2.6

2.22

2.25

g/l

0.21

948

Other obstructed labour

431

4211

1.03

0.19

2.5

2.4

2.51

2.44

g/l

1.96

396

3909

Lichen striatus

1.22

0.19

3.3

2.6

2.39

2.47

g/l

—

Fetal death of unspecified cause

1.23

0.19

5.9

2.3

2.38

2.47

g/l

—

Cervical root disorders

329

1.11

0.19

2.0

2.3

2.37

2.32

g/l

0.27

304

Unspecific neurodegenerative disorder

3970

26978

1.01

0.19

2.1

2.7

2.21

2.25

g/l

4.55

3467

24744

Benign neoplasm: Brain, infratentorial

310

1.11

0.19

2.7

2.32

2.36

g/l

0.15

285

Exposure to high and low air pressure and changes in air pressure

1.15

0.18

2.6

1.8

2.10

2.21

g/l

—

Degenerative and vascular disorders of ear

1.19

0.17

2.1

2.4

2.71

2.27

g/l

—

Pedestrian injured in collision with other nonmotor vehicle

0.75

0.17

2.8

2.5

2.58

2.34

g/l

—

Mumps, including avohilmo

138

1329

1.04

0.16

2.3

2.6

2.39

2.35

g/l

0.30

121

1237

Rubella [German measles]

168

1737

0.96

0.16

3.5

2.7

2.34

2.32

g/l

0.17

162

1646

Acquired stenosis of external ear canal

585

1.07

0.16

3.4

2.6

2.36

2.25

g/l

0.71

541

Accidental poisoning by and exposure to alcohol

868

1.05

0.16

2.9

2.5

2.47

2.34

g/l

1.17

791

Abnormalities of forces of labour

566

5758

0.98

0.16

2.2

2.4

2.50

2.46

g/l

1.11

535

5364

Communicating hydrocephalus

117

1217

0.95

0.16

2.8

2.6

2.17

2.30

g/l

1.78

110

1135

Carcinoma in situ of larynx

0.76

0.16

3.0

2.28

2.22

g/l

—

Gender identity disorders

564

0.93

0.15

2.3

2.4

2.54

2.53

g/l

0.03

523

Non-small cell lung cancer, squamous

286

2792

1.03

0.15

2.0

2.7

2.14

2.20

g/l

0.97

267

2522

Postpartum hemorraghe, all women as controls

1580

15265

1.01

0.14

2.1

2.3

2.53

2.50

g/l

1.71

1433

14166

Fetus and newborn affected by other complications of labour and delivery

1.21

0.14

5.9

4.0

2.63

2.60

g/l

—

Rubella [German measles], including avohilmo

169

1741

0.97

0.14

3.5

2.7

2.34

2.32

g/l

0.16

163

1649

Inflammation of lacrimal passages (chronic)

912

1.05

0.14

1.8

2.6

2.24

2.28

g/l

0.38

829

Upper arm

127

0.85

0.13

3.0

2.7

2.03

2.28

g/l

1.02

113

Multiple gestation

513

5055

1.02

0.12

2.2

2.4

2.46

2.48

g/l

0.35

468

4721

Erythema in diseases classified elsewhere

124

1.16

0.12

2.5

2.38

2.32

g/l

0.12

113

Presbyopia

473

4660

1.02

0.12

2.7

2.5

2.33

2.36

g/l

0.66

440

4364

Melanoma in situ of lower limb, including hip

396

1.07

0.12

3.8

2.4

2.15

2.31

g/l

1.38

363

Twin gestation

494

4870

1.02

0.12

2.2

2.5

2.46

2.48

g/l

0.43

451

4551

Benign neoplasm: Vagina

661

1.05

0.12

1.9

2.2

2.35

2.38

g/l

0.12

612

Carcinoma in situ of cervix uteri, endocervix

583

1.05

0.11

2.6

2.3

2.43

2.47

g/l

0.25

538

Alzheimer disease, including avohilmo

3481

24201

0.99

0.11

2.2

2.7

2.19

2.24

g/l

5.91

3085

22097

Carcinoma in situ of breast, lobular

378

1.07

0.11

2.2

2.4

2.39

2.38

g/l

0.03

353

Indeterminate sex and pseudohermaphroditism

1.19

0.10

1.2

2.4

2.66

2.34

g/l

—

Use of benzatropine

1.11

0.10

2.0

2.4

2.25

2.41

g/l

—

Brain mixed glioma

1.15

0.10

2.4

3.4

2.11

2.24

g/l

—

Melanoma in situ of scalp and neck

184

1.11

0.10

1.9

2.3

2.28

2.21

g/l

0.26

167

Chondromalacia

151

1474

1.03

0.10

2.4

2.6

2.44

2.35

g/l

1.21

142

1377

Maternal care related to the fetus and amniotic cavity and possible delivery problems

2891

17026

0.99

0.10

2.1

2.4

2.50

2.47

g/l

2.91

2656

15852

Postpartum haemorrhage

1580

13115

0.99

0.09

2.1

2.4

2.53

2.48

g/l

3.06

1433

12192

Other and unspecified disease of Bartholin gland

159

1556

1.03

0.09

2.6

2.4

2.32

2.38

g/l

0.57

144

1432

Congenital and developmental myasthenia

1.06

0.09

1.7

2.1

2.49

2.52

g/l

—

Organic amnesic syndrome, not induced by alcohol and other psychoactive substances

0.83

0.09

4.6

2.5

1.81

2.33

g/l

—

Unspecified hairloss

1.11

0.08

2.3

2.1

2.54

2.23

g/l

—

Haematosalpinx/Haematoma of broad ligament

1.12

0.08

2.1

2.5

2.45

g/l

—

Schistosomiasis [bilharziasis]

1.07

0.08

2.6

2.1

2.48

2.34

g/l

—

Pemphigus foliaceus

1.05

0.08

1.7

2.5

2.00

2.21

g/l

—

Disorders of hypoglossal nerve

0.79

0.08

3.3

1.9

2.37

2.33

g/l

—

Otosclerosis

460

4649

0.99

0.08

2.7

2.31

g/l

0.05

429

4303

Use of selegiline

291

2872

1.02

0.07

2.2

2.7

2.29

2.25

g/l

0.58

255

2649

Myasthenia gravis, drug-induced

1.15

0.07

2.0

2.5

2.58

2.40

g/l

—

Acquired atrophy of ovary and fallopian tube

118

1.12

0.07

1.7

2.4

2.59

2.38

g/l

0.60

112

Tympanosclerosis

103

0.86

0.07

4.6

2.8

2.63

2.35

g/l

—

Fat embolism (traumatic)

102

0.87

0.07

3.1

2.8

2.18

2.26

g/l

—

Pedal cyclist injured in collision with motor vehicle

173

1703

1.02

0.06

1.7

2.5

2.41

2.35

g/l

0.70

161

1586

Frontotemporal dementia

346

1.05

0.06

1.7

2.4

2.20

2.26

g/l

0.25

321

Malignant neoplasm of brain, including Hilmo

258

2609

0.99

0.05

2.3

2.6

2.27

2.32

g/l

0.85

243

2401

Malignant neoplasm of eye, brain and central nervous system

236

2333

1.01

0.05

1.9

2.6

2.28

2.32

g/l

0.46

220

2152

Carcinoma in situ of breast, other/unspecified

763

1.03

0.05

2.3

2.23

2.37

g/l

1.40

707

Other diseases of appendix

644

1.03

0.05

3.4

2.4

2.29

2.30

g/l

0.03

595

Other congenital malformations of upper alimentary tract

407

1.04

0.04

4.5

2.6

2.40

2.31

g/l

0.40

376

597

6004

0.99

0.04

2.5

2.8

1.94

2.24

g/l

16.31

543

5586

Retained placenta and membranes, without haemorrhage

711

7083

1.00

0.03

2.3

2.5

2.47

2.43

g/l

1.04

655

6559

Maternal care for known or suspected malpresentation of fetus

1129

8072

1.00

0.03

2.2

2.4

2.55

2.51

g/l

1.72

1041

7516

Complications following myocardial infarction

410

1.03

0.03

2.8

2.2

2.22

2.19

g/l

0.12

368

Maternal care for known or suspected fetal abnormality and damage

941

7945

1.00

0.02

2.0

2.4

2.49

2.50

g/l

0.36

862

7415

Systemic atrophies primarily affecting the central nervous system

260

2614

0.99

0.02

2.5

2.7

2.26

2.27

g/l

0.14

233

2420

Acrodermatitis chronica atrophicans

103

1.08

0.02

3.8

2.5

2.45

2.39

g/l

0.16

Defect, injury or illness of lumbar spine

153

1.05

0.01

2.4

2.52

2.45

g/l

0.23

139

Unattended death

557

0.99

0.01

2.4

2.6

2.27

2.23

g/l

0.24

513

Anoxic brain damage

803

1.01

0.01

3.5

2.6

2.29

2.23

g/l

0.38

745

Carcinoma in situ of middle ear and respiratory system

254

1.03

0.00

2.5

2.26

2.22

g/l

0.17

236

Hyperfunction of pituitary gland, other and/or unspecified

101

0.99

0.00

1.4

1.9

2.17

2.35

g/l

—

Other cestode infections, including avohilmo

193

0.98

0.00

2.2

2.1

2.49

2.25

g/l

0.91

174

Frontotemporal dementia, wide, incl. Pick's disease

405

0.99

0.00

1.7

2.5

2.26

g/l

0.02

377

Erythema annulare centrifugum

105

0.94

0.00

3.9

2.5

2.40

2.39

g/l

—

Other and unspecified neuropathies

238

1.01

0.00

2.0

2.6

2.21

2.29

g/l

0.21

214

Intentional self-harm by drowning and submersion

106

1.04

0.00

1.6

2.3

2.47

2.33

g/l

0.35

Crushing injury of lower leg

124

0.96

0.00

1.7

2.1

2.51

2.34

g/l

0.76

112

Benign neoplasm: Male genital organ, other/unspecified

0.88

0.00

2.6

1.9

2.32

2.14

g/l

—

Acne tropica

0.00

0.0

1.0

—

2.60

—

Use of metixene

0.00

-0.00

0.0

2.0

—

2.28

—

Omphalitis of newborn with or without mild haemorrhage

0.00

-0.00

0.0

2.3

—

2.59

—

Use of bromocriptine

0.88

-0.00

4.9

2.3

2.42

2.37

g/l

—

Carcinoma in situ of trachea

0.00

-0.00

0.0

2.0

—

2.46

—

≡ Risteys

R14

FinnGen R13 + FinRegistry

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Transferrin [Mass/volume] in Serum or Plasma

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS